sampleID	_EVENT	_INTEGRATION	OS.time	OS	OS.unit	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_PANCAN	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_OV	_PANCAN_mutation_PANCAN	_PATIENT	RFS.time	RFS	RFS.unit	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	clinical_stage	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	eastern_cancer_oncology_group	followup_case_report_form_submission_reason	followup_treatment_success	form_completion_date	gender	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_pathologic_diagnosis_method	initial_weight	intermediate_dimension	is_ffpe	karnofsky_performance_score	longest_dimension	lost_follow_up	lymphatic_invasion	neoplasm_histologic_grade	new_neoplasm_event_type	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	oct_embedded	other_dx	pathology_report_file_name	patient_id	performance_status_scale_timing	person_neoplasm_cancer_status	postoperative_rx_tx	primary_therapy_outcome_success	progression_determined_by	radiation_therapy	residual_tumor	sample_type	sample_type_id	shortest_dimension	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_residual_disease	tumor_tissue_site	venous_invasion	vial_number	vital_status	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_OV_PDMRNAseq	_GENOMIC_ID_data/public/TCGA/OV/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_OV_mutation_bcm_solid_gene	_GENOMIC_ID_TCGA_OV_exp_u133a	_GENOMIC_ID_TCGA_OV_hMethyl450	_GENOMIC_ID_TCGA_OV_miRNA_HiSeq	_GENOMIC_ID_TCGA_OV_mutation_curated_bcm_solid_gene	_GENOMIC_ID_TCGA_OV_hMethyl27	_GENOMIC_ID_TCGA_OV_mutation_wustl_hiseq_gene	_GENOMIC_ID_TCGA_OV_RPPA_RBN	_GENOMIC_ID_TCGA_OV_mutation_wustl_gene	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_OV_gistic2thd	_GENOMIC_ID_TCGA_OV_PDMarray	_GENOMIC_ID_TCGA_OV_RPPA	_GENOMIC_ID_TCGA_OV_exp_HiSeq	_GENOMIC_ID_TCGA_OV_gistic2	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_OV_exp_HiSeq_exon	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2	_GENOMIC_ID_TCGA_OV_mutation_broad_gene	_GENOMIC_ID_TCGA_OV_PDMarrayCNV	_GENOMIC_ID_TCGA_OV_PDMRNAseqCNV	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_OV_mutation	_GENOMIC_ID_TCGA_OV_G4502A_07_3	_GENOMIC_ID_TCGA_OV_G4502A_07_2
TCGA-01-0628-11		TCGA-01-0628-11			days									TCGA-01-0628			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0628-11A																						0.4	NO		0.4																		Solid Tissue Normal	11	0.4							A						78fc9d0c-7cb2-475b-bd98-e36f04d16358				TCGA-01-0628-11A-01D-0383-05																		TCGA-01-0628-11A-01R-0363-07	
TCGA-01-0629-11		TCGA-01-0629-11			days									TCGA-01-0629			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary																																																																					TCGA-01-0629-11A-01D-0383-05																		TCGA-01-0629-11A-01R-0363-07	
TCGA-01-0630-11		TCGA-01-0630-11			days									TCGA-01-0630			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0630-11A																						0.4	NO		1																		Solid Tissue Normal	11	0.4							A						a87c0a4d-bb41-412c-abd4-7fa010fb18d8				TCGA-01-0630-11A-01D-0383-05																			TCGA-01-0630-11A-01R-0363-07
TCGA-01-0631-11		TCGA-01-0631-11			days									TCGA-01-0631			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0631-11A																						0.8	NO		1																		Solid Tissue Normal	11	0.8							A						0c490ce9-9178-4dfe-8384-208d3d2d46c5				TCGA-01-0631-11A-01D-0383-05																			TCGA-01-0631-11A-01R-0363-07
TCGA-01-0633-11		TCGA-01-0633-11			days									TCGA-01-0633			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0633-11A																						0.4	NO		0.8																		Solid Tissue Normal	11	0.3							A						eb14ef88-0adc-424d-b0a7-dd449f0907c6				TCGA-01-0633-11A-01D-0383-05																			TCGA-01-0633-11A-01R-0363-07
TCGA-01-0636-11		TCGA-01-0636-11			days									TCGA-01-0636			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0636-11A																						0.8	NO		1.1																		Solid Tissue Normal	11	0.8							A						f17680d1-12eb-45ad-83bc-ba3d14485d10				TCGA-01-0636-11A-01D-0383-05																			TCGA-01-0636-11A-01R-0363-07
TCGA-01-0637-11		TCGA-01-0637-11			days									TCGA-01-0637			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0637-11A																						0.7	NO		0.7																		Solid Tissue Normal	11	0.3							A						c22da589-1714-4d0c-aa00-e16b466e8a64				TCGA-01-0637-11A-01D-0383-05																			TCGA-01-0637-11A-01R-0363-07
TCGA-01-0638-11		TCGA-01-0638-11			days									TCGA-01-0638			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary																																																																					TCGA-01-0638-11A-02D-0383-05																			TCGA-01-0638-11A-02R-0363-07
TCGA-01-0639-11		TCGA-01-0639-11			days									TCGA-01-0639			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0639-11A																						0.8	NO		0.9																		Solid Tissue Normal	11	0.5							A						c417e63f-8714-4777-af37-5b39e34492c9				TCGA-01-0639-11A-01D-0383-05																		TCGA-01-0639-11A-01R-0363-07	
TCGA-01-0642-11		TCGA-01-0642-11			days									TCGA-01-0642			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-01-0642-11A																						0.8	NO		0.8																		Solid Tissue Normal	11	0.4							A						4a42ad28-e3d0-4ec8-9c54-40179a2e2953				TCGA-01-0642-11A-02D-0383-05																		TCGA-01-0642-11A-02R-0363-07	
TCGA-04-1331-01	1	TCGA-04-1331-01	1336	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1331			days	1336	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	78	Bilateral	TCGA-04-1331-F23906	TCGA-04-1331	TCGA-04-1331-01A	Stage IIIC	-28848		1336	0	1224		459				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.5		YES	G3	Recurrence					TCGA-04-1331.2CF541C5-B56A-4946-A5C4-DBB4D71D7908.pdf	1331		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary	NO	A	DECEASED	2004		TCGA-04-1331-01		96db4ec8-524f-4a9a-a23c-30fade0992b7		TCGA-04-1331-01		TCGA-04-1331-01A-01D-0432-05					TCGA-04-1331-01A-01D-0428-01	TCGA-04-1331-01			TCGA-04-1331-01A-01D-0428-01				TCGA-04-1331-01A-01W-0486-08	TCGA-04-1331-01			TCGA-04-1331-01A-01W-0486-08	TCGA-04-1331-01A-01R-0436-07	
TCGA-04-1332-01	1	TCGA-04-1332-01	1247	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1332			days	1247	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Bilateral	TCGA-04-1332-F23911	TCGA-04-1332		Stage IIIC	-25786		1247	0	1247		393	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G3	Recurrence						1332	Preoperative	WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01				04	1-10 mm	Ovary			DECEASED	2002				e984c174-f724-49b0-84bf-788ff370d89f				TCGA-04-1332-01A-01D-0432-05	TCGA-04-1332-01A-01W-0488-09		TCGA-04-1332-01A-01W-0488-09		TCGA-04-1332-01A-01D-0428-01	TCGA-04-1332-01			TCGA-04-1332-01A-01D-0428-01					TCGA-04-1332-01			TCGA-04-1332-01A-01W-0488-09	TCGA-04-1332-01A-01R-0436-07	
TCGA-04-1335-01	1	TCGA-04-1335-01	55	1	days	Squamous		OV-like c1	OV-like c4					TCGA-04-1335			days	55	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Bilateral	TCGA-04-1335-F23924	TCGA-04-1335	TCGA-04-1335-01A	Stage IB	-21963		55	0							2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5		NO	G2						TCGA-04-1335.A3CEAB60-287E-41D1-A0BD-12B6626BA574.pdf	1335	Preoperative	WITH TUMOR	NO			NO		Primary Tumor	01	0.4			04		Ovary	NO	A	DECEASED	2005				51038814-3401-4377-a815-92b9ce678f3d				TCGA-04-1335-01A-01D-0432-05		TCGA-04-1335-01A-21-20			TCGA-04-1335-01A-01D-0428-01	TCGA-04-1335-01	b1473202-11db-484b-8896-56abe5a3296e		TCGA-04-1335-01A-01D-0428-01					TCGA-04-1335-01				TCGA-04-1335-01A-01R-0436-07	
TCGA-04-1336-01	0	TCGA-04-1336-01	1495	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1336			days	1495	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Bilateral	TCGA-04-1336-F23926	TCGA-04-1336	TCGA-04-1336-01A	Stage IIIB	-20271			0	1495						2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1		NO	G3						TCGA-04-1336.D66DA590-83E1-4607-8806-6402DF3F3385.pdf	1336		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	LIVING	2005		TCGA-04-1336-01		e53eba00-2869-4168-98aa-a6c491b69fc6		TCGA-04-1336-01		TCGA-04-1336-01A-01D-0432-05	TCGA-04-1336-01A-01W-0488-09	TCGA-04-1336-01A-21-20	TCGA-04-1336-01A-01W-0488-09		TCGA-04-1336-01A-01D-0428-01	TCGA-04-1336-01	7892f3fd-fdb3-43a0-8fd9-390927061f7a		TCGA-04-1336-01A-01D-0428-01					TCGA-04-1336-01			TCGA-04-1336-01A-01W-0488-09	TCGA-04-1336-01A-01R-0436-07	
TCGA-04-1337-01	1	TCGA-04-1337-01	61	1	days	BRCA-LUAD+		UCEC Serous c4			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1337			days	61	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Bilateral	TCGA-04-1337-F23931	TCGA-04-1337	TCGA-04-1337-01A	Stage IIIC	-28626		61	0				1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2		NO	G2						TCGA-04-1337.BA3A3AFD-9687-4FD3-B43A-2A5E623E3B31.pdf	1337	Preoperative	WITH TUMOR	NO			NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	DECEASED	2005		TCGA-04-1337-01	TCGA-04-1337-01A-01W-0484-10	543cc1e4-76ee-4e0a-80fa-7ad8477d8d40		TCGA-04-1337-01	TCGA-04-1337-01A-01W-0484-10	TCGA-04-1337-01A-01D-0432-05					TCGA-04-1337-01A-01D-0428-01	TCGA-04-1337-01			TCGA-04-1337-01A-01D-0428-01					TCGA-04-1337-01			TCGA-04-1337-01A-01W-0484-10	TCGA-04-1337-01A-01R-0436-07	
TCGA-04-1338-01	0	TCGA-04-1338-01	1418	0	days	High	C9-OV	OV-like c1	OV-like c4				mutation cluster 5	TCGA-04-1338			days	1418	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	78	Bilateral	TCGA-04-1338-F23933	TCGA-04-1338	TCGA-04-1338-01A	Stage IIIC	-28789			0	1418		380	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence					TCGA-04-1338.889AF2DB-7FF9-45B1-8FD4-28D57CF870A7.pdf	1338	Preoperative	WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary		A	LIVING	2005			TCGA-04-1338-01A-01W-0484-10	17aa44c9-3071-4184-9692-4c04fabb5a4b			TCGA-04-1338-01A-01W-0484-10	TCGA-04-1338-01A-01D-0432-05		TCGA-04-1338-01A-21-20			TCGA-04-1338-01A-01D-0428-01	TCGA-04-1338-01	ee14145d-2ec8-4323-804e-c0a15371559b		TCGA-04-1338-01A-01D-0428-01					TCGA-04-1338-01			TCGA-04-1338-01A-01W-0484-10	TCGA-04-1338-01A-01R-0436-07	
TCGA-04-1341-01	0	TCGA-04-1341-01	33	0	days	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-04-1341			days	33	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			85		TCGA-04-1341-F23940	TCGA-04-1341	TCGA-04-1341-01A		-31215			0	33				Scheduled Follow-up Submission		2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES			1	NO		1.5			G3						TCGA-04-1341.9DB095E5-19F0-4ECE-9E54-2F030190FDB5.pdf	1341		WITH TUMOR		Complete Remission/Response		NO		Primary Tumor	01	0.4	NO	YES	04		Ovary		A	LIVING	2006		TCGA-04-1341-01		a9e75af6-31c2-4d32-8c4e-ee9538e77b0e		TCGA-04-1341-01		TCGA-04-1341-01A-01D-0432-05		TCGA-04-1341-01A-21-20			TCGA-04-1341-01A-01D-0428-01	TCGA-04-1341-01	9e5cf025-e667-4a73-94a3-e45255194ec3		TCGA-04-1341-01A-01D-0428-01					TCGA-04-1341-01				TCGA-04-1341-01A-01R-0436-07	
TCGA-04-1342-01	1	TCGA-04-1342-01	563	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1342			days	563	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			80	Bilateral	TCGA-04-1342-F23942	TCGA-04-1342	TCGA-04-1342-01A	Stage IV	-29501		563	0				2			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		2			G2						TCGA-04-1342.B296EAFA-9EE4-4611-888A-FA0B58EC2A88.pdf	1342	Preoperative	WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.2			04	>20 mm	Ovary		A	DECEASED	2006		TCGA-04-1342-01		3cfa7f01-3d75-4c1a-8e7f-ac849f5fde70		TCGA-04-1342-01		TCGA-04-1342-01A-01D-0432-05		TCGA-04-1342-01A-21-20			TCGA-04-1342-01A-01D-0428-01	TCGA-04-1342-01	e79f6986-9f15-4826-901b-1a97c2b8ae42		TCGA-04-1342-01A-01D-0428-01				TCGA-04-1342-01A-01W-0486-08	TCGA-04-1342-01			TCGA-04-1342-01A-01W-0486-08	TCGA-04-1342-01A-01R-0436-07	
TCGA-04-1343-01	1	TCGA-04-1343-01	361	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1343			days	361	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			72	Bilateral	TCGA-04-1343-F23949	TCGA-04-1343	TCGA-04-1343-01A	Stage IV	-26428		361	0				3			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3						TCGA-04-1343.E62828D9-A46C-498F-9976-CC430D16057E.pdf	1343	Preoperative	WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.4			04	>20 mm	Ovary		A	DECEASED	2002		TCGA-04-1343-01		ecfe5ba4-b146-4757-894e-ee6e44f4ba5c		TCGA-04-1343-01		TCGA-04-1343-01A-01D-0432-05	TCGA-04-1343-01A-01W-0488-09	TCGA-04-1343-01A-21-20	TCGA-04-1343-01A-01W-0488-09		TCGA-04-1343-01A-01D-0428-01	TCGA-04-1343-01	58f649ec-b1cd-4775-8c03-4ebdfe0ad072		TCGA-04-1343-01A-01D-0428-01					TCGA-04-1343-01			TCGA-04-1343-01A-01W-0488-09	TCGA-04-1343-01A-01R-0436-07	
TCGA-04-1346-01	0	TCGA-04-1346-01	1993	0	days	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1346			days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Bilateral	TCGA-04-1346-F23959	TCGA-04-1346	TCGA-04-1346-01A	Stage IIIC	-26865			0	1993						2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO	100	2		YES	G2						TCGA-04-1346.40C05C93-8968-4FF0-855F-09E2F7FAAB68.pdf	1346		TUMOR FREE	NO	Complete Remission/Response		NO		Primary Tumor	01	0.3			04		Ovary		A	LIVING	2003		TCGA-04-1346-01		3b372510-9632-40d8-a82b-d58e0a0c0ba6		TCGA-04-1346-01		TCGA-04-1346-01A-01D-0432-05	TCGA-04-1346-01A-01W-0488-09		TCGA-04-1346-01A-01W-0488-09		TCGA-04-1346-01A-01D-0428-01	TCGA-04-1346-01			TCGA-04-1346-01A-01D-0428-01					TCGA-04-1346-01			TCGA-04-1346-01A-01W-0488-09	TCGA-04-1346-01A-01R-0436-07	
TCGA-04-1347-01	0	TCGA-04-1347-01	1919	0	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1347			days	1919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			81	Bilateral	TCGA-04-1347-F23961	TCGA-04-1347	TCGA-04-1347-01A	Stage IV	-29695			0	1919			0			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	100	1.1		NO	G3						TCGA-04-1347.18BFB10C-5EDC-4253-A2A8-93533CB4B471.pdf	1347	Preoperative	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.1			04	No Macroscopic disease	Ovary	NO	A	LIVING	2004		TCGA-04-1347-01		886f150b-23d2-4000-b550-e0fda444ca61		TCGA-04-1347-01		TCGA-04-1347-01A-01D-0432-05	TCGA-04-1347-01A-01W-0488-09		TCGA-04-1347-01A-01W-0488-09		TCGA-04-1347-01A-01D-0428-01	TCGA-04-1347-01			TCGA-04-1347-01A-01D-0428-01					TCGA-04-1347-01			TCGA-04-1347-01A-01W-0488-09	TCGA-04-1347-01A-01R-0436-07	
TCGA-04-1348-01	1	TCGA-04-1348-01	1483	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1348			days	1483	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-04-1348-F23967	TCGA-04-1348	TCGA-04-1348-01A	Stage IIIB	-16236		1483	0			575				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3	Recurrence					TCGA-04-1348.51B558EF-C11B-41A7-A7BF-15D201506006.pdf	1348		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary		A	DECEASED	2004	TCGA-04-1348-01	TCGA-04-1348-01		6b5e9411-a6df-45a9-8281-75228283c4f4		TCGA-04-1348-01		TCGA-04-1348-01A-01D-0460-05	TCGA-04-1348-01A-01W-0494-09	TCGA-04-1348-01A-21-20	TCGA-04-1348-01A-01W-0494-09	1465139e-d1b2-4026-a532-08513fe0ad4d	TCGA-04-1348-01A-01D-0452-01	TCGA-04-1348-01	21a891e7-6da2-4d9e-a1e3-e760605d9dee		TCGA-04-1348-01A-01D-0452-01	1465139e-d1b2-4026-a532-08513fe0ad4d		1465139e-d1b2-4026-a532-08513fe0ad4d		TCGA-04-1348-01	TCGA-04-1348-01	1465139e-d1b2-4026-a532-08513fe0ad4d	TCGA-04-1348-01A-01W-0494-09	TCGA-04-1348-01A-01R-0456-07	
TCGA-04-1349-01	1	TCGA-04-1349-01	656	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1349			days	656	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Bilateral	TCGA-04-1349-F23977	TCGA-04-1349	TCGA-04-1349-01A	Stage IV	-25213		656	0			428				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1		YES	G3	Recurrence					TCGA-04-1349.8D470D24-17DD-4180-987E-F33FA31535AE.pdf	1349		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.2			04		Ovary		A	DECEASED	2004		TCGA-04-1349-01		83332db9-57b5-40ce-ad30-cf81d48a7cd6		TCGA-04-1349-01		TCGA-04-1349-01A-01D-0460-05	TCGA-04-1349-01A-01W-0494-09	TCGA-04-1349-01A-21-20	TCGA-04-1349-01A-01W-0494-09		TCGA-04-1349-01A-01D-0452-01	TCGA-04-1349-01	2a143727-7310-4103-beec-3522534165fe		TCGA-04-1349-01A-01D-0452-01					TCGA-04-1349-01			TCGA-04-1349-01A-01W-0494-09	TCGA-04-1349-01A-01R-0456-07	
TCGA-04-1350-01	1	TCGA-04-1350-01	1946	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1350			days	1946	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	46	Bilateral	TCGA-04-1350-F23988	TCGA-04-1350	TCGA-04-1350-01A	Stage IIIC	-16942		1946	0			111	0			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence					TCGA-04-1350.C4BB615C-ABBA-4136-AAB4-52EA1FE88D14.pdf	1350	Preoperative	WITH TUMOR	NO	Stable Disease	Imaging Study	NO		Primary Tumor	01	0.4			04	>20 mm	Ovary		A	DECEASED	2003		TCGA-04-1350-01	TCGA-04-1350-01A-01W-0490-10	339c6cc0-96b2-4225-b3bc-6cac497c7b92		TCGA-04-1350-01	TCGA-04-1350-01A-01W-0490-10	TCGA-04-1350-01A-01D-0460-05					TCGA-04-1350-01A-01D-0452-01	TCGA-04-1350-01			TCGA-04-1350-01A-01D-0452-01					TCGA-04-1350-01			TCGA-04-1350-01A-01W-0490-10	TCGA-04-1350-01A-01R-0456-07	
TCGA-04-1351-01	0	TCGA-04-1351-01	1991	0	days	High		OV-like c1						TCGA-04-1351			days	1991	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76		TCGA-04-1351-F24001	TCGA-04-1351		Stage IIIC	-28045			0	1991		1658				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy				100				G2	Recurrence						1351		TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				04		Ovary			LIVING	2004			TCGA-04-1351-01A-01W-0490-10	a8c3bbb4-24aa-4975-916a-50c6ba1f7eac			TCGA-04-1351-01A-01W-0490-10	TCGA-04-1351-01A-01D-0460-05					TCGA-04-1351-01A-01D-0452-01	TCGA-04-1351-01			TCGA-04-1351-01A-01D-0452-01					TCGA-04-1351-01				TCGA-04-1351-01A-01R-0456-07	
TCGA-04-1353-01	0	TCGA-04-1353-01	16	0	days	High		OV-like c1						TCGA-04-1353			days	16	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64		TCGA-04-1353-F65201	TCGA-04-1353		Stage IIIC	-23611			0	16				Scheduled Follow-up Submission		2014-9-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES							NO							No		1353								Primary Tumor	01		NO	YES	04		Ovary			LIVING	2003				b4d1d595-41fa-4b9d-9f01-e820fdace4f6				TCGA-04-1353-01A-01D-1047-05			TCGA-04-1353-01A-01D-1526-09		TCGA-04-1353-01A-01D-1043-01	TCGA-04-1353-01			TCGA-04-1353-01A-01D-1043-01					TCGA-04-1353-01				TCGA-04-1353-01A-01R-1050-07	
TCGA-04-1353-11	0	TCGA-04-1353-11	16	0	days									TCGA-04-1353			days	16	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64		TCGA-04-1353-F65201	TCGA-04-1353	TCGA-04-1353-11B	Stage IIIC	-23611			0	16				Scheduled Follow-up Submission		2014-9-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES			0.4	NO		1.5	NO							No		1353								Solid Tissue Normal	11	0.2	NO	YES	04		Ovary		B	LIVING	2003								TCGA-04-1353-11B-01D-1047-05																			
TCGA-04-1356-01	1	TCGA-04-1356-01	1499	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1356			days	1499	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Bilateral	TCGA-04-1356-F24005	TCGA-04-1356	TCGA-04-1356-01A	Stage IIC	-22855		1499	0			156				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	80	1.2		YES	G3	Recurrence					TCGA-04-1356.7D26B212-1DE7-43CC-A0DC-A9071C3A534F.pdf	1356	Preoperative	WITH TUMOR	NO	Progressive Disease	Physical Examination	NO		Primary Tumor	01	0.4			04		Ovary	YES	A	DECEASED	2004		TCGA-04-1356-01		9e919b59-a80e-4165-ba65-02ae5c35e910		TCGA-04-1356-01		TCGA-04-1356-01A-01D-0460-05		TCGA-04-1356-01A-21-20			TCGA-04-1356-01A-01D-0452-01	TCGA-04-1356-01	6b9482bd-967a-447e-8f6f-324c7ec41b4d		TCGA-04-1356-01A-01D-0452-01				TCGA-04-1356-01A-01W-0492-08	TCGA-04-1356-01			TCGA-04-1356-01A-01W-0492-08	TCGA-04-1356-01A-01R-0456-07	
TCGA-04-1357-01		TCGA-04-1357-01			days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1357			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52		TCGA-04-1357-F24009	TCGA-04-1357		Stage IIIB	-18999			0							2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES									G3							1357			YES			NO		Primary Tumor	01				04		Ovary			LIVING	2005	TCGA-04-1357-01	TCGA-04-1357-01		ab3d12c9-29b5-41b0-98dd-56670fe303d9		TCGA-04-1357-01		TCGA-04-1357-01A-01D-0460-05		TCGA-04-1357-01A-21-20		ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	TCGA-04-1357-01A-01D-0452-01	TCGA-04-1357-01	fcbf9267-5e2a-4a94-8851-9f7151aee4a0		TCGA-04-1357-01A-01D-0452-01	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862		ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	TCGA-04-1357-01A-01W-0492-08	TCGA-04-1357-01	TCGA-04-1357-01	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	TCGA-04-1357-01A-01W-0492-08	TCGA-04-1357-01A-01R-0456-07	
TCGA-04-1360-01		TCGA-04-1360-01			days	High		OV-like c1	OV-like c4					TCGA-04-1360			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			65		TCGA-04-1360-F24011	TCGA-04-1360	TCGA-04-1360-01A	Stage IA	-23993			0							2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES			0.8	NO		1			G3						TCGA-04-1360.D215D37F-D04B-44BC-AF17-D3B8C804A3E9.pdf	1360			YES			NO		Primary Tumor	01	0.4			04		Ovary		A	LIVING	2005				09afddf6-c527-4561-b476-cbc9bcc7ca24				TCGA-04-1360-01A-01D-0460-05		TCGA-04-1360-01A-21-20			TCGA-04-1360-01A-01D-0452-01	TCGA-04-1360-01	e470041a-5d0c-4818-8246-bd4530cc81e0		TCGA-04-1360-01A-01D-0452-01					TCGA-04-1360-01				TCGA-04-1360-01A-01R-0456-07	
TCGA-04-1361-01	0	TCGA-04-1361-01	989	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1361			days	989	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-04-1361-F24013	TCGA-04-1361	TCGA-04-1361-01A	Stage IIIB	-20860			0	989		927	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8			G3	Recurrence					TCGA-04-1361.5116FD62-7A2C-425A-A99E-D47C1B456961.pdf	1361			YES	Stable Disease	Imaging Study	NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	LIVING	2005		TCGA-04-1361-01		874772d1-76e5-4480-9fb5-0130d66f1b3a		TCGA-04-1361-01		TCGA-04-1361-01A-01D-0460-05	TCGA-04-1361-01A-01W-0494-09	TCGA-04-1361-01A-21-20	TCGA-04-1361-01A-01W-0494-09		TCGA-04-1361-01A-01D-0452-01	TCGA-04-1361-01	62d06e8a-aed1-4904-8651-c9912e5b1eae		TCGA-04-1361-01A-01D-0452-01					TCGA-04-1361-01			TCGA-04-1361-01A-01W-0494-09	TCGA-04-1361-01A-01R-0456-07	
TCGA-04-1362-01	1	TCGA-04-1362-01	1348	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1362			days	1348	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-04-1362-F24020	TCGA-04-1362	TCGA-04-1362-01A	Stage IIC	-21745		1348	0			223	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3	Recurrence					TCGA-04-1362.D3757F96-E669-4D0E-BBCB-41696AB72004.pdf	1362	Pre-Adjuvant Therapy	WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01	0.6			04	1-10 mm	Ovary		A	DECEASED	2002	TCGA-04-1362-01	TCGA-04-1362-01		9dcb2e40-d569-439e-8359-4178124447b5		TCGA-04-1362-01		TCGA-04-1362-01A-01D-0460-05	TCGA-04-1362-01A-01W-0494-09	TCGA-04-1362-01A-21-20	TCGA-04-1362-01A-01W-0494-09	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	TCGA-04-1362-01A-01D-0452-01	TCGA-04-1362-01	e6a03e2b-8fcf-4ad5-9b40-be38c0b08786		TCGA-04-1362-01A-01D-0452-01	802ea3c6-e07f-49a1-a1c2-8f90e3197e62		802ea3c6-e07f-49a1-a1c2-8f90e3197e62		TCGA-04-1362-01	TCGA-04-1362-01	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	TCGA-04-1362-01A-01W-0494-09	TCGA-04-1362-01A-01R-0456-07	
TCGA-04-1364-01	1	TCGA-04-1364-01	1024	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1364			days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-04-1364-F24028	TCGA-04-1364	TCGA-04-1364-01A	Stage IIIC	-22294		1024	0			288	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2		NO	G3	Recurrence					TCGA-04-1364.CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4.pdf	1364	Preoperative	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	2003	TCGA-04-1364-01	TCGA-04-1364-01	TCGA-04-1364-01A-01W-0490-10	0e23070a-25c9-49b4-8c4a-a9994de3a312		TCGA-04-1364-01	TCGA-04-1364-01A-01W-0490-10	TCGA-04-1364-01A-01D-0460-05				2fadaf5a-402b-483d-bc26-08feb3dc162d	TCGA-04-1364-01A-01D-0452-01	TCGA-04-1364-01			TCGA-04-1364-01A-01D-0452-01	2fadaf5a-402b-483d-bc26-08feb3dc162d		2fadaf5a-402b-483d-bc26-08feb3dc162d		TCGA-04-1364-01	TCGA-04-1364-01	2fadaf5a-402b-483d-bc26-08feb3dc162d	TCGA-04-1364-01A-01W-0490-10	TCGA-04-1364-01A-01R-0456-07	
TCGA-04-1365-01	0	TCGA-04-1365-01	2329	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1365			days	2329	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	87	Left	TCGA-04-1365-F24044	TCGA-04-1365	TCGA-04-1365-01A	Stage IIIB	-31925			0	2329		1328	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.2		NO	G3	Recurrence					TCGA-04-1365.049FC54E-4D17-4B68-9E41-268529C9F18F.pdf	1365	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.6			04		Ovary		A	LIVING	2003	TCGA-04-1365-01	TCGA-04-1365-01	TCGA-04-1365-01A-01W-0490-10	a64bec02-eddf-4723-90a8-6742267b4f51		TCGA-04-1365-01	TCGA-04-1365-01A-01W-0490-10	TCGA-04-1365-01A-01D-0460-05				2535da6b-39f0-41de-afd3-82cb37916b95	TCGA-04-1365-01A-01D-0452-01	TCGA-04-1365-01			TCGA-04-1365-01A-01D-0452-01	2535da6b-39f0-41de-afd3-82cb37916b95		2535da6b-39f0-41de-afd3-82cb37916b95		TCGA-04-1365-01	TCGA-04-1365-01	2535da6b-39f0-41de-afd3-82cb37916b95	TCGA-04-1365-01A-01W-0490-10	TCGA-04-1365-01A-01R-0456-07	
TCGA-04-1367-01	0	TCGA-04-1367-01	3145	0	days	High		OV-like c1			miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-04-1367	3145	0	days	3145	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-04-1367-F62486	TCGA-04-1367	TCGA-04-1367-01A	Stage IIIC	-18577			0	3145		2997	0	Scheduled Follow-up Submission	Progressive Disease	2014-7-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO	100	0.7	NO	NO	G3	Progression of Disease		NO			TCGA-04-1367.78E00062-0996-45A9-80FC-125409EE370A.pdf	1367	Preoperative	WITH TUMOR	NO	Progressive Disease	Molecular Markers	NO		Primary Tumor	01	0.5	NO	YES	04	No Macroscopic disease	Ovary	NO	A	LIVING	2003		TCGA-04-1367-01		69b2dded-5eff-448b-8220-8163c264e63b		TCGA-04-1367-01		TCGA-04-1367-01A-01D-0460-05					TCGA-04-1367-01A-01D-0452-01	TCGA-04-1367-01			TCGA-04-1367-01A-01D-0452-01				TCGA-04-1367-01A-01W-0492-08	TCGA-04-1367-01			TCGA-04-1367-01A-01W-0492-08	TCGA-04-1367-01A-01R-0456-07	
TCGA-04-1369-01	1	TCGA-04-1369-01	642	1	days			OV-like c1	OV-like c4					TCGA-04-1369			days	642	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-04-1369-F24056	TCGA-04-1369	TCGA-04-1369-01A	Stage IIIC	-19571		642	0			315	0			2010-8-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1			G2	Progression of Disease					TCGA-04-1369.5C54C779-C561-4625-B8F0-029BE2D3C91B.pdf	1369	Pre-Adjuvant Therapy	WITH TUMOR	YES		Imaging Study	NO	R1	Primary Tumor	01	0.2			04	1-10 mm	Ovary		A	DECEASED	2004				940c48c2-f75f-498a-9c40-a33d65dfbce1				TCGA-04-1369-01A-02D-1047-05		TCGA-04-1369-01A-11-1562-20	TCGA-04-1369-01A-02D-1526-09			TCGA-04-1369-01	40f6f0ca-e0e0-4c0b-96b1-3d305aa93f95											TCGA-04-1369-01A-02R-1050-07	
TCGA-04-1369-11	1	TCGA-04-1369-11	642	1	days									TCGA-04-1369			days	642	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-04-1369-F24056	TCGA-04-1369	TCGA-04-1369-11A	Stage IIIC	-19571		642	0			315	0			2010-8-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5			G2	Progression of Disease						1369	Pre-Adjuvant Therapy	WITH TUMOR	YES		Imaging Study	NO	R1	Solid Tissue Normal	11	0.3			04	1-10 mm	Ovary		A	DECEASED	2004								TCGA-04-1369-11A-01D-1047-05																			
TCGA-04-1370-01	0	TCGA-04-1370-01	1824	0	days				OV-like c4					TCGA-04-1370			days	1824	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Bilateral	TCGA-04-1370-F24062	TCGA-04-1370	TCGA-04-1370-01A	Stage IIIC	-19329			0	1824			1			2010-8-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		2			G3						TCGA-04-1370.6E990DE9-ED0A-4152-A862-866FBF8A41DE.pdf	1370	Pre-Adjuvant Therapy		YES			NO	R1	Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	LIVING	2004										TCGA-04-1370-01A-21-1562-20					4234f147-09cf-480f-bfca-5ae6c5d338f9												
TCGA-04-1371-01	0	TCGA-04-1371-01	2506	0	days	High		OV-like c1						TCGA-04-1371			days	2506	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-04-1371-F24066	TCGA-04-1371		Stage IIIC	-21243			0	2506			0			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3							1371	Pre-Adjuvant Therapy	TUMOR FREE	YES			NO		Primary Tumor	01				04	1-10 mm	Ovary			LIVING	2001				bf67f8d7-e33c-4b18-9801-4b78ce0b41bb				TCGA-04-1371-01A-01D-0460-05					TCGA-04-1371-01A-01D-0452-01	TCGA-04-1371-01			TCGA-04-1371-01A-01D-0452-01					TCGA-04-1371-01				TCGA-04-1371-01A-01R-0456-07	
TCGA-04-1514-01	1	TCGA-04-1514-01	1720	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1514			days	1720	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Bilateral	TCGA-04-1514-F24071	TCGA-04-1514	TCGA-04-1514-01A	Stage IIIA	-16725		1720	0			1221	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1		NO	G2	Recurrence					TCGA-04-1514.A0487B93-029F-48EB-AF5C-06A2F5A3FAAA.pdf	1514	Preoperative	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			04	No Macroscopic disease	Ovary		A	DECEASED	2004	TCGA-04-1514-01	TCGA-04-1514-01	TCGA-04-1514-01A-01W-0552-10	c7e3fccc-4e03-4914-874c-e5034bcc6941		TCGA-04-1514-01	TCGA-04-1514-01A-01W-0552-10	TCGA-04-1514-01A-01D-0501-05		TCGA-04-1514-01A-21-1558-20		cc5e2498-a9e6-48be-bbda-9aa101546ca4	TCGA-04-1514-01A-01D-0497-01	TCGA-04-1514-01	8fcd1179-3170-4ca1-b961-dbaa7a391ea4		TCGA-04-1514-01A-01D-0497-01	cc5e2498-a9e6-48be-bbda-9aa101546ca4		cc5e2498-a9e6-48be-bbda-9aa101546ca4		TCGA-04-1514-01	TCGA-04-1514-01	cc5e2498-a9e6-48be-bbda-9aa101546ca4	TCGA-04-1514-01A-01W-0552-10	TCGA-04-1514-01A-01R-0504-07	
TCGA-04-1516-01	0	TCGA-04-1516-01	1265	0	days	High		OV-like c1	OV-like c4					TCGA-04-1516			days	1265	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Left	TCGA-04-1516-F24087	TCGA-04-1516	TCGA-04-1516-01A	Stage IA	-17768			0	1265			0			2010-6-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G3						TCGA-04-1516.434BDC72-1BE6-4235-AFBA-10ADE94C8901.pdf	1516	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO	R0	Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	LIVING	2006				0c2520a9-0937-40b7-a09f-9f21a4726876				TCGA-04-1516-01A-01D-1047-05		TCGA-04-1516-01A-21-1558-20	TCGA-04-1516-01A-01D-1526-09		TCGA-04-1516-01A-01D-1043-01	TCGA-04-1516-01	556a186c-d6ab-4f84-9cac-2b237c3bb4fc		TCGA-04-1516-01A-01D-1043-01					TCGA-04-1516-01				TCGA-04-1516-01A-01R-1050-07	
TCGA-04-1516-11	0	TCGA-04-1516-11	1265	0	days									TCGA-04-1516			days	1265	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Left	TCGA-04-1516-F24087	TCGA-04-1516	TCGA-04-1516-11B	Stage IA	-17768			0	1265			0			2010-6-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G3							1516	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO	R0	Solid Tissue Normal	11	0.5			04	No Macroscopic disease	Ovary		B	LIVING	2006								TCGA-04-1516-11B-01D-1047-05																			
TCGA-04-1517-01	1	TCGA-04-1517-01	608	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-04-1517			days	608	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	79	Bilateral	TCGA-04-1517-F24092	TCGA-04-1517	TCGA-04-1517-01A	Stage IIIC	-29045		608	0			349				2009-6-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5		NO	G3	Recurrence					TCGA-04-1517.ED992763-74E1-466F-A71A-AC0455AD40F6.pdf	1517		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			04	>20 mm	Ovary	NO	A	DECEASED	2006		TCGA-04-1517-01	TCGA-04-1517-01A-01W-0615-10	663aa6bd-30d1-47fb-8aec-2baece0cbb87		TCGA-04-1517-01	TCGA-04-1517-01A-01W-0615-10	TCGA-04-1517-01A-01D-0536-05		TCGA-04-1517-01A-21-1558-20			TCGA-04-1517-01A-01D-0533-01	TCGA-04-1517-01	9e4ae9f4-e1ef-40a6-af24-7ea99c9beccd		TCGA-04-1517-01A-01D-0533-01					TCGA-04-1517-01			TCGA-04-1517-01A-01W-0615-10	TCGA-04-1517-01A-01R-0540-07	
TCGA-04-1519-01	0	TCGA-04-1519-01	24	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-04-1519			days	24	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48		TCGA-04-1519-F58470	TCGA-04-1519	TCGA-04-1519-01A	Stage IIIC	-17671			0	24				Scheduled Follow-up Submission		2014-4-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES			0.4	NO		1.3	YES		G3						TCGA-04-1519.53840C6E-E1AA-415E-BB85-8E1B8976F45C.pdf	1519								Primary Tumor	01	0.4			04		Ovary		A	LIVING	2007	TCGA-04-1519-01	TCGA-04-1519-01	TCGA-04-1519-01A-01W-0615-10	87caa261-28f0-4d9d-bec5-3842c715d23a		TCGA-04-1519-01	TCGA-04-1519-01A-01W-0615-10	TCGA-04-1519-01A-01D-0536-05		TCGA-04-1519-01A-21-1558-20		193d3e7f-ec7f-453a-9c2a-77b240c4ba19	TCGA-04-1519-01A-01D-0533-01	TCGA-04-1519-01	0ed2d853-f94d-49d0-856b-85d54e4817f5		TCGA-04-1519-01A-01D-0533-01	193d3e7f-ec7f-453a-9c2a-77b240c4ba19		193d3e7f-ec7f-453a-9c2a-77b240c4ba19		TCGA-04-1519-01	TCGA-04-1519-01	193d3e7f-ec7f-453a-9c2a-77b240c4ba19		TCGA-04-1519-01A-01R-0540-07	
TCGA-04-1525-01	1	TCGA-04-1525-01	1167	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-04-1525			days	1167	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-04-1525-F24099	TCGA-04-1525	TCGA-04-1525-01A	Stage IIIC	-17469		1167	0	1167		213				2009-6-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		2		NO	G3	Recurrence					TCGA-04-1525.B84E0C8B-B383-453F-9099-92B5445691D6.pdf	1525		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.2			04	1-10 mm	Ovary	NO	A	DECEASED	2005		TCGA-04-1525-01	TCGA-04-1525-01A-01W-0615-10	9fffbdac-8e68-4ea7-ba2f-b2f6156e9f15		TCGA-04-1525-01	TCGA-04-1525-01A-01W-0615-10	TCGA-04-1525-01A-01D-0536-05		TCGA-04-1525-01A-21-1558-20			TCGA-04-1525-01A-01D-0533-01	TCGA-04-1525-01	1ea5f6bb-950e-4383-b76b-f3918c0a0366		TCGA-04-1525-01A-01D-0533-01					TCGA-04-1525-01			TCGA-04-1525-01A-01W-0615-10	TCGA-04-1525-01A-01R-0540-07	
TCGA-04-1530-01	1	TCGA-04-1530-01	3622	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1530			days	3622	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-04-1530-F24104	TCGA-04-1530	TCGA-04-1530-01A	Stage IIIC	-25013		3622	0			350				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.4		NO	G3	Recurrence					TCGA-04-1530.6CB3AECE-ADBB-4AED-A036-2E2D28D68369.pdf	1530		WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary	NO	A	DECEASED	1995		TCGA-04-1530-01	TCGA-04-1530-01A-02W-0552-10	4271a8fa-e416-4274-8a37-49673f212605		TCGA-04-1530-01	TCGA-04-1530-01A-02W-0552-10	TCGA-04-1530-01A-02D-0501-05					TCGA-04-1530-01A-02D-0497-01	TCGA-04-1530-01			TCGA-04-1530-01A-02D-0497-01					TCGA-04-1530-01			TCGA-04-1530-01A-02W-0552-10	TCGA-04-1530-01A-02R-0504-07	
TCGA-04-1536-01	1	TCGA-04-1536-01	885	1	days	High		OV-like c1			miRNA cluster 1	cluster 4		TCGA-04-1536			days	885	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-04-1536-F24110	TCGA-04-1536		Stage IV	-21939		885	0			498	0			2009-6-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3	Recurrence						1536		WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01				04	1-10 mm	Ovary			DECEASED	2001		TCGA-04-1536-01		f2c0342a-1302-47ff-8615-8d3eb700e3a5		TCGA-04-1536-01		TCGA-04-1536-01A-01D-0536-05					TCGA-04-1536-01A-01D-0533-01	TCGA-04-1536-01			TCGA-04-1536-01A-01D-0533-01					TCGA-04-1536-01				TCGA-04-1536-01A-01R-0540-07	
TCGA-04-1542-01	1	TCGA-04-1542-01	2561	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1542			days	2561	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Bilateral	TCGA-04-1542-F24118	TCGA-04-1542	TCGA-04-1542-01A	Stage IIIB	-19263		2561	0			1020	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G2	Recurrence					TCGA-04-1542.E3103C8A-50CB-43FE-9670-2BFB5D1DC318.pdf	1542	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	2001		TCGA-04-1542-01		7a29ab3a-5d05-47e9-bd87-2cf0285fc8a6		TCGA-04-1542-01		TCGA-04-1542-01A-01D-0501-05	TCGA-04-1542-01A-01W-0553-09	TCGA-04-1542-01A-21-1558-20	TCGA-04-1542-01A-01W-0553-09		TCGA-04-1542-01A-01D-0497-01	TCGA-04-1542-01	abafb551-fa90-465c-8122-6a8c2793c2d8		TCGA-04-1542-01A-01D-0497-01					TCGA-04-1542-01			TCGA-04-1542-01A-01W-0553-09	TCGA-04-1542-01A-01R-0504-07	
TCGA-04-1638-01	1	TCGA-04-1638-01	1686	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-04-1638			days	1686	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	57		TCGA-04-1638-F24136	TCGA-04-1638	TCGA-04-1638-01A	Stage IV	-20987		1686	0			298	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6			G3	Recurrence					TCGA-04-1638.5CA47F76-8E99-4594-B84C-FAC31BB42269.pdf	1638	Pre-Adjuvant Therapy	TUMOR FREE	YES		Other Method	NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	DECEASED	2002		TCGA-04-1638-01		11e368d8-9506-45d7-90e6-3ddf23c9e903		TCGA-04-1638-01		TCGA-04-1638-01A-01D-0581-05		TCGA-04-1638-01A-21-1558-20	TCGA-04-1638-01A-01W-0639-09		TCGA-04-1638-01A-01D-0577-01	TCGA-04-1638-01	66049405-6d0c-4409-a9be-166eda4f96b6		TCGA-04-1638-01A-01D-0577-01					TCGA-04-1638-01				TCGA-04-1638-01A-01R-0584-07	
TCGA-04-1644-01	1	TCGA-04-1644-01	1487	1	days	Squamous		OV-like c1	OV-like c4					TCGA-04-1644			days	1487	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-04-1644-F24145	TCGA-04-1644	TCGA-04-1644-01A	Stage IIIC	-17725		1487	0			634	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Progression of Disease					TCGA-04-1644.7AA7FF0A-C1C4-42A1-A340-A1E03CED8DEB.pdf	1644	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.4			04	>20 mm	Ovary		A	DECEASED	2002				5c14dcb5-1dd3-4eaa-a71a-e7b62d4698ee				TCGA-04-1644-01B-01D-1047-05		TCGA-04-1644-01A-11-1562-20	TCGA-04-1644-01B-01D-1526-09		TCGA-04-1644-01B-01D-1043-01	TCGA-04-1644-01	3fa1c199-830d-486c-859f-2179bb86e5bf		TCGA-04-1644-01B-01D-1043-01					TCGA-04-1644-01				TCGA-04-1644-01B-01R-1050-07	
TCGA-04-1644-11	1	TCGA-04-1644-11	1487	1	days									TCGA-04-1644			days	1487	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-04-1644-F24145	TCGA-04-1644	TCGA-04-1644-11A	Stage IIIC	-17725		1487	0			634	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.1			G3	Progression of Disease						1644	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Solid Tissue Normal	11	0.4			04	>20 mm	Ovary		A	DECEASED	2002								TCGA-04-1644-11A-01D-1047-05																			
TCGA-04-1646-01	1	TCGA-04-1646-01	848	1	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-04-1646			days	848	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-04-1646-F24152	TCGA-04-1646		Stage IIIC	-22207		848	0			508	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1646	Pre-Adjuvant Therapy	WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01				04	1-10 mm	Ovary			DECEASED	2003		TCGA-04-1646-01		d6a1fffb-cecf-4137-865c-95d7d95fae2d		TCGA-04-1646-01		TCGA-04-1646-01A-01D-0581-05		TCGA-04-1646-01A-21-1558-20	TCGA-04-1646-01A-01W-0639-09		TCGA-04-1646-01A-01D-0577-01	TCGA-04-1646-01	c278e930-af50-4be7-a706-48a80e58b24f		TCGA-04-1646-01A-01D-0577-01					TCGA-04-1646-01				TCGA-04-1646-01A-01R-0584-07	
TCGA-04-1648-01	1	TCGA-04-1648-01	871	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-04-1648			days	871	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57		TCGA-04-1648-F24159	TCGA-04-1648		Stage IIIC	-21113		871	0			412	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G2	Recurrence						1648	Pre-Adjuvant Therapy		YES		Molecular Markers	NO		Primary Tumor	01				04	1-10 mm	Ovary			DECEASED	2003		TCGA-04-1648-01		b145279e-8242-4087-9584-0519d4639d31		TCGA-04-1648-01		TCGA-04-1648-01A-01D-0581-05		TCGA-04-1648-01A-21-1558-20	TCGA-04-1648-01A-01W-0639-09		TCGA-04-1648-01A-01D-0577-01	TCGA-04-1648-01	f904c338-e425-42f1-a15e-b5eb2dcfe829		TCGA-04-1648-01A-01D-0577-01					TCGA-04-1648-01				TCGA-04-1648-01A-01R-0584-07	
TCGA-04-1649-01	0	TCGA-04-1649-01	1966	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-04-1649			days	1966	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-04-1649-F24168	TCGA-04-1649	TCGA-04-1649-01A	Stage IIIC	-27165			0	1966		1672	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.7			G3	Recurrence					TCGA-04-1649.C0A1166D-7233-4843-A007-DDF16A45A5E8.pdf	1649	Preoperative		NO		Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	LIVING	2003		TCGA-04-1649-01		3ae3b762-3f04-450d-86db-44daec23ca9f		TCGA-04-1649-01		TCGA-04-1649-01A-01D-0581-05		TCGA-04-1649-01A-21-1558-20	TCGA-04-1649-01A-01W-0639-09		TCGA-04-1649-01A-01D-0577-01	TCGA-04-1649-01	fd9ff078-e2fe-4ab6-9e62-445caba9e611		TCGA-04-1649-01A-01D-0577-01					TCGA-04-1649-01				TCGA-04-1649-01A-01R-0584-07	
TCGA-04-1651-01	1	TCGA-04-1651-01	1102	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 5		TCGA-04-1651			days	1102	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-04-1651-F24172	TCGA-04-1651	TCGA-04-1651-01A	Stage IIIC	-19628		1102	0			990	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.4	NO		1.5			G3	Recurrence					TCGA-04-1651.703BEFE1-07E0-48AE-826E-133A59F97068.pdf	1651	Pre-Adjuvant Therapy		YES		Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	2004		TCGA-04-1651-01		797b7d36-42e2-4f9d-9f8f-7d3fb52219ff		TCGA-04-1651-01		TCGA-04-1651-01A-01D-0581-05		TCGA-04-1651-01A-21-1558-20	TCGA-04-1651-01A-01W-0639-09		TCGA-04-1651-01A-01D-0577-01	TCGA-04-1651-01	5c0f2819-0ecd-43de-aa9b-6073e34779e5		TCGA-04-1651-01A-01D-0577-01					TCGA-04-1651-01				TCGA-04-1651-01A-01R-0584-07	
TCGA-04-1652-01	1	TCGA-04-1652-01	969	1	days	High		OV-like c1			miRNA cluster 1	cluster 2		TCGA-04-1652			days	969	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Right	TCGA-04-1652-F24179	TCGA-04-1652		Stage IIIC	-28101		969	0			880				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G2	Recurrence						1652		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01				04		Ovary	NO		DECEASED	2004		TCGA-04-1652-01		dd1addbf-ba25-418f-98d9-efe155026fdd		TCGA-04-1652-01		TCGA-04-1652-01A-01D-0581-05			TCGA-04-1652-01A-01W-0639-09		TCGA-04-1652-01A-01D-0577-01	TCGA-04-1652-01			TCGA-04-1652-01A-01D-0577-01					TCGA-04-1652-01				TCGA-04-1652-01A-01R-0584-07	
TCGA-04-1654-01	1	TCGA-04-1654-01	1451	1	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-04-1654			days	1451	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Bilateral	TCGA-04-1654-F24185	TCGA-04-1654	TCGA-04-1654-01A	Stage IIIC	-25387		1451	0			808	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.2			G2	Recurrence					TCGA-04-1654.E6F4CDD1-DD1B-4C69-8A9F-0DCA88F8C539.pdf	1654	Pre-Adjuvant Therapy		YES		Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	1999		TCGA-04-1654-01		bf9a9a62-9471-41f7-b10f-35a1316f63c3		TCGA-04-1654-01		TCGA-04-1654-01A-02D-0652-05		TCGA-04-1654-01A-11-1562-20			TCGA-04-1654-01A-02D-0648-01	TCGA-04-1654-01	2b44138a-955e-46f3-bf8e-c8ace62e6389		TCGA-04-1654-01A-02D-0648-01					TCGA-04-1654-01				TCGA-04-1654-01A-02R-0655-07	
TCGA-04-1655-01	1	TCGA-04-1655-01	1380	1	days	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-04-1655			days	1380	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-04-1655-F24191	TCGA-04-1655	TCGA-04-1655-01A	Stage IIIB	-17988		1380	0			819	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		1.1			G2	Recurrence					TCGA-04-1655.D808763E-D67C-460C-B5D6-85CC5C1C05BC.pdf	1655	Pre-Adjuvant Therapy		YES		Physical Examination	NO		Primary Tumor	01	0.4			04	No Macroscopic disease	Ovary		A	DECEASED	1999		TCGA-04-1655-01		461a33bb-1055-403e-b7e0-7f16d1c10f7b		TCGA-04-1655-01		TCGA-04-1655-01A-01D-0563-05			TCGA-04-1655-01A-01W-0633-09		TCGA-04-1655-01A-01D-0559-01	TCGA-04-1655-01			TCGA-04-1655-01A-01D-0559-01					TCGA-04-1655-01				TCGA-04-1655-01A-01R-0566-07	
TCGA-09-0364-01	1	TCGA-09-0364-01	887	1	days	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-0364			days	887	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	80	Right	TCGA-09-0364-F24198	TCGA-09-0364	TCGA-09-0364-01A	Stage IIC	-29262		887	0			395				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection			NO				NO	G3	Recurrence					TCGA-09-0364.27b9efd3-7748-4deb-96a2-3869a19bfa6f.pdf	0364		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				09	11-20 mm	Ovary	NO	A	DECEASED	1998	TCGA-09-0364-01	TCGA-09-0364-01	TCGA-09-0364-01A-02W-0370-10	0ba4e8de-0013-421a-8605-efb4f3ebfc0a		TCGA-09-0364-01	TCGA-09-0364-01A-02W-0370-10	TCGA-09-0364-01A-02D-0359-05				2d0702a8-bf85-458e-879c-ebc03a2aa3d1	TCGA-09-0364-01A-02D-0356-01	TCGA-09-0364-01			TCGA-09-0364-01A-02D-0356-01	2d0702a8-bf85-458e-879c-ebc03a2aa3d1		2d0702a8-bf85-458e-879c-ebc03a2aa3d1		TCGA-09-0364-01	TCGA-09-0364-01	2d0702a8-bf85-458e-879c-ebc03a2aa3d1			TCGA-09-0364-01A-02R-0363-07
TCGA-09-0365-01	1	TCGA-09-0365-01	288	1	days	GBM		OV-like c1						TCGA-09-0365			days	288	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Left	TCGA-09-0365-F24203	TCGA-09-0365	TCGA-09-0365-01A	Stage IIIC	-25703		288	0			251				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)			NO				NO	G3	Recurrence					TCGA-09-0365.459f8df7-b386-47c6-bf17-73af831441d4.pdf	0365		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				09	No Macroscopic disease	Ovary	NO	A	DECEASED	1999				16f6b497-da7d-4156-9b83-dda375a1c04f				TCGA-09-0365-01A-02D-0359-05					TCGA-09-0365-01A-02D-0356-01	TCGA-09-0365-01			TCGA-09-0365-01A-02D-0356-01					TCGA-09-0365-01					TCGA-09-0365-01A-02R-0363-07
TCGA-09-0366-01	1	TCGA-09-0366-01	1757	1	days	BRCA-LUAD+	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-09-0366			days	1757	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-09-0366-F24207	TCGA-09-0366		Stage IIIC	-20440		1757	0			190				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Tumor resection							NO	G3	Recurrence						0366		WITH TUMOR	YES	Stable Disease	Imaging Study	NO		Primary Tumor	01				09	1-10 mm	Ovary	NO		DECEASED	1999	TCGA-09-0366-01	TCGA-09-0366-01		e091ea57-ec3e-4357-8929-b4e149dfa3f5		TCGA-09-0366-01		TCGA-09-0366-01A-01D-0359-05	TCGA-09-0366-01A-01W-0372-09		TCGA-09-0366-01A-01W-0372-09	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	TCGA-09-0366-01A-01D-0356-01	TCGA-09-0366-01			TCGA-09-0366-01A-01D-0356-01	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7		cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7		TCGA-09-0366-01	TCGA-09-0366-01	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	TCGA-09-0366-01A-01W-0372-09		TCGA-09-0366-01A-01R-0363-07
TCGA-09-0367-01	1	TCGA-09-0367-01	547	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-0367			days	547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			67	Bilateral	TCGA-09-0367-F24212	TCGA-09-0367	TCGA-09-0367-01A	Stage IIIC	-24473		547	0							2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection			NO				YES	G3						TCGA-09-0367.8a24fe8a-9f7f-4fbf-86c7-704427ccaf89.pdf	0367		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01				09	1-10 mm	Ovary	YES	A	DECEASED	2001	TCGA-09-0367-01	TCGA-09-0367-01		129c93c0-eb2f-47c5-acdc-4fd083e9dc8a		TCGA-09-0367-01		TCGA-09-0367-01A-01D-0359-05				047e04aa-6a91-4535-b279-50430098e638	TCGA-09-0367-01A-01D-0356-01	TCGA-09-0367-01			TCGA-09-0367-01A-01D-0356-01	047e04aa-6a91-4535-b279-50430098e638		047e04aa-6a91-4535-b279-50430098e638		TCGA-09-0367-01	TCGA-09-0367-01	047e04aa-6a91-4535-b279-50430098e638			TCGA-09-0367-01A-01R-0363-07
TCGA-09-0369-01	1	TCGA-09-0369-01	1082	1	days	High	C9-OV	OV-like c1		OV-like c16			mutation cluster 5	TCGA-09-0369			days	1082	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Left	TCGA-09-0369-F24217	TCGA-09-0369	TCGA-09-0369-01A	Stage IIIC	-20705		1082	0			274				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection			NO				YES	G3	Recurrence					TCGA-09-0369.c052e190-b5c2-44bf-b5b0-2b37cde18cee.pdf	0369		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				09	No Macroscopic disease	Ovary	YES	A	DECEASED	2003	TCGA-09-0369-01			11197914-6f55-4542-9138-ad6b451c3350				TCGA-09-0369-01A-01D-0359-05	TCGA-09-0369-01A-01W-0372-09		TCGA-09-0369-01A-01W-0372-09	1f972766-2f58-4d41-b84c-3493ef2dd0c4	TCGA-09-0369-01A-01D-0356-01	TCGA-09-0369-01			TCGA-09-0369-01A-01D-0356-01	1f972766-2f58-4d41-b84c-3493ef2dd0c4		1f972766-2f58-4d41-b84c-3493ef2dd0c4		TCGA-09-0369-01	TCGA-09-0369-01	1f972766-2f58-4d41-b84c-3493ef2dd0c4	TCGA-09-0369-01A-01W-0372-09		TCGA-09-0369-01A-01R-0363-07
TCGA-09-1659-01	1	TCGA-09-1659-01	304	1	days	High		OV-like c1					mutation cluster 5	TCGA-09-1659			days	304	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-09-1659-F24226	TCGA-09-1659	TCGA-09-1659-01B	Stage IIIC	-18733		304	0							2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3						TCGA-09-1659.f10b2e12-02b2-42e0-a5b2-a02c1daabbdf.pdf	1659		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.4			09	>20 mm	Ovary	NO	B	DECEASED	1997	TCGA-09-1659-01		TCGA-09-1659-01B-01W-0615-10	5203ba2e-518a-4492-8f15-25182bff1dec			TCGA-09-1659-01B-01W-0615-10	TCGA-09-1659-01B-01D-0536-05				32d5209e-2ef2-4ef0-b902-585542d7d16b	TCGA-09-1659-01B-01D-0533-01	TCGA-09-1659-01			TCGA-09-1659-01B-01D-0533-01	32d5209e-2ef2-4ef0-b902-585542d7d16b		32d5209e-2ef2-4ef0-b902-585542d7d16b		TCGA-09-1659-01	TCGA-09-1659-01	32d5209e-2ef2-4ef0-b902-585542d7d16b	TCGA-09-1659-01B-01W-0615-10	TCGA-09-1659-01B-01R-0540-07	
TCGA-09-1661-01	1	TCGA-09-1661-01	1169	1	days	High		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-09-1661			days	1169	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			75	Right	TCGA-09-1661-F24233	TCGA-09-1661	TCGA-09-1661-01B	Stage IIIC	-27486		1169	0							2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		NO	G3						TCGA-09-1661.1910251f-8c5c-4067-91dc-87bfdaf77283.pdf	1661		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.1			09	1-10 mm	Ovary	NO	B	DECEASED	2000		TCGA-09-1661-01	TCGA-09-1661-01B-01W-0615-10	956ee2ec-8a47-417a-a82b-dc4c91f9cf46		TCGA-09-1661-01	TCGA-09-1661-01B-01W-0615-10	TCGA-09-1661-01B-01D-0536-05					TCGA-09-1661-01B-01D-0533-01	TCGA-09-1661-01			TCGA-09-1661-01B-01D-0533-01					TCGA-09-1661-01			TCGA-09-1661-01B-01W-0615-10	TCGA-09-1661-01B-01R-0540-07	
TCGA-09-1662-01	1	TCGA-09-1662-01	2717	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-09-1662			days	2717	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Left	TCGA-09-1662-F24243	TCGA-09-1662	TCGA-09-1662-01A	Stage IV	-21246		2717	0			1046				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G3	Recurrence					TCGA-09-1662.8e2676a4-2ac3-42af-be7d-cf74b6d82f2f.pdf	1662		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			09	1-10 mm	Ovary	YES	A	DECEASED	2001	TCGA-09-1662-01	TCGA-09-1662-01	TCGA-09-1662-01A-01W-0615-10	0fc0fc51-c5b7-428e-92c6-d55c8514b689		TCGA-09-1662-01	TCGA-09-1662-01A-01W-0615-10	TCGA-09-1662-01A-01D-0536-05		TCGA-09-1662-01A-21-1558-20		759060d9-af2e-4098-b4ee-7aa2214acba8	TCGA-09-1662-01A-01D-0533-01	TCGA-09-1662-01	253b785e-f10b-4d0e-88cb-4db4a3610c7c		TCGA-09-1662-01A-01D-0533-01	759060d9-af2e-4098-b4ee-7aa2214acba8		759060d9-af2e-4098-b4ee-7aa2214acba8		TCGA-09-1662-01	TCGA-09-1662-01	759060d9-af2e-4098-b4ee-7aa2214acba8	TCGA-09-1662-01A-01W-0615-10	TCGA-09-1662-01A-01R-0540-07	
TCGA-09-1664-01	1	TCGA-09-1664-01	2279	1	days	Squamous		OV-like c1	OV-like c4					TCGA-09-1664			days	2279	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			37	Bilateral	TCGA-09-1664-F24268	TCGA-09-1664		Stage IIIC	-13739		2279	0							2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G1							1664			YES	Complete Remission/Response		NO		Primary Tumor	01				09	1-10 mm	Ovary	NO		DECEASED	2002				ab246047-1519-4cd8-b1c5-abb4ef58697a				TCGA-09-1664-01A-01D-0581-05		TCGA-09-1664-01A-21-1558-20	TCGA-09-1664-01A-01W-0639-09		TCGA-09-1664-01A-01D-0577-01	TCGA-09-1664-01	e2007adb-55b1-4b8b-99c0-4e6a61a2da29		TCGA-09-1664-01A-01D-0577-01					TCGA-09-1664-01				TCGA-09-1664-01A-01R-0584-07	
TCGA-09-1665-01	1	TCGA-09-1665-01	1266	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-1665			days	1266	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	73	Left	TCGA-09-1665-F24272	TCGA-09-1665	TCGA-09-1665-01B	Stage IIIC	-27010		1266	0			468				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		YES	G2	Recurrence					TCGA-09-1665.0e311879-9b25-453d-b41a-7cc3048bb05e.pdf	1665		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			09	No Macroscopic disease	Ovary	YES	B	DECEASED	2002		TCGA-09-1665-01	TCGA-09-1665-01B-01W-0615-10	5b880786-e40d-41ff-9fee-f542f1b5a27c		TCGA-09-1665-01	TCGA-09-1665-01B-01W-0615-10	TCGA-09-1665-01B-01D-0536-05		TCGA-09-1665-01B-21-1558-20			TCGA-09-1665-01B-01D-0533-01	TCGA-09-1665-01	a565c52a-a226-47db-b68c-d579055e4c06		TCGA-09-1665-01B-01D-0533-01					TCGA-09-1665-01			TCGA-09-1665-01B-01W-0615-10	TCGA-09-1665-01B-01R-0540-07	
TCGA-09-1666-01	0	TCGA-09-1666-01	1752	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-1666			days	1752	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-09-1666-F24279	TCGA-09-1666	TCGA-09-1666-01A	Stage IIIC	-21066			0	1752		480				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		NO	G3	Recurrence					TCGA-09-1666.2de50dd9-b607-4a87-baae-468c4bf43205.pdf	1666		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			09	No Macroscopic disease	Ovary	NO	A	LIVING	2003	TCGA-09-1666-01	TCGA-09-1666-01	TCGA-09-1666-01A-01W-0615-10	fc1d50d5-b097-41f0-a9b2-0efd207d6ebd		TCGA-09-1666-01	TCGA-09-1666-01A-01W-0615-10	TCGA-09-1666-01A-01D-0536-05		TCGA-09-1666-01A-21-1558-20		529b7dd2-075c-4e93-b8c8-6990d3297c30	TCGA-09-1666-01A-01D-0533-01	TCGA-09-1666-01	aa4fad88-9a21-4085-9ac7-21b349113168		TCGA-09-1666-01A-01D-0533-01	529b7dd2-075c-4e93-b8c8-6990d3297c30		529b7dd2-075c-4e93-b8c8-6990d3297c30		TCGA-09-1666-01	TCGA-09-1666-01	529b7dd2-075c-4e93-b8c8-6990d3297c30	TCGA-09-1666-01A-01W-0615-10	TCGA-09-1666-01A-01R-0540-07	
TCGA-09-1667-01	0	TCGA-09-1667-01	1882	0	days	High		OV-like c1		OV-like c16	miRNA cluster 2	cluster 1		TCGA-09-1667			days	1882	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Bilateral	TCGA-09-1667-F24292	TCGA-09-1667	TCGA-09-1667-01C	Stage IIC	-22306			0	1882		460				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1		NO	G2	Recurrence					TCGA-09-1667.0f3fbc34-6dce-467f-a837-442815ebc159.pdf	1667		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	C	LIVING	2004	TCGA-09-1667-01	TCGA-09-1667-01		64fbf0df-6693-4ea5-a868-925636d9d20f		TCGA-09-1667-01		TCGA-09-1667-01C-01D-0536-05				9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	TCGA-09-1667-01C-01D-0533-01	TCGA-09-1667-01			TCGA-09-1667-01C-01D-0533-01	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e		9b7a1eb0-014f-4cd6-bde8-fd96131fac3e		TCGA-09-1667-01	TCGA-09-1667-01	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e		TCGA-09-1667-01C-01R-0540-07	
TCGA-09-1668-01	0	TCGA-09-1668-01	1684	0	days	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-1668			days	1684	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Right	TCGA-09-1668-F24300	TCGA-09-1668	TCGA-09-1668-01B	Stage IIIC	-20972			0	1684						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		0.7		NO	G3						TCGA-09-1668.7740b3ec-1d81-4408-be9e-45ccd7e91b3a.pdf	1668		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			09		Ovary	NO	B	LIVING	2004	TCGA-09-1668-01	TCGA-09-1668-01		fe849a8b-cfb0-44a3-a264-75ccef069be3		TCGA-09-1668-01		TCGA-09-1668-01B-01D-0536-05				66894abe-8af5-4fd9-9a59-cf24e57fc07f	TCGA-09-1668-01B-01D-0533-01	TCGA-09-1668-01			TCGA-09-1668-01B-01D-0533-01	66894abe-8af5-4fd9-9a59-cf24e57fc07f		66894abe-8af5-4fd9-9a59-cf24e57fc07f		TCGA-09-1668-01	TCGA-09-1668-01	66894abe-8af5-4fd9-9a59-cf24e57fc07f		TCGA-09-1668-01B-01R-0540-07	
TCGA-09-1669-01	0	TCGA-09-1669-01	928	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-1669			days	928	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			54	Right	TCGA-09-1669-F24305	TCGA-09-1669	TCGA-09-1669-01A	Stage IIIA	-20052			0	928						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.9		NO	G3						TCGA-09-1669.7870b5a7-a96c-4e55-b56f-8eca45918251.pdf	1669		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	NO	A	LIVING	2004	TCGA-09-1669-01	TCGA-09-1669-01	TCGA-09-1669-01A-01W-0615-10	01119e56-c4b0-4d4f-876c-fd34e4185af3		TCGA-09-1669-01	TCGA-09-1669-01A-01W-0615-10	TCGA-09-1669-01A-01D-0536-05				a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	TCGA-09-1669-01A-01D-0533-01	TCGA-09-1669-01			TCGA-09-1669-01A-01D-0533-01	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8		a56ccd4c-1959-44a9-968d-57e6c5bc0cf8		TCGA-09-1669-01	TCGA-09-1669-01	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	TCGA-09-1669-01A-01W-0615-10	TCGA-09-1669-01A-01R-0540-07	
TCGA-09-1670-01	0	TCGA-09-1670-01	547	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-09-1670			days	547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-09-1670-F24309	TCGA-09-1670	TCGA-09-1670-01A	Stage IIIA	-21147			0	547		547				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.6		NO	G3	Recurrence					TCGA-09-1670.5cc85cd9-99c4-4087-bdc5-8039b0369538.pdf	1670		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	A	LIVING	2005	TCGA-09-1670-01	TCGA-09-1670-01		99b305e7-c4d7-4174-955d-7618d91f84d0		TCGA-09-1670-01		TCGA-09-1670-01A-01D-0563-05		TCGA-09-1670-01A-21-1558-20	TCGA-09-1670-01A-01W-0633-09	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	TCGA-09-1670-01A-01D-0559-01	TCGA-09-1670-01	950ea36f-87d6-4730-b11d-e8eae3e0fe79		TCGA-09-1670-01A-01D-0559-01	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4		eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4		TCGA-09-1670-01	TCGA-09-1670-01	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4		TCGA-09-1670-01A-01R-0566-07	
TCGA-09-1672-01	0	TCGA-09-1672-01	178	0	days	BRCA-LUAD+		OV-like c1						TCGA-09-1672			days	178	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Right	TCGA-09-1672-F24314	TCGA-09-1672	TCGA-09-1672-01A	Stage IIIC	-28556			0	178						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G1						TCGA-09-1672.103ad514-77dc-42fd-8cf2-31e9de128a74.pdf	1672		TUMOR FREE	YES			NO		Primary Tumor	01	0.3			09		Ovary	YES	A	LIVING	2008				67029a85-41d6-41a6-844e-cecf63941f3e				TCGA-09-1672-01A-01D-0563-05			TCGA-09-1672-01A-01W-0633-09		TCGA-09-1672-01A-01D-0559-01	TCGA-09-1672-01			TCGA-09-1672-01A-01D-0559-01					TCGA-09-1672-01				TCGA-09-1672-01A-01R-0566-07	
TCGA-09-1673-01	0	TCGA-09-1673-01	92	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-09-1673			days	92	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Bilateral	TCGA-09-1673-F24318	TCGA-09-1673	TCGA-09-1673-01A	Stage IV	-18599			0	92						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		3		YES	G3						TCGA-09-1673.d4f7aa96-11e8-4d66-a1be-595ec22de450.pdf	1673		WITH TUMOR	YES			NO		Primary Tumor	01	0.6			09	>20 mm	Ovary	YES	A	LIVING	2008	TCGA-09-1673-01	TCGA-09-1673-01		f45664bd-409f-4819-bb3f-b16ce74e7d9c		TCGA-09-1673-01		TCGA-09-1673-01A-01D-0563-05		TCGA-09-1673-01A-21-1558-20	TCGA-09-1673-01A-01W-0633-09	37037dcf-fa69-4cd3-b83d-e474d69059b4	TCGA-09-1673-01A-01D-0559-01	TCGA-09-1673-01	ca0ee85f-6e38-447b-b232-49812c6e2a97		TCGA-09-1673-01A-01D-0559-01	37037dcf-fa69-4cd3-b83d-e474d69059b4		37037dcf-fa69-4cd3-b83d-e474d69059b4		TCGA-09-1673-01	TCGA-09-1673-01	37037dcf-fa69-4cd3-b83d-e474d69059b4		TCGA-09-1673-01A-01R-0566-07	
TCGA-09-1674-01	0	TCGA-09-1674-01	260	0	days	High	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 2	cluster 1		TCGA-09-1674			days	260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			79	Bilateral	TCGA-09-1674-F24322	TCGA-09-1674	TCGA-09-1674-01A	Stage IIIC	-28878			0	260						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		2.1		NO	G3						TCGA-09-1674.d8e0ddd2-304d-4f5e-9225-2cd88ae9984e.pdf	1674		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01	0.7			09	1-10 mm	Ovary	NO	A	LIVING	2008	TCGA-09-1674-01	TCGA-09-1674-01		995f3a5f-4e3d-4e69-a473-4b53da943923		TCGA-09-1674-01		TCGA-09-1674-01A-01D-0563-05		TCGA-09-1674-01A-21-1558-20	TCGA-09-1674-01A-01W-0633-09	3a81f083-56dc-48a5-be8d-b69a146db93b	TCGA-09-1674-01A-01D-0559-01	TCGA-09-1674-01	872b7aec-febf-4104-8269-bfb0c72fbeec		TCGA-09-1674-01A-01D-0559-01	3a81f083-56dc-48a5-be8d-b69a146db93b		3a81f083-56dc-48a5-be8d-b69a146db93b		TCGA-09-1674-01	TCGA-09-1674-01	3a81f083-56dc-48a5-be8d-b69a146db93b		TCGA-09-1674-01A-01R-0566-07	
TCGA-09-1675-01	0	TCGA-09-1675-01	2967	0	days	Squamous		OV-like c1						TCGA-09-1675			days	2967	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Left	TCGA-09-1675-F24326	TCGA-09-1675	TCGA-09-1675-01B	Stage IC	-18596			0	2967						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1.1		NO	G2						TCGA-09-1675.f981f103-fc2d-4f41-9f71-015f194391f5.pdf	1675		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.1			09	No Macroscopic disease	Ovary	NO	B	LIVING	2001				690beb52-7ca9-448a-a134-7317be4f8289				TCGA-09-1675-01B-01D-0563-05			TCGA-09-1675-01B-01W-0633-09		TCGA-09-1675-01B-01D-0559-01	TCGA-09-1675-01			TCGA-09-1675-01B-01D-0559-01					TCGA-09-1675-01				TCGA-09-1675-01B-01R-0566-07	
TCGA-09-2043-01	0	TCGA-09-2043-01	188	0	days	High		OV-like c1	OV-like c4					TCGA-09-2043			days	188	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			69	Left	TCGA-09-2043-F24332	TCGA-09-2043	TCGA-09-2043-01A	Stage IC	-25480			0	188						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		2		NO	G3						TCGA-09-2043.1fa4e0b8-344f-4ebb-b150-c3ace0ec4a00.pdf	2043		TUMOR FREE	NO	Complete Remission/Response		NO		Primary Tumor	01	0.1			09	No Macroscopic disease	Ovary	NO	A	LIVING	2009				dec0d15f-9489-4987-83ff-3613cf21c379				TCGA-09-2043-01A-01D-0708-05		TCGA-09-2043-01A-21-1560-20			TCGA-09-2043-01A-01D-0704-01	TCGA-09-2043-01	066f35fb-d0a8-4968-acf1-1da9ec81748e		TCGA-09-2043-01A-01D-0704-01					TCGA-09-2043-01				TCGA-09-2043-01A-01R-0711-07	
TCGA-09-2044-01	0	TCGA-09-2044-01	186	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-09-2044			days	186	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			77	Right	TCGA-09-2044-F24334	TCGA-09-2044	TCGA-09-2044-01B	Stage IIB	-28231			0	186						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.4	NO		1.8		NO	G3						TCGA-09-2044.42d7c4ad-b379-4dc0-ba67-16aa6ead89d9.pdf	2044		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	B	LIVING	2009	TCGA-09-2044-01	TCGA-09-2044-01		0b4c7448-2729-45db-b1b2-0fba79016c76		TCGA-09-2044-01		TCGA-09-2044-01B-01D-0708-05		TCGA-09-2044-01B-21-1560-20		658b4847-33bc-414c-a2bb-ce9379ef57bd	TCGA-09-2044-01B-01D-0704-01	TCGA-09-2044-01	32c1a264-b1dd-4307-ab4d-f710ea9692cc		TCGA-09-2044-01B-01D-0704-01	658b4847-33bc-414c-a2bb-ce9379ef57bd		658b4847-33bc-414c-a2bb-ce9379ef57bd	TCGA-09-2044-01B-01W-0799-08	TCGA-09-2044-01	TCGA-09-2044-01	658b4847-33bc-414c-a2bb-ce9379ef57bd	TCGA-09-2044-01B-01W-0799-08	TCGA-09-2044-01B-01R-0711-07	
TCGA-09-2045-01	1	TCGA-09-2045-01	1069	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 8	TCGA-09-2045			days	1069	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-09-2045-F24338	TCGA-09-2045	TCGA-09-2045-01A	Stage IV	-18285		1069	0			631				2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G2	Recurrence					TCGA-09-2045.6c826e9d-b1aa-4c84-b294-c8fb41818da1.pdf	2045		WITH TUMOR	YES	Stable Disease	Physical Examination	NO		Primary Tumor	01	0.4			09	1-10 mm	Ovary	YES	A	DECEASED	1996	TCGA-09-2045-01	TCGA-09-2045-01		4456d296-bac1-461d-bda9-d3c52aba590c		TCGA-09-2045-01		TCGA-09-2045-01A-01D-0708-05		TCGA-09-2045-01A-21-1560-20		7b412fd9-4414-440f-b768-70666037c768	TCGA-09-2045-01A-01D-0704-01	TCGA-09-2045-01	51c5bf06-26be-471c-927c-1cb07bf10a2b		TCGA-09-2045-01A-01D-0704-01	7b412fd9-4414-440f-b768-70666037c768		7b412fd9-4414-440f-b768-70666037c768	TCGA-09-2045-01A-01W-0799-08	TCGA-09-2045-01	TCGA-09-2045-01	7b412fd9-4414-440f-b768-70666037c768	TCGA-09-2045-01A-01W-0799-08	TCGA-09-2045-01A-01R-0711-07	
TCGA-09-2048-01	1	TCGA-09-2048-01	138	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-2048			days	138	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Bilateral	TCGA-09-2048-F24351	TCGA-09-2048	TCGA-09-2048-01A	Stage IIIC	-23043		138	0							2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1		YES	G3						TCGA-09-2048.0755D708-ADF5-4219-ABC6-BCD9C2BCA089.pdf	2048		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.2			09	1-10 mm	Ovary	YES	A	DECEASED	1999	TCGA-09-2048-01	TCGA-09-2048-01		8d5f3a67-69eb-49b0-a1bc-f626eb70c76f		TCGA-09-2048-01		TCGA-09-2048-01A-01D-0708-05				d3220bce-1bf3-47c4-951f-937dac7581be	TCGA-09-2048-01A-01D-0704-01	TCGA-09-2048-01			TCGA-09-2048-01A-01D-0704-01	d3220bce-1bf3-47c4-951f-937dac7581be		d3220bce-1bf3-47c4-951f-937dac7581be		TCGA-09-2048-01	TCGA-09-2048-01	d3220bce-1bf3-47c4-951f-937dac7581be		TCGA-09-2048-01A-01R-0711-07	
TCGA-09-2049-01	0	TCGA-09-2049-01	3419	0	days	High	C9-OV	OV-like c1	OV-like c4				mutation cluster 8	TCGA-09-2049			days	3419	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Left	TCGA-09-2049-F24354	TCGA-09-2049	TCGA-09-2049-01D	Stage IIIC	-23410			0	3419		953				2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1		NO	G3	Recurrence					TCGA-09-2049.17564604-ce57-4087-887a-f97a5b280b26.pdf	2049		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			09	>20 mm	Ovary	NO	D	LIVING	1999				870e7182-fd31-4863-b19b-001fb9a2a11d				TCGA-09-2049-01D-01D-0708-05		TCGA-09-2049-01D-21-1560-20			TCGA-09-2049-01D-01D-0704-01	TCGA-09-2049-01	ccaa932c-805b-4a2c-825f-d742a9fddb2c		TCGA-09-2049-01D-01D-0704-01				TCGA-09-2049-01D-01W-0799-08	TCGA-09-2049-01			TCGA-09-2049-01D-01W-0799-08	TCGA-09-2049-01D-01R-0711-07	
TCGA-09-2050-01	0	TCGA-09-2050-01	2163	0	days	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-2050			days	2163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			65	Bilateral	TCGA-09-2050-F24367	TCGA-09-2050	TCGA-09-2050-01A	Stage IIA	-23987			0	2163						2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6		NO	G2						TCGA-09-2050.fb343129-010d-430b-aae4-f7beb7122279.pdf	2050		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	NO	A	LIVING	2003		TCGA-09-2050-01		968defb5-7701-4ec8-9c4f-7b73a13b0411		TCGA-09-2050-01		TCGA-09-2050-01A-01D-0708-05					TCGA-09-2050-01A-01D-0704-01	TCGA-09-2050-01			TCGA-09-2050-01A-01D-0704-01				TCGA-09-2050-01A-01W-0799-08	TCGA-09-2050-01			TCGA-09-2050-01A-01W-0799-08	TCGA-09-2050-01A-01R-0711-07	
TCGA-09-2051-01	0	TCGA-09-2051-01	1919	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-2051			days	1919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Bilateral	TCGA-09-2051-F24373	TCGA-09-2051	TCGA-09-2051-01A	Stage IIIC	-15650			0	1919		583				2009-11-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3	Recurrence					TCGA-09-2051.242a1ff3-05ad-4623-b5aa-9bb556e2cfa9.pdf	2051		TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	YES	A	LIVING	2004	TCGA-09-2051-01	TCGA-09-2051-01		34b0a38d-33f0-436f-a30b-4c730a37e27c		TCGA-09-2051-01		TCGA-09-2051-01A-01D-0708-05		TCGA-09-2051-01A-21-1560-20		6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	TCGA-09-2051-01A-01D-0704-01	TCGA-09-2051-01	5bcc9755-b429-47c1-9a00-af84edd803aa		TCGA-09-2051-01A-01D-0704-01	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a		6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	TCGA-09-2051-01A-01W-0799-08	TCGA-09-2051-01	TCGA-09-2051-01	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	TCGA-09-2051-01A-01W-0799-08	TCGA-09-2051-01A-01R-0711-07	
TCGA-09-2053-01	0	TCGA-09-2053-01	1209	0	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-2053			days	1209	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			72	Left	TCGA-09-2053-F24384	TCGA-09-2053	TCGA-09-2053-01C	Stage IIIC	-26433			0	1209						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.7		NO	G3						TCGA-09-2053.0d28e549-3ed0-4a22-bac7-9cbe24e44f53.pdf	2053		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	NO	C	LIVING	2005		TCGA-09-2053-01		00fdb098-d819-43f1-995d-a43f2499afe7		TCGA-09-2053-01		TCGA-09-2053-01C-01D-0667-05					TCGA-09-2053-01C-01D-0663-01	TCGA-09-2053-01			TCGA-09-2053-01C-01D-0663-01				TCGA-09-2053-01C-01W-0722-08	TCGA-09-2053-01			TCGA-09-2053-01C-01W-0722-08	TCGA-09-2053-01C-01R-0670-07	
TCGA-09-2054-01	1	TCGA-09-2054-01	637	1	days	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 3		TCGA-09-2054			days	637	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-09-2054-F24388	TCGA-09-2054	TCGA-09-2054-01A	Stage IIIC	-21285		637	0	637						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		2		YES	G3						TCGA-09-2054.4f0eb2a1-996c-4816-a956-835ce5085438.pdf	2054		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.4			09	1-10 mm	Ovary	YES	A	DECEASED	2005	TCGA-09-2054-01	TCGA-09-2054-01		f6aa28c5-b1f6-4552-82a7-a6a170814534		TCGA-09-2054-01		TCGA-09-2054-01A-01D-0667-05		TCGA-09-2054-01A-21-1560-20		5cd7faa0-323a-4ea3-a658-859d0336e0ac	TCGA-09-2054-01A-01D-0663-01	TCGA-09-2054-01	3b31fec3-6dd6-4ef7-bcb4-8c67007f6937		TCGA-09-2054-01A-01D-0663-01	5cd7faa0-323a-4ea3-a658-859d0336e0ac		5cd7faa0-323a-4ea3-a658-859d0336e0ac		TCGA-09-2054-01	TCGA-09-2054-01	5cd7faa0-323a-4ea3-a658-859d0336e0ac		TCGA-09-2054-01A-01R-0670-07	
TCGA-09-2055-01	0	TCGA-09-2055-01	819	0	days	Squamous		OV-like c1	OV-like c4					TCGA-09-2055			days	819	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Left	TCGA-09-2055-F24395	TCGA-09-2055	TCGA-09-2055-01B	Stage IC	-17545			0	819						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.8		NO	G3						TCGA-09-2055.4cff882a-1ce5-4586-a808-a7f00e319743.pdf	2055		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			09	No Macroscopic disease	Ovary	NO	B	LIVING	2007				7c240854-d066-4ecd-905d-1f6dea67d509				TCGA-09-2055-01B-01D-0708-05		TCGA-09-2055-01A-11-1563-20			TCGA-09-2055-01B-01D-0704-01	TCGA-09-2055-01	b02ef957-7893-4222-983a-3784ee59dfdd		TCGA-09-2055-01B-01D-0704-01					TCGA-09-2055-01				TCGA-09-2055-01B-01R-0711-07	
TCGA-09-2056-01	0	TCGA-09-2056-01	379	0	days	BRCA-LUAD+	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation c1uster 9	TCGA-09-2056			days	379	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Bilateral	TCGA-09-2056-F24399	TCGA-09-2056	TCGA-09-2056-01B	Stage IIIC	-22864			0	379						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.6		NO	G3						TCGA-09-2056.67bdb457-cfb8-4052-bd33-bff86c736910.pdf	2056		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	B	LIVING	2008	TCGA-09-2056-01			6c194f10-5bf3-4331-b035-f50e93536dda				TCGA-09-2056-01B-01D-0667-05		TCGA-09-2056-01B-21-1560-20		67670628-ad07-41ef-8977-890080616900	TCGA-09-2056-01B-01D-0663-01	TCGA-09-2056-01	568718ea-3d9d-4d09-b155-0b8467a10bbe		TCGA-09-2056-01B-01D-0663-01	67670628-ad07-41ef-8977-890080616900		67670628-ad07-41ef-8977-890080616900	TCGA-09-2056-01B-01W-0722-08	TCGA-09-2056-01	TCGA-09-2056-01	67670628-ad07-41ef-8977-890080616900	TCGA-09-2056-01B-01W-0722-08	TCGA-09-2056-01B-01R-0670-07	
TCGA-10-0925-01	1	TCGA-10-0925-01	1652	1	days	BRCA-LUAD+		OV-like c1	OV-like c4					TCGA-10-0925			days	1652	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-10-0925-F24403	TCGA-10-0925	TCGA-10-0925-01B	Stage IIIB	-21498		1652	0	1652		558				2010-2-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO	80	0.7			G1	Recurrence					TCGA-10-0925.96f0f453-84f9-401a-9fd0-0a8712a87be5.pdf	0925	Preoperative	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			10	1-10 mm	Ovary		B	DECEASED	2000				54016305-6747-489d-b09b-8db5be8409dc				TCGA-10-0925-01B-01D-0652-05		TCGA-10-0925-01A-11-20			TCGA-10-0925-01B-01D-0648-01	TCGA-10-0925-01	ee2bb61b-4b7c-4cb4-b9e8-381285ad51f7		TCGA-10-0925-01B-01D-0648-01					TCGA-10-0925-01				TCGA-10-0925-01B-01R-0655-07	
TCGA-10-0926-01	1	TCGA-10-0926-01	788	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-10-0926			days	788	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-10-0926-F24413	TCGA-10-0926	TCGA-10-0926-01A	Stage IIIC	-23307		788	0	788		287				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1		NO	G3	Recurrence					TCGA-10-0926.b940b1b3-8278-400e-b43a-e7897e0361b7.pdf	0926	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	YES		Primary Tumor	01	0.6			10	11-20 mm	Ovary	NO	A	DECEASED	2000				892ce3d6-a97f-480f-85fb-5491e5ab9afa				TCGA-10-0926-01A-01D-0402-05		TCGA-10-0926-01A-21-20			TCGA-10-0926-01A-01D-0399-01	TCGA-10-0926-01	fb5e42c3-de28-4dc9-8e33-c56685b72e5e		TCGA-10-0926-01A-01D-0399-01				TCGA-10-0926-01A-01W-0420-08	TCGA-10-0926-01			TCGA-10-0926-01A-01W-0420-08	TCGA-10-0926-01A-01R-0406-07	
TCGA-10-0927-01	1	TCGA-10-0927-01	2490	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-10-0927			days	2490	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-10-0927-F24420	TCGA-10-0927		Stage IIIC	-23982		2490	0	2478		1001				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G2	Recurrence						0927		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				10	1-10 mm	Ovary			DECEASED	2000		TCGA-10-0927-01	TCGA-10-0927-01A-02W-0419-10	c4ec4774-a95e-4097-bd99-7b0862020450		TCGA-10-0927-01	TCGA-10-0927-01A-02W-0419-10	TCGA-10-0927-01A-02D-0402-05					TCGA-10-0927-01A-02D-0399-01	TCGA-10-0927-01			TCGA-10-0927-01A-02D-0399-01					TCGA-10-0927-01			TCGA-10-0927-01	TCGA-10-0927-01A-02R-0406-07	
TCGA-10-0928-01	1	TCGA-10-0928-01	563	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 2	TCGA-10-0928			days	563	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Bilateral	TCGA-10-0928-F24430	TCGA-10-0928	TCGA-10-0928-01A	Stage IIIC	-26066		563	0	563			0			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G3						TCGA-10-0928.859b2662-493a-4ead-9ac7-0aa8d0a7a3d8.pdf	0928		WITH TUMOR	YES			NO		Primary Tumor	01	0.4			10	1-10 mm	Ovary	NO	A	DECEASED	2000	TCGA-10-0928-01	TCGA-10-0928-01	TCGA-10-0928-01A-02W-0419-10	3534ce20-56e1-409a-a438-50513c622602		TCGA-10-0928-01	TCGA-10-0928-01A-02W-0419-10	TCGA-10-0928-01A-02D-0402-05				9aa3ae15-1033-46f1-a304-993f5d41cd50	TCGA-10-0928-01A-02D-0399-01	TCGA-10-0928-01			TCGA-10-0928-01A-02D-0399-01	9aa3ae15-1033-46f1-a304-993f5d41cd50		9aa3ae15-1033-46f1-a304-993f5d41cd50		TCGA-10-0928-01	TCGA-10-0928-01	9aa3ae15-1033-46f1-a304-993f5d41cd50	TCGA-10-0928-01A-02W-0419-10	TCGA-10-0928-01A-02R-0406-07	
TCGA-10-0930-01	1	TCGA-10-0930-01	1040	1	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-10-0930			days	1040	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Left	TCGA-10-0930-F24432	TCGA-10-0930	TCGA-10-0930-01A	Stage IIIC	-25737		1040	0	1011		680				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8			G3	Recurrence					TCGA-10-0930.89034658-e10d-47d3-9ad8-d79aa51cf234.pdf	0930		WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO		Primary Tumor	01	0.3			10	1-10 mm	Ovary		A	DECEASED	2002		TCGA-10-0930-01		36457b1f-1ee7-4bdc-82f4-75f3fccceb66		TCGA-10-0930-01		TCGA-10-0930-01A-02D-0402-05	TCGA-10-0930-01A-02W-0421-09		TCGA-10-0930-01A-02W-0421-09		TCGA-10-0930-01A-02D-0399-01	TCGA-10-0930-01			TCGA-10-0930-01A-02D-0399-01					TCGA-10-0930-01			TCGA-10-0930-01A-02W-0421-09	TCGA-10-0930-01A-02R-0406-07	
TCGA-10-0931-01	1	TCGA-10-0931-01	1000	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-10-0931			days	1000	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-10-0931-F24440	TCGA-10-0931	TCGA-10-0931-01A	Stage IIIC	-16262		1000	0	982		300	1			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5			G3	Recurrence					TCGA-10-0931.45d8f828-6dfb-4e68-8282-f2ee74671461.pdf	0931	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			10	1-10 mm	Ovary	NO	A	DECEASED	2002		TCGA-10-0931-01		3d021366-16ec-4c18-8ce6-17beebce1e9c		TCGA-10-0931-01		TCGA-10-0931-01A-01D-0402-05		TCGA-10-0931-01A-21-20			TCGA-10-0931-01A-01D-0399-01	TCGA-10-0931-01	25a69746-6f70-41eb-9805-6299ea0a4728		TCGA-10-0931-01A-01D-0399-01				TCGA-10-0931-01A-01W-0420-08	TCGA-10-0931-01			TCGA-10-0931-01A-01W-0420-08	TCGA-10-0931-01A-01R-0406-07	
TCGA-10-0933-01	1	TCGA-10-0933-01	446	1	days	High	C9-OV	UCEC Serous c4	OV-like c4		miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-10-0933			days	446	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Bilateral	TCGA-10-0933-F24454	TCGA-10-0933	TCGA-10-0933-01A	Stage IIIC	-28433		446	0	356		356	1			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1			G3	Recurrence					TCGA-10-0933.f973309d-55dd-489b-a7ca-9348666a9129.pdf	0933	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			10	No Macroscopic disease	Ovary		A	DECEASED	2003		TCGA-10-0933-01		99221367-1f21-45c5-944f-f734178e1468		TCGA-10-0933-01		TCGA-10-0933-01A-01D-0402-05	TCGA-10-0933-01A-01W-0421-09	TCGA-10-0933-01A-21-20	TCGA-10-0933-01A-01W-0421-09		TCGA-10-0933-01A-01D-0399-01	TCGA-10-0933-01	7c7459b2-2a24-4866-a4fc-e960ef606d39		TCGA-10-0933-01A-01D-0399-01					TCGA-10-0933-01			TCGA-10-0933-01A-01W-0421-09	TCGA-10-0933-01A-01R-0406-07	
TCGA-10-0934-01	1	TCGA-10-0934-01	204	1	days	High		UCEC non-CIMP c3			miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-10-0934			days	204	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-10-0934-F24458	TCGA-10-0934		Stage IIIC	-18602		204	0	119		111				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G3	Recurrence						0934		WITH TUMOR	YES	Progressive Disease	First Seen At Further Surgery	NO		Primary Tumor	01				10	1-10 mm	Ovary			DECEASED	2003				cb990c79-c1bf-45d1-88ff-04a916bf3a16				TCGA-10-0934-01A-02D-0402-05					TCGA-10-0934-01A-02D-0399-01	TCGA-10-0934-01			TCGA-10-0934-01A-02D-0399-01				TCGA-10-0934-01A-02W-0420-08	TCGA-10-0934-01			TCGA-10-0934-01A-02W-0420-08	TCGA-10-0934-01A-02R-0406-07	
TCGA-10-0935-01	1	TCGA-10-0935-01	1078	1	days	BRCA-LUAD+		OV-like c1					mutation cluster 5	TCGA-10-0935			days	1078	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			68	Bilateral	TCGA-10-0935-F24462	TCGA-10-0935		Stage IIIC	-25098		1078	0	1078						2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3							0935		WITH TUMOR	YES			NO		Primary Tumor	01				10	1-10 mm	Ovary	YES		DECEASED	2003				da4b7cf0-830b-42de-9bd5-fa065c331362				TCGA-10-0935-01A-03D-0402-05	TCGA-10-0935-01A-03W-0421-09		TCGA-10-0935-01A-03W-0421-09		TCGA-10-0935-01A-03D-0399-01	TCGA-10-0935-01			TCGA-10-0935-01A-03D-0399-01					TCGA-10-0935-01			TCGA-10-0935-01A-03W-0421-09	TCGA-10-0935-01A-02R-0406-07	
TCGA-10-0936-01	1	TCGA-10-0936-01	1123	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 2		TCGA-10-0936			days	1123	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			69	Bilateral	TCGA-10-0936-F24466	TCGA-10-0936	TCGA-10-0936-01A	Stage IIIC	-25454		1123	0	1089			0			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3						TCGA-10-0936.6b9a13e4-760e-476f-a0a7-fb42ab7c63c5.pdf	0936	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.5			10	>20 mm	Ovary		A	DECEASED	2005	TCGA-10-0936-01	TCGA-10-0936-01		8492ae5a-2139-4159-8b99-133e01b12568		TCGA-10-0936-01		TCGA-10-0936-01A-01D-0402-05		TCGA-10-0936-01A-21-20		04112b9c-6ef4-49cd-bed8-43151b5bbe1f	TCGA-10-0936-01A-01D-0399-01	TCGA-10-0936-01	5e8ac787-50cc-45ea-9fc4-efe67b6d05ff		TCGA-10-0936-01A-01D-0399-01	04112b9c-6ef4-49cd-bed8-43151b5bbe1f		04112b9c-6ef4-49cd-bed8-43151b5bbe1f		TCGA-10-0936-01	TCGA-10-0936-01	04112b9c-6ef4-49cd-bed8-43151b5bbe1f		TCGA-10-0936-01A-01R-0406-07	
TCGA-10-0937-01	1	TCGA-10-0937-01	608	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-10-0937			days	608	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-10-0937-F24476	TCGA-10-0937		Stage IIIC	-16222		608	0	460		235	0			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						0937	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				10	1-10 mm	Ovary			DECEASED	2005			TCGA-10-0937-01A-02W-0419-10	a104dfcb-8b29-4ab3-99ad-9ccbac4b2d4d			TCGA-10-0937-01A-02W-0419-10	TCGA-10-0937-01A-02D-0402-05					TCGA-10-0937-01A-02D-0399-01	TCGA-10-0937-01			TCGA-10-0937-01A-02D-0399-01					TCGA-10-0937-01			TCGA-10-0937-01A-02W-0419-10	TCGA-10-0937-01A-02R-0406-07	
TCGA-10-0938-01	1	TCGA-10-0938-01	636	1	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-10-0938			days	636	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			80	Bilateral	TCGA-10-0938-F24483	TCGA-10-0938	TCGA-10-0938-01A	Stage IIIC	-29558		636	0	604		362	2			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES			0.6	NO		1			G3	Progression of Disease					TCGA-10-0938.faa8920a-3b4a-4767-bdb1-5d086e51fe92.pdf	0938		WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.6			10	>20 mm	Ovary		A	DECEASED	2002		TCGA-10-0938-01	TCGA-10-0938-01A-02W-0419-10	02e1cf40-826f-451a-bb3c-a3c7c94e8104		TCGA-10-0938-01	TCGA-10-0938-01A-02W-0419-10	TCGA-10-0938-01A-02D-0402-05					TCGA-10-0938-01A-02D-0399-01	TCGA-10-0938-01			TCGA-10-0938-01A-02D-0399-01					TCGA-10-0938-01			TCGA-10-0938-01A-02W-0419-10	TCGA-10-0938-01A-02R-0406-07	
TCGA-13-0714-01	1	TCGA-13-0714-01	189	1	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0714			days	189	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-13-0714-F24489	TCGA-13-0714	TCGA-13-0714-01A	Stage IV	-20109		189	0	189		110				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	80	1.2			G3	Progression of Disease					TCGA-13-0714.96EB4BD1-CE3B-44D8-8095-076712A3E082.pdf	0714	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2000		TCGA-13-0714-01	TCGA-13-0714-01A-01W-0370-10	408156df-a8fa-4068-9b87-f92bd60ca873		TCGA-13-0714-01	TCGA-13-0714-01A-01W-0370-10	TCGA-13-0714-01A-01D-0359-05					TCGA-13-0714-01A-01D-0356-01	TCGA-13-0714-01			TCGA-13-0714-01A-01D-0356-01					TCGA-13-0714-01			TCGA-13-0714-01A-01W-0370-10		TCGA-13-0714-01A-01R-0363-07
TCGA-13-0717-01	1	TCGA-13-0717-01	748	1	days	High		OV-like c1					mutation cluster 8	TCGA-13-0717			days	748	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-13-0717-F24494	TCGA-13-0717		Stage IIIC	-20042		748	0	748		294				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						0717		WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO		Primary Tumor	01				13	>20 mm	Ovary			DECEASED	2000			TCGA-13-0717-01A-01W-0370-10	d6012831-3668-402e-8be1-849c011767a6			TCGA-13-0717-01A-01W-0370-10	TCGA-13-0717-01A-01D-0359-05					TCGA-13-0717-01A-01D-0356-01	TCGA-13-0717-01			TCGA-13-0717-01A-01D-0356-01					TCGA-13-0717-01			TCGA-13-0717-01A-01W-0370-10		TCGA-13-0717-01A-01R-0363-07
TCGA-13-0720-01	1	TCGA-13-0720-01	1355	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-13-0720			days	1355	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-13-0720-F24498	TCGA-13-0720	TCGA-13-0720-01A	Stage IIIC	-17799		1355	0	1355		292				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO	80	8			G3	Recurrence					TCGA-13-0720.0A196866-A083-40AC-90E3-5ECA3B141645.pdf	0720	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2001		TCGA-13-0720-01	TCGA-13-0720-01A-01W-0370-10	595dacaa-2763-4482-998c-eb748907f146		TCGA-13-0720-01	TCGA-13-0720-01A-01W-0370-10	TCGA-13-0720-01A-01D-0359-05		TCGA-13-0720-01A-21-20			TCGA-13-0720-01A-01D-0356-01	TCGA-13-0720-01	5864cd1e-a0da-4553-b12b-75f8941ecbab		TCGA-13-0720-01A-01D-0356-01					TCGA-13-0720-01			TCGA-13-0720-01A-01W-0370-10	TCGA-13-0720-01A-01R-0363-07	
TCGA-13-0723-01	1	TCGA-13-0723-01	1204	1	days	High		OV-like c1			miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-13-0723			days	1204	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	63	Bilateral	TCGA-13-0723-F24503	TCGA-13-0723	TCGA-13-0723-01A	Stage IIIC	-23094		1204	0	1204		210				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.3			G3	Progression of Disease					TCGA-13-0723.0A628FDD-EDDF-48BA-A083-8E2676DD9B5C.pdf	0723		WITH TUMOR	YES	Progressive Disease	Molecular Markers	NO		Primary Tumor	01	0.3			13	>20 mm	Ovary		A	DECEASED	2002		TCGA-13-0723-01		95906f3c-8c5d-4eb9-8183-a444efde2a18		TCGA-13-0723-01		TCGA-13-0723-01A-02D-0359-05	TCGA-13-0723-01A-02W-0372-09		TCGA-13-0723-01A-02W-0372-09		TCGA-13-0723-01A-02D-0356-01	TCGA-13-0723-01			TCGA-13-0723-01A-02D-0356-01					TCGA-13-0723-01			TCGA-13-0723-01A-02W-0372-09		TCGA-13-0723-01A-02R-0363-07
TCGA-13-0724-01	1	TCGA-13-0724-01	83	1	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0724			days	83	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Right	TCGA-13-0724-F24507	TCGA-13-0724		Stage IV	-26342		83	0	83		83				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy				80				G3	Progression of Disease						0724	Preoperative	WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2002		TCGA-13-0724-01		fb6ffde7-3b9f-4f28-845c-e2bb245db90b		TCGA-13-0724-01		TCGA-13-0724-01A-01D-0359-05	TCGA-13-0724-01A-01W-0372-09		TCGA-13-0724-01A-01W-0372-09		TCGA-13-0724-01A-01D-0356-01	TCGA-13-0724-01			TCGA-13-0724-01A-01D-0356-01					TCGA-13-0724-01			TCGA-13-0724-01A-01W-0372-09		TCGA-13-0724-01A-01R-0363-07
TCGA-13-0725-01	1	TCGA-13-0725-01	377	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-13-0725			days	377	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-13-0725-F24510	TCGA-13-0725	TCGA-13-0725-01A	Stage IIIC	-16086		377	0	377		190				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.5			G3	Recurrence					TCGA-13-0725.A6CD74F2-47A0-4790-BB81-6C636DA16ADC.pdf	0725		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2002		TCGA-13-0725-01		c030245e-982a-40d5-a03d-c7896105b062		TCGA-13-0725-01		TCGA-13-0725-01A-01D-0359-05		TCGA-13-0725-01A-21-20			TCGA-13-0725-01A-01D-0356-01	TCGA-13-0725-01	6701705e-cbfb-4af1-b1ab-898298de7c02		TCGA-13-0725-01A-01D-0356-01					TCGA-13-0725-01					TCGA-13-0725-01A-01R-0363-07
TCGA-13-0726-01	1	TCGA-13-0726-01	949	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0726			days	949	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-13-0726-F24515	TCGA-13-0726		Stage IIIC	-20134		949	0	946		392				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								GX	Recurrence						0726		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2002		TCGA-13-0726-01		ec64c4e0-8c79-4161-bc31-56abd101de2c		TCGA-13-0726-01		TCGA-13-0726-01A-01D-0359-05	TCGA-13-0726-01A-01W-0372-09		TCGA-13-0726-01A-01W-0372-09		TCGA-13-0726-01A-01D-0356-01	TCGA-13-0726-01			TCGA-13-0726-01A-01D-0356-01					TCGA-13-0726-01			TCGA-13-0726-01A-01W-0372-09		TCGA-13-0726-01A-01R-0363-07
TCGA-13-0727-01	1	TCGA-13-0727-01	462	1	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-13-0727			days	462	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-13-0727-F24519	TCGA-13-0727		Stage IIIC	-26185		462	0	462		253				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						0727		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2003		TCGA-13-0727-01	TCGA-13-0727-01A-01W-0370-10	ccf2280b-6308-40ad-bf39-f222aa67a91b		TCGA-13-0727-01	TCGA-13-0727-01A-01W-0370-10	TCGA-13-0727-01A-01D-0359-05					TCGA-13-0727-01A-01D-0356-01	TCGA-13-0727-01			TCGA-13-0727-01A-01D-0356-01					TCGA-13-0727-01			TCGA-13-0727-01A-01W-0370-10		TCGA-13-0727-01A-01R-0363-07
TCGA-13-0730-01	1	TCGA-13-0730-01	542	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0730			days	542	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Bilateral	TCGA-13-0730-F60695	TCGA-13-0730	TCGA-13-0730-01A	Stage IIIC	-26086		542	0					Scheduled Follow-up Submission		2014-6-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		0.6	NO		1.1	NO		G3						TCGA-13-0730.2AF2844E-F1DC-4938-85D3-08B07BB9DCFF.pdf	0730								Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2003	TCGA-13-0730-01	TCGA-13-0730-01	TCGA-13-0730-01A-01W-0370-10	1bd423e8-af33-4277-8ded-7d8c3f675f4b		TCGA-13-0730-01	TCGA-13-0730-01A-01W-0370-10	TCGA-13-0730-01A-01D-0359-05				754dfe07-22f4-4070-bbcb-10bfbb649def	TCGA-13-0730-01A-01D-0356-01	TCGA-13-0730-01			TCGA-13-0730-01A-01D-0356-01	754dfe07-22f4-4070-bbcb-10bfbb649def		754dfe07-22f4-4070-bbcb-10bfbb649def		TCGA-13-0730-01	TCGA-13-0730-01	754dfe07-22f4-4070-bbcb-10bfbb649def	TCGA-13-0730-01A-01W-0370-10		TCGA-13-0730-01A-01R-0363-07
TCGA-13-0751-01	1	TCGA-13-0751-01	1678	1	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0751			days	1678	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-13-0751-F24525	TCGA-13-0751	TCGA-13-0751-01A	Stage IIIC	-16304		1678	0	1678		653				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1			GX	Recurrence					TCGA-13-0751.61280768-69DF-4601-BED6-E78C1F82E5BC.pdf	0751		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	1999		TCGA-13-0751-01		625f1703-3f6c-4434-b30d-8bf174c438d7		TCGA-13-0751-01		TCGA-13-0751-01A-01D-0359-05					TCGA-13-0751-01A-01D-0356-01	TCGA-13-0751-01			TCGA-13-0751-01A-01D-0356-01				TCGA-13-0751-01A-01D-0446-08	TCGA-13-0751-01			TCGA-13-0751-01	TCGA-13-0751-01A-01R-0363-07	
TCGA-13-0755-01	1	TCGA-13-0755-01	76	1	days	Squamous		OV-like c1			miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-13-0755			days	76	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	75	Bilateral	TCGA-13-0755-F24531	TCGA-13-0755		Stage IV	-27438		76	0	76		34				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				40				G3	Progression of Disease						0755	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2003		TCGA-13-0755-01		b14fdd08-b406-4db3-ac74-d1fdb6b213a2		TCGA-13-0755-01		TCGA-13-0755-01A-01D-0359-05	TCGA-13-0755-01A-01W-0372-09		TCGA-13-0755-01A-01W-0372-09		TCGA-13-0755-01A-01D-0356-01	TCGA-13-0755-01			TCGA-13-0755-01A-01D-0356-01					TCGA-13-0755-01			TCGA-13-0755-01A-01W-0372-09	TCGA-13-0755-01A-01R-0363-07	
TCGA-13-0757-01	1	TCGA-13-0757-01	340	1	days	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0757			days	340	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-13-0757-F24534	TCGA-13-0757	TCGA-13-0757-01A	Stage IIIC	-25999		340	0	340		293				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO	60	0.9			G3	Recurrence					TCGA-13-0757.81F1B0FB-CEB7-4313-AA0D-71DA495AEABE.pdf	0757	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2005		TCGA-13-0757-01		69337aad-1fe3-4b0e-943e-ca5ac6dc6076		TCGA-13-0757-01		TCGA-13-0757-01A-01D-0359-05					TCGA-13-0757-01A-01D-0356-01	TCGA-13-0757-01			TCGA-13-0757-01A-01D-0356-01					TCGA-13-0757-01					TCGA-13-0757-01A-01R-0363-07
TCGA-13-0758-01	1	TCGA-13-0758-01	346	1	days	Squamous		OV-like c1						TCGA-13-0758			days	346	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-13-0758-F24539	TCGA-13-0758	TCGA-13-0758-01A	Stage IV	-22088		346	0	346		212				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO	60	1.3			G3	Progression of Disease					TCGA-13-0758.37B557BB-D2C4-42A9-B224-F1DFFC9B8FE3.pdf	0758	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2005				4d8ca9f7-21f4-49d8-b985-53a096e48428				TCGA-13-0758-01A-01D-0359-05					TCGA-13-0758-01A-01D-0356-01	TCGA-13-0758-01			TCGA-13-0758-01A-01D-0356-01					TCGA-13-0758-01					TCGA-13-0758-01A-01R-0363-07
TCGA-13-0760-01	1	TCGA-13-0760-01	351	1	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0760			days	351	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Bilateral	TCGA-13-0760-F24543	TCGA-13-0760		Stage IV	-23036		351	0	351						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy				80				G3							0760	Pre-Adjuvant Therapy		YES			NO		Primary Tumor	01				13	No Macroscopic disease	Ovary			DECEASED	2006		TCGA-13-0760-01				TCGA-13-0760-01		TCGA-13-0760-01A-01D-0359-05	TCGA-13-0760-01A-01W-0372-09		TCGA-13-0760-01A-01W-0372-09		TCGA-13-0760-01A-01D-0356-01	TCGA-13-0760-01			TCGA-13-0760-01A-01D-0356-01					TCGA-13-0760-01			TCGA-13-0760-01A-01W-0372-09		TCGA-13-0760-01A-01R-0363-07
TCGA-13-0761-01	1	TCGA-13-0761-01	1156	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-13-0761	424	1	days	1156	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-13-0761-F72596	TCGA-13-0761	TCGA-13-0761-01A	Stage IV	-18697		1156	0	1036		424			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3			YES			TCGA-13-0761.9609319A-2534-4753-9C71-3F59BFD20F15.pdf	0761		WITH TUMOR						Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	DECEASED	2006		TCGA-13-0761-01	TCGA-13-0761-01A-01W-0370-10	31361f65-a9de-4272-9de7-d884d15db3f0		TCGA-13-0761-01	TCGA-13-0761-01A-01W-0370-10	TCGA-13-0761-01A-01D-0359-05					TCGA-13-0761-01A-01D-0356-01	TCGA-13-0761-01			TCGA-13-0761-01A-01D-0356-01					TCGA-13-0761-01			TCGA-13-0761-01A-01W-0370-10		TCGA-13-0761-01A-01R-0363-07
TCGA-13-0762-01	0	TCGA-13-0762-01	3400	0	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 2	TCGA-13-0762	1003	1	days	3400	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			65	Bilateral	TCGA-13-0762-F72597	TCGA-13-0762		Stage IIIC	-23960			0	3400		1003			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				80				G3			YES				0762	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01				13	No Macroscopic disease	Ovary			LIVING	2006		TCGA-13-0762-01	TCGA-13-0762-01A-01W-0370-10	f33f5749-bed4-403d-b311-176f59fb32bc		TCGA-13-0762-01	TCGA-13-0762-01A-01W-0370-10	TCGA-13-0762-01A-01D-0359-05					TCGA-13-0762-01A-01D-0356-01	TCGA-13-0762-01			TCGA-13-0762-01A-01D-0356-01					TCGA-13-0762-01			TCGA-13-0762-01A-01W-0370-10		TCGA-13-0762-01A-01R-0363-07
TCGA-13-0764-01	1	TCGA-13-0764-01	1881	1	days	High		OV-like c1						TCGA-13-0764	272	1	days	1881	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Bilateral	TCGA-13-0764-F72599	TCGA-13-0764		Stage IV	-22965		1881	0	944		272			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES					80				G3			YES				0764	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2006				b72f0610-8aaa-48ac-afed-333e5f4159cd				TCGA-13-0764-01A-03D-0359-05					TCGA-13-0764-01A-03D-0356-01	TCGA-13-0764-01			TCGA-13-0764-01A-03D-0356-01					TCGA-13-0764-01					TCGA-13-0764-01A-03R-0363-07
TCGA-13-0765-01	1	TCGA-13-0765-01	1389	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0765	668	1	days	1389	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Bilateral	TCGA-13-0765-F72600	TCGA-13-0765	TCGA-13-0765-01A	Stage IIIC	-18574		1389	0	869		668			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2			G3			YES			TCGA-13-0765.96588189-C273-4095-88C5-9E22368813C0.pdf	0765		WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2006		TCGA-13-0765-01		17962695-e9c2-45f2-b4a2-00b7bfd1ffd6		TCGA-13-0765-01		TCGA-13-0765-01A-01D-0359-05	TCGA-13-0765-01A-01W-0372-09		TCGA-13-0765-01A-01W-0372-09			TCGA-13-0765-01											TCGA-13-0765-01A-01W-0372-09	TCGA-13-0765-01A-01R-0363-07	
TCGA-13-0766-01	1	TCGA-13-0766-01	1725	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0766	628	1	days	1725	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			42	Bilateral	TCGA-13-0766-F72601	TCGA-13-0766	TCGA-13-0766-01A	Stage IIIC	-15571		1725	0	651		628				2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.7			G3			YES			TCGA-13-0766.7F283E4B-70F9-4834-866C-B91024C74EA3.pdf	0766		WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2006		TCGA-13-0766-01		2b1e48b5-b8f4-4f57-8089-8293f470f466		TCGA-13-0766-01		TCGA-13-0766-01A-02D-0359-05					TCGA-13-0766-01A-02D-0356-01	TCGA-13-0766-01			TCGA-13-0766-01A-02D-0356-01					TCGA-13-0766-01				TCGA-13-0766-01A-02R-0363-07	
TCGA-13-0768-01	1	TCGA-13-0768-01	1784	1	days	High		OV-like c1			miRNA cluster 3	cluster 5		TCGA-13-0768	398	1	days	1784	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Bilateral	TCGA-13-0768-F72603	TCGA-13-0768	TCGA-13-0768-01A	Stage IIIC	-26999		1784	0	257		398			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO	60	0.8			G3			YES			TCGA-13-0768.7D67D0D3-105C-4A00-B104-106BE26FEE2D.pdf	0768	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2008		TCGA-13-0768-01		282e4c72-a430-4a70-9393-c259a90d9ee3		TCGA-13-0768-01		TCGA-13-0768-01A-01D-0359-05					TCGA-13-0768-01A-01D-0356-01	TCGA-13-0768-01			TCGA-13-0768-01A-01D-0356-01					TCGA-13-0768-01					TCGA-13-0768-01A-01R-0363-07
TCGA-13-0791-01	1	TCGA-13-0791-01	1224	1	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0791	281	1	days	1224	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-13-0791-F72604	TCGA-13-0791	TCGA-13-0791-01A	Stage IIIC	-21380		1224	0	1184		281			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	80	1.8			G3			YES			TCGA-13-0791.BDF98098-6E0F-4387-9C2C-30CF1812073A.pdf	0791	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	DECEASED	2005		TCGA-13-0791-01		7290ea9e-baf6-4777-b512-ab1da9bf62cd		TCGA-13-0791-01		TCGA-13-0791-01A-01D-0359-05	TCGA-13-0791-01A-01W-0372-09		TCGA-13-0791-01A-01W-0372-09		TCGA-13-0791-01A-01D-0356-01	TCGA-13-0791-01			TCGA-13-0791-01A-01D-0356-01					TCGA-13-0791-01			TCGA-13-0791-01A-01W-0372-09		TCGA-13-0791-01A-01R-0363-07
TCGA-13-0791-02	1	TCGA-13-0791-02	1224	1	days			OV-like c1			miRNA cluster 2		mutation cluster 5	TCGA-13-0791	281	1	days	1224	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-13-0791-F72604	TCGA-13-0791	TCGA-13-0791-02A	Stage IIIC	-21380		1224	0	1184		281			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO	80	1			G3			YES			TCGA-13-0791.60B0A7B2-179E-47CE-908C-A1360EA6BB6B.pdf	0791	Pre-Adjuvant Therapy	WITH TUMOR						Recurrent Tumor	02	0.1			13	No Macroscopic disease	Ovary		A	DECEASED	2005		TCGA-13-0791-02		3038dbe5-a4fd-4ebf-b582-503b3041822b		TCGA-13-0791-02		TCGA-13-0791-02A-01D-0807-05																		TCGA-13-0791-02A-01R-0810-07	
TCGA-13-0792-01	0	TCGA-13-0792-01	3602	0	days	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0792	816	1	days	3602	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			40	Bilateral	TCGA-13-0792-F72605	TCGA-13-0792	TCGA-13-0792-01A	Stage IIIC	-14729			0	3602		816			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1.2			G3			YES			TCGA-13-0792.3FBB8BEC-64D0-4AC8-9E15-C8FA9627E451.pdf	0792	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2005		TCGA-13-0792-01	TCGA-13-0792-01A-01W-0370-10	3a6c89bc-5db4-4816-b7f4-d77cf1d8eb0b		TCGA-13-0792-01	TCGA-13-0792-01A-01W-0370-10	TCGA-13-0792-01A-01D-0359-05					TCGA-13-0792-01A-01D-0356-01	TCGA-13-0792-01			TCGA-13-0792-01A-01D-0356-01					TCGA-13-0792-01			TCGA-13-0792-01A-01W-0370-10		TCGA-13-0792-01A-01R-0363-07
TCGA-13-0793-01	0	TCGA-13-0793-01	3263	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0793	351	1	days	3263	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			40	Left	TCGA-13-0793-F72606	TCGA-13-0793	TCGA-13-0793-01A	Stage IV	-14708			0	3263		351			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO	80	1.6			G3			YES			TCGA-13-0793.43781B94-0865-4824-94B9-1476AC2F8677.pdf	0793	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2006		TCGA-13-0793-01	TCGA-13-0793-01A-01W-0370-10	447c38c0-ac42-4a58-ad55-c1c68258cdf4		TCGA-13-0793-01	TCGA-13-0793-01A-01W-0370-10	TCGA-13-0793-01A-01D-0359-05		TCGA-13-0793-01A-03-20			TCGA-13-0793-01A-01D-0356-01	TCGA-13-0793-01	7a9e7c44-9e41-4f1c-bf87-3faa086b0306		TCGA-13-0793-01A-01D-0356-01					TCGA-13-0793-01			TCGA-13-0793-01A-01W-0370-10		TCGA-13-0793-01A-01R-0363-07
TCGA-13-0794-01	1	TCGA-13-0794-01	1919	1	days	BRCA-LUAD+		OV-like c1	OV-like c4		miRNA cluster 2	cluster 3		TCGA-13-0794	845	1	days	1919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Bilateral	TCGA-13-0794-F72607	TCGA-13-0794		Stage IIIC	-21945		1919	0	923		845			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				60				G3			YES				0794	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2006		TCGA-13-0794-01		c9dd6b81-e436-410c-abe3-aefea5b82103		TCGA-13-0794-01		TCGA-13-0794-01A-01D-0359-05		TCGA-13-0794-01A-03-20			TCGA-13-0794-01A-01D-0356-01	TCGA-13-0794-01	fde6d311-beb0-4efa-92af-36b426444dd4		TCGA-13-0794-01A-01D-0356-01					TCGA-13-0794-01					TCGA-13-0794-01A-01R-0363-07
TCGA-13-0795-01	1	TCGA-13-0795-01	619	1	days	High		OV-like c1			miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-0795	325	1	days	619	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			66	Bilateral	TCGA-13-0795-F72608	TCGA-13-0795	TCGA-13-0795-01A	Stage IIIC	-24403		619	0	596		325			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		0.9	NO	80	1.4			G3			YES			TCGA-13-0795.B98206EC-73D1-404F-B497-BAD6C817D9B7.pdf	0795	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	>20 mm	Ovary		A	DECEASED	2007		TCGA-13-0795-01		8a90ef9c-f444-4bff-92df-7356ec1c07ad		TCGA-13-0795-01		TCGA-13-0795-01A-01D-0359-05	TCGA-13-0795-01A-01W-0372-09		TCGA-13-0795-01A-01W-0372-09		TCGA-13-0795-01A-01D-0356-01	TCGA-13-0795-01			TCGA-13-0795-01A-01D-0356-01					TCGA-13-0795-01			TCGA-13-0795-01A-01W-0372-09		TCGA-13-0795-01A-01R-0363-07
TCGA-13-0797-01	0	TCGA-13-0797-01	2121	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 5		TCGA-13-0797	525	1	days	2121	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-13-0797-F72609	TCGA-13-0797	TCGA-13-0797-01A	Stage IIIC	-18051			0	2121		525			Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO	80	1.6			G3			YES			TCGA-13-0797.84ED21CA-E018-44C5-86E4-57927ABBCC9A.pdf	0797	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-0797-01		9efea7f4-e521-4520-8abb-c764fa2a6a8c		TCGA-13-0797-01		TCGA-13-0797-01A-01D-0359-05		TCGA-13-0797-01A-03-20			TCGA-13-0797-01A-01D-0356-01	TCGA-13-0797-01	0a64d08c-7d28-4c74-ab75-2ff02f1a4de0		TCGA-13-0797-01A-01D-0356-01					TCGA-13-0797-01				TCGA-13-0797-01A-01R-0363-07	
TCGA-13-0799-01	0	TCGA-13-0799-01	2535	0	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-13-0799	1262	1	days	2535	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			44	Bilateral	TCGA-13-0799-F72611	TCGA-13-0799	TCGA-13-0799-01A	Stage IIIC	-16171			0	2535		1262			Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO	80	1.6			G3			YES			TCGA-13-0799.CBB83CF3-9846-409B-858B-C8A7E74CDFF1.pdf	0799	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008	TCGA-13-0799-01	TCGA-13-0799-01		1197c1db-5ef3-475a-bbdb-c81da71b6ccf		TCGA-13-0799-01		TCGA-13-0799-01A-01D-0359-05		TCGA-13-0799-01A-03-1562-20		a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	TCGA-13-0799-01A-01D-0356-01	TCGA-13-0799-01	c91f1247-0579-4c10-8da1-2d62d276e58e		TCGA-13-0799-01A-01D-0356-01	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3		a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3		TCGA-13-0799-01	TCGA-13-0799-01	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3		TCGA-13-0799-01A-01R-0363-07	
TCGA-13-0800-01	0	TCGA-13-0800-01	2661	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 3	TCGA-13-0800	1396	1	days	2661	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Bilateral	TCGA-13-0800-F72612	TCGA-13-0800	TCGA-13-0800-01A	Stage IIIC	-19087			0	2661		1396			Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5			G3			YES			TCGA-13-0800.E3206F00-3BC6-44B4-848E-F2ED70E094BD.pdf	0800		TUMOR FREE						Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008	TCGA-13-0800-01	TCGA-13-0800-01		b637c4e1-2685-4843-9d5f-f63db155b468		TCGA-13-0800-01		TCGA-13-0800-01A-01D-0359-05	TCGA-13-0800-01A-01W-0372-09	TCGA-13-0800-01A-03-1562-20	TCGA-13-0800-01A-01W-0372-09	cd93531b-4d92-4be3-95e5-032636dd1ad8	TCGA-13-0800-01A-01D-0356-01	TCGA-13-0800-01	81737798-92c9-46d7-a85c-751fc5b102e8		TCGA-13-0800-01A-01D-0356-01	cd93531b-4d92-4be3-95e5-032636dd1ad8		cd93531b-4d92-4be3-95e5-032636dd1ad8		TCGA-13-0800-01	TCGA-13-0800-01	cd93531b-4d92-4be3-95e5-032636dd1ad8	TCGA-13-0800-01A-01W-0372-09		TCGA-13-0800-01A-01R-0363-07
TCGA-13-0801-01	1	TCGA-13-0801-01	1399	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-13-0801	345	1	days	1399	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			46	Bilateral	TCGA-13-0801-F72613	TCGA-13-0801	TCGA-13-0801-01A	Stage IIIC	-16812		1399	0	252		345			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	80	1.5			G3			YES			TCGA-13-0801.FA63535E-7499-41E3-AFB1-98EB18DA7371.pdf	0801	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	DECEASED	2008	TCGA-13-0801-01	TCGA-13-0801-01	TCGA-13-0801-01A-01W-0370-10	98d97019-658a-4493-bea0-5c571e196889		TCGA-13-0801-01	TCGA-13-0801-01A-01W-0370-10	TCGA-13-0801-01A-01D-0359-05		TCGA-13-0801-01A-03-20		c51dee3c-5047-4dde-b454-2474de5cf025	TCGA-13-0801-01A-01D-0356-01	TCGA-13-0801-01	1c4d4161-a528-4601-b512-eb2d5ed8d992		TCGA-13-0801-01A-01D-0356-01	c51dee3c-5047-4dde-b454-2474de5cf025		c51dee3c-5047-4dde-b454-2474de5cf025		TCGA-13-0801-01	TCGA-13-0801-01	c51dee3c-5047-4dde-b454-2474de5cf025			TCGA-13-0801-01A-01R-0363-07
TCGA-13-0802-01	1	TCGA-13-0802-01	1552	1	days	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 3		TCGA-13-0802	510	1	days	1552	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			79	Bilateral	TCGA-13-0802-F72615	TCGA-13-0802		Stage IIIC	-29075		1552	0	249		510			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				60				G3			YES				0802	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01				13	No Macroscopic disease	Ovary			DECEASED	2008		TCGA-13-0802-01	TCGA-13-0802-01A-01W-0370-10	eb96b8fd-6402-434d-9b98-bfa40b4be522		TCGA-13-0802-01	TCGA-13-0802-01A-01W-0370-10	TCGA-13-0802-01A-01D-0359-05		TCGA-13-0802-01A-03-1562-20			TCGA-13-0802-01A-01D-0356-01	TCGA-13-0802-01	e8448d63-f837-4512-89bf-06201938b152		TCGA-13-0802-01A-01D-0356-01					TCGA-13-0802-01					TCGA-13-0802-01A-01R-0363-07
TCGA-13-0803-01	1	TCGA-13-0803-01	1334	1	days	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0803			days	1334	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	81	Bilateral	TCGA-13-0803-F24629	TCGA-13-0803		Stage IIIC	-29685		1334	0	1334		337				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3	Recurrence						0803		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01				13	No Macroscopic disease	Ovary			DECEASED	2001		TCGA-13-0803-01		f17806bc-e184-49dc-99aa-cd5547ebb032		TCGA-13-0803-01		TCGA-13-0803-01A-01D-0359-05					TCGA-13-0803-01A-01D-0356-01	TCGA-13-0803-01			TCGA-13-0803-01A-01D-0356-01					TCGA-13-0803-01					TCGA-13-0803-01A-01R-0363-07
TCGA-13-0804-01	1	TCGA-13-0804-01	1073	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0804			days	1073	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-13-0804-F24633	TCGA-13-0804	TCGA-13-0804-01A	Stage IIIC	-27021		1073	0	1073		329				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.5			G3	Recurrence					TCGA-13-0804.34870541-DEE9-4B39-A292-117E443B1CBF.pdf	0804		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2003				a7711b62-2471-4ee7-8461-279e9732e83b				TCGA-13-0804-01A-01D-0359-05	TCGA-13-0804-01A-01W-0372-09	TCGA-13-0804-01A-03-20	TCGA-13-0804-01A-01W-0372-09		TCGA-13-0804-01A-01D-0356-01	TCGA-13-0804-01	50ffbcf0-99c5-4528-bd60-8a054b3566a8		TCGA-13-0804-01A-01D-0356-01					TCGA-13-0804-01			TCGA-13-0804-01A-01W-0372-09		TCGA-13-0804-01A-01R-0363-07
TCGA-13-0805-01	1	TCGA-13-0805-01	1074	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0805			days	1074	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-13-0805-F24638	TCGA-13-0805		Stage IIIC	-21014		1074	0	1073		177				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Progression of Disease						0805		WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2005		TCGA-13-0805-01		fbd0a639-044c-453b-a29c-3d914f431bd9		TCGA-13-0805-01		TCGA-13-0805-01A-01D-0359-05					TCGA-13-0805-01A-01D-0356-01	TCGA-13-0805-01			TCGA-13-0805-01A-01D-0356-01					TCGA-13-0805-01					TCGA-13-0805-01A-01R-0363-07
TCGA-13-0807-01	1	TCGA-13-0807-01	414	1	days	Squamous		OV-like c1					mutation cluster 5	TCGA-13-0807			days	414	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			54		TCGA-13-0807-F24642	TCGA-13-0807	TCGA-13-0807-01B	Stage IIIC	-19890		414	0	414						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection			NO					G3						TCGA-13-0807.E28B5574-1AC3-4E5E-BDD5-5B548E450F28.pdf	0807			YES			NO	R1	Primary Tumor	01				13	>20 mm	Ovary		B	DECEASED	2005				8fee0dca-afdb-46a8-b7b3-e16ed7ba4e32				TCGA-13-0807-01B-02D-0402-05	TCGA-13-0807-01B-02W-0421-09		TCGA-13-0807-01B-02W-0421-09		TCGA-13-0807-01B-02D-0399-01	TCGA-13-0807-01			TCGA-13-0807-01B-02D-0399-01					TCGA-13-0807-01			TCGA-13-0807-01B-02W-0421-09	TCGA-13-0807-01B-01R-0406-07	
TCGA-13-0883-01	1	TCGA-13-0883-01	2097	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0883			days	2097	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-13-0883-F24646	TCGA-13-0883	TCGA-13-0883-01A	Stage IIIC	-22395		2097	0	2097		819				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.1	NO		1.4			G3	Recurrence					TCGA-13-0883.7AC6471C-1BA0-4AA5-9A2E-70413C9768F8.pdf	0883		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2002		TCGA-13-0883-01		8b92a7da-e2b2-41c4-9ea2-8c3f87c2f5e9		TCGA-13-0883-01		TCGA-13-0883-01A-02D-0402-05					TCGA-13-0883-01A-02D-0399-01	TCGA-13-0883-01			TCGA-13-0883-01A-02D-0399-01				TCGA-13-0883-01A-02W-0420-08	TCGA-13-0883-01			TCGA-13-0883-01A-02W-0420-08	TCGA-13-0883-01A-02R-0406-07	
TCGA-13-0884-01	1	TCGA-13-0884-01	3260	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0884			days	3260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	39	Bilateral	TCGA-13-0884-F24651	TCGA-13-0884	TCGA-13-0884-01B	Stage IIIC	-14538		3260	0	3260		1251				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		1.3			G3	Recurrence					TCGA-13-0884.D15552F3-1407-4C01-9B59-DFAC5D4EF095.pdf	0884		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		B	DECEASED	1999		TCGA-13-0884-01		3b4e9ec5-9001-40af-8397-8802341611ad		TCGA-13-0884-01		TCGA-13-0884-01B-01D-0460-05	TCGA-13-0884-01B-01W-0494-09	TCGA-13-0884-01B-21-1562-20	TCGA-13-0884-01B-01W-0494-09		TCGA-13-0884-01B-01D-0452-01	TCGA-13-0884-01	2185ae8b-2257-4cc5-b08d-cf91dffa760d		TCGA-13-0884-01B-01D-0452-01					TCGA-13-0884-01			TCGA-13-0884-01B-01W-0494-09	TCGA-13-0884-01B-01R-0456-07	
TCGA-13-0885-01	0	TCGA-13-0885-01	3388	0	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-0885			days	3388	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			70	Left	TCGA-13-0885-F72616	TCGA-13-0885	TCGA-13-0885-01A	Stage IIIC	-25763			0	3388						2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	80	1.2			G3						TCGA-13-0885.81DFFD49-45F0-4A20-AC27-B8316B2E0289.pdf	0885	Pre-Adjuvant Therapy							Primary Tumor	01	0.4			13	11-20 mm	Ovary		A	LIVING	2000		TCGA-13-0885-01		22d268ea-7e43-46f4-8d1c-7a557d2f1664		TCGA-13-0885-01		TCGA-13-0885-01A-02D-0402-05	TCGA-13-0885-01A-02W-0421-09		TCGA-13-0885-01A-02W-0421-09		TCGA-13-0885-01A-02D-0399-01	TCGA-13-0885-01			TCGA-13-0885-01A-02D-0399-01					TCGA-13-0885-01			TCGA-13-0885-01A-02W-0421-09	TCGA-13-0885-01A-02R-0406-07	
TCGA-13-0886-01	0	TCGA-13-0886-01	4665	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0886	4665	0	days	4665	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			67	Bilateral	TCGA-13-0886-F72617	TCGA-13-0886	TCGA-13-0886-01A	Stage IIIC	-24724			0	4665					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3			NO			TCGA-13-0886.2FB5824C-F30B-4E0B-B787-CBF93A6A48AE.pdf	0886		TUMOR FREE						Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	LIVING	2002		TCGA-13-0886-01		de22b463-bc0e-4f81-9a06-0e55353b1412		TCGA-13-0886-01		TCGA-13-0886-01A-01D-0402-05		TCGA-13-0886-01A-21-20			TCGA-13-0886-01A-01D-0399-01	TCGA-13-0886-01	97f40569-5280-4c67-831d-dc8fa952e0f8		TCGA-13-0886-01A-01D-0399-01				TCGA-13-0886-01A-01W-0420-08	TCGA-13-0886-01			TCGA-13-0886-01A-01W-0420-08	TCGA-13-0886-01A-01R-0406-07	
TCGA-13-0887-01	1	TCGA-13-0887-01	2028	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0887			days	2028	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Bilateral	TCGA-13-0887-F24668	TCGA-13-0887	TCGA-13-0887-01A	Stage IIIC	-15669		2028	0	2028		514				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO	80	1.3			G3	Recurrence					TCGA-13-0887.AAEBFF3C-EA12-4D58-A424-2463307484A3.pdf	0887	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2002		TCGA-13-0887-01		3bc498df-2e02-4182-87f5-381fbde2f225		TCGA-13-0887-01		TCGA-13-0887-01A-01D-0402-05	TCGA-13-0887-01A-01W-0421-09	TCGA-13-0887-01A-21-20	TCGA-13-0887-01A-01W-0421-09		TCGA-13-0887-01A-01D-0399-01	TCGA-13-0887-01	0226becf-0ff4-4457-a446-0ed079324b0d		TCGA-13-0887-01A-01D-0399-01					TCGA-13-0887-01			TCGA-13-0887-01A-01W-0421-09	TCGA-13-0887-01A-01R-0406-07	
TCGA-13-0888-01	1	TCGA-13-0888-01	2811	1	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-13-0888	2811	0	days	2811	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Right	TCGA-13-0888-F72618	TCGA-13-0888	TCGA-13-0888-01A	Stage IIIC	-28498		2811	0	2141					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1.2			G3			NO			TCGA-13-0888.DFDEBDE5-C16E-4B29-9986-8EB557648AC5.pdf	0888	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	DECEASED	2003		TCGA-13-0888-01		2b24ddb3-3774-46ac-aa6f-48abfec30a81		TCGA-13-0888-01		TCGA-13-0888-01A-01D-0402-05		TCGA-13-0888-01A-21-20			TCGA-13-0888-01A-01D-0399-01	TCGA-13-0888-01	bb0f85fb-5126-4934-89bc-39e1044dee03		TCGA-13-0888-01A-01D-0399-01					TCGA-13-0888-01				TCGA-13-0888-01A-01R-0406-07	
TCGA-13-0889-01	1	TCGA-13-0889-01	2894	1	days	Squamous		UCEC Serous c4			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0889			days	2894	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			75	Right	TCGA-13-0889-F72619	TCGA-13-0889	TCGA-13-0889-01A	Stage IV	-27674		2894	0	1881						2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	60	1.5			GX						TCGA-13-0889.262B6A57-D2DF-47E3-BDB2-1FB956D8ABE9.pdf	0889	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2003		TCGA-13-0889-01	TCGA-13-0889-01A-01W-0419-10	8f64648c-7481-4814-865a-c392da1968bd		TCGA-13-0889-01	TCGA-13-0889-01A-01W-0419-10	TCGA-13-0889-01A-01D-0402-05					TCGA-13-0889-01A-01D-0399-01	TCGA-13-0889-01			TCGA-13-0889-01A-01D-0399-01					TCGA-13-0889-01			TCGA-13-0889-01A-01W-0419-10	TCGA-13-0889-01A-01R-0406-07	
TCGA-13-0890-01	0	TCGA-13-0890-01	4424	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0890	4424	0	days	4424	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			56	Bilateral	TCGA-13-0890-F72620	TCGA-13-0890	TCGA-13-0890-01A	Stage IIIC	-20770			0	4424					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		1.5			G3			NO			TCGA-13-0890.78888517-0ADC-4A78-B7FA-9ACE201795AB.pdf	0890		TUMOR FREE						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2003	TCGA-13-0890-01	TCGA-13-0890-01		9b5c97b8-eba5-431b-96cc-c60f5ee91a62		TCGA-13-0890-01		TCGA-13-0890-01A-01D-0402-05	TCGA-13-0890-01A-01W-0421-09		TCGA-13-0890-01A-01W-0421-09	65cc3a15-cfa9-48fb-b9e4-801398b073b8	TCGA-13-0890-01A-01D-0399-01	TCGA-13-0890-01			TCGA-13-0890-01A-01D-0399-01	65cc3a15-cfa9-48fb-b9e4-801398b073b8		65cc3a15-cfa9-48fb-b9e4-801398b073b8		TCGA-13-0890-01	TCGA-13-0890-01	65cc3a15-cfa9-48fb-b9e4-801398b073b8	TCGA-13-0890-01A-01W-0421-09	TCGA-13-0890-01A-01R-0406-07	
TCGA-13-0891-01	1	TCGA-13-0891-01	3128	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-0891	762	1	days	3128	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Bilateral	TCGA-13-0891-F72621	TCGA-13-0891	TCGA-13-0891-01A	Stage IV	-26886		3128	0	2099		762			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		1.2	NO	80	1.4			G3			YES			TCGA-13-0891.7DF79B3C-8CD7-446D-A13A-BBB69DFE2394.pdf	0891	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	DECEASED	2003		TCGA-13-0891-01		7d27ea62-19e6-4032-9e7f-799be4d3eaef		TCGA-13-0891-01		TCGA-13-0891-01A-01D-0402-05		TCGA-13-0891-01A-21-20			TCGA-13-0891-01A-01D-0399-01	TCGA-13-0891-01	f305890a-3b48-4e7b-8f31-f2653a5582b8		TCGA-13-0891-01A-01D-0399-01				TCGA-13-0891-01A-01W-0420-08	TCGA-13-0891-01			TCGA-13-0891-01A-01W-0420-08	TCGA-13-0891-01A-01R-0406-07	
TCGA-13-0893-01	1	TCGA-13-0893-01	1319	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-0893			days	1319	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-13-0893-F24690	TCGA-13-0893	TCGA-13-0893-01B	Stage IIIC	-17573		1319	0	1319		461				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.2			G3	Recurrence					TCGA-13-0893.0648E74B-766C-4AB7-BEEE-D45895413E5E.pdf	0893		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			13	11-20 mm	Ovary		B	DECEASED	2003	TCGA-13-0893-01	TCGA-13-0893-01		901a306b-6a5b-4f94-aac0-6eb7c767bb2e		TCGA-13-0893-01		TCGA-13-0893-01B-01D-0460-05	TCGA-13-0893-01B-01W-0494-09		TCGA-13-0893-01B-01W-0494-09	2b2d5fc7-b109-4d11-a632-db8016268840	TCGA-13-0893-01B-01D-0452-01	TCGA-13-0893-01			TCGA-13-0893-01B-01D-0452-01	2b2d5fc7-b109-4d11-a632-db8016268840		2b2d5fc7-b109-4d11-a632-db8016268840		TCGA-13-0893-01	TCGA-13-0893-01	2b2d5fc7-b109-4d11-a632-db8016268840	TCGA-13-0893-01B-01W-0494-09	TCGA-13-0893-01B-01R-0456-07	
TCGA-13-0894-01	1	TCGA-13-0894-01	1509	1	days	High	C9-OV	Low purity c2	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0894			days	1509	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-13-0894-F24695	TCGA-13-0894	TCGA-13-0894-01B	Stage IIIC	-19466		1509	0	1509		565				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.1	NO	80	1.5			G3	Recurrence					TCGA-13-0894.305FFF39-3453-49A4-8ED6-0532C9119AF0.pdf	0894	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		B	DECEASED	2003		TCGA-13-0894-01		2f62cd27-7bac-44c6-baa8-7e8593962402		TCGA-13-0894-01		TCGA-13-0894-01B-01D-0460-05	TCGA-13-0894-01B-01W-0494-09	TCGA-13-0894-01B-03-1562-20	TCGA-13-0894-01B-01W-0494-09			TCGA-13-0894-01	7e63800a-f2db-4a2a-82ab-2867707caf14										TCGA-13-0894-01B-01W-0494-09	TCGA-13-0894-01B-01R-0456-07	
TCGA-13-0897-01	1	TCGA-13-0897-01	2182	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0897	554	1	days	2182	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			54	Right	TCGA-13-0897-F72622	TCGA-13-0897	TCGA-13-0897-01A	Stage IIIC	-19894		2182	0	1748		554			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.5	NO	80	1.1			G3			YES			TCGA-13-0897.058A5354-D36C-4398-AC2C-12447FDB0966.pdf	0897	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2004	TCGA-13-0897-01	TCGA-13-0897-01		5ae3b33e-162f-4784-b007-cce51fdcfa5e		TCGA-13-0897-01		TCGA-13-0897-01A-01D-0402-05	TCGA-13-0897-01A-01W-0421-09	TCGA-13-0897-01A-21-20	TCGA-13-0897-01A-01W-0421-09	479b74bf-5003-45e1-9505-687146a5fc45	TCGA-13-0897-01A-01D-0399-01	TCGA-13-0897-01	7a6431cb-6461-4534-89e9-fc15b639bfac		TCGA-13-0897-01A-01D-0399-01	479b74bf-5003-45e1-9505-687146a5fc45		479b74bf-5003-45e1-9505-687146a5fc45		TCGA-13-0897-01	TCGA-13-0897-01	479b74bf-5003-45e1-9505-687146a5fc45	TCGA-13-0897-01A-01W-0421-09	TCGA-13-0897-01A-01R-0406-07	
TCGA-13-0899-01	1	TCGA-13-0899-01	2012	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0899	547	1	days	2012	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Bilateral	TCGA-13-0899-F72623	TCGA-13-0899	TCGA-13-0899-01A	Stage IIIC	-22031		2012	0	1708		547			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.6			G3			YES			TCGA-13-0899.AB15D325-CCD6-452F-8662-158E3153AFC4.pdf	0899		WITH TUMOR						Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2004	TCGA-13-0899-01	TCGA-13-0899-01		f5878d06-b37c-49fd-8a70-aaaaa270a14c		TCGA-13-0899-01		TCGA-13-0899-01A-01D-0402-05		TCGA-13-0899-01A-21-20		605d0aed-4637-4a09-82dd-eedd1aa76ca0	TCGA-13-0899-01A-01D-0399-01	TCGA-13-0899-01	eacc42b9-bd6e-468c-8560-6d699ae97737		TCGA-13-0899-01A-01D-0399-01	605d0aed-4637-4a09-82dd-eedd1aa76ca0		605d0aed-4637-4a09-82dd-eedd1aa76ca0	TCGA-13-0899-01A-01W-0420-08	TCGA-13-0899-01	TCGA-13-0899-01	605d0aed-4637-4a09-82dd-eedd1aa76ca0	TCGA-13-0899-01A-01W-0420-08	TCGA-13-0899-01A-01R-0406-07	
TCGA-13-0900-01	0	TCGA-13-0900-01	4077	0	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 11	TCGA-13-0900	4077	0	days	4077	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Bilateral	TCGA-13-0900-F72637	TCGA-13-0900	TCGA-13-0900-01B	Stage IIIC	-21698			0	4077					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	60	1.5			G3			NO			TCGA-13-0900.27A4B579-9123-431C-95B6-FBC5CB5142C9.pdf	0900	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.1			13		Ovary		B	LIVING	2004		TCGA-13-0900-01	TCGA-13-0900-01B-01W-0490-10	443f369f-d9cf-433a-a115-7934c20bf98a		TCGA-13-0900-01	TCGA-13-0900-01B-01W-0490-10	TCGA-13-0900-01B-01D-0460-05					TCGA-13-0900-01B-01D-0452-01	TCGA-13-0900-01			TCGA-13-0900-01B-01D-0452-01					TCGA-13-0900-01			TCGA-13-0900-01B-01W-0490-10	TCGA-13-0900-01B-01R-0456-07	
TCGA-13-0901-01	0	TCGA-13-0901-01	589	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 5		TCGA-13-0901			days	589	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	41	Bilateral	TCGA-13-0901-F24712	TCGA-13-0901	TCGA-13-0901-01A	Stage IIIC	-15333			0	589		390				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	80	1.3			G3	Recurrence					TCGA-13-0901.5613318C-D3D4-436D-B22F-BE8FC36D9686.pdf	0901	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	LIVING	2004		TCGA-13-0901-01	TCGA-13-0901-01B-01W-0490-10	9a07f778-ddd0-4290-af0b-9cf85da4b123		TCGA-13-0901-01	TCGA-13-0901-01B-01W-0490-10	TCGA-13-0901-01B-01D-0460-05		TCGA-13-0901-01A-21-20			TCGA-13-0901-01B-01D-0452-01	TCGA-13-0901-01	0f0ae870-f5a7-4572-998d-d39403507fbe		TCGA-13-0901-01B-01D-0452-01					TCGA-13-0901-01				TCGA-13-0901-01B-01R-0456-07	
TCGA-13-0903-01	0	TCGA-13-0903-01	3887	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0903	3887	0	days	3887	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			42	Bilateral	TCGA-13-0903-F72624	TCGA-13-0903	TCGA-13-0903-01A	Stage IV	-15705			0	3887					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1			G3			NO			TCGA-13-0903.A0EC0825-B2E7-40A0-868C-8C93A5D01AD8.pdf	0903	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2004		TCGA-13-0903-01		0931f0af-d4ff-4d49-9671-44f7f972ad49		TCGA-13-0903-01		TCGA-13-0903-01A-01D-0402-05	TCGA-13-0903-01A-01W-0421-09	TCGA-13-0903-01A-21-20	TCGA-13-0903-01A-01W-0421-09		TCGA-13-0903-01A-01D-0399-01	TCGA-13-0903-01	1eb38ad5-a108-4461-8d9c-2246c4e5174c		TCGA-13-0903-01A-01D-0399-01					TCGA-13-0903-01			TCGA-13-0903-01A-01W-0421-09	TCGA-13-0903-01A-01R-0406-07	
TCGA-13-0904-01	1	TCGA-13-0904-01	1532	1	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 2	TCGA-13-0904	330	1	days	1532	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Bilateral	TCGA-13-0904-F72625	TCGA-13-0904	TCGA-13-0904-01A	Stage IIIC	-23278		1532	0	1470		330			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		0.7	NO	80	1.5			G3			YES			TCGA-13-0904.4355BCD7-7A04-4F75-9415-83D3D6E18A24.pdf	0904	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2004		TCGA-13-0904-01		8db1ce50-4f8c-40a6-a56b-8266f0a16d28		TCGA-13-0904-01		TCGA-13-0904-01A-02D-0402-05					TCGA-13-0904-01A-02D-0399-01	TCGA-13-0904-01			TCGA-13-0904-01A-02D-0399-01				TCGA-13-0904-01A-02W-0420-08	TCGA-13-0904-01			TCGA-13-0904-01A-02W-0420-08	TCGA-13-0904-01A-02R-0406-07	
TCGA-13-0905-01	0	TCGA-13-0905-01	3746	0	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0905	1535	1	days	3746	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Left	TCGA-13-0905-F72638	TCGA-13-0905	TCGA-13-0905-01B	Stage IIIC	-18757			0	3746		1535			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	80	1.2			G3			YES			TCGA-13-0905.4EC6E47F-60BD-413E-9371-D70E1E89D0CA.pdf	0905	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13		Ovary		B	LIVING	2005		TCGA-13-0905-01		05762312-1eb7-48bd-b497-97e2f94a86ff		TCGA-13-0905-01		TCGA-13-0905-01B-01D-0460-05					TCGA-13-0905-01B-01D-0452-01	TCGA-13-0905-01			TCGA-13-0905-01B-01D-0452-01				TCGA-13-0905-01B-01W-0492-08	TCGA-13-0905-01			TCGA-13-0905-01B-01W-0492-08	TCGA-13-0905-01B-01R-0456-07	
TCGA-13-0906-01	0	TCGA-13-0906-01	3619	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0906	3619	0	days	3619	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Bilateral	TCGA-13-0906-F72626	TCGA-13-0906	TCGA-13-0906-01A	Stage IIIC	-18383			0	3619					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	60	1.1			G3			NO			TCGA-13-0906.D75790B2-C93F-4723-B691-84EE94656FF1.pdf	0906	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2005		TCGA-13-0906-01	TCGA-13-0906-01A-01W-0419-10	8cba78d8-365d-4f21-9024-b1c65e7aebd9		TCGA-13-0906-01	TCGA-13-0906-01A-01W-0419-10	TCGA-13-0906-01A-01D-0402-05		TCGA-13-0906-01A-21-20			TCGA-13-0906-01A-01D-0399-01	TCGA-13-0906-01	80aaf315-cf54-47e5-b82a-1343e25938ca		TCGA-13-0906-01A-01D-0399-01					TCGA-13-0906-01			TCGA-13-0906-01A-01W-0419-10	TCGA-13-0906-01A-01R-0406-07	
TCGA-13-0908-01	1	TCGA-13-0908-01	1843	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 6		TCGA-13-0908	552	1	days	1843	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-13-0908-F72639	TCGA-13-0908	TCGA-13-0908-01B	Stage IV	-21422		1843	0	1364		552			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.4			G3			YES			TCGA-13-0908.AE735D44-31EA-4345-9B3E-E92C7F236569.pdf	0908		WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		B	DECEASED	2005		TCGA-13-0908-01		1a0d9712-cc09-46fa-a588-2d9db23c751b		TCGA-13-0908-01		TCGA-13-0908-01B-01D-0460-05					TCGA-13-0908-01B-01D-0452-01	TCGA-13-0908-01			TCGA-13-0908-01B-01D-0452-01					TCGA-13-0908-01				TCGA-13-0908-01B-01R-0456-07	
TCGA-13-0910-01	0	TCGA-13-0910-01	3548	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0910	1212	1	days	3548	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-13-0910-F72627	TCGA-13-0910		Stage IIIC	-21473			0	3548		1212			Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				60				G3			YES				0910	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01				13	1-10 mm	Ovary			LIVING	2005		TCGA-13-0910-01		c86a6b6b-046a-46c9-a89d-d365adafedd7		TCGA-13-0910-01		TCGA-13-0910-01A-01D-0402-05	TCGA-13-0910-01A-01W-0421-09	TCGA-13-0910-01A-21-20	TCGA-13-0910-01A-01W-0421-09		TCGA-13-0910-01A-01D-0399-01	TCGA-13-0910-01	a7d2bac8-709d-455d-8613-e87b8fd8fe19		TCGA-13-0910-01A-01D-0399-01					TCGA-13-0910-01			TCGA-13-0910-01A-01W-0421-09	TCGA-13-0910-01A-01R-0406-07	
TCGA-13-0911-01	1	TCGA-13-0911-01	1355	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0911	279	1	days	1355	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Bilateral	TCGA-13-0911-F72628	TCGA-13-0911	TCGA-13-0911-01A	Stage IV	-20276		1355	0	843		279			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	80	1.5			G3			YES			TCGA-13-0911.0DE80BC5-8AA8-423A-B99B-9CD9883F27C2.pdf	0911	Pre-Adjuvant Therapy	WITH TUMOR					R1	Primary Tumor	01	0.8			13	1-10 mm	Ovary		A	DECEASED	2005		TCGA-13-0911-01		68069103-49df-4246-8858-31d6b3571145		TCGA-13-0911-01		TCGA-13-0911-01A-01D-0402-05		TCGA-13-0911-01A-21-20			TCGA-13-0911-01A-01D-0399-01	TCGA-13-0911-01	c2fbc465-c862-412d-8966-d88e0e414316		TCGA-13-0911-01A-01D-0399-01				TCGA-13-0911-01A-01W-0420-08	TCGA-13-0911-01			TCGA-13-0911-01A-01W-0420-08	TCGA-13-0911-01A-01R-0406-07	
TCGA-13-0912-01	1	TCGA-13-0912-01	1145	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0912	469	1	days	1145	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-13-0912-F72629	TCGA-13-0912	TCGA-13-0912-01A	Stage IIIC	-21427		1145	0	1036		469			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO	80	1.2			G3			YES			TCGA-13-0912.E6BF50DE-3E1D-447C-88B6-497B3C4C835F.pdf	0912	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	DECEASED	2006		TCGA-13-0912-01		1daa5008-c4db-41ea-8e40-e551632f8bec		TCGA-13-0912-01		TCGA-13-0912-01A-01D-0402-05	TCGA-13-0912-01A-01W-0421-09		TCGA-13-0912-01A-01W-0421-09		TCGA-13-0912-01A-01D-0399-01	TCGA-13-0912-01			TCGA-13-0912-01A-01D-0399-01					TCGA-13-0912-01			TCGA-13-0912-01A-01W-0421-09	TCGA-13-0912-01A-01R-0406-07	
TCGA-13-0913-01	0	TCGA-13-0913-01	3325	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0913	871	1	days	3325	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			53	Bilateral	TCGA-13-0913-F72630	TCGA-13-0913	TCGA-13-0913-01A	Stage IIIC	-19573			0	3325		871			Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO	80	1.3			G3			YES			TCGA-13-0913.E8FB6EA9-586A-452F-B6A6-0746F16B51DB.pdf	0913	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2006	TCGA-13-0913-01	TCGA-13-0913-01		e993c6b2-05c7-4404-b8d8-a4e3ce8a8253		TCGA-13-0913-01		TCGA-13-0913-01A-01D-0402-05		TCGA-13-0913-01A-21-20		cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	TCGA-13-0913-01A-01D-0399-01	TCGA-13-0913-01	8887c7f4-1bc4-4ec6-874f-453c17e1646e,0c76e11e-e654-49d5-9469-aec43bc8eb96		TCGA-13-0913-01A-01D-0399-01	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9		cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	TCGA-13-0913-01A-01W-0420-08	TCGA-13-0913-01	TCGA-13-0913-01	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	TCGA-13-0913-01A-01W-0420-08	TCGA-13-0913-01A-01R-0406-07	
TCGA-13-0913-02	0	TCGA-13-0913-02	3325	0	days		C9-OV	OV-like c1			miRNA cluster 2		mutation cluster 5	TCGA-13-0913	871	1	days	3325	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			53	Bilateral	TCGA-13-0913-F72630	TCGA-13-0913	TCGA-13-0913-02A	Stage IIIC	-19573			0	3325		871			Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	80	1.4			G3			YES			TCGA-13-0913.61FBF10C-A508-4D83-971D-5A48BA81F08A.pdf	0913	Pre-Adjuvant Therapy	WITH TUMOR						Recurrent Tumor	02	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-13-0913-02		b9367a1a-2b4b-4beb-a02f-743f826bf85d		TCGA-13-0913-02		TCGA-13-0913-02A-01D-0807-05							8c5c67e0-0a80-43b4-b35f-ddd51163b452											TCGA-13-0913-02A-01R-0810-07	
TCGA-13-0916-01	0	TCGA-13-0916-01	1785	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0916	1785	0	days	1785	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-13-0916-F72631	TCGA-13-0916	TCGA-13-0916-01A	Stage IIIC	-18189			0	1785					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3			NO			TCGA-13-0916.28A2A65C-70A2-40D2-A03A-F68884457C14.pdf	0916		TUMOR FREE						Primary Tumor	01	0.6			13	No Macroscopic disease	Ovary		A	LIVING	2006	TCGA-13-0916-01	TCGA-13-0916-01		468b249e-69a0-4728-a0a3-cbe7fad18499		TCGA-13-0916-01		TCGA-13-0916-01A-01D-0402-05		TCGA-13-0916-01A-21-20		63c52e46-68cf-4dac-9bd7-37081daa4474	TCGA-13-0916-01A-01D-0399-01	TCGA-13-0916-01	3a88bad5-3325-409f-8023-5e2df3ba1bf4		TCGA-13-0916-01A-01D-0399-01	63c52e46-68cf-4dac-9bd7-37081daa4474		63c52e46-68cf-4dac-9bd7-37081daa4474	TCGA-13-0916-01A-01W-0420-08	TCGA-13-0916-01	TCGA-13-0916-01	63c52e46-68cf-4dac-9bd7-37081daa4474	TCGA-13-0916-01A-01W-0420-08	TCGA-13-0916-01A-01R-0406-07	
TCGA-13-0919-01	0	TCGA-13-0919-01	2571	0	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-0919	2571	0	days	2571	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Bilateral	TCGA-13-0919-F72632	TCGA-13-0919		Stage IIIC	-19337			0	2571					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				80				G3			NO				0919	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01				13	No Macroscopic disease	Ovary			LIVING	2007		TCGA-13-0919-01	TCGA-13-0919-01A-01W-0419-10	f00f1225-2b6a-4d61-a3e1-909fd595b624		TCGA-13-0919-01	TCGA-13-0919-01A-01W-0419-10	TCGA-13-0919-01A-01D-0402-05					TCGA-13-0919-01A-01D-0399-01	TCGA-13-0919-01			TCGA-13-0919-01A-01D-0399-01					TCGA-13-0919-01			TCGA-13-0919-01A-01W-0419-10	TCGA-13-0919-01A-01R-0406-07	
TCGA-13-0920-01	1	TCGA-13-0920-01	1484	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0920	297	1	days	1484	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			65	Bilateral	TCGA-13-0920-F72633	TCGA-13-0920	TCGA-13-0920-01A	Stage IIIC	-24064		1484	0	420		297			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G3			YES			TCGA-13-0920.6880B406-08B2-43CE-9274-5826B1BE9114.pdf	0920		WITH TUMOR						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2007	TCGA-13-0920-01	TCGA-13-0920-01		f109f013-990a-4e2d-9bce-b3dce60e5b0f		TCGA-13-0920-01		TCGA-13-0920-01A-01D-0402-05	TCGA-13-0920-01A-01W-0421-09	TCGA-13-0920-01A-21-20	TCGA-13-0920-01A-01W-0421-09	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	TCGA-13-0920-01A-01D-0399-01	TCGA-13-0920-01	1aaaee17-5206-42cc-b678-f4a4e712ae54		TCGA-13-0920-01A-01D-0399-01	2d8e1b4d-85d0-4bfd-99f7-59559dabe978		2d8e1b4d-85d0-4bfd-99f7-59559dabe978		TCGA-13-0920-01	TCGA-13-0920-01	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	TCGA-13-0920-01A-01W-0421-09	TCGA-13-0920-01A-01R-0406-07	
TCGA-13-0921-01	1	TCGA-13-0921-01	1483	1	days	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 3		TCGA-13-0921			days	1483	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			72	Bilateral	TCGA-13-0921-F72634	TCGA-13-0921	TCGA-13-0921-01A	Stage IIIC	-26606		1483	0	141						2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3						TCGA-13-0921.307EC276-EE89-45D3-8B61-4F217C0F61C4.pdf	0921		TUMOR FREE						Primary Tumor	01	0.2			13	No Macroscopic disease	Ovary		A	DECEASED	2008		TCGA-13-0921-01		d4b09b28-c890-406a-97d4-3354bb5484c6		TCGA-13-0921-01		TCGA-13-0921-01A-01D-0402-05		TCGA-13-0921-01A-21-20			TCGA-13-0921-01A-01D-0399-01	TCGA-13-0921-01	56e2b31e-e133-45fa-a38c-9f1c8825194c		TCGA-13-0921-01A-01D-0399-01					TCGA-13-0921-01				TCGA-13-0921-01A-01R-0406-07	
TCGA-13-0923-01	0	TCGA-13-0923-01	2547	0	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0923	1719	1	days	2547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			74	Right	TCGA-13-0923-F72635	TCGA-13-0923	TCGA-13-0923-01A	Stage IIIC	-27081			0	2547		1719			Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection			NO					G3			YES			TCGA-13-0923.06AB5B8C-7B57-43B0-8376-7A05C58AFC1A.pdf	0923		TUMOR FREE						Primary Tumor	01				13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-0923-01		5e88feda-6485-4934-9c79-2c5c88e908de		TCGA-13-0923-01		TCGA-13-0923-01A-01D-0402-05					TCGA-13-0923-01A-01D-0399-01	TCGA-13-0923-01			TCGA-13-0923-01A-01D-0399-01				TCGA-13-0923-01A-01W-0420-08	TCGA-13-0923-01			TCGA-13-0923-01A-01W-0420-08	TCGA-13-0923-01A-01R-0406-07	
TCGA-13-0924-01	0	TCGA-13-0924-01	2614	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0924	962	1	days	2614	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Bilateral	TCGA-13-0924-F72636	TCGA-13-0924	TCGA-13-0924-01A	Stage IV	-16670			0	2614		962			Stable Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)			NO					G3			YES			TCGA-13-0924.2EA17F21-1594-430A-97E3-29C5F49CB3BC.pdf	0924		WITH TUMOR						Primary Tumor	01				13	1-10 mm	Ovary		A	LIVING	2008	TCGA-13-0924-01	TCGA-13-0924-01		b0dae9c4-1401-4b88-94cb-bef931901b94		TCGA-13-0924-01		TCGA-13-0924-01A-01D-0402-05	TCGA-13-0924-01A-01W-0421-09		TCGA-13-0924-01A-01W-0421-09	85a4c41b-9829-48f8-9c7a-a9de870332b6	TCGA-13-0924-01A-01D-0399-01	TCGA-13-0924-01			TCGA-13-0924-01A-01D-0399-01	85a4c41b-9829-48f8-9c7a-a9de870332b6		85a4c41b-9829-48f8-9c7a-a9de870332b6		TCGA-13-0924-01	TCGA-13-0924-01	85a4c41b-9829-48f8-9c7a-a9de870332b6	TCGA-13-0924-01A-01W-0421-09	TCGA-13-0924-01A-01R-0406-07	
TCGA-13-1403-01	1	TCGA-13-1403-01	2345	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1403	418	1	days	2345	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Left	TCGA-13-1403-F72653	TCGA-13-1403	TCGA-13-1403-01A	Stage IIIC	-17697		2345	0	331		418			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.2			G3			YES			TCGA-13-1403.435619AB-01F5-4AC3-8D28-A8CC0054699F.pdf	1403		WITH TUMOR						Primary Tumor	01	0.4			13		Ovary		A	DECEASED	2008	TCGA-13-1403-01	TCGA-13-1403-01		88424970-6ba5-4c0f-ac01-f06513be5b42		TCGA-13-1403-01		TCGA-13-1403-01A-01D-0460-05	TCGA-13-1403-01A-01W-0494-09		TCGA-13-1403-01A-01W-0494-09	3217dd54-d41c-4c63-8bab-ff2c4baaee10	TCGA-13-1403-01A-01D-0452-01	TCGA-13-1403-01			TCGA-13-1403-01A-01D-0452-01	3217dd54-d41c-4c63-8bab-ff2c4baaee10		3217dd54-d41c-4c63-8bab-ff2c4baaee10		TCGA-13-1403-01	TCGA-13-1403-01	3217dd54-d41c-4c63-8bab-ff2c4baaee10	TCGA-13-1403-01A-01W-0494-09	TCGA-13-1403-01A-01R-0456-07	
TCGA-13-1404-01	0	TCGA-13-1404-01	2469	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1404	1581	1	days	2469	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Bilateral	TCGA-13-1404-F72655	TCGA-13-1404	TCGA-13-1404-01A	Stage IIIC	-17784			0	2469		1581			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	60	1.5			G3			YES			TCGA-13-1404.39B73962-A374-4521-BFBB-F10D117979F9.pdf	1404	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1404-01		454548ae-a10c-4811-a88b-5e893ffe1caa		TCGA-13-1404-01		TCGA-13-1404-01A-01D-0460-05	TCGA-13-1404-01A-01W-0494-09	TCGA-13-1404-01A-21-1562-20	TCGA-13-1404-01A-01W-0494-09		TCGA-13-1404-01A-01D-0452-01	TCGA-13-1404-01	b9dd3b0f-e45a-400a-8078-5d421d257726		TCGA-13-1404-01A-01D-0452-01					TCGA-13-1404-01			TCGA-13-1404-01A-01W-0494-09	TCGA-13-1404-01A-01R-0456-07	
TCGA-13-1405-01	1	TCGA-13-1405-01	868	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1405	228	1	days	868	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-13-1405-F72656	TCGA-13-1405	TCGA-13-1405-01A	Stage IV	-18218		868	0	224		228			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO	80	1.3			G3			YES			TCGA-13-1405.DFB9F8B2-986C-4963-B2D2-837E54174CF0.pdf	1405	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2008	TCGA-13-1405-01	TCGA-13-1405-01		04d8cf12-0689-4e2d-a8e9-771920563560		TCGA-13-1405-01		TCGA-13-1405-01A-01D-0460-05	TCGA-13-1405-01A-01W-0494-09	TCGA-13-1405-01A-21-1562-20	TCGA-13-1405-01A-01W-0494-09	044d949f-0eb4-44c9-8327-90226936fc7c	TCGA-13-1405-01A-01D-0452-01	TCGA-13-1405-01	79cd114a-31d2-468d-92e6-5ea925e61918		TCGA-13-1405-01A-01D-0452-01	044d949f-0eb4-44c9-8327-90226936fc7c		044d949f-0eb4-44c9-8327-90226936fc7c		TCGA-13-1405-01	TCGA-13-1405-01	044d949f-0eb4-44c9-8327-90226936fc7c	TCGA-13-1405-01A-01W-0494-09	TCGA-13-1405-01A-01R-0456-07	
TCGA-13-1407-01	0	TCGA-13-1407-01	2534	0	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-1407	1333	1	days	2534	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-13-1407-F72657	TCGA-13-1407		Stage IIIC	-18896			0	2534		1333			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3			YES				1407		WITH TUMOR						Primary Tumor	01				13		Ovary			LIVING	2008		TCGA-13-1407-01	TCGA-13-1407-01A-01W-0490-10	ba5b2281-2b96-47e8-92b9-0221c434b4e9		TCGA-13-1407-01	TCGA-13-1407-01A-01W-0490-10	TCGA-13-1407-01A-01D-0460-05					TCGA-13-1407-01A-01D-0452-01	TCGA-13-1407-01			TCGA-13-1407-01A-01D-0452-01					TCGA-13-1407-01			TCGA-13-1407-01A-01W-0490-10	TCGA-13-1407-01A-01R-0456-07	
TCGA-13-1408-01	1	TCGA-13-1408-01	1680	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 14	TCGA-13-1408	765	1	days	1680	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59		TCGA-13-1408-F72659	TCGA-13-1408	TCGA-13-1408-01A	Stage IIIC	-21635		1680	0	180		765			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.8			G3			YES			TCGA-13-1408.39435FCB-699F-4A2F-9005-E67C9A41C766.pdf	1408		WITH TUMOR						Primary Tumor	01	0.3			13	>20 mm	Ovary		A	DECEASED	2008		TCGA-13-1408-01	TCGA-13-1408-01A-01W-0490-10	3f056922-bdb4-4a8f-8a4d-9116cae32ae8		TCGA-13-1408-01	TCGA-13-1408-01A-01W-0490-10	TCGA-13-1408-01A-01D-0460-05		TCGA-13-1408-01A-21-1562-20			TCGA-13-1408-01A-01D-0452-01	TCGA-13-1408-01	c9dc89ec-e887-4acc-90a5-6fd20f4a1483		TCGA-13-1408-01A-01D-0452-01					TCGA-13-1408-01			TCGA-13-1408-01A-01W-0490-10	TCGA-13-1408-01A-01R-0456-07	
TCGA-13-1409-01	1	TCGA-13-1409-01	1742	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1409	690	1	days	1742	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73		TCGA-13-1409-F72660	TCGA-13-1409	TCGA-13-1409-01A	Stage IIIC	-26836		1742	0	208		690			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		1	NO	60	1.6			G3			YES			TCGA-13-1409.3F18B612-EE50-4459-8CAF-61A12157DD8A.pdf	1409	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.6			13	1-10 mm	Ovary		A	DECEASED	2008		TCGA-13-1409-01		c4293c0c-8d5d-40b4-9f84-42633383f950		TCGA-13-1409-01		TCGA-13-1409-01A-01D-0460-05		TCGA-13-1409-01A-21-20			TCGA-13-1409-01A-01D-0452-01	TCGA-13-1409-01	8c0c5cc9-dbb0-49ed-96c4-7fde7d37fd25		TCGA-13-1409-01A-01D-0452-01				TCGA-13-1409-01A-01W-0492-08	TCGA-13-1409-01			TCGA-13-1409-01A-01W-0492-08	TCGA-13-1409-01A-01R-0456-07	
TCGA-13-1410-01	0	TCGA-13-1410-01	2464	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1410	319	1	days	2464	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Bilateral	TCGA-13-1410-F72661	TCGA-13-1410	TCGA-13-1410-01A	Stage IV	-20950			0	2464		319			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO	60	1.9			GX			YES			TCGA-13-1410.0F641D88-673B-48C4-97F5-730DA3FD343C.pdf	1410	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.5			13		Ovary		A	LIVING	2008	TCGA-13-1410-01	TCGA-13-1410-01		e8da901b-05d8-4448-8e0c-52c558fe2ea8		TCGA-13-1410-01		TCGA-13-1410-01A-01D-0460-05		TCGA-13-1410-01A-21-20		fdda1428-ad6b-4337-a959-83bae1f9664b	TCGA-13-1410-01A-01D-0452-01	TCGA-13-1410-01	3f2151ce-1e04-4a0e-8ded-e59696b705cb		TCGA-13-1410-01A-01D-0452-01	fdda1428-ad6b-4337-a959-83bae1f9664b		fdda1428-ad6b-4337-a959-83bae1f9664b	TCGA-13-1410-01A-01W-0492-08	TCGA-13-1410-01	TCGA-13-1410-01	fdda1428-ad6b-4337-a959-83bae1f9664b	TCGA-13-1410-01A-01W-0492-08	TCGA-13-1410-01A-01R-0456-07	
TCGA-13-1411-01	1	TCGA-13-1411-01	531	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-1411	238	1	days	531	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			81		TCGA-13-1411-F72662	TCGA-13-1411	TCGA-13-1411-01A	Stage IIIC	-29874		531	0	128		238			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		1.7			G3			YES			TCGA-13-1411.F73F2D6F-3FD9-4457-921A-9EE0E47A6470.pdf	1411		WITH TUMOR						Primary Tumor	01	0.3			13	>20 mm	Ovary		A	DECEASED	2008	TCGA-13-1411-01	TCGA-13-1411-01		88a02ee5-0e09-4181-ad62-88ec7f877f45		TCGA-13-1411-01		TCGA-13-1411-01A-01D-0460-05	TCGA-13-1411-01A-01W-0494-09	TCGA-13-1411-01A-21-20	TCGA-13-1411-01A-01W-0494-09	0069c63d-f699-41d4-9798-9a109d1c09df	TCGA-13-1411-01A-01D-0452-01	TCGA-13-1411-01	438d9016-0b99-46f7-b8ad-21c125f4bedd		TCGA-13-1411-01A-01D-0452-01	0069c63d-f699-41d4-9798-9a109d1c09df		0069c63d-f699-41d4-9798-9a109d1c09df		TCGA-13-1411-01	TCGA-13-1411-01	0069c63d-f699-41d4-9798-9a109d1c09df	TCGA-13-1411-01A-01W-0494-09	TCGA-13-1411-01A-01R-0456-07	
TCGA-13-1412-01	1	TCGA-13-1412-01	984	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1412	409	1	days	984	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			41	Bilateral	TCGA-13-1412-F72669	TCGA-13-1412	TCGA-13-1412-01A	Stage IV	-15119		984	0	162		409			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO	80	1.1			G3			YES			TCGA-13-1412.D36FA0B4-9605-498F-B815-1BE4BF64E100.pdf	1412	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2008		TCGA-13-1412-01		54620fb3-d7d9-4d00-a77b-4d8dcfee4d55		TCGA-13-1412-01		TCGA-13-1412-01A-01D-0460-05	TCGA-13-1412-01A-01W-0494-09	TCGA-13-1412-01A-21-20	TCGA-13-1412-01A-01W-0494-09		TCGA-13-1412-01A-01D-0452-01	TCGA-13-1412-01	b22eb00b-8fcc-4fd5-b396-1169f7f025fd		TCGA-13-1412-01A-01D-0452-01					TCGA-13-1412-01			TCGA-13-1412-01A-01W-0494-09	TCGA-13-1412-01A-01R-0456-07	
TCGA-13-1477-01	1	TCGA-13-1477-01	1662	1	days	Iq	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-13-1477			days	1662	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	49	Bilateral	TCGA-13-1477-F24839	TCGA-13-1477	TCGA-13-1477-01A	Stage IV	-18111		1662	0	1662		235				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		1.3	NO		1.3			G2	Progression of Disease					TCGA-13-1477.2507FA0F-9709-4B5D-9EC1-907637FB373A.pdf	1477	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2000		TCGA-13-1477-01		7bc1d947-f625-418c-b577-c66aea3e33c4		TCGA-13-1477-01		TCGA-13-1477-01A-01D-0475-05		TCGA-13-1477-01A-21-1562-20			TCGA-13-1477-01A-01D-0472-01	TCGA-13-1477-01	fa473bf9-b927-4d17-ac77-ad0e52f01cac		TCGA-13-1477-01A-01D-0472-01				TCGA-13-1477-01A-01D-0472-08	TCGA-13-1477-01			TCGA-13-1477-01A-01D-0472-08	TCGA-13-1477-01A-01R-0479-07	
TCGA-13-1479-01		TCGA-13-1479-01			days									TCGA-13-1479			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary																																																																					TCGA-13-1479-01A-01D-0475-05																		TCGA-13-1479-01A-01R-0479-07	
TCGA-13-1481-01	1	TCGA-13-1481-01	2648	1	days	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1481			days	2648	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			76	Right	TCGA-13-1481-F24843	TCGA-13-1481	TCGA-13-1481-01A	Stage IIIC	-27898		2648	0	2648						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.4			G2						TCGA-13-1481.4832CBA4-9482-4A2A-A9E1-4E8489B0F157.pdf	1481		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2000	TCGA-13-1481-01	TCGA-13-1481-01		2b0cdd7b-9556-4bd5-bf80-1daa495b38e3		TCGA-13-1481-01		TCGA-13-1481-01A-01D-0475-05	TCGA-13-1481-01A-01W-0549-09	TCGA-13-1481-01A-21-1562-20	TCGA-13-1481-01A-01W-0549-09	761f9668-304f-4e22-87cd-2005aa86152c	TCGA-13-1481-01A-01D-0472-01	TCGA-13-1481-01	8b7b0f6e-4f3b-40f2-8ca0-7de1000f473a		TCGA-13-1481-01A-01D-0472-01	761f9668-304f-4e22-87cd-2005aa86152c		761f9668-304f-4e22-87cd-2005aa86152c		TCGA-13-1481-01	TCGA-13-1481-01	761f9668-304f-4e22-87cd-2005aa86152c	TCGA-13-1481-01A-01W-0549-09	TCGA-13-1481-01A-01R-0479-07	
TCGA-13-1482-01	1	TCGA-13-1482-01	1877	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1482			days	1877	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52		TCGA-13-1482-F24848	TCGA-13-1482		Stage IV	-19178		1877	0	1877		602				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)				80				G2	Recurrence						1482	Preoperative	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01				13	>20 mm	Ovary			DECEASED	2000		TCGA-13-1482-01		c2b1ef9b-a1b3-4fe9-b35f-841893a6092d		TCGA-13-1482-01		TCGA-13-1482-01A-01D-0475-05	TCGA-13-1482-01A-01W-0549-09	TCGA-13-1482-01A-21-1562-20	TCGA-13-1482-01A-01W-0549-09		TCGA-13-1482-01A-01D-0472-01	TCGA-13-1482-01	db641a43-1973-4213-a4ed-42fa9ff8e8ec		TCGA-13-1482-01A-01D-0472-01					TCGA-13-1482-01			TCGA-13-1482-01A-01W-0549-09	TCGA-13-1482-01A-01R-0479-07	
TCGA-13-1483-01	1	TCGA-13-1483-01	895	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-1483			days	895	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61		TCGA-13-1483-F24852	TCGA-13-1483	TCGA-13-1483-01A	Stage IIIC	-22342		895	0	895		297				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		1.4	NO	60	1.8			G3	Recurrence					TCGA-13-1483.c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db.pdf	1483	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2000		TCGA-13-1483-01		ba90cac1-6c52-4111-99f5-8cb3cb11faeb		TCGA-13-1483-01		TCGA-13-1483-01A-01D-0475-05	TCGA-13-1483-01A-01W-0549-09	TCGA-13-1483-01A-21-1562-20	TCGA-13-1483-01A-01W-0549-09		TCGA-13-1483-01A-01D-0472-01	TCGA-13-1483-01	3ab7ed23-61b4-4c74-8668-25b7ee186bf7		TCGA-13-1483-01A-01D-0472-01					TCGA-13-1483-01			TCGA-13-1483-01A-01W-0549-09	TCGA-13-1483-01A-01R-0479-07	
TCGA-13-1484-01	1	TCGA-13-1484-01	3785	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6		miRNA cluster 1	cluster 6	mutation cluster 8	TCGA-13-1484	497	1	days	3785	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62		TCGA-13-1484-F72640	TCGA-13-1484	TCGA-13-1484-01A	Stage IIIC	-22698		3785	0	2982		497			Progressive Disease	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		0.6	NO	80	1.5			G3			YES			TCGA-13-1484.CF223E16-1613-4FAB-A4DA-86D5ECE7B55E.pdf	1484	Preoperative	WITH TUMOR						Primary Tumor	01	0.3			13		Ovary		A	DECEASED	2000		TCGA-13-1484-01		53f117b0-5e33-4abf-9720-e3358f62ed9a		TCGA-13-1484-01		TCGA-13-1484-01A-01D-0475-05		TCGA-13-1484-01A-21-1562-20			TCGA-13-1484-01A-01D-0472-01	TCGA-13-1484-01	d48335c8-f1dd-472d-a4d6-6ad7eb5d081d		TCGA-13-1484-01A-01D-0472-01				TCGA-13-1484-01A-01W-0545-08	TCGA-13-1484-01			TCGA-13-1484-01A-01W-0545-08	TCGA-13-1484-01A-01R-0479-07	
TCGA-13-1485-01	1	TCGA-13-1485-01	629	1	days	High		OV-like c1			miRNA cluster 3	cluster 6		TCGA-13-1485			days	629	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-13-1485-F24861	TCGA-13-1485		Stage IV	-17642		629	0	629		170				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy				80				G2	Progression of Disease						1485	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2001		TCGA-13-1485-01		a1378617-e3ff-4bfa-adef-03e4c07512fa		TCGA-13-1485-01		TCGA-13-1485-01A-02D-0475-05					TCGA-13-1485-01A-02D-0472-01	TCGA-13-1485-01			TCGA-13-1485-01A-02D-0472-01					TCGA-13-1485-01				TCGA-13-1485-01A-02R-0479-07	
TCGA-13-1487-01	1	TCGA-13-1487-01	681	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1487			days	681	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74		TCGA-13-1487-F24865	TCGA-13-1487		Stage IV	-27176		681	0	681		412				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								GX	Recurrence						1487		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01				13		Ovary			DECEASED	2002		TCGA-13-1487-01		a7c48735-a4be-424a-a3cd-125cf2e2a274		TCGA-13-1487-01		TCGA-13-1487-01A-01D-0475-05		TCGA-13-1487-01A-21-1562-20			TCGA-13-1487-01A-01D-0472-01	TCGA-13-1487-01	f10389e0-3564-4067-b82a-d0be5d5eec92		TCGA-13-1487-01A-01D-0472-01				TCGA-13-1487-01A-01D-0472-08	TCGA-13-1487-01			TCGA-13-1487-01A-01D-0472-08	TCGA-13-1487-01A-01R-0479-07	
TCGA-13-1488-01	1	TCGA-13-1488-01	2154	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1488			days	2154	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-13-1488-F24871	TCGA-13-1488	TCGA-13-1488-01A	Stage IV	-21726		2154	0	2154		351				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	80	2.3			G3	Recurrence					TCGA-13-1488.79A91E41-0B59-4328-B7BB-2B4EEAD46A89.pdf	1488	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			13	11-20 mm	Ovary		A	DECEASED	2002		TCGA-13-1488-01		6b1d30b6-321c-4d55-bf9f-dfb4be92210b		TCGA-13-1488-01		TCGA-13-1488-01A-01D-0475-05	TCGA-13-1488-01A-01W-0549-09	TCGA-13-1488-01A-21-1562-20	TCGA-13-1488-01A-01W-0549-09		TCGA-13-1488-01A-01D-0472-01	TCGA-13-1488-01	1ec3bf38-f06e-4789-a298-cde202cf3649		TCGA-13-1488-01A-01D-0472-01					TCGA-13-1488-01			TCGA-13-1488-01A-01W-0549-09	TCGA-13-1488-01A-01R-0479-07	
TCGA-13-1489-01	1	TCGA-13-1489-01	2553	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-13-1489	806	1	days	2553	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			70	Bilateral	TCGA-13-1489-F72641	TCGA-13-1489		Stage IIIC	-25768		2553	0	2521		806			Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				80				G2			YES				1489	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01				13		Ovary			DECEASED	2002		TCGA-13-1489-01		aeb47cad-0087-4bf3-aa09-3751a6dcb269		TCGA-13-1489-01		TCGA-13-1489-01A-01D-0475-05	TCGA-13-1489-01A-01W-0549-09	TCGA-13-1489-01A-21-1562-20	TCGA-13-1489-01A-01W-0549-09		TCGA-13-1489-01A-01D-0472-01	TCGA-13-1489-01	f99befac-a46e-43a1-91b7-e4a492dae82f,c35fe897-f2eb-4dcb-a571-89f2c27ffa6a		TCGA-13-1489-01A-01D-0472-01					TCGA-13-1489-01			TCGA-13-1489-01A-01W-0549-09	TCGA-13-1489-01A-01R-0479-07	
TCGA-13-1489-02	1	TCGA-13-1489-02	2553	1	days		C9-OV	OV-like c1		OV-like c16	miRNA cluster 3		mutation cluster 5	TCGA-13-1489	806	1	days	2553	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			70	Bilateral	TCGA-13-1489-F72641	TCGA-13-1489	TCGA-13-1489-02A	Stage IIIC	-25768		2553	0	2521		806			Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1			G2			YES			TCGA-13-1489.639712E8-5C63-433C-8F23-4C78FF37D8FC.pdf	1489	Pre-Adjuvant Therapy	TUMOR FREE						Recurrent Tumor	02	0.4			13		Ovary		A	DECEASED	2002		TCGA-13-1489-02		141d2716-c6c3-4495-b30f-12dc204d77a3		TCGA-13-1489-02		TCGA-13-1489-02A-01D-0807-05				d8cd1ca1-dc00-4a48-ab81-5d23daed6fce			d95612da-1768-4b34-bb28-607208c05c38			d8cd1ca1-dc00-4a48-ab81-5d23daed6fce		d8cd1ca1-dc00-4a48-ab81-5d23daed6fce				d8cd1ca1-dc00-4a48-ab81-5d23daed6fce		TCGA-13-1489-02A-01R-0810-07	
TCGA-13-1491-01	1	TCGA-13-1491-01	1595	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1491			days	1595	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-13-1491-F24884	TCGA-13-1491	TCGA-13-1491-01A	Stage IIIC	-20262		1595	0	1595		508				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		0.6	NO	60	2			G3	Recurrence					TCGA-13-1491.051EAB19-C9CF-407E-A0C3-19CB76368C22.pdf	1491	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			13		Ovary		A	DECEASED	2002		TCGA-13-1491-01		7ae5754b-5508-416e-96ec-fe3221d6e2ff		TCGA-13-1491-01		TCGA-13-1491-01A-01D-0475-05	TCGA-13-1491-01A-01W-0549-09	TCGA-13-1491-01A-21-1562-20	TCGA-13-1491-01A-01W-0549-09		TCGA-13-1491-01A-01D-0472-01	TCGA-13-1491-01	a2142ff2-fb53-4517-b0d5-9f25ba91ea1a		TCGA-13-1491-01A-01D-0472-01					TCGA-13-1491-01			TCGA-13-1491-01A-01W-0549-09	TCGA-13-1491-01A-01R-0479-07	
TCGA-13-1492-01	1	TCGA-13-1492-01	3819	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1492	3819	0	days	3819	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			66		TCGA-13-1492-F72643	TCGA-13-1492	TCGA-13-1492-01A	Stage IIIC	-24332		3819	0	2237					Complete Remission/Response	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		1.2	NO	80	2.5			G3			NO			TCGA-13-1492.566BE185-8A2E-43C4-9762-65216AB9AC44.pdf	1492	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.4			13		Ovary		A	DECEASED	2002		TCGA-13-1492-01		c37d0090-3b9a-4832-934a-299d8a7f6a2d		TCGA-13-1492-01		TCGA-13-1492-01A-01D-0475-05		TCGA-13-1492-01A-21-1562-20			TCGA-13-1492-01A-01D-0472-01	TCGA-13-1492-01	943e741f-3371-4167-99e0-fd795663874c		TCGA-13-1492-01A-01D-0472-01				TCGA-13-1492-01A-01D-0472-08	TCGA-13-1492-01			TCGA-13-1492-01A-01D-0472-08	TCGA-13-1492-01A-01R-0479-07	
TCGA-13-1494-01	1	TCGA-13-1494-01	2856	1	days	Squamous	C9-OV	OV-like c1	KIRC-like c1		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1494	693	1	days	2856	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			43	Bilateral	TCGA-13-1494-F72644	TCGA-13-1494		Stage IV	-15993		2856	0	1162		693				2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy								G3			YES				1494		WITH TUMOR						Primary Tumor	01				13		Ovary			DECEASED	2004		TCGA-13-1494-01		d8a57388-6e4e-4865-a68f-7485dec8304f		TCGA-13-1494-01		TCGA-13-1494-01A-01D-0475-05		TCGA-13-1494-01A-21-1562-20			TCGA-13-1494-01A-01D-0472-01	TCGA-13-1494-01	af9b3f69-ef63-4303-85c6-8f6936dc6b6e		TCGA-13-1494-01A-01D-0472-01				TCGA-13-1494-01A-01W-0545-08	TCGA-13-1494-01			TCGA-13-1494-01A-01W-0545-08	TCGA-13-1494-01A-01R-0479-07	
TCGA-13-1495-01	1	TCGA-13-1495-01	2749	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-1495	977	1	days	2749	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Bilateral	TCGA-13-1495-F72645	TCGA-13-1495	TCGA-13-1495-01A	Stage IIIC	-22046		2749	0	1498		977				2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	80	2.1			G2			YES			TCGA-13-1495.51F0A8BF-0E86-402D-BE9F-D41771ED98A3.pdf	1495	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2004		TCGA-13-1495-01		2476b238-9e59-49ae-ac0d-456ad4fe4ffc		TCGA-13-1495-01		TCGA-13-1495-01A-01D-0475-05		TCGA-13-1495-01A-21-1562-20			TCGA-13-1495-01A-01D-0472-01	TCGA-13-1495-01	15443f5b-51c9-496d-bf7a-99693ca3b943		TCGA-13-1495-01A-01D-0472-01				TCGA-13-1495-01A-01W-0545-08	TCGA-13-1495-01			TCGA-13-1495-01A-01W-0545-08	TCGA-13-1495-01A-01R-0479-07	
TCGA-13-1496-01	1	TCGA-13-1496-01	129	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1496			days	129	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			65	Bilateral	TCGA-13-1496-F24904	TCGA-13-1496	TCGA-13-1496-01A	Stage IIIC	-23993		129	0	129						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.1			G3						TCGA-13-1496.BCDD1BDE-689B-455D-81A7-C2522417E055.pdf	1496			YES			NO		Primary Tumor	01	0.3			13	>20 mm	Ovary		A	DECEASED	2004		TCGA-13-1496-01		e75a75ac-204d-48b0-891e-c3d6e979d4d4		TCGA-13-1496-01		TCGA-13-1496-01A-01D-0475-05		TCGA-13-1496-01A-21-1562-20			TCGA-13-1496-01A-01D-0472-01	TCGA-13-1496-01	35781069-501d-45c3-b3f0-7292b0186211		TCGA-13-1496-01A-01D-0472-01				TCGA-13-1496-01A-01W-0545-08	TCGA-13-1496-01			TCGA-13-1496-01A-01W-0545-08	TCGA-13-1496-01A-01R-0479-07	
TCGA-13-1497-01	0	TCGA-13-1497-01	3871	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1497	813	1	days	3871	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			47		TCGA-13-1497-F72646	TCGA-13-1497		Stage IIIC	-17528			0	3871		813			Complete Remission/Response	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)				80				G3			YES				1497	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01				13		Ovary			LIVING	2004	TCGA-13-1497-01	TCGA-13-1497-01		d53c30c7-126f-40ec-9e02-4a1d2a3e2681		TCGA-13-1497-01		TCGA-13-1497-01A-01D-0475-05	TCGA-13-1497-01A-01W-0549-09		TCGA-13-1497-01A-01W-0549-09	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	TCGA-13-1497-01A-01D-0472-01	TCGA-13-1497-01			TCGA-13-1497-01A-01D-0472-01	eb61bd52-e5fa-4c33-a2e4-1353a42184d9		eb61bd52-e5fa-4c33-a2e4-1353a42184d9		TCGA-13-1497-01	TCGA-13-1497-01	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	TCGA-13-1497-01A-01W-0549-09	TCGA-13-1497-01A-01R-0479-07	
TCGA-13-1498-01	1	TCGA-13-1498-01	2012	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-1498	534	1	days	2012	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73		TCGA-13-1498-F72647	TCGA-13-1498	TCGA-13-1498-01A	Stage IIIC	-26820		2012	0	1144		534			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO	60	1.1			G3			YES			TCGA-13-1498.0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1.pdf	1498	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2006	TCGA-13-1498-01	TCGA-13-1498-01		0fe423b7-115f-48a2-bc4a-9eec87f319e2		TCGA-13-1498-01		TCGA-13-1498-01A-01D-0475-05	TCGA-13-1498-01A-01W-0549-09	TCGA-13-1498-01A-21-1562-20	TCGA-13-1498-01A-01W-0549-09	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	TCGA-13-1498-01A-01D-0472-01	TCGA-13-1498-01	17dca857-f830-4be9-9f2b-5619ae7eb73f		TCGA-13-1498-01A-01D-0472-01	176d1ca2-eb1d-4f49-9b10-c129c822fa5a		176d1ca2-eb1d-4f49-9b10-c129c822fa5a		TCGA-13-1498-01	TCGA-13-1498-01	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	TCGA-13-1498-01A-01W-0549-09	TCGA-13-1498-01A-01R-0479-07	
TCGA-13-1499-01	0	TCGA-13-1499-01	3500	0	days	Squamous	C9-OV	Low purity c2	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1499	583	1	days	3500	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			56		TCGA-13-1499-F72649	TCGA-13-1499	TCGA-13-1499-01A	Stage IIIC	-20668			0	3500		583			Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		1.1	NO	80	2.1			G3			YES			TCGA-13-1499.3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0.pdf	1499	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13		Ovary		A	LIVING	2005		TCGA-13-1499-01		f54b35ad-c934-4df9-ba57-089c4c9d5c1e		TCGA-13-1499-01		TCGA-13-1499-01A-01D-0475-05	TCGA-13-1499-01A-01W-0549-09	TCGA-13-1499-01A-21-1562-20	TCGA-13-1499-01A-01W-0549-09		TCGA-13-1499-01A-01D-0472-01	TCGA-13-1499-01	21c833c6-d2bc-4308-a233-894c7a6636f1		TCGA-13-1499-01A-01D-0472-01					TCGA-13-1499-01			TCGA-13-1499-01A-01W-0549-09	TCGA-13-1499-01A-01R-0479-07	
TCGA-13-1500-01	1	TCGA-13-1500-01	425	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-13-1500			days	425	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-13-1500-F24926	TCGA-13-1500	TCGA-13-1500-01A	Stage IIIC	-26172		425	0	425		253				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.2	NO	80	1.7			G3	Recurrence					TCGA-13-1500.BFC92139-677F-4AD6-93D4-B479B8121449.pdf	1500	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.4			13	11-20 mm	Ovary		A	DECEASED	2006		TCGA-13-1500-01		6bd685eb-c19d-404d-bb70-0d7590034653		TCGA-13-1500-01		TCGA-13-1500-01A-01D-0475-05		TCGA-13-1500-01A-21-1562-20			TCGA-13-1500-01A-01D-0472-01	TCGA-13-1500-01	639afc90-9b92-45f2-a350-6b7e355bbcbc		TCGA-13-1500-01A-01D-0472-01					TCGA-13-1500-01				TCGA-13-1500-01A-01R-0479-07	
TCGA-13-1501-01	1	TCGA-13-1501-01	1314	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-1501	392	1	days	1314	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Bilateral	TCGA-13-1501-F72651	TCGA-13-1501	TCGA-13-1501-01A	Stage IV	-18393		1314	0	999		392			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.2	NO	80	1.5			G3			YES			TCGA-13-1501.7D27D441-D069-4674-A761-299E315D67C1.pdf	1501	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2006		TCGA-13-1501-01		cf8ec1d5-56c7-45b7-8208-58fc6f5d6aa6		TCGA-13-1501-01		TCGA-13-1501-01A-01D-0475-05		TCGA-13-1501-01A-21-1562-20			TCGA-13-1501-01A-01D-0472-01	TCGA-13-1501-01	9f507427-22ed-408e-807f-39a90244bef4		TCGA-13-1501-01A-01D-0472-01				TCGA-13-1501-01A-01W-0545-08	TCGA-13-1501-01			TCGA-13-1501-01A-01W-0545-08	TCGA-13-1501-01A-01R-0479-07	
TCGA-13-1504-01	1	TCGA-13-1504-01	1059	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1504	548	1	days	1059	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			68	Bilateral	TCGA-13-1504-F72652	TCGA-13-1504	TCGA-13-1504-01A	Stage IIIC	-25008		1059	0	504		548			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	60	1.6			G3			YES			TCGA-13-1504.DB8A8258-9893-4968-A91B-5D9D319D0585.pdf	1504	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13		Ovary		A	DECEASED	2007		TCGA-13-1504-01		6ad70118-653d-4476-b26c-4e276f556aaf		TCGA-13-1504-01		TCGA-13-1504-01A-01D-0475-05		TCGA-13-1504-01A-21-1562-20			TCGA-13-1504-01A-01D-0472-01	TCGA-13-1504-01	f1e3f6ff-3c3d-4045-9ab3-bf5803828428		TCGA-13-1504-01A-01D-0472-01				TCGA-13-1504-01A-01W-0545-08	TCGA-13-1504-01			TCGA-13-1504-01A-01W-0545-08	TCGA-13-1504-01A-01R-0479-07	
TCGA-13-1505-01	0	TCGA-13-1505-01	1998	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1505	1561	1	days	1998	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Bilateral	TCGA-13-1505-F72674	TCGA-13-1505	TCGA-13-1505-01A	Stage IIIC	-23238			0	1998		1561			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.2			G3			YES			TCGA-13-1505.ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF.pdf	1505		WITH TUMOR						Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2008	TCGA-13-1505-01	TCGA-13-1505-01		3237c7be-aa7d-47d1-8c46-8d6b4ce5d1c4		TCGA-13-1505-01		TCGA-13-1505-01A-01D-0475-05		TCGA-13-1505-01A-21-1562-20		7774b7d4-2935-4b9b-bf76-312a625629e1	TCGA-13-1505-01A-01D-0472-01	TCGA-13-1505-01	d15e55f3-d7f1-4276-9fe1-17cc18dc2515		TCGA-13-1505-01A-01D-0472-01	7774b7d4-2935-4b9b-bf76-312a625629e1		7774b7d4-2935-4b9b-bf76-312a625629e1	TCGA-13-1505-01A-01D-0472-08	TCGA-13-1505-01	TCGA-13-1505-01	7774b7d4-2935-4b9b-bf76-312a625629e1	TCGA-13-1505-01A-01D-0472-08	TCGA-13-1505-01A-01R-0479-07	
TCGA-13-1506-01	1	TCGA-13-1506-01	1039	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-1506	666	1	days	1039	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Bilateral	TCGA-13-1506-F72675	TCGA-13-1506	TCGA-13-1506-01A	Stage IIIC	-16734		1039	0	134		666			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO	80	1.1			G3			YES			TCGA-13-1506.88E423FF-4070-4F01-A0B0-41B45443E762.pdf	1506	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.2			13		Ovary		A	DECEASED	2008	TCGA-13-1506-01	TCGA-13-1506-01		e9c25372-66bb-4c51-9b0f-8fb53262f48b		TCGA-13-1506-01		TCGA-13-1506-01A-01D-0475-05	TCGA-13-1506-01A-01W-0549-09	TCGA-13-1506-01A-21-1562-20	TCGA-13-1506-01A-01W-0549-09	927c7b6d-3997-453b-81b1-b947341d5819	TCGA-13-1506-01A-01D-0472-01	TCGA-13-1506-01	6bdc5656-6cff-48e4-9625-e953d683aed5		TCGA-13-1506-01A-01D-0472-01	927c7b6d-3997-453b-81b1-b947341d5819		927c7b6d-3997-453b-81b1-b947341d5819		TCGA-13-1506-01	TCGA-13-1506-01	927c7b6d-3997-453b-81b1-b947341d5819	TCGA-13-1506-01A-01W-0549-09	TCGA-13-1506-01A-01R-0479-07	
TCGA-13-1507-01	1	TCGA-13-1507-01	1993	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1507	324	1	days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			77	Bilateral	TCGA-13-1507-F72677	TCGA-13-1507	TCGA-13-1507-01A	Stage IIIC	-28445		1993	0	145		324	1		Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.1	NO	60	2			G3			YES			TCGA-13-1507.0B6D1513-8119-459C-8D5A-8942B8C31179.pdf	1507	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2008	TCGA-13-1507-01	TCGA-13-1507-01		c374d509-5dff-45a7-bb49-b7e273b6f229		TCGA-13-1507-01		TCGA-13-1507-01A-01D-0475-05	TCGA-13-1507-01A-01W-0549-09	TCGA-13-1507-01A-21-1562-20	TCGA-13-1507-01A-01W-0549-09	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	TCGA-13-1507-01A-01D-0472-01	TCGA-13-1507-01	307d0834-99b0-416a-aafb-60d7ec74406f		TCGA-13-1507-01A-01D-0472-01	41a5fa6b-4594-4ef8-b841-fe75c17a13c2		41a5fa6b-4594-4ef8-b841-fe75c17a13c2		TCGA-13-1507-01	TCGA-13-1507-01	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	TCGA-13-1507-01A-01W-0549-09	TCGA-13-1507-01A-01R-0479-07	
TCGA-13-1509-01	0	TCGA-13-1509-01	2438	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1509	578	1	days	2438	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64	Bilateral	TCGA-13-1509-F72678	TCGA-13-1509	TCGA-13-1509-01A	Stage IV	-23481			0	2438		578			Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	40	1.7			G3			YES			TCGA-13-1509.5FB47FA9-299B-4466-A324-20D44C788F8B.pdf	1509	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1509-01		36181328-ff8f-4ad6-9521-7020c689acfe		TCGA-13-1509-01		TCGA-13-1509-01A-01D-0475-05	TCGA-13-1509-01A-01W-0549-09	TCGA-13-1509-01A-21-1562-20	TCGA-13-1509-01A-01W-0549-09		TCGA-13-1509-01A-01D-0472-01	TCGA-13-1509-01	a35cc137-a072-4287-8248-dbc4df213144		TCGA-13-1509-01A-01D-0472-01					TCGA-13-1509-01			TCGA-13-1509-01A-01W-0549-09	TCGA-13-1509-01A-01R-0479-07	
TCGA-13-1510-01	1	TCGA-13-1510-01	1359	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1510	1189	1	days	1359	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Left	TCGA-13-1510-F72679	TCGA-13-1510	TCGA-13-1510-01A	Stage IIIC	-22708		1359	0	78		1189			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		2			G3			YES			TCGA-13-1510.D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D.pdf	1510		WITH TUMOR						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	DECEASED	2008		TCGA-13-1510-01		614859a5-6f16-4f6b-8c26-60646708c1ba		TCGA-13-1510-01		TCGA-13-1510-01A-02D-0475-05					TCGA-13-1510-01A-02D-0472-01	TCGA-13-1510-01			TCGA-13-1510-01A-02D-0472-01				TCGA-13-1510-01A-02D-0472-08	TCGA-13-1510-01			TCGA-13-1510-01A-02D-0472-08	TCGA-13-1510-01A-02R-0479-07	
TCGA-13-1511-01	1	TCGA-13-1511-01	1650	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-13-1511	459	1	days	1650	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Bilateral	TCGA-13-1511-F72680	TCGA-13-1511	TCGA-13-1511-01A	Stage IV	-19258		1650	0	119		459			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.6	NO	60	2.2			G3			YES			TCGA-13-1511.CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0.pdf	1511	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2008	TCGA-13-1511-01	TCGA-13-1511-01		96a8f10e-4b72-4262-9ad7-3ba062ce7f85		TCGA-13-1511-01		TCGA-13-1511-01A-01D-0475-05		TCGA-13-1511-01A-21-1562-20		ccd83080-7a51-4952-b4af-d13e9c182bc0	TCGA-13-1511-01A-01D-0472-01	TCGA-13-1511-01	a5d23561-577b-4b73-979e-8908b15b223e		TCGA-13-1511-01A-01D-0472-01	ccd83080-7a51-4952-b4af-d13e9c182bc0		ccd83080-7a51-4952-b4af-d13e9c182bc0		TCGA-13-1511-01	TCGA-13-1511-01	ccd83080-7a51-4952-b4af-d13e9c182bc0		TCGA-13-1511-01A-01R-0479-07	
TCGA-13-1512-01	0	TCGA-13-1512-01	442	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-13-1512	427	1	days	442	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-13-1512-F72681	TCGA-13-1512	TCGA-13-1512-01A	Stage IIIC	-18134			0	442		427			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		1.4	NO	60	2			G3			YES			TCGA-13-1512.66DC098E-9ADD-4446-AB6D-FEA35D5FD33B.pdf	1512	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2008	TCGA-13-1512-01	TCGA-13-1512-01		59b113ee-0571-4e46-b437-9c48e04697eb		TCGA-13-1512-01		TCGA-13-1512-01A-01D-0475-05		TCGA-13-1512-01A-21-1558-20		67e85198-4b8c-45db-b433-683b1899f3ea	TCGA-13-1512-01A-01D-0472-01	TCGA-13-1512-01	70bd95ea-f6ca-4b5a-b744-e174576d1063		TCGA-13-1512-01A-01D-0472-01	67e85198-4b8c-45db-b433-683b1899f3ea		67e85198-4b8c-45db-b433-683b1899f3ea	TCGA-13-1512-01A-01W-0545-08	TCGA-13-1512-01	TCGA-13-1512-01	67e85198-4b8c-45db-b433-683b1899f3ea	TCGA-13-1512-01A-01W-0545-08	TCGA-13-1512-01A-01R-0479-07	
TCGA-13-1817-01	1	TCGA-13-1817-01	1024	1	days	High		Cluster 6	OV-like c4					TCGA-13-1817			days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-13-1817-F24974	TCGA-13-1817	TCGA-13-1817-01A	Stage IIIC	-20771		1024	0	1024		541				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.4	NO		1.5			G3	Recurrence					TCGA-13-1817.76F55E61-714E-4C20-A9BD-2ECF28E5444F.pdf	1817		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2001				aad798d8-5b4a-4f23-8ebe-fb68cb37fd51				TCGA-13-1817-01A-01D-0807-05		TCGA-13-1817-01A-21-1559-20			TCGA-13-1817-01A-01D-2069-01	TCGA-13-1817-01	82a5bb6f-81aa-4ba2-9a74-c0a7ea48cabc,cfa86d7b-f1c9-42b9-8d0e-dc7366aec542		TCGA-13-1817-01A-01D-2069-01					TCGA-13-1817-01				TCGA-13-1817-01A-01R-0810-07	
TCGA-13-1817-02	1	TCGA-13-1817-02	1024	1	days			Cluster 6						TCGA-13-1817			days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-13-1817-F24974	TCGA-13-1817	TCGA-13-1817-02A	Stage IIIC	-20771		1024	0	1024		541				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3	Recurrence					TCGA-13-1817.AF88642C-B18E-4C22-A8B7-C6B2D259B4E9.pdf	1817		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Recurrent Tumor	02	0.4			13	>20 mm	Ovary		A	DECEASED	2001				29cf6928-081b-4498-89b3-89bd24b61608				TCGA-13-1817-02A-01D-0807-05							5823971e-18e2-4fec-8872-a309b1a6914f											TCGA-13-1817-02A-01R-0810-07	
TCGA-13-1819-01	1	TCGA-13-1819-01	2025	1	days	High		OV-like c1	OV-like c4					TCGA-13-1819	429	1	days	2025	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Right	TCGA-13-1819-F72642	TCGA-13-1819	TCGA-13-1819-01A	Stage IIC	-21635		2025	0	1946		429			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3			YES			TCGA-13-1819.27225767-34C2-48F2-A347-867FDDC907E9.pdf	1819		WITH TUMOR						Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	DECEASED	2004				3816ef10-585d-4480-bee6-d3d3fe9cbef5				TCGA-13-1819-01A-01D-0807-05		TCGA-13-1819-01A-21-1559-20			TCGA-13-1819-01A-01D-2069-01	TCGA-13-1819-01	249b311f-42e8-4ae2-88a1-11e80c3c02f9,6b5c65d5-0279-43ca-80fb-ef142bf820b7		TCGA-13-1819-01A-01D-2069-01					TCGA-13-1819-01				TCGA-13-1819-01A-01R-0810-07	
TCGA-13-1819-02	1	TCGA-13-1819-02	2025	1	days			OV-like c1						TCGA-13-1819	429	1	days	2025	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Right	TCGA-13-1819-F72642	TCGA-13-1819	TCGA-13-1819-02A	Stage IIC	-21635		2025	0	1946		429			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		2.1			G3			YES			TCGA-13-1819.EABB4610-CCE8-4DC5-A416-0FABFA634056.pdf	1819		WITH TUMOR						Recurrent Tumor	02	0.3			13	No Macroscopic disease	Ovary		A	DECEASED	2004				71492b0a-c202-4688-bb17-1828ed1d9d97				TCGA-13-1819-02A-01D-0807-05							f3945f2a-3281-446e-b8b9-d65ac2c770a9											TCGA-13-1819-02A-01R-0810-07	
TCGA-13-2057-01	0	TCGA-13-2057-01	2434	0	days	High		UCEC Serous c4						TCGA-13-2057	897	1	days	2434	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Bilateral	TCGA-13-2057-F72682	TCGA-13-2057	TCGA-13-2057-01A	Stage IIIC	-21554			0	2434		897			Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		1.5	NO	60	3			G3			YES			TCGA-13-2057.112EC7A2-A410-4D98-A974-BD6BF75E156F.pdf	2057	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008				0b1c95cf-0eb2-4297-956e-85702b3bbbc3				TCGA-13-2057-01A-02D-1047-05			TCGA-13-2057-01A-02D-1526-09		TCGA-13-2057-01A-02D-1043-01	TCGA-13-2057-01			TCGA-13-2057-01A-02D-1043-01					TCGA-13-2057-01				TCGA-13-2057-01A-02R-1050-07	
TCGA-13-2059-01	0	TCGA-13-2059-01	2387	0	days	High		OV-like c1	OV-like c4					TCGA-13-2059	1005	1	days	2387	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Bilateral	TCGA-13-2059-F72684	TCGA-13-2059	TCGA-13-2059-01A	Stage IIIC	-18449			0	2387		1005			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	80	2			G3			YES			TCGA-13-2059.E3673116-F004-4011-A609-D8E1693DBA62.pdf	2059	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2009				96ef4c4d-9292-4281-b23d-8e29fe47119f				TCGA-13-2059-01A-01D-1047-05		TCGA-13-2059-01A-03-1563-20	TCGA-13-2059-01A-01D-1526-09		TCGA-13-2059-01A-01D-1043-01	TCGA-13-2059-01	6af82345-1327-40dc-bbe3-1a4b5feb1da5		TCGA-13-2059-01A-01D-1043-01					TCGA-13-2059-01				TCGA-13-2059-01A-01R-1050-07	
TCGA-13-2060-01	0	TCGA-13-2060-01	2369	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-2060	1475	1	days	2369	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-13-2060-F72683	TCGA-13-2060	TCGA-13-2060-01A	Stage IV	-18635			0	2369		1475			Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	80	2.5			G3			YES			TCGA-13-2060.F6986C14-4627-424E-81C5-74E1CE38D52D.pdf	2060	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	LIVING	2009	TCGA-13-2060-01	TCGA-13-2060-01		60beab4b-53c5-4c97-af8f-21f4076b4850		TCGA-13-2060-01		TCGA-13-2060-01A-01D-0708-05		TCGA-13-2060-01A-21-1560-20		32de1e4d-198a-4616-8227-4d633c80124b	TCGA-13-2060-01A-01D-0704-01	TCGA-13-2060-01	19465a94-b5e9-4700-8f19-0724f72dd3a4		TCGA-13-2060-01A-01D-0704-01	32de1e4d-198a-4616-8227-4d633c80124b		32de1e4d-198a-4616-8227-4d633c80124b	TCGA-13-2060-01A-01W-0799-08	TCGA-13-2060-01	TCGA-13-2060-01	32de1e4d-198a-4616-8227-4d633c80124b	TCGA-13-2060-01A-01W-0799-08	TCGA-13-2060-01A-01R-0711-07	
TCGA-13-2061-01	0	TCGA-13-2061-01	2339	0	days	Squamous		OV-like c1	OV-like c4					TCGA-13-2061	2339	0	days	2339	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-13-2061-F72686	TCGA-13-2061	TCGA-13-2061-01A	Stage IIIC	-21543			0	2339					Complete Remission/Response	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	80	1.9			G3			NO			TCGA-13-2061.57D9D913-A6F9-4406-BF4D-0770004131D5.pdf	2061	Pre-Adjuvant Therapy	TUMOR FREE						Primary Tumor	01	0.5			13	No Macroscopic disease	Ovary		A	LIVING	2009				7183ed35-46c8-49c5-b247-09d01df7f6de				TCGA-13-2061-01A-01D-1047-05		TCGA-13-2061-01A-03-1563-20	TCGA-13-2061-01A-01D-1526-09		TCGA-13-2061-01A-01D-1043-01	TCGA-13-2061-01	7fd07232-c71d-43b3-8f05-8855c8028871		TCGA-13-2061-01A-01D-1043-01					TCGA-13-2061-01				TCGA-13-2061-01A-01R-1050-07	
TCGA-13-2065-01	0	TCGA-13-2065-01	1993	0	days	Squamous		OV-like c1	OV-like c4					TCGA-13-2065	946	1	days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Bilateral	TCGA-13-2065-F72688	TCGA-13-2065		Stage IIIC	-25973			0	1993		946			Stable Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3			YES				2065		WITH TUMOR						Primary Tumor	01				13	1-10 mm	Ovary			LIVING	2009				d020829d-93e8-4b1d-9b6e-006efc029547				TCGA-13-2065-01A-01D-1047-05		TCGA-13-2065-01A-03-1563-20	TCGA-13-2065-01A-01D-1526-09		TCGA-13-2065-01A-01D-1043-01	TCGA-13-2065-01	c8f40939-b3f0-4392-bad8-38608d23f320		TCGA-13-2065-01A-01D-1043-01					TCGA-13-2065-01				TCGA-13-2065-01A-01R-1050-07	
TCGA-13-2066-01	1	TCGA-13-2066-01	2133	1	days			OV-like c1	UCEC-like c5					TCGA-13-2066	1028	1	days	2133	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-13-2066-F72687	TCGA-13-2066		Stage IV	-18170		2133	0	295		1028			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection				80				G3			YES				2066	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2009				bfe15bbc-6ec4-4c49-b86d-4b01aa23093a				TCGA-13-2066-01A-01D-1047-05		TCGA-13-2066-01A-03-1562-20	TCGA-13-2066-01A-01D-1526-09			TCGA-13-2066-01	f2fa59a1-7ceb-4483-9925-3b2707f18d51											TCGA-13-2066-01A-01R-1050-07	
TCGA-13-2071-01	1	TCGA-13-2071-01	773	1	days	Squamous		OV-like c1						TCGA-13-2071	322	1	days	773	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Bilateral	TCGA-13-2071-F72689	TCGA-13-2071	TCGA-13-2071-01A	Stage IV	-23367		773	0	191		322			Progressive Disease	2015-7-31	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		2	NO	80	2.5			G3			YES			TCGA-13-2071.882BE278-9263-466C-BF61-E30543690FD7.pdf	2071	Pre-Adjuvant Therapy	WITH TUMOR						Primary Tumor	01	0.6			13	1-10 mm	Ovary		A	DECEASED	2009				97c72a04-f6a3-4f0e-89ca-8b6a47ee6d25				TCGA-13-2071-01A-02D-1047-05			TCGA-13-2071-01A-02D-1526-09		TCGA-13-2071-01A-02D-1043-01	TCGA-13-2071-01			TCGA-13-2071-01A-02D-1043-01					TCGA-13-2071-01				TCGA-13-2071-01A-02R-1050-07	
TCGA-13-A5FT-01	0	TCGA-13-A5FT-01	2143	0	days									TCGA-13-A5FT	2143	0	days	2143	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			67	Bilateral	TCGA-13-A5FT-F72595	TCGA-13-A5FT	TCGA-13-A5FT-01A	Stage IIIC	-24743	1211		0	2143					Complete Remission/Response	2015-7-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	230		NO	70				G3			NO	true	No	TCGA-13-A5FT.B67517DE-A483-4563-8698-51CB95DC5CF1.pdf	A5FT	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO	RX	Primary Tumor	01		NO	YES	13	No Macroscopic disease	Ovary		A	LIVING	2009	TCGA-13-A5FT-01	TCGA-13-A5FT-01			TCGA-13-A5FT-01A-11D-A409-05	TCGA-13-A5FT-01						819ce36b-9256-4ea0-947f-694029850c9d	TCGA-13-A5FT-01A-11D-A402-01		2066E3C1-00C3-4264-AA5A-A441AA209F55	TCGA-13-A5FT-01A-11R-A406-31	TCGA-13-A5FT-01A-11D-A402-01	819ce36b-9256-4ea0-947f-694029850c9d	TCGA-13-A5FT-01A-11R-A406-31	819ce36b-9256-4ea0-947f-694029850c9d			TCGA-13-A5FT-01	819ce36b-9256-4ea0-947f-694029850c9d			
TCGA-13-A5FU-01	1	TCGA-13-A5FU-01	256	1	days									TCGA-13-A5FU	256	0	days	256	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Bilateral		TCGA-13-A5FU	TCGA-13-A5FU-01A	Stage IV	-22256	1151	256	0							2013-5-26	FEMALE	Serous Cystadenocarcinoma	No	C48.0	8441/3	C48.0	YES	Tumor resection	210		NO	50				G3			NO	true	No	TCGA-13-A5FU.81DED60F-76BC-47E8-A15C-4488C6FDA1A5.pdf	A5FU	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		NO	R2	Primary Tumor	01		NO	YES	13	1-10 mm	Ovary		A	DECEASED	2009		TCGA-13-A5FU-01			TCGA-13-A5FU-01A-11D-A409-05	TCGA-13-A5FU-01							TCGA-13-A5FU-01A-11D-A402-01		71773ABF-D6B1-46D1-BE6D-95F3B01E04A4		TCGA-13-A5FU-01A-11D-A402-01										
TCGA-20-0987-01	1	TCGA-20-0987-01	701	1	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-20-0987			days	701	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-20-0987-F25518	TCGA-20-0987		Stage IIIC	-22287		701	0			442				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy								G3	Recurrence						0987		WITH TUMOR	YES		Physical Examination	NO		Primary Tumor	01				20	1-10 mm	Ovary			DECEASED	2004				e770e1d2-f6bc-4fc0-87c5-15f0939a189b				TCGA-20-0987-01A-02D-0432-05					TCGA-20-0987-01A-02D-0428-01	TCGA-20-0987-01			TCGA-20-0987-01A-02D-0428-01				TCGA-20-0987-01A-02W-0486-08	TCGA-20-0987-01			TCGA-20-0987-01A-02W-0486-08	TCGA-20-0987-01A-02R-0436-07	
TCGA-20-0990-01	0	TCGA-20-0990-01	789	0	days	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-20-0990			days	789	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-20-0990-F25523	TCGA-20-0990	TCGA-20-0990-01A	Stage IIIC	-27170			0	789		871	1			2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		0.6	NO		0.7			G3	Recurrence					TCGA-20-0990.2380A6A4-8F10-40BE-BEE6-DCC116803763.pdf	0990	Post-Adjuvant Therapy	WITH TUMOR	YES		Molecular Markers	NO		Primary Tumor	01	0.3			20		Ovary		A	LIVING	2005		TCGA-20-0990-01		8179bb45-deba-42a6-9306-73030e4aa5d8		TCGA-20-0990-01		TCGA-20-0990-01A-01D-0432-05					TCGA-20-0990-01A-01D-0428-01	TCGA-20-0990-01			TCGA-20-0990-01A-01D-0428-01				TCGA-20-0990-01A-01W-0486-08	TCGA-20-0990-01			TCGA-20-0990-01A-01W-0486-08	TCGA-20-0990-01A-01R-0436-07	
TCGA-20-0991-01	0	TCGA-20-0991-01	797	0	days	High		OV-like c1			miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-20-0991			days	797	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Right	TCGA-20-0991-F25530	TCGA-20-0991		Stage IIB	-28694			0	797			0			2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3							0991	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				20	No Macroscopic disease	Ovary			LIVING	2006		TCGA-20-0991-01		bc5c2691-a35b-4548-99ed-7a3e6e95153f		TCGA-20-0991-01		TCGA-20-0991-01A-03D-0432-05					TCGA-20-0991-01A-03D-0428-01	TCGA-20-0991-01			TCGA-20-0991-01A-03D-0428-01				TCGA-20-0991-01A-03D-0428-08	TCGA-20-0991-01			TCGA-20-0991-01A-03D-0428-08	TCGA-20-0991-01A-01R-0436-07	
TCGA-20-0996-01	0	TCGA-20-0996-01	2196	0	days	Kirc+		OV-like c1						TCGA-20-0996			days	2196	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Bilateral	TCGA-20-0996-F25533	TCGA-20-0996		Stage IIIC	-21572			0	2196			0			2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G2							0996	Post-Adjuvant Therapy	WITH TUMOR	YES			NO		Primary Tumor	01				20	1-10 mm	Ovary			LIVING	2001				c1396756-4582-49ae-ac88-857ff11b377d				TCGA-20-0996-01A-03D-0432-05					TCGA-20-0996-01A-03D-0428-01	TCGA-20-0996-01			TCGA-20-0996-01A-03D-0428-01					TCGA-20-0996-01				TCGA-20-0996-01A-02R-0436-07	
TCGA-20-1682-01	0	TCGA-20-1682-01	837	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-20-1682			days	837	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			56	Bilateral	TCGA-20-1682-F25540	TCGA-20-1682	TCGA-20-1682-01A	Stage IIIC	-20583			0	837			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1		YES	GX						TCGA-20-1682.cf49ea4d-478c-469d-ace2-7ef52b66a332.pdf	1682	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			20	11-20 mm	Ovary	YES	A	LIVING	2007	TCGA-20-1682-01	TCGA-20-1682-01		3feadfdb-a932-4ead-8a20-59698a0655ae		TCGA-20-1682-01		TCGA-20-1682-01A-01D-0563-05		TCGA-20-1682-01A-21-1558-20	TCGA-20-1682-01A-01W-0633-09	f03d023b-cba8-413d-a88d-0378ee7b7748	TCGA-20-1682-01A-01D-0559-01	TCGA-20-1682-01	a999220b-fed5-446d-8bba-c4c59428d473		TCGA-20-1682-01A-01D-0559-01	f03d023b-cba8-413d-a88d-0378ee7b7748		f03d023b-cba8-413d-a88d-0378ee7b7748		TCGA-20-1682-01	TCGA-20-1682-01	f03d023b-cba8-413d-a88d-0378ee7b7748		TCGA-20-1682-01A-01R-0566-07	
TCGA-20-1683-01	0	TCGA-20-1683-01	772	0	days	High	C9-OV	Cluster 6	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6		TCGA-20-1683			days	772	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Right	TCGA-20-1683-F25544	TCGA-20-1683	TCGA-20-1683-01A	Stage IIIC	-24006			0	772		618	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1			G3	Recurrence					TCGA-20-1683.5a83e4b3-8be2-4628-bd4b-93d040b43856.pdf	1683	Post-Adjuvant Therapy	TUMOR FREE	YES	Stable Disease	Molecular Markers	NO		Primary Tumor	01	0.4			20	No Macroscopic disease	Ovary		A	LIVING	2007	TCGA-20-1683-01	TCGA-20-1683-01		f44d8a5e-bb22-4961-bfa5-be4ba92c8729		TCGA-20-1683-01		TCGA-20-1683-01A-01D-0563-05		TCGA-20-1683-01A-21-1558-20	TCGA-20-1683-01A-01W-0633-09	e78c6cd7-67f2-4ac8-9dd9-c46392459835	TCGA-20-1683-01A-01D-0559-01	TCGA-20-1683-01	78abd251-6a19-4b51-bd1d-7c8dba5f324e		TCGA-20-1683-01A-01D-0559-01	e78c6cd7-67f2-4ac8-9dd9-c46392459835		e78c6cd7-67f2-4ac8-9dd9-c46392459835		TCGA-20-1683-01	TCGA-20-1683-01	e78c6cd7-67f2-4ac8-9dd9-c46392459835		TCGA-20-1683-01A-01R-0566-07	
TCGA-20-1684-01	0	TCGA-20-1684-01	581	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-20-1684			days	581	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-20-1684-F25549	TCGA-20-1684	TCGA-20-1684-01A	Stage IIIC	-18755			0	581			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1		NO	G3						TCGA-20-1684.3ce61823-9e89-424f-9ce2-a8987420b2a9.pdf	1684	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			20	1-10 mm	Ovary	NO	A	LIVING	2007	TCGA-20-1684-01	TCGA-20-1684-01		c0d9b7e3-7c05-4db3-a77e-ae8a6a4ab4e7		TCGA-20-1684-01		TCGA-20-1684-01A-01D-0563-05		TCGA-20-1684-01A-21-1558-20	TCGA-20-1684-01A-01W-0633-09	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	TCGA-20-1684-01A-01D-0559-01	TCGA-20-1684-01	8ba9a6e5-3dc8-4e7b-80ca-17470663b495		TCGA-20-1684-01A-01D-0559-01	91b2872a-73bc-4f52-a8f6-96ce81cbef8a		91b2872a-73bc-4f52-a8f6-96ce81cbef8a		TCGA-20-1684-01	TCGA-20-1684-01	91b2872a-73bc-4f52-a8f6-96ce81cbef8a		TCGA-20-1684-01A-01R-0566-07	
TCGA-20-1685-01	0	TCGA-20-1685-01	508	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-20-1685			days	508	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Bilateral	TCGA-20-1685-F25554	TCGA-20-1685	TCGA-20-1685-01A	Stage IIIC	-16745			0	508			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		NO	G3						TCGA-20-1685.09b7c163-7ad3-42a2-bc06-32bd55f80327.pdf	1685	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			20	1-10 mm	Ovary	NO	A	LIVING	2008	TCGA-20-1685-01	TCGA-20-1685-01		923bc90c-b380-4710-b062-5c3deb27de44		TCGA-20-1685-01		TCGA-20-1685-01A-01D-0563-05		TCGA-20-1685-01A-21-1558-20	TCGA-20-1685-01A-01W-0633-09	9f6dd4ad-0130-46fe-9c49-72f378a753fe	TCGA-20-1685-01A-01D-0559-01	TCGA-20-1685-01	b1b57151-ff27-4b55-bf89-6e25a61f1060		TCGA-20-1685-01A-01D-0559-01	9f6dd4ad-0130-46fe-9c49-72f378a753fe		9f6dd4ad-0130-46fe-9c49-72f378a753fe		TCGA-20-1685-01	TCGA-20-1685-01	9f6dd4ad-0130-46fe-9c49-72f378a753fe		TCGA-20-1685-01A-01R-0566-07	
TCGA-20-1686-01	0	TCGA-20-1686-01	89	0	days	High		OV-like c1	BRCA basal-like c6		miRNA cluster 2	cluster 2		TCGA-20-1686			days	89	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			75	Bilateral	TCGA-20-1686-F25559	TCGA-20-1686	TCGA-20-1686-01A	Stage IIIC	-27588			0	89			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8		NO	G3						TCGA-20-1686.c87ff195-1793-455a-bb19-e495a915befe.pdf	1686	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			20	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-20-1686-01		91fb24d3-6a1d-4fd1-9bf3-d891ab25017c		TCGA-20-1686-01		TCGA-20-1686-01A-01D-0563-05		TCGA-20-1686-01A-21-1558-20	TCGA-20-1686-01A-01W-0633-09		TCGA-20-1686-01A-01D-0559-01	TCGA-20-1686-01	92c3ac1c-3e84-4448-8587-8c95329d0549		TCGA-20-1686-01A-01D-0559-01					TCGA-20-1686-01				TCGA-20-1686-01A-01R-0566-07	
TCGA-20-1687-01	0	TCGA-20-1687-01	81	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-20-1687			days	81	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			46	Bilateral	TCGA-20-1687-F25563	TCGA-20-1687	TCGA-20-1687-01A	Stage IV	-16961			0	81						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.8		YES	G3						TCGA-20-1687.e966d90f-0e5f-42e6-b487-1f10fbef204f.pdf	1687		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			20	No Macroscopic disease	Ovary		A	LIVING	2008	TCGA-20-1687-01	TCGA-20-1687-01		7221f0cf-2235-4717-938b-425c949730e3		TCGA-20-1687-01		TCGA-20-1687-01A-01D-0563-05		TCGA-20-1687-01A-21-1558-20	TCGA-20-1687-01A-01W-0633-09	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	TCGA-20-1687-01A-01D-0559-01	TCGA-20-1687-01	a3332b9e-1a9c-4a7e-81c0-e19de968609b		TCGA-20-1687-01A-01D-0559-01	ad7529aa-47f7-4207-b0a9-8684ff1e6e80		ad7529aa-47f7-4207-b0a9-8684ff1e6e80		TCGA-20-1687-01	TCGA-20-1687-01	ad7529aa-47f7-4207-b0a9-8684ff1e6e80		TCGA-20-1687-01A-01R-0566-07	
TCGA-23-1021-01	1	TCGA-23-1021-01	1446	1	days	High		OV-like c1			miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-23-1021			days	1446	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Right	TCGA-23-1021-F25567	TCGA-23-1021		Stage IV	-16484		1446	0	1446	1181					2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Locoregional Disease	YES					1021		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01				23	>20 mm	Ovary	YES		DECEASED	2004		TCGA-23-1021-01		eb55cb66-59d1-4b7c-a99e-3dd5e38cca85		TCGA-23-1021-01		TCGA-23-1021-01B-01D-0432-05	TCGA-23-1021-01B-01W-0488-09		TCGA-23-1021-01B-01W-0488-09		TCGA-23-1021-01B-01D-0428-01	TCGA-23-1021-01			TCGA-23-1021-01B-01D-0428-01					TCGA-23-1021-01			TCGA-23-1021-01B-01W-0488-09	TCGA-23-1021-01B-01R-0436-07	
TCGA-23-1022-01	1	TCGA-23-1022-01	1511	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1022			days	1511	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Left	TCGA-23-1022-F25576	TCGA-23-1022	TCGA-23-1022-01A	Stage IIIC	-24798		1511	0			450				2009-2-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.7		YES	G3	Recurrence					TCGA-23-1022.1A674838-E992-4E9B-82AE-FAFA0AD3BF56.pdf	1022		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary	YES	A	DECEASED	2003		TCGA-23-1022-01		430ab09f-2d3f-4a3d-9aac-d6c678e983db		TCGA-23-1022-01		TCGA-23-1022-01A-02D-0432-05	TCGA-23-1022-01A-02W-0488-09		TCGA-23-1022-01A-02W-0488-09		TCGA-23-1022-01A-02D-0428-01	TCGA-23-1022-01			TCGA-23-1022-01A-02D-0428-01					TCGA-23-1022-01			TCGA-23-1022-01A-02W-0488-09	TCGA-23-1022-01A-01R-0436-07	
TCGA-23-1023-01	0	TCGA-23-1023-01	1233	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-23-1023			days	1233	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Right	TCGA-23-1023-F25587	TCGA-23-1023	TCGA-23-1023-01R	Stage IIIC	-23826			0	1233		490				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3	Recurrence					TCGA-23-1023.98EBC356-C54E-4C1E-9726-BA61397DDA38.pdf	1023		WITH TUMOR	YES	Complete Remission/Response	Other Method	NO		Recurrent Tumor	02	0.3			23	1-10 mm	Ovary	YES	R	LIVING	2005	TCGA-23-1023-01	TCGA-23-1023-01	TCGA-23-1023-01A-03W-0484-10	fcd199f1-6a2a-4b56-977a-6e0959335ca9,d00090cb-c5e2-427f-bdee-5602808ec406		TCGA-23-1023-01	TCGA-23-1023-01A-03W-0484-10	TCGA-23-1023-01A-03D-0432-05,TCGA-23-1023-01R-01D-0807-05				1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf	TCGA-23-1023-01A-03D-0428-01	TCGA-23-1023-01			TCGA-23-1023-01A-03D-0428-01	1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf		1c88dde8-4fe6-49e9-8d76-40668ed783ff,69bec2db-02c3-46ca-b17b-60eae9a1e0bf		TCGA-23-1023-01	TCGA-23-1023-01	69bec2db-02c3-46ca-b17b-60eae9a1e0bf,1c88dde8-4fe6-49e9-8d76-40668ed783ff	TCGA-23-1023-01A-03W-0484-10	TCGA-23-1023-01R-01R-0810-07,TCGA-23-1023-01A-02R-0436-07	
TCGA-23-1024-01	0	TCGA-23-1024-01	468	0	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-1024			days	468	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Right	TCGA-23-1024-F25604	TCGA-23-1024	TCGA-23-1024-01A	Stage IV	-19052			0	468						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8			G3						TCGA-23-1024.1CCE5978-6A4D-427A-9875-47617F6A4258.pdf	1024		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.2			23	1-10 mm	Ovary		A	LIVING	2007		TCGA-23-1024-01	TCGA-23-1024-01A-02W-0484-10	15e969ea-df91-4ade-9f5f-91f317ac7573		TCGA-23-1024-01	TCGA-23-1024-01A-02W-0484-10	TCGA-23-1024-01A-02D-0432-05					TCGA-23-1024-01A-02D-0428-01	TCGA-23-1024-01			TCGA-23-1024-01A-02D-0428-01					TCGA-23-1024-01			TCGA-23-1024-01A-02W-0484-10	TCGA-23-1024-01A-02R-0436-07	
TCGA-23-1026-01	0	TCGA-23-1026-01	816	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-23-1026			days	816	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Left	TCGA-23-1026-F25610	TCGA-23-1026	TCGA-23-1026-01B	Stage IIIC	-16442			0	816		797				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8			G3	Recurrence					TCGA-23-1026.E41E1018-422B-4B4A-8732-C9389847830D.pdf	1026		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary		B	LIVING	2004	TCGA-23-1026-01	TCGA-23-1026-01	TCGA-23-1026-01B-01W-0484-10	fca7646c-094b-4720-a550-f3e066f24431		TCGA-23-1026-01	TCGA-23-1026-01B-01W-0484-10	TCGA-23-1026-01B-01D-0432-05				973907c7-f259-4d1a-b9df-68db1837af91	TCGA-23-1026-01B-01D-0428-01	TCGA-23-1026-01			TCGA-23-1026-01B-01D-0428-01	973907c7-f259-4d1a-b9df-68db1837af91		973907c7-f259-4d1a-b9df-68db1837af91		TCGA-23-1026-01	TCGA-23-1026-01	973907c7-f259-4d1a-b9df-68db1837af91	TCGA-23-1026-01B-01W-0484-10	TCGA-23-1026-01B-01R-0436-07	
TCGA-23-1027-01	1	TCGA-23-1027-01	976	1	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1027			days	976	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Right	TCGA-23-1027-F25616	TCGA-23-1027		Stage IIIC	-17588		976	0	966		114				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence						1027			YES	Progressive Disease		NO		Primary Tumor	01				23	1-10 mm	Ovary	YES		DECEASED	2005	TCGA-23-1027-01	TCGA-23-1027-01		acb73086-38dd-4ed6-9d1c-d14dcd155936		TCGA-23-1027-01		TCGA-23-1027-01A-02D-0432-05				edbc81a6-2593-45c5-8131-3c4615d1807f	TCGA-23-1027-01A-02D-0428-01	TCGA-23-1027-01			TCGA-23-1027-01A-02D-0428-01	edbc81a6-2593-45c5-8131-3c4615d1807f		edbc81a6-2593-45c5-8131-3c4615d1807f	TCGA-23-1027-01A-02W-0486-08	TCGA-23-1027-01	TCGA-23-1027-01	edbc81a6-2593-45c5-8131-3c4615d1807f	TCGA-23-1027-01A-02W-0486-08	TCGA-23-1027-01A-02R-0436-07	
TCGA-23-1028-01	0	TCGA-23-1028-01	1503	0	days	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-1028			days	1503	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	43	Left	TCGA-23-1028-F25624	TCGA-23-1028	TCGA-23-1028-01A	Stage IIIC	-16018			0	1503		133				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		0.8		YES	G3	Recurrence					TCGA-23-1028.CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2.pdf	1028		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary	YES	A	LIVING	2004		TCGA-23-1028-01	TCGA-23-1028-01A-01W-0484-10	511adb99-1cae-481e-8da7-f4cdc4d5f385		TCGA-23-1028-01	TCGA-23-1028-01A-01W-0484-10	TCGA-23-1028-01A-01D-0432-05					TCGA-23-1028-01A-01D-0428-01	TCGA-23-1028-01			TCGA-23-1028-01A-01D-0428-01					TCGA-23-1028-01			TCGA-23-1028-01A-01W-0484-10	TCGA-23-1028-01A-01R-0436-07	
TCGA-23-1029-01	0	TCGA-23-1029-01	268	0	days	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-23-1029			days	268	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			46	Right	TCGA-23-1029-F25639	TCGA-23-1029	TCGA-23-1029-01B	Stage IIIC	-16889			0	268						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8			G3						TCGA-23-1029.89E1F403-12CB-442A-9588-CF5C0AC0E0A6.pdf	1029		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary		B	LIVING	2007	TCGA-23-1029-01	TCGA-23-1029-01		fcd48515-450a-4a24-b92d-8fb4eb4890b3		TCGA-23-1029-01		TCGA-23-1029-01B-01D-0581-05			TCGA-23-1029-01B-01W-0639-09	9a54d0fe-f998-4866-bb1f-92be472d843a	TCGA-23-1029-01B-01D-0577-01	TCGA-23-1029-01			TCGA-23-1029-01B-01D-0577-01	9a54d0fe-f998-4866-bb1f-92be472d843a		9a54d0fe-f998-4866-bb1f-92be472d843a		TCGA-23-1029-01	TCGA-23-1029-01	9a54d0fe-f998-4866-bb1f-92be472d843a		TCGA-23-1029-01B-01R-0584-07	
TCGA-23-1030-01	0	TCGA-23-1030-01	886	0	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-1030			days	886	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Left	TCGA-23-1030-F25643	TCGA-23-1030		Stage IIIC	-23416			0	886		544				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence						1030		TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				23	1-10 mm	Ovary	YES		LIVING	2006		TCGA-23-1030-01		b1f62bf0-8681-4b6d-ab78-a7c5757770a4		TCGA-23-1030-01		TCGA-23-1030-01A-02D-0432-05					TCGA-23-1030-01A-02D-0428-01	TCGA-23-1030-01			TCGA-23-1030-01A-02D-0428-01				TCGA-23-1030-01A-02W-0486-08	TCGA-23-1030-01			TCGA-23-1030-01A-02W-0486-08	TCGA-23-1030-01A-02R-0436-07	
TCGA-23-1031-01	1	TCGA-23-1031-01	575	1	days	High		OV-like c1					mutation cluster 5	TCGA-23-1031			days	575	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Left	TCGA-23-1031-F25649	TCGA-23-1031		Stage IV	-22225		575	0	575						2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3							1031		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01				23	1-10 mm	Ovary			DECEASED	2003				c85b3936-20a5-41cb-ad0d-d184c2c1f6d9				TCGA-23-1031-01A-01D-0432-05					TCGA-23-1031-01A-01D-0428-01	TCGA-23-1031-01			TCGA-23-1031-01A-01D-0428-01				TCGA-23-1031-01A-01W-0486-08	TCGA-23-1031-01			TCGA-23-1031-01A-01W-0486-08	TCGA-23-1031-01A-01R-0436-07	
TCGA-23-1032-01	1	TCGA-23-1032-01	84	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1032			days	84	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Right	TCGA-23-1032-F25659	TCGA-23-1032	TCGA-23-1032-01A	Stage IV	-26715		84	0	68						2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1			G3						TCGA-23-1032.6E8A5413-EB7E-49D8-8E11-8CA6A912ED50.pdf	1032		WITH TUMOR	NO			NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary		A	DECEASED	2002		TCGA-23-1032-01		986863dd-b61b-48c2-a37c-af21fed7e778		TCGA-23-1032-01		TCGA-23-1032-01A-02D-0432-05					TCGA-23-1032-01A-02D-0428-01	TCGA-23-1032-01			TCGA-23-1032-01A-02D-0428-01				TCGA-23-1032-01A-02W-0486-08	TCGA-23-1032-01			TCGA-23-1032-01A-02W-0486-08	TCGA-23-1032-01A-02R-0436-07	
TCGA-23-1107-01	1	TCGA-23-1107-01	9	1	days	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-23-1107			days	9	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Left	TCGA-23-1107-F25661	TCGA-23-1107	TCGA-23-1107-01A	Stage IV	-21561		9	0	9						2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3						TCGA-23-1107.700802e6-8058-4485-8210-3e5b8f10bbf3.pdf	1107		WITH TUMOR	NO			NO		Primary Tumor	01	0.6			23	>20 mm	Ovary		A	DECEASED	1999		TCGA-23-1107-01	TCGA-23-1107-01A-01W-0484-10	7f426322-5acf-4d04-8bd6-93ec56bffd0f		TCGA-23-1107-01	TCGA-23-1107-01A-01W-0484-10	TCGA-23-1107-01A-01D-0432-05						TCGA-23-1107-01												TCGA-23-1107-01A-01R-0436-07	
TCGA-23-1109-01	1	TCGA-23-1109-01	1562	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2		TCGA-23-1109			days	1562	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	62	Right	TCGA-23-1109-F25663	TCGA-23-1109		Stage IIIC	-23002		1562	0	1562		987				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1109		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01				23	1-10 mm	Ovary			DECEASED	1999	TCGA-23-1109-01	TCGA-23-1109-01	TCGA-23-1109-01A-01W-0484-10	ef6ecfd8-badc-4863-a3d5-fc20161f09dc		TCGA-23-1109-01	TCGA-23-1109-01A-01W-0484-10	TCGA-23-1109-01A-01D-0432-05		TCGA-23-1109-01A-21-1562-20		d47e074a-f78e-40c5-8af4-f737ce010041	TCGA-23-1109-01A-01D-0428-01	TCGA-23-1109-01	b8d71b4b-6d11-47da-b15d-a3eac835a9a9		TCGA-23-1109-01A-01D-0428-01	d47e074a-f78e-40c5-8af4-f737ce010041		d47e074a-f78e-40c5-8af4-f737ce010041		TCGA-23-1109-01	TCGA-23-1109-01	d47e074a-f78e-40c5-8af4-f737ce010041		TCGA-23-1109-01A-01R-0436-07	
TCGA-23-1110-01	0	TCGA-23-1110-01	1658	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-23-1110			days	1658	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Right	TCGA-23-1110-F25666	TCGA-23-1110	TCGA-23-1110-01A	Stage IIIC	-15383			0	1658		326				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		YES	G3	Recurrence					TCGA-23-1110.07361efd-0b7d-4dcb-afe3-464200f59ac0.pdf	1110		TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			23	No Macroscopic disease	Ovary	YES	A	LIVING	2003		TCGA-23-1110-01		811e848e-6289-4821-8640-c645e2b3f57e		TCGA-23-1110-01		TCGA-23-1110-01A-01D-0432-05		TCGA-23-1110-01A-11-1562-20			TCGA-23-1110-01A-01D-0428-01	TCGA-23-1110-01	e36ba512-a711-4e42-80ce-94edb0be836e		TCGA-23-1110-01A-01D-0428-01				TCGA-23-1110-01A-01D-0428-08	TCGA-23-1110-01			TCGA-23-1110-01A-01D-0428-08	TCGA-23-1110-01A-01R-0436-07	
TCGA-23-1111-01	0	TCGA-23-1111-01	98	0	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 4		TCGA-23-1111			days	98	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Right	TCGA-23-1111-F25672	TCGA-23-1111	TCGA-23-1111-01A	Stage IIIC	-23171			0	98						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		0.9		YES	G3						TCGA-23-1111.ba3ae03c-74d4-4b5f-849f-71466bae7c0e.pdf	1111			YES			NO		Primary Tumor	01	0.4			23	>20 mm	Ovary		A	LIVING	2008	TCGA-23-1111-01	TCGA-23-1111-01		190f5d18-230f-417f-b10c-992c28dcf418		TCGA-23-1111-01		TCGA-23-1111-01A-01D-0581-05		TCGA-23-1111-01A-21-20	TCGA-23-1111-01A-01W-0639-09	f38e46dc-67b9-448a-8d24-507291e55bca	TCGA-23-1111-01A-01D-0577-01	TCGA-23-1111-01	8e14b0f8-af54-486f-9ecc-8b62eb434ad4		TCGA-23-1111-01A-01D-0577-01	f38e46dc-67b9-448a-8d24-507291e55bca		f38e46dc-67b9-448a-8d24-507291e55bca		TCGA-23-1111-01	TCGA-23-1111-01	f38e46dc-67b9-448a-8d24-507291e55bca		TCGA-23-1111-01A-01R-0584-07	
TCGA-23-1113-01	1	TCGA-23-1113-01	949	1	days	Squamous		OV-like c1			miRNA cluster 2	cluster 1		TCGA-23-1113			days	949	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Left	TCGA-23-1113-F25677	TCGA-23-1113		Stage IV	-17791		949	0							2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3							1113		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01				23	1-10 mm	Ovary			DECEASED	2002		TCGA-23-1113-01		a418120d-175f-4f72-b81f-02528d563418		TCGA-23-1113-01		TCGA-23-1113-01A-01D-0432-05					TCGA-23-1113-01A-01D-0428-01	TCGA-23-1113-01			TCGA-23-1113-01A-01D-0428-01					TCGA-23-1113-01				TCGA-23-1113-01A-01R-0436-07	
TCGA-23-1114-01	1	TCGA-23-1114-01	2089	1	days	High		OV-like c1		OV-like c16	miRNA cluster 2	cluster 1		TCGA-23-1114			days	2089	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Left	TCGA-23-1114-F25685	TCGA-23-1114	TCGA-23-1114-01B	Stage IIIC	-20409		2089	0	2089		634				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3	Recurrence					TCGA-23-1114.d5c00586-d7e4-4909-be2b-ffc4f9ef2e82.pdf	1114		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			23	No Macroscopic disease	Ovary		B	DECEASED	2000	TCGA-23-1114-01	TCGA-23-1114-01		7ee203ae-339a-4534-9e72-0dd723890ad1		TCGA-23-1114-01		TCGA-23-1114-01B-01D-0563-05			TCGA-23-1114-01B-01W-0633-09	7cfe1419-65be-4860-9f99-75f4a139d9ac	TCGA-23-1114-01B-01D-0559-01	TCGA-23-1114-01			TCGA-23-1114-01B-01D-0559-01	7cfe1419-65be-4860-9f99-75f4a139d9ac		7cfe1419-65be-4860-9f99-75f4a139d9ac		TCGA-23-1114-01	TCGA-23-1114-01	7cfe1419-65be-4860-9f99-75f4a139d9ac		TCGA-23-1114-01B-01R-0566-07	
TCGA-23-1116-01	1	TCGA-23-1116-01	592	1	days	High		OV-like c1					mutation cluster 8	TCGA-23-1116	286	1	days	592	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	83	Left	TCGA-23-1116-F72416	TCGA-23-1116		Stage IIIC	-30464		592	0	139		286		Additional New Tumor Event	Progressive Disease	2015-6-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection						NO	YES	G3	Recurrence		YES				1116		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01				23	>20 mm	Ovary	YES		DECEASED	2008				e7a2e1cf-9175-4d4b-9f6a-ccace71a5267				TCGA-23-1116-01A-01D-0432-05					TCGA-23-1116-01A-01D-0428-01	TCGA-23-1116-01			TCGA-23-1116-01A-01D-0428-01				TCGA-23-1116-01A-01W-0486-08	TCGA-23-1116-01			TCGA-23-1116-01A-01W-0486-08	TCGA-23-1116-01A-01R-0436-07	
TCGA-23-1117-01	1	TCGA-23-1117-01	1013	1	days	High		OV-like c1					mutation cluster 8	TCGA-23-1117			days	1013	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Left	TCGA-23-1117-F25699	TCGA-23-1117	TCGA-23-1117-01A	Stage IIIC	-15690		1013	0			418				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.7		YES	G3	Recurrence					TCGA-23-1117.abc636a1-677d-49e5-9259-5b5b828a575e.pdf	1117		WITH TUMOR	NO	Complete Remission/Response	Other Method	YES		Primary Tumor	01	0.4			23	1-10 mm	Ovary	YES	A	DECEASED	1998				7cf2b05a-4475-44db-af64-1889f8073941				TCGA-23-1117-01A-02D-0432-05	TCGA-23-1117-01A-02W-0488-09		TCGA-23-1117-01A-02W-0488-09		TCGA-23-1117-01A-02D-0428-01	TCGA-23-1117-01			TCGA-23-1117-01A-02D-0428-01					TCGA-23-1117-01			TCGA-23-1117-01A-02W-0488-09	TCGA-23-1117-01A-02R-0436-07	
TCGA-23-1118-01	0	TCGA-23-1118-01	2616	0	days	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-1118			days	2616	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Left	TCGA-23-1118-F25708	TCGA-23-1118		Stage IIIC	-16471			0	2616						2009-2-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3							1118		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				23	>20 mm	Ovary	YES		LIVING	2001		TCGA-23-1118-01		cbd86cfc-faa7-40dd-a544-3c0dba5849aa		TCGA-23-1118-01		TCGA-23-1118-01A-01D-0432-05	TCGA-23-1118-01A-01W-0488-09		TCGA-23-1118-01A-01W-0488-09		TCGA-23-1118-01A-01D-0428-01	TCGA-23-1118-01			TCGA-23-1118-01A-01D-0428-01					TCGA-23-1118-01			TCGA-23-1118-01A-01W-0488-09	TCGA-23-1118-01A-01R-0436-07	
TCGA-23-1119-01	0	TCGA-23-1119-01	3953	0	days	Squamous		OV-like c1			miRNA cluster 1	cluster 4		TCGA-23-1119			days	3953	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Left	TCGA-23-1119-F25711	TCGA-23-1119	TCGA-23-1119-01A	Stage IIIC	-23686			0	3953		3378				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		YES	G3	Recurrence					TCGA-23-1119.86389912-6945-49e6-9255-e7a41fde197a.pdf	1119		TUMOR FREE	YES	Complete Remission/Response	Other Method	NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary	YES	A	LIVING	1997		TCGA-23-1119-01	TCGA-23-1119-01A-02W-0484-10	14dd1630-da1d-47ca-bae2-457903a26761		TCGA-23-1119-01	TCGA-23-1119-01A-02W-0484-10	TCGA-23-1119-01A-02D-0432-05					TCGA-23-1119-01A-02D-0428-01	TCGA-23-1119-01			TCGA-23-1119-01A-02D-0428-01					TCGA-23-1119-01				TCGA-23-1119-01A-02R-0436-07	
TCGA-23-1120-01	0	TCGA-23-1120-01	130	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 3	mutation cluster 2	TCGA-23-1120			days	130	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Right	TCGA-23-1120-F25715	TCGA-23-1120	TCGA-23-1120-01A	Stage IIIC	-22148			0	130						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.8		NO	G3						TCGA-23-1120.e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37.pdf	1120			YES	Complete Remission/Response		NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary	NO	A	LIVING	2008	TCGA-23-1120-01	TCGA-23-1120-01	TCGA-23-1120-01A-02W-0484-10	0486be96-3c9f-41a7-9115-295646258378		TCGA-23-1120-01	TCGA-23-1120-01A-02W-0484-10	TCGA-23-1120-01A-02D-0432-05				9b64998e-eed9-428b-97ac-4de398caaf81	TCGA-23-1120-01A-02D-0428-01	TCGA-23-1120-01			TCGA-23-1120-01A-02D-0428-01	9b64998e-eed9-428b-97ac-4de398caaf81		9b64998e-eed9-428b-97ac-4de398caaf81		TCGA-23-1120-01	TCGA-23-1120-01	9b64998e-eed9-428b-97ac-4de398caaf81	TCGA-23-1120-01A-02W-0484-10	TCGA-23-1120-01A-02R-0436-07	
TCGA-23-1121-01	0	TCGA-23-1121-01	194	0	days	High		Cluster 5	OV-like c4		miRNA cluster 1	cluster 5		TCGA-23-1121			days	194	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Left	TCGA-23-1121-F25719	TCGA-23-1121	TCGA-23-1121-01A	Stage IIIC	-18983			0	194						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.2		YES	G3						TCGA-23-1121.ed14039c-9ecf-4e01-9a1c-7a227847b8a3.pdf	1121			YES			NO		Primary Tumor	01	0.6			23	>20 mm	Ovary		A	LIVING	2008		TCGA-23-1121-01		e3fca11d-248c-4852-ad4b-09867693fd39		TCGA-23-1121-01		TCGA-23-1121-01A-01D-0432-05		TCGA-23-1121-01A-11-1562-20			TCGA-23-1121-01A-01D-0428-01	TCGA-23-1121-01	97eb2839-fc59-4c0a-a075-b5fd802799c6		TCGA-23-1121-01A-01D-0428-01					TCGA-23-1121-01				TCGA-23-1121-01A-01R-0436-07	
TCGA-23-1122-01	1	TCGA-23-1122-01	1189	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1122			days	1189	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	53	Left	TCGA-23-1122-F25724	TCGA-23-1122	TCGA-23-1122-01A	Stage IIIC	-19537		1189	0			447				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1		NO	G3	Recurrence					TCGA-23-1122.9507d553-b1c7-4b71-90c1-064fd8ef15ba.pdf	1122		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			23	1-10 mm	Ovary		A	DECEASED	1998	TCGA-23-1122-01	TCGA-23-1122-01		c619e051-c770-4ed9-957b-b27ec8784864		TCGA-23-1122-01		TCGA-23-1122-01A-01D-0432-05		TCGA-23-1122-01A-11-1562-20		54b75801-ad36-49a1-b0c2-edc0053b897e	TCGA-23-1122-01A-01D-0428-01	TCGA-23-1122-01	2877f544-7459-4a43-9e89-a014008f6a58		TCGA-23-1122-01A-01D-0428-01	54b75801-ad36-49a1-b0c2-edc0053b897e		54b75801-ad36-49a1-b0c2-edc0053b897e	TCGA-23-1122-01A-01W-0486-08	TCGA-23-1122-01	TCGA-23-1122-01	54b75801-ad36-49a1-b0c2-edc0053b897e	TCGA-23-1122-01A-01W-0486-08	TCGA-23-1122-01A-01R-0436-07	
TCGA-23-1123-01	1	TCGA-23-1123-01	1018	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-23-1123			days	1018	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Left	TCGA-23-1123-F25733	TCGA-23-1123	TCGA-23-1123-01A	Stage IIIC	-21552		1018	0							2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		YES	G3						TCGA-23-1123.28f9189b-24eb-4540-8551-4eaacc296c20.pdf	1123		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.6			23	11-20 mm	Ovary		A	DECEASED	1998	TCGA-23-1123-01	TCGA-23-1123-01		c7657407-5f4d-441a-a943-90315de8c660		TCGA-23-1123-01		TCGA-23-1123-01A-01D-0432-05	TCGA-23-1123-01A-01W-0488-09	TCGA-23-1123-01A-11-1562-20	TCGA-23-1123-01A-01W-0488-09	71543abc-9f15-48d9-994d-e7b963a4d8f3	TCGA-23-1123-01A-01D-0428-01	TCGA-23-1123-01	184da43f-2906-495a-a714-031b30a78cdb		TCGA-23-1123-01A-01D-0428-01	71543abc-9f15-48d9-994d-e7b963a4d8f3		71543abc-9f15-48d9-994d-e7b963a4d8f3		TCGA-23-1123-01	TCGA-23-1123-01	71543abc-9f15-48d9-994d-e7b963a4d8f3	TCGA-23-1123-01A-01W-0488-09	TCGA-23-1123-01A-01R-0436-07	
TCGA-23-1124-01	1	TCGA-23-1124-01	1768	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-23-1124			days	1768	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Left	TCGA-23-1124-F25739	TCGA-23-1124		Stage IIIC	-23005		1768	0			641				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence						1124		WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01				23	No Macroscopic disease	Ovary	YES		DECEASED	1999		TCGA-23-1124-01		e707d0a2-6e26-48dc-9020-ae36b666321a		TCGA-23-1124-01		TCGA-23-1124-01A-01D-0432-05	TCGA-23-1124-01A-01W-0488-09	TCGA-23-1124-01A-11-1562-20	TCGA-23-1124-01A-01W-0488-09		TCGA-23-1124-01A-01D-0428-01	TCGA-23-1124-01	fe87e0a2-b27c-402c-81d8-ec0d24e7ce81		TCGA-23-1124-01A-01D-0428-01					TCGA-23-1124-01			TCGA-23-1124-01A-01W-0488-09	TCGA-23-1124-01A-01R-0436-07	
TCGA-23-1809-01	0	TCGA-23-1809-01	16	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-23-1809			days	16	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Right	TCGA-23-1809-F25753	TCGA-23-1809	TCGA-23-1809-01A	Stage IIC	-23111			0	16						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		0.9		NO	G3						TCGA-23-1809.f69b3aba-61df-4fd8-94d7-9bb80692464c.pdf	1809			YES			NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary	NO	A	LIVING	2009	TCGA-23-1809-01	TCGA-23-1809-01		2bf22a99-e464-4889-9c1c-0208d5df2f36		TCGA-23-1809-01		TCGA-23-1809-01A-01D-0563-05		TCGA-23-1809-01A-21-1559-20	TCGA-23-1809-01A-01W-0633-09	ac764277-4d48-489a-8625-f27541b11258	TCGA-23-1809-01A-01D-0559-01	TCGA-23-1809-01	2341af5b-d30e-4ae0-9384-119f66a797ed		TCGA-23-1809-01A-01D-0559-01	ac764277-4d48-489a-8625-f27541b11258		ac764277-4d48-489a-8625-f27541b11258		TCGA-23-1809-01	TCGA-23-1809-01	ac764277-4d48-489a-8625-f27541b11258		TCGA-23-1809-01A-01R-0566-07	
TCGA-23-2072-01	1	TCGA-23-2072-01	759	1	days	High		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-2072			days	759	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Right	TCGA-23-2072-F25757	TCGA-23-2072	TCGA-23-2072-01A	Stage IV	-21523		759	0			476				2009-11-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence					TCGA-23-2072.b0475cc1-edd5-451c-8f26-ec3594811f2e.pdf	2072		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.2			23	>20 mm	Ovary		A	DECEASED	2000		TCGA-23-2072-01		5ba9bc54-191b-4a8b-8571-24a780a2e7d5		TCGA-23-2072-01		TCGA-23-2072-01A-01D-0667-05					TCGA-23-2072-01A-01D-0663-01	TCGA-23-2072-01			TCGA-23-2072-01A-01D-0663-01				TCGA-23-2072-01A-01W-0722-08	TCGA-23-2072-01			TCGA-23-2072-01A-01W-0722-08	TCGA-23-2072-01A-01R-0670-07	
TCGA-23-2077-01	0	TCGA-23-2077-01	3525	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 8	TCGA-23-2077			days	3525	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Left	TCGA-23-2077-F25763	TCGA-23-2077	TCGA-23-2077-01A	Stage IIIC	-16552			0	3525		1232				2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.1		NO	G3	Recurrence					TCGA-23-2077.55589297-f28e-422c-beee-6cb19a2350be.pdf	2077		TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			23	No Macroscopic disease	Ovary	YES	A	LIVING	1999	TCGA-23-2077-01	TCGA-23-2077-01		2db607b0-cd7f-4686-9f85-a119b089ed7f		TCGA-23-2077-01		TCGA-23-2077-01A-01D-0667-05		TCGA-23-2077-01A-21-1560-20		16c61c5a-a9b3-4022-9b79-d593e3519794	TCGA-23-2077-01A-01D-0663-01	TCGA-23-2077-01	3848ccad-5f29-40f6-8407-05e548a3b8e5		TCGA-23-2077-01A-01D-0663-01	16c61c5a-a9b3-4022-9b79-d593e3519794		16c61c5a-a9b3-4022-9b79-d593e3519794	TCGA-23-2077-01A-01W-0722-08	TCGA-23-2077-01	TCGA-23-2077-01	16c61c5a-a9b3-4022-9b79-d593e3519794	TCGA-23-2077-01A-01W-0722-08	TCGA-23-2077-01A-01R-0670-07	
TCGA-23-2078-01	0	TCGA-23-2078-01	2661	0	days	Squamous	C9-OV	OV-like c1	KIRC-like c1		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-2078			days	2661	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			66	Bilateral	TCGA-23-2078-F25771	TCGA-23-2078	TCGA-23-2078-01A	Stage IIIC	-24223			0	2661						2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		0.9		YES	G3						TCGA-23-2078.19ed5fbe-17e1-43f3-bfa0-32f474a00be8.pdf	2078		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			23	No Macroscopic disease	Ovary	YES	A	LIVING	2001	TCGA-23-2078-01	TCGA-23-2078-01		ec2fe757-24f2-4ffc-bf20-f6d6632eb775		TCGA-23-2078-01		TCGA-23-2078-01A-01D-0667-05		TCGA-23-2078-01A-21-1560-20		9f35075d-4d81-44f2-a672-12028d6231be	TCGA-23-2078-01A-01D-0663-01	TCGA-23-2078-01	5ea02416-3cd8-443c-8336-4ad367757f38		TCGA-23-2078-01A-01D-0663-01	9f35075d-4d81-44f2-a672-12028d6231be		9f35075d-4d81-44f2-a672-12028d6231be	TCGA-23-2078-01A-01W-0722-08	TCGA-23-2078-01	TCGA-23-2078-01	9f35075d-4d81-44f2-a672-12028d6231be	TCGA-23-2078-01A-01W-0722-08	TCGA-23-2078-01A-01R-0670-07	
TCGA-23-2079-01	0	TCGA-23-2079-01	2788	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation c1uster 9	TCGA-23-2079			days	2788	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	46	Bilateral	TCGA-23-2079-F25775	TCGA-23-2079	TCGA-23-2079-01A	Stage IIIC	-17122			0	2788		283				2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3	Recurrence					TCGA-23-2079.66ace408-fc31-463b-a218-94fdef0afaaf.pdf	2079		TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			23	No Macroscopic disease	Ovary	YES	A	LIVING	2001		TCGA-23-2079-01		6bbbfad0-800f-4537-99f2-6d5f1e5bdab0		TCGA-23-2079-01		TCGA-23-2079-01A-01D-0667-05		TCGA-23-2079-01A-21-1560-20			TCGA-23-2079-01A-01D-0663-01	TCGA-23-2079-01	527e6a80-10fe-4b9d-9169-63ea62681e4a		TCGA-23-2079-01A-01D-0663-01				TCGA-23-2079-01A-01W-0722-08	TCGA-23-2079-01			TCGA-23-2079-01A-01W-0722-08	TCGA-23-2079-01A-01R-0670-07	
TCGA-23-2081-01	1	TCGA-23-2081-01	2342	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-23-2081			days	2342	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-23-2081-F25781	TCGA-23-2081	TCGA-23-2081-01A	Stage IV	-18162		2342	0		250					2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3	Locoregional Disease	YES				TCGA-23-2081.05dc597f-052a-461e-a67c-27dac0d10972.pdf	2081		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.5			23	1-10 mm	Ovary		A	DECEASED	2000	TCGA-23-2081-01	TCGA-23-2081-01		c5bdab9f-b9fc-4f96-bc7b-b5a65ec3cf68		TCGA-23-2081-01		TCGA-23-2081-01A-01D-0667-05		TCGA-23-2081-01A-21-1560-20		4c8dd391-5a1c-490e-a7d7-fde372c3ec47	TCGA-23-2081-01A-01D-0663-01	TCGA-23-2081-01	330a8af7-1a12-46a0-8ede-ca4e244de117		TCGA-23-2081-01A-01D-0663-01	4c8dd391-5a1c-490e-a7d7-fde372c3ec47		4c8dd391-5a1c-490e-a7d7-fde372c3ec47	TCGA-23-2081-01A-01W-0722-08	TCGA-23-2081-01	TCGA-23-2081-01	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	TCGA-23-2081-01A-01W-0722-08	TCGA-23-2081-01A-01R-0670-07	
TCGA-23-2084-01	1	TCGA-23-2084-01	1516	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 6		TCGA-23-2084			days	1516	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Right	TCGA-23-2084-F25795	TCGA-23-2084	TCGA-23-2084-01A	Stage IV	-16493		1516	0			619				2009-11-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.4		YES	G3	Recurrence					TCGA-23-2084.00fd3d04-b48e-434e-8d25-0f0949e796cc.pdf	2084		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			23	No Macroscopic disease	Ovary	YES	A	DECEASED	2000	TCGA-23-2084-01	TCGA-23-2084-01		6c08e99a-bd74-4e72-8d22-4295edfe6225		TCGA-23-2084-01		TCGA-23-2084-01A-02D-0667-05				858a382c-49dc-4990-8c0f-017fedd9a6db	TCGA-23-2084-01A-02D-0663-01	TCGA-23-2084-01			TCGA-23-2084-01A-02D-0663-01	858a382c-49dc-4990-8c0f-017fedd9a6db		858a382c-49dc-4990-8c0f-017fedd9a6db		TCGA-23-2084-01	TCGA-23-2084-01	858a382c-49dc-4990-8c0f-017fedd9a6db		TCGA-23-2084-01A-02R-0670-07	
TCGA-23-2641-01	0	TCGA-23-2641-01	84	0	days	Squamous		OV-like c1	OV-like c4					TCGA-23-2641			days	84	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			85	Left	TCGA-23-2641-F25810	TCGA-23-2641	TCGA-23-2641-01A	Stage IIIC	-31232			0	84						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3						TCGA-23-2641.0b8f79ba-dbf1-4978-9661-bb0b0dcc8768.pdf	2641			YES			NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary		A	LIVING	2009				c7559a8a-552e-44e1-97dd-d3a333a5e283				TCGA-23-2641-01A-01D-1047-05		TCGA-23-2641-01A-21-20	TCGA-23-2641-01A-01D-1526-09		TCGA-23-2641-01A-01D-1043-01	TCGA-23-2641-01	42dc7e58-4deb-4a79-8b08-67295835b807		TCGA-23-2641-01A-01D-1043-01					TCGA-23-2641-01				TCGA-23-2641-01A-01R-1050-07	
TCGA-23-2643-01	0	TCGA-23-2643-01	143	0	days	High		OV-like c1	OV-like c4					TCGA-23-2643			days	143	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			74	Right	TCGA-23-2643-F25812	TCGA-23-2643	TCGA-23-2643-01A	Stage IIIC	-27093			0	143						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.2			G3						TCGA-23-2643.8481bd3e-147d-4a67-acdd-08fea5be431a.pdf	2643		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary		A	LIVING	2009				02d0fc82-4de5-4543-88e1-b069652b6c4b				TCGA-23-2643-01A-01D-1047-05		TCGA-23-2643-01A-21-20	TCGA-23-2643-01A-01D-1526-09		TCGA-23-2643-01A-01D-1043-01	TCGA-23-2643-01	061c8e23-337c-49f7-84bb-9289b1e71595		TCGA-23-2643-01A-01D-1043-01					TCGA-23-2643-01				TCGA-23-2643-01A-01R-1050-07	
TCGA-23-2645-01	0	TCGA-23-2645-01	137	0	days	High		OV-like c1	OV-like c4					TCGA-23-2645			days	137	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			54	Right	TCGA-23-2645-F25818	TCGA-23-2645	TCGA-23-2645-01A	Stage IIIC	-19758			0	137						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3						TCGA-23-2645.e1651bbc-ed16-4e45-b6f8-283459d72568.pdf	2645			YES			NO		Primary Tumor	01	0.5			23	No Macroscopic disease	Ovary		A	LIVING	2009				f6880438-40e9-4c78-ac4b-fbdf71637a68				TCGA-23-2645-01A-01D-1047-05		TCGA-23-2645-01A-21-20	TCGA-23-2645-01A-01W-1091-09		TCGA-23-2645-01A-01D-1043-01	TCGA-23-2645-01	7326a637-b5db-47d8-a114-030db3a91417		TCGA-23-2645-01A-01D-1043-01					TCGA-23-2645-01				TCGA-23-2645-01A-01R-1050-07	
TCGA-23-2647-01	0	TCGA-23-2647-01	135	0	days			OV-like c1	OV-like c4					TCGA-23-2647			days	135	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-23-2647-F25820	TCGA-23-2647		Stage IIIC	-18205			0	135						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3							2647			YES			NO		Primary Tumor	01				23	1-10 mm	Ovary	YES		LIVING	2009				f50b14e1-8106-4823-9bbd-68cf5f17189b				TCGA-23-2647-01A-01D-1047-05		TCGA-23-2647-01A-21-20	TCGA-23-2647-01A-01D-1526-09			TCGA-23-2647-01	eeaa45e2-a17d-475c-b9a9-fbec7fa7ecd1											TCGA-23-2647-01A-01R-1050-07	
TCGA-23-2649-01	0	TCGA-23-2649-01	116	0	days			OV-like c1	OV-like c4					TCGA-23-2649			days	116	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Left	TCGA-23-2649-F25822	TCGA-23-2649	TCGA-23-2649-01A	Stage IIIC	-22210			0	116						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		YES	G3						TCGA-23-2649.7a0bd8e4-1c7b-4bbc-bddc-e06902fc4db5.pdf	2649			YES			NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary	YES	A	LIVING	2009				408178f3-62ee-4c5d-a160-355deedc69c8				TCGA-23-2649-01A-01D-1047-05		TCGA-23-2649-01A-21-20	TCGA-23-2649-01A-01D-1526-09			TCGA-23-2649-01	2d3ae942-c1d4-4e80-a0e1-4b7fbc15952a											TCGA-23-2649-01A-01R-1050-07	
TCGA-24-0966-01	0	TCGA-24-0966-01	232	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 2	TCGA-24-0966			days	232	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Bilateral	TCGA-24-0966-F25875	TCGA-24-0966	TCGA-24-0966-01A	Stage IIIC	-28529			0	232						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.3		YES	G3						TCGA-24-0966.99D5CA9E-3E3F-4037-96B9-9D4A34C614B3.pdf	0966		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	LIVING	2008		TCGA-24-0966-01		5f1ed5e0-4a91-404f-a3b9-e855ff3ac303		TCGA-24-0966-01		TCGA-24-0966-01A-01D-0402-05	TCGA-24-0966-01A-01W-0977-09	TCGA-24-0966-01A-21-1562-20	TCGA-24-0966-01A-01W-0977-09		TCGA-24-0966-01A-01D-0399-01	TCGA-24-0966-01	02ebd198-faca-4fb3-ba5a-531389b4fffa		TCGA-24-0966-01A-01D-0399-01					TCGA-24-0966-01			TCGA-24-0966-01A-01W-0977-09	TCGA-24-0966-01A-01R-0406-07	
TCGA-24-0968-01		TCGA-24-0968-01			days	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-0968			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Left	TCGA-24-0968-F25880	TCGA-24-0968		Stage IIIC	-21664			0	598						2009-3-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)							YES	G3							0968		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01				24	1-10 mm	Ovary			DECEASED	2005		TCGA-24-0968-01	TCGA-24-0968-01A-01W-0484-10	e6f5bb0e-aab8-4243-b233-e07b2e5811f4		TCGA-24-0968-01	TCGA-24-0968-01A-01W-0484-10	TCGA-24-0968-01A-01D-0432-05					TCGA-24-0968-01A-01D-0428-01	TCGA-24-0968-01			TCGA-24-0968-01A-01D-0428-01					TCGA-24-0968-01			TCGA-24-0968-01A-01W-0484-10	TCGA-24-0968-01A-01R-0436-07	
TCGA-24-0970-01	1	TCGA-24-0970-01	354	1	days	High	C9-OV	Low purity c2	OV-like c4		miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-24-0970			days	354	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-24-0970-F25870	TCGA-24-0970	TCGA-24-0970-01B	Stage IIIC	-23276		354	0	354		280				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		0.8	NO		2		YES	G3	Recurrence					TCGA-24-0970.50AB91D8-AEC6-46B6-95C1-8F008EE0ED8F.pdf	0970		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.8			24	>20 mm	Ovary		B	DECEASED	2005		TCGA-24-0970-01		ec3d35b4-27f6-4dd6-a6f2-596eed1a6547		TCGA-24-0970-01		TCGA-24-0970-01B-01D-0432-05		TCGA-24-0970-01B-11-1562-20			TCGA-24-0970-01B-01D-0428-01	TCGA-24-0970-01	02d6074d-90c9-472f-a355-c799e2c96f4a		TCGA-24-0970-01B-01D-0428-01				TCGA-24-0970-01B-01W-0486-08	TCGA-24-0970-01			TCGA-24-0970-01B-01W-0486-08	TCGA-24-0970-01B-01R-0436-07	
TCGA-24-0975-01	1	TCGA-24-0975-01	663	1	days	High	C9-OV	Low purity c2		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-24-0975			days	663	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-24-0975-F25861	TCGA-24-0975	TCGA-24-0975-01A	Stage IIIC	-21417		663	0	663						2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.5			G3						TCGA-24-0975.8AA65DCA-E057-486F-AEFA-D8A3485416EC.pdf	0975		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	DECEASED	2004	TCGA-24-0975-01	TCGA-24-0975-01		9f531d00-af98-4a8e-9614-74c063fa2f15		TCGA-24-0975-01		TCGA-24-0975-01B-02D-0432-05				a16723c4-d5b1-40a0-9890-570351738879	TCGA-24-0975-01B-02D-0428-01	TCGA-24-0975-01			TCGA-24-0975-01B-02D-0428-01	a16723c4-d5b1-40a0-9890-570351738879		a16723c4-d5b1-40a0-9890-570351738879	TCGA-24-0975-01B-02W-0486-08	TCGA-24-0975-01	TCGA-24-0975-01	a16723c4-d5b1-40a0-9890-570351738879	TCGA-24-0975-01B-02W-0486-08	TCGA-24-0975-01A-02R-0436-07	
TCGA-24-0979-01	1	TCGA-24-0979-01	1264	1	days	High	C9-OV	Low purity c2	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-0979			days	1264	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	53	Bilateral	TCGA-24-0979-F25891	TCGA-24-0979	TCGA-24-0979-01A	Stage IV	-19595		1264	0	1264		428				2009-5-11	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		0.8			G3	Recurrence					TCGA-24-0979.3385E5B4-EBD4-4317-8805-EE6EA47A2E4A.pdf	0979		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	2003		TCGA-24-0979-01		3a1401ac-2bfc-4baa-9018-bb71de5cfb51		TCGA-24-0979-01		TCGA-24-0979-01A-01D-0432-05		TCGA-24-0979-01A-21-20			TCGA-24-0979-01A-01D-0428-01	TCGA-24-0979-01	1c5c8013-17c7-4be1-888c-ab0da1e3afdd		TCGA-24-0979-01A-01D-0428-01				TCGA-24-0979-01A-01W-0486-08	TCGA-24-0979-01			TCGA-24-0979-01A-01W-0486-08	TCGA-24-0979-01A-01R-0436-07	
TCGA-24-0980-01	1	TCGA-24-0980-01	233	1	days	Squamous	C9-OV	OV-like c1	OV-like c4				mutation cluster 5	TCGA-24-0980			days	233	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-0980-F25896	TCGA-24-0980		Stage IIIC	-19579		233	0	233		145				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)							YES	G3	Recurrence						0980		WITH TUMOR	YES	Progressive Disease	Other Method	NO		Primary Tumor	01				24	>20 mm	Ovary			DECEASED	2003				eed170f8-eef5-4e58-8dda-64324bf900e2				TCGA-24-0980-01A-01D-0402-05	TCGA-24-0980-01A-01W-0421-09	TCGA-24-0980-01A-21-20	TCGA-24-0980-01A-01W-0421-09		TCGA-24-0980-01A-01D-0399-01	TCGA-24-0980-01	e09cff37-f92b-48f7-a2d6-e72b68d0a8b4		TCGA-24-0980-01A-01D-0399-01					TCGA-24-0980-01			TCGA-24-0980-01A-01W-0421-09	TCGA-24-0980-01A-01R-0406-07	
TCGA-24-0981-01		TCGA-24-0981-01			days									TCGA-24-0981			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary																																																																					TCGA-24-0981-01A-01D-0432-05																		TCGA-24-0981-01A-01R-0436-07	
TCGA-24-0982-01	1	TCGA-24-0982-01	679	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-0982			days	679	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Bilateral	TCGA-24-0982-F25900	TCGA-24-0982		Stage IIIC	-28201		679	0	679		153				2009-3-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3	Recurrence						0982		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				24	1-10 mm	Ovary			DECEASED	2003		TCGA-24-0982-01		fc2dbc4a-dd8a-4174-a186-15ceaaaac881		TCGA-24-0982-01		TCGA-24-0982-01A-01D-0432-05	TCGA-24-0982-01A-01W-0488-09	TCGA-24-0982-01A-21-20	TCGA-24-0982-01A-01W-0488-09		TCGA-24-0982-01A-01D-0428-01	TCGA-24-0982-01	d712585f-3d02-4e1a-a11a-4ffac7295711		TCGA-24-0982-01A-01D-0428-01					TCGA-24-0982-01			TCGA-24-0982-01A-01W-0488-09	TCGA-24-0982-01A-01R-0436-07	
TCGA-24-1103-01	1	TCGA-24-1103-01	1646	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1103			days	1646	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-24-1103-F25824	TCGA-24-1103	TCGA-24-1103-01A	Stage IIIC	-18583		1646	0	1646		678				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence					TCGA-24-1103.B9628222-5530-4A82-9F13-2773173A0C95.pdf	1103		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	2001	TCGA-24-1103-01	TCGA-24-1103-01		77d9fb44-1cbe-41aa-8abe-e66fa774a33e		TCGA-24-1103-01		TCGA-24-1103-01A-01D-0432-05	TCGA-24-1103-01A-01W-0488-09	TCGA-24-1103-01A-11-1562-20	TCGA-24-1103-01A-01W-0488-09	202abe19-20e0-4ea9-8653-bf5145da351c	TCGA-24-1103-01A-01D-0428-01	TCGA-24-1103-01	6f0a19c3-b3d6-44da-8962-79cd723f0fab		TCGA-24-1103-01A-01D-0428-01	202abe19-20e0-4ea9-8653-bf5145da351c		202abe19-20e0-4ea9-8653-bf5145da351c		TCGA-24-1103-01	TCGA-24-1103-01	202abe19-20e0-4ea9-8653-bf5145da351c	TCGA-24-1103-01A-01W-0488-09	TCGA-24-1103-01A-01R-0436-07	
TCGA-24-1104-01	1	TCGA-24-1104-01	1933	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-24-1104			days	1933	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	56	Left	TCGA-24-1104-F25834	TCGA-24-1104	TCGA-24-1104-01A	Stage IV	-20527		1933	0	1933		959				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.5			G3	Recurrence					TCGA-24-1104.4991D5F7-0259-430F-AFF7-1307DF563E41.pdf	1104		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	DECEASED	2001		TCGA-24-1104-01		14fde2bb-46b6-410f-89c6-f32a6f084668		TCGA-24-1104-01		TCGA-24-1104-01A-01D-0432-05	TCGA-24-1104-01A-01W-0488-09	TCGA-24-1104-01A-21-1562-20	TCGA-24-1104-01A-01W-0488-09		TCGA-24-1104-01A-01D-0428-01	TCGA-24-1104-01	14177a50-0360-47ce-b24b-3468b4a2b75f		TCGA-24-1104-01A-01D-0428-01					TCGA-24-1104-01			TCGA-24-1104-01A-01W-0488-09	TCGA-24-1104-01A-01R-0436-07	
TCGA-24-1105-01	1	TCGA-24-1105-01	1442	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1105			days	1442	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	36	Bilateral	TCGA-24-1105-F25844	TCGA-24-1105	TCGA-24-1105-01A	Stage IIIC	-13187		1442	0	1442		470				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.4			G3	Recurrence					TCGA-24-1105.DE593AFC-BC21-4183-94A6-B8BA9931B70F.pdf	1105		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.8			24	1-10 mm	Ovary		A	DECEASED	2001		TCGA-24-1105-01	TCGA-24-1105-01A-01W-0484-10	9840b4a9-5f2f-4263-905f-e395092e2cea		TCGA-24-1105-01	TCGA-24-1105-01A-01W-0484-10	TCGA-24-1105-01A-01D-0432-05		TCGA-24-1105-01A-21-1562-20			TCGA-24-1105-01A-01D-0428-01	TCGA-24-1105-01	ea5d304a-364c-4633-860b-f2e7be2ca00e		TCGA-24-1105-01A-01D-0428-01					TCGA-24-1105-01			TCGA-24-1105-01A-01W-0484-10	TCGA-24-1105-01A-01R-0436-07	
TCGA-24-1413-01	0	TCGA-24-1413-01	192	0	days	BRCA-LUAD+	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1413			days	192	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-24-1413-F25910	TCGA-24-1413	TCGA-24-1413-01A	Stage IIIC	-18846			0	192						2009-3-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.1		YES	G3						TCGA-24-1413.2ca18d08-e930-4244-a0d5-316dfbca0fb4.pdf	1413		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2008	TCGA-24-1413-01	TCGA-24-1413-01		78f0e50d-6dc9-4c74-8674-3cb6800ea7a6		TCGA-24-1413-01		TCGA-24-1413-01A-01D-0460-05	TCGA-24-1413-01A-01W-0494-09		TCGA-24-1413-01A-01W-0494-09	545867ef-1299-410d-bbbf-d6c189344b0f	TCGA-24-1413-01A-01D-0452-01	TCGA-24-1413-01			TCGA-24-1413-01A-01D-0452-01	545867ef-1299-410d-bbbf-d6c189344b0f		545867ef-1299-410d-bbbf-d6c189344b0f		TCGA-24-1413-01	TCGA-24-1413-01	545867ef-1299-410d-bbbf-d6c189344b0f	TCGA-24-1413-01A-01W-0494-09	TCGA-24-1413-01A-01R-0456-07	
TCGA-24-1416-01	0	TCGA-24-1416-01	194	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 3	TCGA-24-1416			days	194	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			34	Bilateral	TCGA-24-1416-F25914	TCGA-24-1416	TCGA-24-1416-01A	Stage IV	-12772			0	194						2009-4-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G3						TCGA-24-1416.c5a7b8b5-65b5-47d0-84dc-882024042a6f.pdf	1416		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2008	TCGA-24-1416-01	TCGA-24-1416-01		f46fbaaf-21ba-40c3-9e27-db0febe3b250		TCGA-24-1416-01		TCGA-24-1416-01A-01D-0475-05	TCGA-24-1416-01A-01W-0549-09	TCGA-24-1416-01A-21-20	TCGA-24-1416-01A-01W-0549-09	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	TCGA-24-1416-01A-01D-0472-01	TCGA-24-1416-01	0eda7c90-97fe-4184-b8ad-73e7820c3b7e		TCGA-24-1416-01A-01D-0472-01	67fcea16-d5bc-4edd-b66d-bfc5d56d976d		67fcea16-d5bc-4edd-b66d-bfc5d56d976d		TCGA-24-1416-01	TCGA-24-1416-01	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	TCGA-24-1416-01A-01W-0549-09	TCGA-24-1416-01A-01R-0479-07	
TCGA-24-1417-01	0	TCGA-24-1417-01	238	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1417			days	238	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			54	Left	TCGA-24-1417-F25920	TCGA-24-1417	TCGA-24-1417-01A	Stage IV	-19775			0	238						2009-4-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.3			G3						TCGA-24-1417.4058a172-a0f6-4c91-9c79-aab63525340f.pdf	1417		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2008	TCGA-24-1417-01	TCGA-24-1417-01		68f0717d-5edc-43f0-bbde-606574f02b4f		TCGA-24-1417-01		TCGA-24-1417-01A-01D-0475-05	TCGA-24-1417-01A-01W-0549-09	TCGA-24-1417-01A-21-20	TCGA-24-1417-01A-01W-0549-09	e76a7745-3193-4650-9a7a-c96329690be3	TCGA-24-1417-01A-01D-0472-01	TCGA-24-1417-01	4e9ef1e1-1dd3-4027-8a72-11dcbce7e12a		TCGA-24-1417-01A-01D-0472-01	e76a7745-3193-4650-9a7a-c96329690be3		e76a7745-3193-4650-9a7a-c96329690be3		TCGA-24-1417-01	TCGA-24-1417-01	e76a7745-3193-4650-9a7a-c96329690be3	TCGA-24-1417-01A-01W-0549-09	TCGA-24-1417-01A-01R-0479-07	
TCGA-24-1418-01	0	TCGA-24-1418-01	243	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1418			days	243	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			68	Bilateral	TCGA-24-1418-F25924	TCGA-24-1418	TCGA-24-1418-01A	Stage IIIC	-24842			0	243			0			2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		1.2	NO		1.2			G3						TCGA-24-1418.14fdb291-ba79-4852-9242-02dc191ca8c5.pdf	1418	Other	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			24	>20 mm	Ovary		A	LIVING	2008	TCGA-24-1418-01	TCGA-24-1418-01		8302128a-2f41-42d9-8ebc-ceedb67f2919		TCGA-24-1418-01		TCGA-24-1418-01A-01D-0475-05	TCGA-24-1418-01A-01W-0549-09		TCGA-24-1418-01A-01W-0549-09	4e701e9f-9127-4d61-8a72-7e440b969fbe	TCGA-24-1418-01A-01D-0472-01	TCGA-24-1418-01			TCGA-24-1418-01A-01D-0472-01	4e701e9f-9127-4d61-8a72-7e440b969fbe		4e701e9f-9127-4d61-8a72-7e440b969fbe		TCGA-24-1418-01	TCGA-24-1418-01	4e701e9f-9127-4d61-8a72-7e440b969fbe	TCGA-24-1418-01A-01W-0549-09	TCGA-24-1418-01A-01R-0479-07	
TCGA-24-1419-01	0	TCGA-24-1419-01	239	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1419			days	239	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Bilateral	TCGA-24-1419-F25929	TCGA-24-1419	TCGA-24-1419-01A	Stage IIIC	-22659			0	239						2009-4-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.8			G3						TCGA-24-1419.0a8c75aa-8031-4f1d-9dba-9029b009d677.pdf	1419		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			24	11-20 mm	Ovary		A	LIVING	2008	TCGA-24-1419-01	TCGA-24-1419-01		8edd134e-95e4-47d2-9a2a-b68b0ca427ea		TCGA-24-1419-01		TCGA-24-1419-01A-01D-0475-05		TCGA-24-1419-01A-21-20		7bf43d51-2714-419e-a52f-863ca54c90e5	TCGA-24-1419-01A-01D-0472-01	TCGA-24-1419-01	e55a0b2e-1cba-4732-a04d-2dc2eb49cdcc		TCGA-24-1419-01A-01D-0472-01	7bf43d51-2714-419e-a52f-863ca54c90e5		7bf43d51-2714-419e-a52f-863ca54c90e5	TCGA-24-1419-01A-01W-0545-08	TCGA-24-1419-01	TCGA-24-1419-01	7bf43d51-2714-419e-a52f-863ca54c90e5	TCGA-24-1419-01A-01W-0545-08	TCGA-24-1419-01A-01R-0479-07	
TCGA-24-1422-01	1	TCGA-24-1422-01	23	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1422			days	23	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			82	Bilateral	TCGA-24-1422-F25934	TCGA-24-1422	TCGA-24-1422-01A	Stage IIIC	-30234		23	0	23						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.8			G3						TCGA-24-1422.8bcb6cf4-84ea-41a1-9113-061a7523c19f.pdf	1422			NO			NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	2008		TCGA-24-1422-01		48e00661-f995-42b5-9400-3391914a90d9		TCGA-24-1422-01		TCGA-24-1422-01A-01D-0475-05		TCGA-24-1422-01A-21-1562-20			TCGA-24-1422-01A-01D-0472-01	TCGA-24-1422-01	52fbe264-2840-4bae-86a9-17f09ebe5053		TCGA-24-1422-01A-01D-0472-01				TCGA-24-1422-01A-01W-0545-08	TCGA-24-1422-01			TCGA-24-1422-01A-01W-0545-08	TCGA-24-1422-01A-01R-0479-07	
TCGA-24-1423-01	0	TCGA-24-1423-01	190	0	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1423			days	190	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			61	Bilateral	TCGA-24-1423-F25936	TCGA-24-1423	TCGA-24-1423-01A	Stage IIIC	-22281			0	190						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.8		YES	G3						TCGA-24-1423.47331163-68e9-44fd-8b80-b9f70058957f.pdf	1423		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	LIVING	2008	TCGA-24-1423-01	TCGA-24-1423-01		670fe1e4-f612-4797-a926-41cd2da84843		TCGA-24-1423-01		TCGA-24-1423-01A-01D-0475-05		TCGA-24-1423-01A-21-1562-20		b493df11-1929-4e35-ac44-49057cdbd86b	TCGA-24-1423-01A-01D-0472-01	TCGA-24-1423-01	5a0afbd0-e504-46d6-b268-2b04d7f8be98		TCGA-24-1423-01A-01D-0472-01	b493df11-1929-4e35-ac44-49057cdbd86b		b493df11-1929-4e35-ac44-49057cdbd86b	TCGA-24-1423-01A-01W-0545-08	TCGA-24-1423-01	TCGA-24-1423-01	b493df11-1929-4e35-ac44-49057cdbd86b	TCGA-24-1423-01A-01W-0545-08	TCGA-24-1423-01A-01R-0479-07	
TCGA-24-1424-01	0	TCGA-24-1424-01	183	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-1424			days	183	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			67	Bilateral	TCGA-24-1424-F25941	TCGA-24-1424		Stage IIIC	-24545			0	183						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3							1424		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				24	1-10 mm	Ovary			LIVING	2008	TCGA-24-1424-01	TCGA-24-1424-01		fdda2c0b-816d-4e49-83e8-2e40d4444f0c		TCGA-24-1424-01		TCGA-24-1424-01A-01D-0475-05	TCGA-24-1424-01A-01W-0549-09	TCGA-24-1424-01A-21-1562-20	TCGA-24-1424-01A-01W-0549-09	d3fbcdaa-11af-4233-9700-57c6e1628c4b	TCGA-24-1424-01A-01D-0472-01	TCGA-24-1424-01	b64c050d-b09e-4fbb-a906-b5d5e3904149		TCGA-24-1424-01A-01D-0472-01	d3fbcdaa-11af-4233-9700-57c6e1628c4b		d3fbcdaa-11af-4233-9700-57c6e1628c4b		TCGA-24-1424-01	TCGA-24-1424-01	d3fbcdaa-11af-4233-9700-57c6e1628c4b	TCGA-24-1424-01A-01W-0549-09	TCGA-24-1424-01A-01R-0479-07	
TCGA-24-1425-01	0	TCGA-24-1425-01	181	0	days	Squamous		OV-like c1			miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-24-1425			days	181	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Bilateral	TCGA-24-1425-F25946	TCGA-24-1425		Stage IIIC	-16764			0	181			0			2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3							1425	Other	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				24	1-10 mm	Ovary			LIVING	2008	TCGA-24-1425-01	TCGA-24-1425-01		f112ed71-765e-48bc-a5ab-196f42740078		TCGA-24-1425-01		TCGA-24-1425-01A-02D-0501-05	TCGA-24-1425-01A-02W-0553-09		TCGA-24-1425-01A-02W-0553-09	f580e84b-b405-43dc-9dae-4588cedf435f	TCGA-24-1425-01A-02D-0497-01	TCGA-24-1425-01			TCGA-24-1425-01A-02D-0497-01	f580e84b-b405-43dc-9dae-4588cedf435f		f580e84b-b405-43dc-9dae-4588cedf435f		TCGA-24-1425-01	TCGA-24-1425-01	f580e84b-b405-43dc-9dae-4588cedf435f	TCGA-24-1425-01A-02W-0553-09	TCGA-24-1425-01A-02R-0504-07	
TCGA-24-1426-01	0	TCGA-24-1426-01	163	0	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-1426			days	163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			43	Bilateral	TCGA-24-1426-F25951	TCGA-24-1426	TCGA-24-1426-01A	Stage IIIC	-15949			0	163						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1.2		YES	G3						TCGA-24-1426.72914511-b2f7-484f-a7ab-3f4f1868f2cb.pdf	1426		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1426-01		8395c4e0-d327-472d-a7e6-3af3e2cbb0be		TCGA-24-1426-01		TCGA-24-1426-01A-01D-0475-05	TCGA-24-1426-01A-01W-0549-09		TCGA-24-1426-01A-01W-0549-09		TCGA-24-1426-01A-01D-0472-01	TCGA-24-1426-01			TCGA-24-1426-01A-01D-0472-01					TCGA-24-1426-01			TCGA-24-1426-01A-01W-0549-09	TCGA-24-1426-01A-01R-0479-07	
TCGA-24-1427-01	0	TCGA-24-1427-01	147	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-1427			days	147	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Bilateral	TCGA-24-1427-F25956	TCGA-24-1427	TCGA-24-1427-01A	Stage IIIC	-21423			0	147						2009-4-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.7		YES	G3						TCGA-24-1427.af63c4e2-2f77-4311-bfe2-ee45cfd200bb.pdf	1427		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	LIVING	2008	TCGA-24-1427-01	TCGA-24-1427-01		5beadb09-fe3f-44aa-8c20-fdf66e0a68ca		TCGA-24-1427-01		TCGA-24-1427-01A-01D-0475-05	TCGA-24-1427-01A-01W-0549-09	TCGA-24-1427-01A-21-1562-20	TCGA-24-1427-01A-01W-0549-09	5a505632-422c-4083-b867-82a7a503b314	TCGA-24-1427-01A-01D-0472-01	TCGA-24-1427-01	87a8658e-3143-4074-9988-b0fed3d25f8b		TCGA-24-1427-01A-01D-0472-01	5a505632-422c-4083-b867-82a7a503b314		5a505632-422c-4083-b867-82a7a503b314		TCGA-24-1427-01	TCGA-24-1427-01	5a505632-422c-4083-b867-82a7a503b314	TCGA-24-1427-01A-01W-0549-09	TCGA-24-1427-01A-01R-0479-07	
TCGA-24-1428-01	0	TCGA-24-1428-01	529	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-24-1428			days	529	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Left	TCGA-24-1428-F25960	TCGA-24-1428	TCGA-24-1428-01A	Stage IIIC	-18306			0	529		448				2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3	Recurrence					TCGA-24-1428.9fcdd584-25e6-4a5a-ae15-f2956de32822.pdf	1428		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2008	TCGA-24-1428-01	TCGA-24-1428-01		c9eb8b63-8b8a-47eb-8fb1-11b089bf4a00		TCGA-24-1428-01		TCGA-24-1428-01A-01D-0475-05	TCGA-24-1428-01A-01W-0549-09	TCGA-24-1428-01A-21-1562-20	TCGA-24-1428-01A-01W-0549-09	30b9b778-1422-4842-ae99-658b8b1d7605	TCGA-24-1428-01A-01D-0472-01	TCGA-24-1428-01	66bafc53-dafe-493e-8ede-22866b714a76		TCGA-24-1428-01A-01D-0472-01	30b9b778-1422-4842-ae99-658b8b1d7605		30b9b778-1422-4842-ae99-658b8b1d7605		TCGA-24-1428-01	TCGA-24-1428-01	30b9b778-1422-4842-ae99-658b8b1d7605	TCGA-24-1428-01A-01W-0549-09	TCGA-24-1428-01A-01R-0479-07	
TCGA-24-1430-01	1	TCGA-24-1430-01	863	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-1430			days	863	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-24-1430-F25966	TCGA-24-1430	TCGA-24-1430-01A	Stage IIIC	-24939		863	0	863		449	1			2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.7	NO		2			G3	Recurrence					TCGA-24-1430.d0f95ced-e33f-4796-a6a4-3030f8e21761.pdf	1430	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.8			24	>20 mm	Ovary		A	DECEASED	2000	TCGA-24-1430-01	TCGA-24-1430-01		0bad8ba4-8a10-49d9-a2f6-5e833fb9f2da		TCGA-24-1430-01		TCGA-24-1430-01A-01D-0475-05		TCGA-24-1430-01A-21-1562-20		4c19d12e-0160-4d01-b621-65335156488b	TCGA-24-1430-01A-01D-0472-01	TCGA-24-1430-01	7dbdc93e-9d1d-48fe-92eb-9615eac2adb6		TCGA-24-1430-01A-01D-0472-01	4c19d12e-0160-4d01-b621-65335156488b		4c19d12e-0160-4d01-b621-65335156488b		TCGA-24-1430-01	TCGA-24-1430-01	4c19d12e-0160-4d01-b621-65335156488b		TCGA-24-1430-01A-01R-0479-07	
TCGA-24-1431-01	1	TCGA-24-1431-01	567	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-1431			days	567	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-24-1431-F25977	TCGA-24-1431		Stage IIIC	-24758		567	0	583		199				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence						1431		WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01				24	1-10 mm	Ovary			DECEASED	1999		TCGA-24-1431-01		e5aed4a1-b8f1-44bd-957c-94acfca519a7		TCGA-24-1431-01		TCGA-24-1431-01A-01D-0475-05		TCGA-24-1431-01A-21-1562-20			TCGA-24-1431-01A-01D-0472-01	TCGA-24-1431-01	a2ff2d82-073d-4ea0-b407-5a68de79f622		TCGA-24-1431-01A-01D-0472-01				TCGA-24-1431-01A-01D-0472-08	TCGA-24-1431-01			TCGA-24-1431-01A-01D-0472-08	TCGA-24-1431-01A-01R-0479-07	
TCGA-24-1434-01	1	TCGA-24-1434-01	568	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1434			days	568	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-24-1434-F25984	TCGA-24-1434	TCGA-24-1434-01A	Stage IIIC	-21810		568	0	568		337				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		1.5		YES	G3	Recurrence					TCGA-24-1434.0a5fd2a4-560b-4769-ba4e-868854471961.pdf	1434		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1434-01	TCGA-24-1434-01		a6c7ca3f-b07b-46d5-a1ba-f1c88a358229		TCGA-24-1434-01		TCGA-24-1434-01A-01D-0475-05		TCGA-24-1434-01A-21-1562-20		368f21cd-dd07-440d-89f5-5874e37fe63b	TCGA-24-1434-01A-01D-0472-01	TCGA-24-1434-01	0106e887-2791-4c17-9260-07bd927e5d9b		TCGA-24-1434-01A-01D-0472-01	368f21cd-dd07-440d-89f5-5874e37fe63b		368f21cd-dd07-440d-89f5-5874e37fe63b	TCGA-24-1434-01A-01W-0545-08	TCGA-24-1434-01	TCGA-24-1434-01	368f21cd-dd07-440d-89f5-5874e37fe63b	TCGA-24-1434-01A-01W-0545-08	TCGA-24-1434-01A-01R-0479-07	
TCGA-24-1435-01	1	TCGA-24-1435-01	1324	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 2	TCGA-24-1435			days	1324	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-24-1435-F25993	TCGA-24-1435	TCGA-24-1435-01A	Stage IIIC	-21107		1324	0	1324		505				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5		NO	G3	Recurrence					TCGA-24-1435.d1574b6c-6cc1-45bc-86d0-97585d8a5c93.pdf	1435		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1435-01	TCGA-24-1435-01		ac8a9858-933c-4d44-ae0c-e8b964344d0c		TCGA-24-1435-01		TCGA-24-1435-01A-01D-0475-05	TCGA-24-1435-01A-01W-0549-09	TCGA-24-1435-01A-21-1562-20	TCGA-24-1435-01A-01W-0549-09	c20ba763-e310-448a-9c85-0b4f680e6196	TCGA-24-1435-01A-01D-0472-01	TCGA-24-1435-01	591cd2fa-3920-42e9-a1ed-d76898930e6f		TCGA-24-1435-01A-01D-0472-01	c20ba763-e310-448a-9c85-0b4f680e6196		c20ba763-e310-448a-9c85-0b4f680e6196		TCGA-24-1435-01	TCGA-24-1435-01	c20ba763-e310-448a-9c85-0b4f680e6196	TCGA-24-1435-01A-01W-0549-09	TCGA-24-1435-01A-01R-0479-07	
TCGA-24-1436-01	1	TCGA-24-1436-01	260	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1436			days	260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Right	TCGA-24-1436-F26004	TCGA-24-1436	TCGA-24-1436-01A	Stage IIIC	-20881		260	0	260						2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G3						TCGA-24-1436.621d3f29-b555-4767-83dd-a6989af0be12.pdf	1436		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1436-01	TCGA-24-1436-01		432c75c7-ece9-49a3-8f6e-ceb61c30ca10		TCGA-24-1436-01		TCGA-24-1436-01A-01D-0475-05	TCGA-24-1436-01A-01W-0549-09	TCGA-24-1436-01A-21-1563-20	TCGA-24-1436-01A-01W-0549-09	45ff767a-721a-4d89-b5e9-0c6e7eba476d	TCGA-24-1436-01A-01D-0472-01	TCGA-24-1436-01	d6aaae43-70fd-461e-b240-8ba220221828		TCGA-24-1436-01A-01D-0472-01	45ff767a-721a-4d89-b5e9-0c6e7eba476d		45ff767a-721a-4d89-b5e9-0c6e7eba476d		TCGA-24-1436-01	TCGA-24-1436-01	45ff767a-721a-4d89-b5e9-0c6e7eba476d	TCGA-24-1436-01A-01W-0549-09	TCGA-24-1436-01A-01R-0479-07	
TCGA-24-1463-01	1	TCGA-24-1463-01	2218	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 2	mutation cluster 2	TCGA-24-1463			days	2218	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Bilateral	TCGA-24-1463-F26009	TCGA-24-1463	TCGA-24-1463-01A	Stage IIIC	-25734		2218	0	2218		971				2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		2			G3	Recurrence					TCGA-24-1463.864CB084-569A-47F0-A83D-F3FA649A6B00.pdf	1463		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	2000	TCGA-24-1463-01	TCGA-24-1463-01		28787351-5cbd-4d64-910c-e306e7f65d8e		TCGA-24-1463-01		TCGA-24-1463-01A-01D-0475-05	TCGA-24-1463-01A-01W-0549-09	TCGA-24-1463-01A-21-1562-20	TCGA-24-1463-01A-01W-0549-09	939d41b7-9ccb-4cf6-be16-f2792aece5eb	TCGA-24-1463-01A-01D-0472-01	TCGA-24-1463-01	62f0c11f-4f42-45f6-9916-f4470a096431		TCGA-24-1463-01A-01D-0472-01	939d41b7-9ccb-4cf6-be16-f2792aece5eb		939d41b7-9ccb-4cf6-be16-f2792aece5eb		TCGA-24-1463-01	TCGA-24-1463-01	939d41b7-9ccb-4cf6-be16-f2792aece5eb	TCGA-24-1463-01A-01W-0549-09	TCGA-24-1463-01A-01R-0479-07	
TCGA-24-1464-01	1	TCGA-24-1464-01	379	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1464			days	379	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	70	Left	TCGA-24-1464-F26022	TCGA-24-1464	TCGA-24-1464-01A	Stage IIIC	-25874		379	0	379		323	1			2009-3-23	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5		YES	G3	Recurrence					TCGA-24-1464.242047B0-E0E3-4BA3-A0DF-95887392602E.pdf	1464	Post-Adjuvant Therapy	WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	DECEASED	1998		TCGA-24-1464-01		2ed4bcf3-8abb-454c-a19d-54101ccf222f		TCGA-24-1464-01		TCGA-24-1464-01A-01D-0475-05	TCGA-24-1464-01A-01W-0549-09	TCGA-24-1464-01A-21-1562-20	TCGA-24-1464-01A-01W-0549-09		TCGA-24-1464-01A-01D-0472-01	TCGA-24-1464-01	eef306a8-dd2b-4d8e-90c2-cb05094fd5f2		TCGA-24-1464-01A-01D-0472-01					TCGA-24-1464-01			TCGA-24-1464-01A-01W-0549-09	TCGA-24-1464-01A-01R-0479-07	
TCGA-24-1466-01	1	TCGA-24-1466-01	1373	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-24-1466			days	1373	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-1466-F26028	TCGA-24-1466	TCGA-24-1466-01A	Stage IIIC	-27307		1373	0	1373		491				2009-4-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.7			G3	Recurrence					TCGA-24-1466.BA86880B-184B-4CB7-8BBF-100D5CBD76C0.pdf	1466		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1998		TCGA-24-1466-01		2f2c0eed-dd98-42f0-af6e-7c2290a12f37		TCGA-24-1466-01		TCGA-24-1466-01A-01D-0475-05		TCGA-24-1466-01A-21-1562-20			TCGA-24-1466-01A-01D-0472-01	TCGA-24-1466-01	b5bd0882-705b-4f50-a748-8dc096d39717		TCGA-24-1466-01A-01D-0472-01				TCGA-24-1466-01A-01W-0545-08	TCGA-24-1466-01			TCGA-24-1466-01A-01W-0545-08	TCGA-24-1466-01A-01R-0479-07	
TCGA-24-1467-01	1	TCGA-24-1467-01	3224	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-1467			days	3224	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Right	TCGA-24-1467-F26039	TCGA-24-1467	TCGA-24-1467-01A	Stage IIIC	-18652		3224	0	3224		1253				2009-4-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.3		YES	G3	Recurrence					TCGA-24-1467.6949EFBE-C2EA-4767-B194-2343254F2752.pdf	1467		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	DECEASED	1998	TCGA-24-1467-01	TCGA-24-1467-01		f521b01e-14ea-4350-ad50-ce4dfa9594b6		TCGA-24-1467-01		TCGA-24-1467-01A-01D-0475-05		TCGA-24-1467-01A-21-1562-20		22902cdb-69f7-4bfc-a5c3-a56229ee501d	TCGA-24-1467-01A-01D-0472-01	TCGA-24-1467-01	efc7b16f-9e40-480e-b0ba-0a92cc54c0b9		TCGA-24-1467-01A-01D-0472-01	22902cdb-69f7-4bfc-a5c3-a56229ee501d		22902cdb-69f7-4bfc-a5c3-a56229ee501d		TCGA-24-1467-01	TCGA-24-1467-01	22902cdb-69f7-4bfc-a5c3-a56229ee501d		TCGA-24-1467-01A-01R-0479-07	
TCGA-24-1469-01	0	TCGA-24-1469-01	277	0	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-24-1469			days	277	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Right	TCGA-24-1469-F26060	TCGA-24-1469	TCGA-24-1469-01A	Stage IIIC	-25937			0	277						2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5			G3						TCGA-24-1469.8f0b80d0-cf56-477c-898b-bb92934f64d4.pdf	1469		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2008	TCGA-24-1469-01	TCGA-24-1469-01		1a83a75d-e788-407c-afae-326d9a553604		TCGA-24-1469-01		TCGA-24-1469-01A-01D-0501-05	TCGA-24-1469-01A-01W-0553-09	TCGA-24-1469-01A-21-1562-20	TCGA-24-1469-01A-01W-0553-09	7b6fe6e3-145b-46e6-884e-fcec23514674	TCGA-24-1469-01A-01D-0497-01	TCGA-24-1469-01	6f95df6b-dcdc-4727-8cf5-76b30b6ae455		TCGA-24-1469-01A-01D-0497-01	7b6fe6e3-145b-46e6-884e-fcec23514674		7b6fe6e3-145b-46e6-884e-fcec23514674		TCGA-24-1469-01	TCGA-24-1469-01	7b6fe6e3-145b-46e6-884e-fcec23514674	TCGA-24-1469-01A-01W-0553-09	TCGA-24-1469-01A-01R-0504-07	
TCGA-24-1470-01	0	TCGA-24-1470-01	105	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1470			days	105	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			54	Bilateral	TCGA-24-1470-F26064	TCGA-24-1470		Stage IIIB	-20007			0	105			1			2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3							1470	Other	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				24	1-10 mm	Ovary			LIVING	2009		TCGA-24-1470-01		a10cd463-df96-48b7-a4cc-21268bce6eb0		TCGA-24-1470-01		TCGA-24-1470-01A-01D-0501-05	TCGA-24-1470-01A-01W-0553-09	TCGA-24-1470-01A-21-1562-20	TCGA-24-1470-01A-01W-0553-09		TCGA-24-1470-01A-01D-0497-01	TCGA-24-1470-01	c9231718-6532-4ff2-b83f-4050d75b82fe		TCGA-24-1470-01A-01D-0497-01					TCGA-24-1470-01			TCGA-24-1470-01A-01W-0553-09	TCGA-24-1470-01A-01R-0504-07	
TCGA-24-1471-01	0	TCGA-24-1471-01	36	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 13	TCGA-24-1471			days	36	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Left	TCGA-24-1471-F26069	TCGA-24-1471	TCGA-24-1471-01A	Stage IIIC	-22081			0	36						2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3						TCGA-24-1471.d20b8ed1-c74e-4ee8-9ae2-5512429810bc.pdf	1471			YES			NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	LIVING	2009		TCGA-24-1471-01		2434de17-87b9-44f4-85b9-e07932d062ae		TCGA-24-1471-01		TCGA-24-1471-01A-01D-0501-05		TCGA-24-1471-01A-21-1562-20			TCGA-24-1471-01A-01D-0497-01	TCGA-24-1471-01	f9ddc125-66a3-4277-ac22-1b3b2acced36		TCGA-24-1471-01A-01D-0497-01				TCGA-24-1471-01A-01W-0551-08	TCGA-24-1471-01			TCGA-24-1471-01A-01W-0551-08	TCGA-24-1471-01A-01R-0504-07	
TCGA-24-1474-01	1	TCGA-24-1474-01	676	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1474			days	676	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Left	TCGA-24-1474-F26073	TCGA-24-1474	TCGA-24-1474-01A	Stage IIIC	-20902		676	0	676		332				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence					TCGA-24-1474.c4d49a95-0478-4399-a5eb-224ca6d16cd7.pdf	1474		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-1474-01	TCGA-24-1474-01		c6e04760-3285-42ad-b307-cb00ffbe2e9e		TCGA-24-1474-01		TCGA-24-1474-01A-01D-0501-05		TCGA-24-1474-01A-21-1562-20		4da3ccd5-53e1-46f5-874d-e5d131dbfc52	TCGA-24-1474-01A-01D-0497-01	TCGA-24-1474-01	e5f26e9b-2fc8-4514-a028-cd97c5390b0a		TCGA-24-1474-01A-01D-0497-01	4da3ccd5-53e1-46f5-874d-e5d131dbfc52		4da3ccd5-53e1-46f5-874d-e5d131dbfc52	TCGA-24-1474-01A-01W-0551-08	TCGA-24-1474-01	TCGA-24-1474-01	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	TCGA-24-1474-01A-01W-0551-08	TCGA-24-1474-01A-01R-0504-07	
TCGA-24-1544-01	1	TCGA-24-1544-01	820	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation c1uster 9	TCGA-24-1544			days	820	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-24-1544-F26080	TCGA-24-1544	TCGA-24-1544-01A	Stage IIIC	-26141		820	0	820		643				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.4			G3	Progression of Disease					TCGA-24-1544.2fd78a14-cc3f-4920-9c50-6051579b6ad4.pdf	1544		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-1544-01	TCGA-24-1544-01	TCGA-24-1544-01A-01W-0615-10	d403d7b8-d8d8-47ba-9821-a314704866bb		TCGA-24-1544-01	TCGA-24-1544-01A-01W-0615-10	TCGA-24-1544-01A-01D-0536-05		TCGA-24-1544-01A-21-1558-20		83333a5a-de0b-4d72-b886-e5488c619827	TCGA-24-1544-01A-01D-0533-01	TCGA-24-1544-01	9653a9c6-37fa-4e38-9c7e-c48ae95933ec		TCGA-24-1544-01A-01D-0533-01	83333a5a-de0b-4d72-b886-e5488c619827		83333a5a-de0b-4d72-b886-e5488c619827		TCGA-24-1544-01	TCGA-24-1544-01	83333a5a-de0b-4d72-b886-e5488c619827	TCGA-24-1544-01A-01W-0615-10	TCGA-24-1544-01A-01R-0540-07	
TCGA-24-1545-01	1	TCGA-24-1545-01	1746	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1545			days	1746	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Bilateral	TCGA-24-1545-F26088	TCGA-24-1545	TCGA-24-1545-01A	Stage IIIC	-25460		1746	0	1746		861	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.8			G3	Recurrence					TCGA-24-1545.0D1CB67F-57E1-4234-AA1A-5EF0E6EC3975.pdf	1545	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	1997	TCGA-24-1545-01	TCGA-24-1545-01	TCGA-24-1545-01A-01W-0615-10	3ed80032-69ae-4f21-8e60-8f177787e9f0		TCGA-24-1545-01	TCGA-24-1545-01A-01W-0615-10	TCGA-24-1545-01A-01D-0536-05		TCGA-24-1545-01A-21-1558-20		e2fcba09-755d-425d-ab4d-cede8ef86e48	TCGA-24-1545-01A-01D-0533-01	TCGA-24-1545-01	f3a3c3dc-4069-4c53-9017-c6dc610240e4		TCGA-24-1545-01A-01D-0533-01	e2fcba09-755d-425d-ab4d-cede8ef86e48		e2fcba09-755d-425d-ab4d-cede8ef86e48		TCGA-24-1545-01	TCGA-24-1545-01	e2fcba09-755d-425d-ab4d-cede8ef86e48	TCGA-24-1545-01A-01W-0615-10	TCGA-24-1545-01A-01R-0540-07	
TCGA-24-1546-01	1	TCGA-24-1546-01	1955	1	days	High		Low purity c2	OV-like c4		miRNA cluster 3	cluster 6		TCGA-24-1546			days	1955	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			46	Bilateral	TCGA-24-1546-F26097	TCGA-24-1546	TCGA-24-1546-01A	Stage IIIC	-17130		1955	0	1955						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1.5			G3						TCGA-24-1546.d6eec9a6-7bfd-40e2-891e-0a3cd7759ace.pdf	1546			YES					Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1546-01	TCGA-24-1546-01	TCGA-24-1546-01A-01W-0615-10	67d70140-fcb4-4b5b-9821-498cbd5d53c2		TCGA-24-1546-01	TCGA-24-1546-01A-01W-0615-10	TCGA-24-1546-01A-01D-0536-05		TCGA-24-1546-01A-21-1563-20		9984be2d-c37f-44cd-9eb8-61b65efcf8cb	TCGA-24-1546-01A-01D-0533-01	TCGA-24-1546-01	9cdbc7ad-cffd-4f34-b805-47e7c57d9978		TCGA-24-1546-01A-01D-0533-01	9984be2d-c37f-44cd-9eb8-61b65efcf8cb		9984be2d-c37f-44cd-9eb8-61b65efcf8cb		TCGA-24-1546-01	TCGA-24-1546-01	9984be2d-c37f-44cd-9eb8-61b65efcf8cb		TCGA-24-1546-01A-01R-0540-07	
TCGA-24-1548-01	1	TCGA-24-1548-01	493	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-1548			days	493	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-24-1548-F26101	TCGA-24-1548	TCGA-24-1548-01A	Stage IIIC	-20945		493	0	493		207				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence					TCGA-24-1548.d7b9bc71-e243-478f-a116-7e9371b87327.pdf	1548		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1548-01	TCGA-24-1548-01	TCGA-24-1548-01A-01W-0615-10	45cc6ed6-17ea-4291-8654-2b5b30c5a5e1		TCGA-24-1548-01	TCGA-24-1548-01A-01W-0615-10	TCGA-24-1548-01A-01D-0536-05		TCGA-24-1548-01A-21-1558-20		77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	TCGA-24-1548-01A-01D-0533-01	TCGA-24-1548-01	adc1690a-194c-44ea-8344-7bac461ab669		TCGA-24-1548-01A-01D-0533-01	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf		77b1c06b-46ef-4c8c-8a82-37f83e3c48cf		TCGA-24-1548-01	TCGA-24-1548-01	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	TCGA-24-1548-01A-01W-0615-10	TCGA-24-1548-01A-01R-0540-07	
TCGA-24-1549-01	1	TCGA-24-1549-01	1721	1	days	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1549			days	1721	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-24-1549-F26113	TCGA-24-1549		Stage IIIB	-21432		1721	0	1721		1042				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1549		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				24		Ovary			DECEASED	1997	TCGA-24-1549-01	TCGA-24-1549-01		f0c19024-16a9-4bc1-af8a-5f55326a22d4		TCGA-24-1549-01		TCGA-24-1549-01A-01D-0501-05	TCGA-24-1549-01A-01W-0553-09	TCGA-24-1549-01A-21-1558-20	TCGA-24-1549-01A-01W-0553-09	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	TCGA-24-1549-01A-01D-0497-01	TCGA-24-1549-01	b18db100-89ea-409a-841a-e90e9e9b65b2		TCGA-24-1549-01A-01D-0497-01	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f		f8ead0c8-9072-4a1d-9e07-f724a0d74a0f		TCGA-24-1549-01	TCGA-24-1549-01	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	TCGA-24-1549-01A-01W-0553-09	TCGA-24-1549-01A-01R-0504-07	
TCGA-24-1550-01	1	TCGA-24-1550-01	1249	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 1		TCGA-24-1550			days	1249	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Left	TCGA-24-1550-F26130	TCGA-24-1550	TCGA-24-1550-01A	Stage IIIC	-18049		1249	0	1249		892	1			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence					TCGA-24-1550.7ebd8d19-0a81-4623-8127-f225ad650d46.pdf	1550	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1550-01	TCGA-24-1550-01		d5e13008-a81c-4dc5-b621-6d11b492883b		TCGA-24-1550-01		TCGA-24-1550-01A-01D-0501-05		TCGA-24-1550-01A-21-1558-20		648cb96f-df1c-48c1-bb15-c37a2784a9db	TCGA-24-1550-01A-01D-0497-01	TCGA-24-1550-01	907ac822-b65b-45f3-87ea-fc78f06bab60		TCGA-24-1550-01A-01D-0497-01	648cb96f-df1c-48c1-bb15-c37a2784a9db		648cb96f-df1c-48c1-bb15-c37a2784a9db		TCGA-24-1550-01	TCGA-24-1550-01	648cb96f-df1c-48c1-bb15-c37a2784a9db		TCGA-24-1550-01A-01R-0504-07	
TCGA-24-1551-01	1	TCGA-24-1551-01	1579	1	days	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1551			days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-1551-F26139	TCGA-24-1551	TCGA-24-1551-01A	Stage IIIC	-19661		1579	0	1579		764	1			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence					TCGA-24-1551.474ac527-45a2-4258-bec4-0a48a3b80742.pdf	1551	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1551-01	TCGA-24-1551-01		6e9136b5-6f84-4b3d-9586-257b42d3d8e2		TCGA-24-1551-01		TCGA-24-1551-01A-01D-0501-05		TCGA-24-1551-01A-21-1558-20		0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	TCGA-24-1551-01A-01D-0497-01	TCGA-24-1551-01	48b26794-efa4-4e9a-b3c0-5a5391b17b03		TCGA-24-1551-01A-01D-0497-01	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8		0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	TCGA-24-1551-01A-01W-0551-08	TCGA-24-1551-01	TCGA-24-1551-01	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	TCGA-24-1551-01A-01W-0551-08	TCGA-24-1551-01A-01R-0504-07	
TCGA-24-1552-01	1	TCGA-24-1552-01	1259	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1552			days	1259	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Left	TCGA-24-1552-F26148	TCGA-24-1552	TCGA-24-1552-01A	Stage IIIC	-28129		1259	0	1259		403	0			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		0.9		YES	G3	Recurrence					TCGA-24-1552.FF7B6D0B-D13B-473E-A924-C63CB0B46511.pdf	1552	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.8			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1552-01	TCGA-24-1552-01		62b27771-c8c0-41f8-852f-07b188f7b8e3		TCGA-24-1552-01		TCGA-24-1552-01A-01D-0501-05		TCGA-24-1552-01A-21-1558-20		990bcb1f-7269-4020-8ea5-8ba338b390b8	TCGA-24-1552-01A-01D-0497-01	TCGA-24-1552-01	ce833a2e-7c81-4720-baa7-49cf52f4f0bd		TCGA-24-1552-01A-01D-0497-01	990bcb1f-7269-4020-8ea5-8ba338b390b8		990bcb1f-7269-4020-8ea5-8ba338b390b8	TCGA-24-1552-01A-01W-0551-08	TCGA-24-1552-01	TCGA-24-1552-01	990bcb1f-7269-4020-8ea5-8ba338b390b8	TCGA-24-1552-01A-01W-0551-08	TCGA-24-1552-01A-01R-0504-07	
TCGA-24-1553-01	1	TCGA-24-1553-01	1767	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1553			days	1767	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-1553-F26157	TCGA-24-1553	TCGA-24-1553-01A	Stage IIIB	-19393		1767	0	1767		553				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.3			G3	Recurrence					TCGA-24-1553.5abe7782-ca53-4add-9a9a-01955859420b.pdf	1553		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1553-01	TCGA-24-1553-01	TCGA-24-1553-01A-01W-0552-10	6007eb37-11b8-4127-b498-f3ada326b0e1		TCGA-24-1553-01	TCGA-24-1553-01A-01W-0552-10	TCGA-24-1553-01A-01D-0501-05		TCGA-24-1553-01A-21-1558-20		7c607e77-a353-4995-855b-36ccaaf3bde6	TCGA-24-1553-01A-01D-0497-01	TCGA-24-1553-01	64c63ba8-750c-4ac7-a0e9-57044507a0a4		TCGA-24-1553-01A-01D-0497-01	7c607e77-a353-4995-855b-36ccaaf3bde6		7c607e77-a353-4995-855b-36ccaaf3bde6		TCGA-24-1553-01	TCGA-24-1553-01	7c607e77-a353-4995-855b-36ccaaf3bde6	TCGA-24-1553-01A-01W-0552-10	TCGA-24-1553-01A-01R-0504-07	
TCGA-24-1555-01	1	TCGA-24-1555-01	2692	1	days	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-24-1555			days	2692	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-24-1555-F26171	TCGA-24-1555	TCGA-24-1555-01A	Stage IIIC	-18404		2692	0	2692		1577	0			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence					TCGA-24-1555.b7b2f370-207a-4849-b7a0-528789363a02.pdf	1555	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24		Ovary		A	DECEASED	1997	TCGA-24-1555-01	TCGA-24-1555-01	TCGA-24-1555-01A-01W-0552-10	b3e00fd1-65a1-4254-ac59-1d56b879c253		TCGA-24-1555-01	TCGA-24-1555-01A-01W-0552-10	TCGA-24-1555-01A-01D-0501-05		TCGA-24-1555-01A-21-1558-20		0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	TCGA-24-1555-01A-01D-0497-01	TCGA-24-1555-01	10cb1259-03bf-4d9e-946e-bea05e4f23bd		TCGA-24-1555-01A-01D-0497-01	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4		0ec7ea28-7bd4-45c3-b03c-d855014fa4f4		TCGA-24-1555-01	TCGA-24-1555-01	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	TCGA-24-1555-01A-01W-0552-10	TCGA-24-1555-01A-01R-0504-07	
TCGA-24-1556-01	1	TCGA-24-1556-01	2148	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1556			days	2148	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	50	Left	TCGA-24-1556-F26184	TCGA-24-1556	TCGA-24-1556-01A	Stage IIB	-18517		2148	0	2148		539				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.9			G3	Recurrence					TCGA-24-1556.75c91323-45a7-4629-b014-f7eda2f1075e.pdf	1556		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-1556-01	TCGA-24-1556-01	TCGA-24-1556-01A-01W-0615-10	3602ad67-bdfb-48a8-8a58-8019bee04630		TCGA-24-1556-01	TCGA-24-1556-01A-01W-0615-10	TCGA-24-1556-01A-01D-0536-05		TCGA-24-1556-01A-21-1558-20		31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	TCGA-24-1556-01A-01D-0533-01	TCGA-24-1556-01	7c4dcb9c-346b-4b52-9b64-f835ebc85dba		TCGA-24-1556-01A-01D-0533-01	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd		31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd		TCGA-24-1556-01	TCGA-24-1556-01	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	TCGA-24-1556-01A-01W-0615-10	TCGA-24-1556-01A-01R-0540-07	
TCGA-24-1557-01	1	TCGA-24-1557-01	1213	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-24-1557			days	1213	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-24-1557-F26194	TCGA-24-1557		Stage IIIC	-17943		1213	0	1213		447				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Progression of Disease						1557		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01				24	>20 mm	Ovary			DECEASED	2000	TCGA-24-1557-01	TCGA-24-1557-01	TCGA-24-1557-01A-01W-0615-10	e9f05aba-2e25-44c7-b49f-9300cb5c61e1		TCGA-24-1557-01	TCGA-24-1557-01A-01W-0615-10	TCGA-24-1557-01A-01D-0536-05		TCGA-24-1557-01A-21-1558-20		bca48aa6-25bc-49e4-8bb5-edf38362b4a8	TCGA-24-1557-01A-01D-0533-01	TCGA-24-1557-01	d534bbdd-5827-426e-ad74-9346b06716f5		TCGA-24-1557-01A-01D-0533-01	bca48aa6-25bc-49e4-8bb5-edf38362b4a8		bca48aa6-25bc-49e4-8bb5-edf38362b4a8		TCGA-24-1557-01	TCGA-24-1557-01	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	TCGA-24-1557-01A-01W-0615-10	TCGA-24-1557-01A-01R-0540-07	
TCGA-24-1558-01	1	TCGA-24-1558-01	594	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 2	TCGA-24-1558			days	594	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-24-1558-F26212	TCGA-24-1558	TCGA-24-1558-01A	Stage IIIC	-27004		594	0	594		273				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.9			G3	Recurrence					TCGA-24-1558.62143e5f-4452-47ca-a67c-cd87036424b1.pdf	1558		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.9			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-1558-01	TCGA-24-1558-01	TCGA-24-1558-01A-01W-0615-10	beca71a6-9c32-4f27-9419-32d96cafed27		TCGA-24-1558-01	TCGA-24-1558-01A-01W-0615-10	TCGA-24-1558-01A-01D-0536-05		TCGA-24-1558-01A-21-1558-20		1b8d5b5e-f671-419a-844a-6640fe5a896d	TCGA-24-1558-01A-01D-0533-01	TCGA-24-1558-01	b37713e8-e63a-4dba-b7fb-aebc5914676d		TCGA-24-1558-01A-01D-0533-01	1b8d5b5e-f671-419a-844a-6640fe5a896d		1b8d5b5e-f671-419a-844a-6640fe5a896d		TCGA-24-1558-01	TCGA-24-1558-01	1b8d5b5e-f671-419a-844a-6640fe5a896d	TCGA-24-1558-01A-01W-0615-10	TCGA-24-1558-01A-01R-0540-07	
TCGA-24-1560-01	1	TCGA-24-1560-01	1341	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1560			days	1341	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Left	TCGA-24-1560-F26221	TCGA-24-1560	TCGA-24-1560-01A	Stage IIIC	-18671		1341	0	1341		143				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G4	Recurrence					TCGA-24-1560.464e1a20-b2d1-49c4-8da5-11b8c0f96b4e.pdf	1560		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1560-01	TCGA-24-1560-01	TCGA-24-1560-01A-01W-0615-10	5b6e5bbe-fe20-4613-b55c-2e544ea51a2b		TCGA-24-1560-01	TCGA-24-1560-01A-01W-0615-10	TCGA-24-1560-01A-01D-0536-05		TCGA-24-1560-01A-21-1558-20		a7ea40ed-6cfb-42b7-92b7-64d6ba988414	TCGA-24-1560-01A-01D-0533-01	TCGA-24-1560-01	15295f32-7794-43cb-a943-03a38d4b6016		TCGA-24-1560-01A-01D-0533-01	a7ea40ed-6cfb-42b7-92b7-64d6ba988414		a7ea40ed-6cfb-42b7-92b7-64d6ba988414		TCGA-24-1560-01	TCGA-24-1560-01	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	TCGA-24-1560-01A-01W-0615-10	TCGA-24-1560-01A-01R-0540-07	
TCGA-24-1562-01	1	TCGA-24-1562-01	1384	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1562			days	1384	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-24-1562-F26237	TCGA-24-1562	TCGA-24-1562-01A	Stage IIIC	-24747		1384	0	1384		229	0			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1			G3	Recurrence					TCGA-24-1562.0ce36daf-9512-4860-a5a3-b2ff7f487c5a.pdf	1562	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1562-01	TCGA-24-1562-01		f36d78a7-5e27-4a7a-8055-a7ca51b8c371		TCGA-24-1562-01		TCGA-24-1562-01A-01D-0501-05	TCGA-24-1562-01A-01W-0553-09	TCGA-24-1562-01A-21-1558-20	TCGA-24-1562-01A-01W-0553-09	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	TCGA-24-1562-01A-01D-0497-01	TCGA-24-1562-01	9082bc34-1aa2-4e77-bb64-22778ee28635		TCGA-24-1562-01A-01D-0497-01	eb8cb3b3-d1b1-4d2d-b048-7394931040bd		eb8cb3b3-d1b1-4d2d-b048-7394931040bd		TCGA-24-1562-01	TCGA-24-1562-01	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	TCGA-24-1562-01A-01W-0553-09	TCGA-24-1562-01A-01R-0504-07	
TCGA-24-1563-01	1	TCGA-24-1563-01	1451	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1563			days	1451	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Left	TCGA-24-1563-F26248	TCGA-24-1563	TCGA-24-1563-01A	Stage IIIC	-24274		1451	0	1451		396				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1			G3	Recurrence					TCGA-24-1563.6fdeb714-439d-49d7-aae0-99166a3e8eba.pdf	1563		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1563-01	TCGA-24-1563-01		70951f22-8982-42be-bf1e-15f24b415708		TCGA-24-1563-01		TCGA-24-1563-01A-01D-0501-05	TCGA-24-1563-01A-01W-0553-09	TCGA-24-1563-01A-21-1558-20	TCGA-24-1563-01A-01W-0553-09	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	TCGA-24-1563-01A-01D-0497-01	TCGA-24-1563-01	e52eaae7-ae99-43fe-a752-89045be81447		TCGA-24-1563-01A-01D-0497-01	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a		a9c4a08c-1db7-49eb-8685-b5ca442c3e7a		TCGA-24-1563-01	TCGA-24-1563-01	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	TCGA-24-1563-01A-01W-0553-09	TCGA-24-1563-01A-01R-0504-07	
TCGA-24-1564-01	1	TCGA-24-1564-01	787	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1564			days	787	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	67	Bilateral	TCGA-24-1564-F26260	TCGA-24-1564	TCGA-24-1564-01A	Stage IIIC	-24668		787	0	787		221				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.4			G3	Recurrence					TCGA-24-1564.fa1c8286-2e55-4137-93ae-c19d470ce2e4.pdf	1564		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1564-01	TCGA-24-1564-01		3b4f61f1-616b-4995-bcb6-6eb2e11be681		TCGA-24-1564-01		TCGA-24-1564-01A-01D-0501-05		TCGA-24-1564-01A-21-1558-20		03b8480f-d19e-43e4-8a09-f9230c525c1e	TCGA-24-1564-01A-01D-0497-01	TCGA-24-1564-01	b6e7fde5-418d-4848-a99e-6fc8c943bd7b		TCGA-24-1564-01A-01D-0497-01	03b8480f-d19e-43e4-8a09-f9230c525c1e		03b8480f-d19e-43e4-8a09-f9230c525c1e	TCGA-24-1564-01A-01W-0551-08	TCGA-24-1564-01	TCGA-24-1564-01	03b8480f-d19e-43e4-8a09-f9230c525c1e	TCGA-24-1564-01A-01W-0551-08	TCGA-24-1564-01A-01R-0504-07	
TCGA-24-1565-01	1	TCGA-24-1565-01	312	1	days	Iq	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation c1uster 9	TCGA-24-1565			days	312	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-1565-F26274	TCGA-24-1565	TCGA-24-1565-01A	Stage IIIC	-27048		312	0	312		145				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3	Recurrence					TCGA-24-1565.f424905e-3dc2-4e37-b6c4-8a77c7ce817b.pdf	1565		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997		TCGA-24-1565-01		8c0e5f5a-fd1e-40de-9746-1b22572df7b8		TCGA-24-1565-01		TCGA-24-1565-01A-01D-0501-05		TCGA-24-1565-01A-21-1558-20			TCGA-24-1565-01A-01D-0497-01	TCGA-24-1565-01	bd856415-5235-4086-a72f-9d0a65b8867b		TCGA-24-1565-01A-01D-0497-01				TCGA-24-1565-01A-01W-0551-08	TCGA-24-1565-01			TCGA-24-1565-01A-01W-0551-08	TCGA-24-1565-01A-01R-0504-07	
TCGA-24-1567-01	1	TCGA-24-1567-01	524	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1567			days	524	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-24-1567-F26279	TCGA-24-1567	TCGA-24-1567-01A	Stage IIIB	-19843		524	0	524		319				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.3	NO		1.1			G3	Recurrence					TCGA-24-1567.90910bbc-49e1-495b-9b06-11056ff401df.pdf	1567		WITH TUMOR	YES		Molecular Markers	NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1567-01	TCGA-24-1567-01	TCGA-24-1567-01A-01W-0615-10	b39f67ca-abb2-4f96-a0c4-79ea6cbe523e		TCGA-24-1567-01	TCGA-24-1567-01A-01W-0615-10	TCGA-24-1567-01A-01D-0536-05		TCGA-24-1567-01A-21-1558-20		97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	TCGA-24-1567-01A-01D-0533-01	TCGA-24-1567-01	e4b66de6-faab-41b2-af46-ad0f9f81bed7		TCGA-24-1567-01A-01D-0533-01	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5		97c0b20f-ee65-42b2-af2d-92dcf48b2cd5		TCGA-24-1567-01	TCGA-24-1567-01	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	TCGA-24-1567-01A-01W-0615-10	TCGA-24-1567-01A-01R-0540-07	
TCGA-24-1603-01	1	TCGA-24-1603-01	2742	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1603			days	2742	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-24-1603-F26284	TCGA-24-1603	TCGA-24-1603-01A	Stage IIIB	-19681		2742	0	2742		992				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence					TCGA-24-1603.b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9.pdf	1603		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.7			24		Ovary		A	DECEASED	1996	TCGA-24-1603-01	TCGA-24-1603-01		74a46153-942a-42e8-b6a0-ac066c006e5d		TCGA-24-1603-01		TCGA-24-1603-01A-01D-0501-05		TCGA-24-1603-01A-21-1558-20		f4187f4f-9c52-4065-818b-c884183a5a70	TCGA-24-1603-01A-01D-0497-01	TCGA-24-1603-01	eecacbb1-98ef-4194-957d-5a49f9548657		TCGA-24-1603-01A-01D-0497-01	f4187f4f-9c52-4065-818b-c884183a5a70		f4187f4f-9c52-4065-818b-c884183a5a70	TCGA-24-1603-01A-01W-0551-08	TCGA-24-1603-01	TCGA-24-1603-01	f4187f4f-9c52-4065-818b-c884183a5a70	TCGA-24-1603-01A-01W-0551-08	TCGA-24-1603-01A-01R-0504-07	
TCGA-24-1604-01	1	TCGA-24-1604-01	2688	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1604			days	2688	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			66	Bilateral	TCGA-24-1604-F26299	TCGA-24-1604	TCGA-24-1604-01A	Stage IIIC	-24471		2688	0	2688						2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.4			G3						TCGA-24-1604.de978a3d-92f9-4bd8-98f4-f8a3ec09b362.pdf	1604		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01	0.6			24		Ovary		A	DECEASED	1996	TCGA-24-1604-01	TCGA-24-1604-01	TCGA-24-1604-01A-01W-0552-10	08109bba-5c11-4400-a968-c858329cbedf		TCGA-24-1604-01	TCGA-24-1604-01A-01W-0552-10	TCGA-24-1604-01A-01D-0501-05		TCGA-24-1604-01A-21-1558-20		a658045c-93a6-4aac-abbb-1cd6093b7735	TCGA-24-1604-01A-01D-0497-01	TCGA-24-1604-01	2350016d-f638-4c02-a24b-76f1df75cb69		TCGA-24-1604-01A-01D-0497-01	a658045c-93a6-4aac-abbb-1cd6093b7735		a658045c-93a6-4aac-abbb-1cd6093b7735		TCGA-24-1604-01	TCGA-24-1604-01	a658045c-93a6-4aac-abbb-1cd6093b7735	TCGA-24-1604-01A-01W-0552-10	TCGA-24-1604-01A-01R-0504-07	
TCGA-24-1614-01	1	TCGA-24-1614-01	1470	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-1614			days	1470	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Right	TCGA-24-1614-F26306	TCGA-24-1614	TCGA-24-1614-01A	Stage IIIC	-20993		1470	0	1470		644				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO	100	1.2			G3	Recurrence					TCGA-24-1614.4e371c15-c0d1-454a-997d-dfbe98b02f7e.pdf	1614	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	DECEASED	2001		TCGA-24-1614-01	TCGA-24-1614-01A-01W-0552-10	a85349ef-886c-4d39-8c23-ff13b920059a		TCGA-24-1614-01	TCGA-24-1614-01A-01W-0552-10	TCGA-24-1614-01A-01D-0501-05		TCGA-24-1614-01A-21-1558-20			TCGA-24-1614-01A-01D-0497-01	TCGA-24-1614-01	6ceece0c-56d0-41e6-93e9-12e2a4fdb4c4		TCGA-24-1614-01A-01D-0497-01					TCGA-24-1614-01			TCGA-24-1614-01A-01W-0552-10	TCGA-24-1614-01A-01R-0504-07	
TCGA-24-1616-01	1	TCGA-24-1616-01	1163	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1616			days	1163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-24-1616-F26315	TCGA-24-1616	TCGA-24-1616-01A	Stage IIIC	-20785		1163	0	1163		405				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.9			G3	Recurrence					TCGA-24-1616.d8c764d9-0fe8-488e-8aa1-da73a8c10b01.pdf	1616		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	2001	TCGA-24-1616-01	TCGA-24-1616-01		e40e646a-09da-49ad-bcca-1e56df395a36		TCGA-24-1616-01		TCGA-24-1616-01A-01D-0501-05	TCGA-24-1616-01A-01W-0553-09	TCGA-24-1616-01A-21-1558-20	TCGA-24-1616-01A-01W-0553-09	c334b353-0652-49fb-8cd6-5bcf8485e5d0	TCGA-24-1616-01A-01D-0497-01	TCGA-24-1616-01	3e449bae-1749-47d9-adc1-6e70b0c829dc		TCGA-24-1616-01A-01D-0497-01	c334b353-0652-49fb-8cd6-5bcf8485e5d0		c334b353-0652-49fb-8cd6-5bcf8485e5d0		TCGA-24-1616-01	TCGA-24-1616-01	c334b353-0652-49fb-8cd6-5bcf8485e5d0	TCGA-24-1616-01A-01W-0553-09	TCGA-24-1616-01A-01R-0504-07	
TCGA-24-1842-01	0	TCGA-24-1842-01	253	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1842			days	253	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-24-1842-F26325	TCGA-24-1842	TCGA-24-1842-01A	Stage IIIC	-18227			0	253			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G3						TCGA-24-1842.3465aae7-0664-44e5-a27f-c02fd73526a1.pdf	1842	Other	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-1842-01	TCGA-24-1842-01		af43832d-2996-4a7f-8e5c-6bd2ec938cfe		TCGA-24-1842-01		TCGA-24-1842-01A-01D-0581-05		TCGA-24-1842-01A-21-1559-20	TCGA-24-1842-01A-01W-0639-09	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	TCGA-24-1842-01A-01D-0577-01	TCGA-24-1842-01	5dcf27b7-8966-4c46-a0f6-5a1450f60d1d		TCGA-24-1842-01A-01D-0577-01	6cb78602-e09f-4dbc-b3e5-684ebe77bddc		6cb78602-e09f-4dbc-b3e5-684ebe77bddc		TCGA-24-1842-01	TCGA-24-1842-01	6cb78602-e09f-4dbc-b3e5-684ebe77bddc		TCGA-24-1842-01A-01R-0584-07	
TCGA-24-1843-01	0	TCGA-24-1843-01	106	0	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1843			days	106	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			66	Right	TCGA-24-1843-F26330	TCGA-24-1843	TCGA-24-1843-01A	Stage IIIC	-24469			0	106						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.4		YES	G3						TCGA-24-1843.d2625c77-0f03-42ea-b5ea-df45769f0fbb.pdf	1843			YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-1843-01	TCGA-24-1843-01		51ac296a-c599-47db-9a67-5aacf572efab		TCGA-24-1843-01		TCGA-24-1843-01A-01D-0581-05			TCGA-24-1843-01A-01W-0639-09	c50cf5af-3375-4748-9894-1f9521f746da	TCGA-24-1843-01A-01D-0577-01	TCGA-24-1843-01			TCGA-24-1843-01A-01D-0577-01	c50cf5af-3375-4748-9894-1f9521f746da		c50cf5af-3375-4748-9894-1f9521f746da		TCGA-24-1843-01	TCGA-24-1843-01	c50cf5af-3375-4748-9894-1f9521f746da		TCGA-24-1843-01A-01R-0584-07	
TCGA-24-1844-01	0	TCGA-24-1844-01	113	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1844			days	113	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64	Bilateral	TCGA-24-1844-F26335	TCGA-24-1844	TCGA-24-1844-01A	Stage IIIC	-23542			0	113						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3						TCGA-24-1844.5fd30c3c-9734-40dd-b81e-ae3f364c8fa8.pdf	1844			YES			NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-1844-01	TCGA-24-1844-01		5f13ef2d-8e72-4552-8ace-f089597b1131		TCGA-24-1844-01		TCGA-24-1844-01A-01D-0581-05		TCGA-24-1844-01A-21-1559-20	TCGA-24-1844-01A-01W-0639-09	53a60e9f-3541-4fe7-a7ea-87ee888c0446	TCGA-24-1844-01A-01D-0577-01	TCGA-24-1844-01	d95c8065-b35e-47b0-899a-305b14ed2a56		TCGA-24-1844-01A-01D-0577-01	53a60e9f-3541-4fe7-a7ea-87ee888c0446		53a60e9f-3541-4fe7-a7ea-87ee888c0446		TCGA-24-1844-01	TCGA-24-1844-01	53a60e9f-3541-4fe7-a7ea-87ee888c0446		TCGA-24-1844-01A-01R-0584-07	
TCGA-24-1845-01	0	TCGA-24-1845-01	116	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 2		TCGA-24-1845			days	116	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			42	Bilateral	TCGA-24-1845-F26340	TCGA-24-1845	TCGA-24-1845-01A	Stage IIIC	-15599			0	116						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.8			G3						TCGA-24-1845.1fda446a-e0d2-422a-a023-57ec5bfae62b.pdf	1845			YES			NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1845-01		24d1e3ea-44ad-4bb9-8aa7-cd448b8bec21		TCGA-24-1845-01		TCGA-24-1845-01A-01D-0581-05		TCGA-24-1845-01A-21-1559-20	TCGA-24-1845-01A-01W-0639-09		TCGA-24-1845-01A-01D-0577-01	TCGA-24-1845-01	cd017460-81cb-4e71-b352-42612cae745e		TCGA-24-1845-01A-01D-0577-01					TCGA-24-1845-01				TCGA-24-1845-01A-01R-0584-07	
TCGA-24-1846-01	0	TCGA-24-1846-01	133	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1846			days	133	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Bilateral	TCGA-24-1846-F26346	TCGA-24-1846	TCGA-24-1846-01A	Stage IIIC	-16534			0	133			1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.1		YES	G3						TCGA-24-1846.fb12e5b3-1529-4873-90fd-7ba0a78dd9f4.pdf	1846	Other		YES			NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-1846-01	TCGA-24-1846-01		50b9dcb5-0fb8-4be7-97ce-5cd477d6c351		TCGA-24-1846-01		TCGA-24-1846-01A-01D-0581-05		TCGA-24-1846-01A-21-1559-20	TCGA-24-1846-01A-01W-0639-09	4b073708-9525-4340-90dc-ede08ee24977	TCGA-24-1846-01A-01D-0577-01	TCGA-24-1846-01	15134c0c-7253-481e-83e3-7d1c57bc521d		TCGA-24-1846-01A-01D-0577-01	4b073708-9525-4340-90dc-ede08ee24977		4b073708-9525-4340-90dc-ede08ee24977		TCGA-24-1846-01	TCGA-24-1846-01	4b073708-9525-4340-90dc-ede08ee24977		TCGA-24-1846-01A-01R-0584-07	
TCGA-24-1847-01	0	TCGA-24-1847-01	343	0	days	High		OV-like c1		OV-like c16	miRNA cluster 3	cluster 6		TCGA-24-1847			days	343	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Bilateral	TCGA-24-1847-F26350	TCGA-24-1847	TCGA-24-1847-01A	Stage IV	-16529			0	343						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy		0.9	NO		1		YES	G3						TCGA-24-1847.20d96d45-40d3-44ad-a9e8-fdc7e545ed5d.pdf	1847		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-1847-01	TCGA-24-1847-01		74b939d6-c502-4edf-a412-df6dc9484eb6		TCGA-24-1847-01		TCGA-24-1847-01A-01D-0563-05			TCGA-24-1847-01A-01W-0633-09	83354694-078e-411e-89d2-029649708528	TCGA-24-1847-01A-01D-0559-01	TCGA-24-1847-01			TCGA-24-1847-01A-01D-0559-01	83354694-078e-411e-89d2-029649708528		83354694-078e-411e-89d2-029649708528		TCGA-24-1847-01	TCGA-24-1847-01	83354694-078e-411e-89d2-029649708528		TCGA-24-1847-01A-01R-0566-07	
TCGA-24-1849-01	0	TCGA-24-1849-01	176	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-24-1849			days	176	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			80	Bilateral	TCGA-24-1849-F26355	TCGA-24-1849	TCGA-24-1849-01A	Stage IIIC	-29555			0	176						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.4	NO		1.8		YES	G3						TCGA-24-1849.a2181913-086c-42a2-99fd-057b17025deb.pdf	1849		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-1849-01	TCGA-24-1849-01		36592a9b-a440-4741-95bc-51e700d14b52		TCGA-24-1849-01		TCGA-24-1849-01A-01D-0581-05		TCGA-24-1849-01A-21-1562-20	TCGA-24-1849-01A-01W-0639-09	58f3764a-4651-4c26-a667-74aef5c5679c	TCGA-24-1849-01A-01D-0577-01	TCGA-24-1849-01	66dc2c60-9fa1-4fb7-8bd4-76da1e11229a		TCGA-24-1849-01A-01D-0577-01	58f3764a-4651-4c26-a667-74aef5c5679c		58f3764a-4651-4c26-a667-74aef5c5679c		TCGA-24-1849-01	TCGA-24-1849-01	58f3764a-4651-4c26-a667-74aef5c5679c		TCGA-24-1849-01A-01R-0584-07	
TCGA-24-1850-01	0	TCGA-24-1850-01	168	0	days	High	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-24-1850			days	168	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			72	Bilateral	TCGA-24-1850-F26359	TCGA-24-1850	TCGA-24-1850-01A	Stage IIIC	-26369			0	168			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		2		YES	G3						TCGA-24-1850.a8c2f09f-6971-48e1-b890-f1d63611cdbd.pdf	1850	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-1850-01	TCGA-24-1850-01		717a05a3-2930-4f69-a497-d884d493edaa		TCGA-24-1850-01		TCGA-24-1850-01A-01D-0581-05		TCGA-24-1850-01A-21-1559-20	TCGA-24-1850-01A-01W-0639-09	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	TCGA-24-1850-01A-01D-0577-01	TCGA-24-1850-01	eacc0479-97ed-45f6-a4cb-9cca12252bd2		TCGA-24-1850-01A-01D-0577-01	9d88c064-c348-4f3f-a1f1-5884e0b66d9e		9d88c064-c348-4f3f-a1f1-5884e0b66d9e		TCGA-24-1850-01	TCGA-24-1850-01	9d88c064-c348-4f3f-a1f1-5884e0b66d9e		TCGA-24-1850-01A-01R-0584-07	
TCGA-24-1852-01	1	TCGA-24-1852-01	2201	1	days	High		OV-like c1	OV-like c4					TCGA-24-1852			days	2201	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-1852-F26363	TCGA-24-1852	TCGA-24-1852-01A	Stage IIIC	-20390		2201	0	2201		1009				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Tumor resection		0.5	NO		1.4			G3	Recurrence					TCGA-24-1852.FC6FD336-EB96-40CD-91FB-9371A305EF76.pdf	1852		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997				8bc4b5b7-b987-475b-90f7-28c8bd19a0fa				TCGA-24-1852-01A-01D-0807-05		TCGA-24-1852-01A-21-1559-20			TCGA-24-1852-01A-01D-0803-01	TCGA-24-1852-01	6800890d-adf7-4831-8a21-68fc3b583fe6,b2810bf7-eaed-4955-b0da-e6ea3c65a9a7		TCGA-24-1852-01A-01D-0803-01					TCGA-24-1852-01				TCGA-24-1852-01A-01R-0810-07	
TCGA-24-1852-02	1	TCGA-24-1852-02	2201	1	days			OV-like c1						TCGA-24-1852			days	2201	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-1852-F26363	TCGA-24-1852	TCGA-24-1852-02A	Stage IIIC	-20390		2201	0	2201		1009				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Tumor resection		0.9	NO		1.2			G3	Recurrence					TCGA-24-1852.FC644609-4B3F-41A5-9164-BC024C95DAB0.pdf	1852		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Recurrent Tumor	02	0.3			24	1-10 mm	Ovary		A	DECEASED	1997				7c459b65-7eca-4081-83f0-ff67f0410a9b				TCGA-24-1852-02A-01D-0807-05							8e296930-ef86-4ff6-ac5c-11ef322d0dc2											TCGA-24-1852-02A-01R-0810-07	
TCGA-24-1920-01	0	TCGA-24-1920-01	298	0	days	High		OV-like c1	BRCA basal-like c6		miRNA cluster 1	cluster 3		TCGA-24-1920			days	298	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			74	Right	TCGA-24-1920-F26373	TCGA-24-1920	TCGA-24-1920-01A	Stage IIIC	-27042			0	298			0			2010-2-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		2			G3						TCGA-24-1920.292d7fe5-e949-458b-b7da-cc55009b1c06.pdf	1920	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1920-01		678cbaa5-cd2a-4cf5-a7e5-34b3db7281cc		TCGA-24-1920-01		TCGA-24-1920-01A-01D-0652-05		TCGA-24-1920-01A-21-1559-20			TCGA-24-1920-01A-01D-0648-01	TCGA-24-1920-01	300fb12e-d372-4a03-ae7f-95d0cef8027a		TCGA-24-1920-01A-01D-0648-01					TCGA-24-1920-01				TCGA-24-1920-01A-01R-0655-07	
TCGA-24-1923-01	1	TCGA-24-1923-01	690	1	days	Squamous		Low purity c2	OV-like c4		miRNA cluster 3	cluster 6		TCGA-24-1923			days	690	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-24-1923-F26379	TCGA-24-1923	TCGA-24-1923-01A	Stage IIIC	-18628		690	0	690		343				2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		0.6	NO		1.3		YES	G3	Recurrence					TCGA-24-1923.6ae8158a-e236-4cc0-88d2-50756216f0e7.pdf	1923		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	2001		TCGA-24-1923-01		fde22a7e-62c4-4c20-ac40-ac1b873edf9a		TCGA-24-1923-01		TCGA-24-1923-01A-01D-0652-05		TCGA-24-1923-01A-21-1559-20			TCGA-24-1923-01A-01D-0648-01	TCGA-24-1923-01	9c88c21f-4bb9-41cc-b942-9c6e73a46511		TCGA-24-1923-01A-01D-0648-01					TCGA-24-1923-01				TCGA-24-1923-01A-01R-0655-07	
TCGA-24-1924-01	1	TCGA-24-1924-01	919	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-1924			days	919	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-24-1924-F26386	TCGA-24-1924	TCGA-24-1924-01A	Stage IIIC	-23801		919	0	919		320				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3	Recurrence					TCGA-24-1924.4199b57a-81f5-4d5f-9f4c-1e514dcd26dc.pdf	1924		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	2001	TCGA-24-1924-01	TCGA-24-1924-01		16cd57f0-1334-447e-828e-989c2339c282		TCGA-24-1924-01		TCGA-24-1924-01A-01D-0652-05		TCGA-24-1924-01A-21-1559-20		2592f314-cc0a-4d00-bdcf-6376afd32bb7	TCGA-24-1924-01A-01D-0648-01	TCGA-24-1924-01	d4067ae4-665b-4539-938c-e86a08523d3f		TCGA-24-1924-01A-01D-0648-01	2592f314-cc0a-4d00-bdcf-6376afd32bb7		2592f314-cc0a-4d00-bdcf-6376afd32bb7		TCGA-24-1924-01	TCGA-24-1924-01	2592f314-cc0a-4d00-bdcf-6376afd32bb7		TCGA-24-1924-01A-01R-0655-07	
TCGA-24-1927-01	1	TCGA-24-1927-01	500	1	days	Squamous		OV-like c1	OV-like c4					TCGA-24-1927			days	500	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-24-1927-F26396	TCGA-24-1927		Stage IIIC	-21719		500	0	500		290				2010-3-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1927		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				24	1-10 mm	Ovary			DECEASED	1999								TCGA-24-1927-01A-01D-0652-05		TCGA-24-1927-01A-21-1559-20			TCGA-24-1927-01A-01D-0648-01	TCGA-24-1927-01	f9b9b275-8678-4ff8-95fe-dd804f20713d		TCGA-24-1927-01A-01D-0648-01					TCGA-24-1927-01				TCGA-24-1927-01A-01R-0655-07	
TCGA-24-1928-01	1	TCGA-24-1928-01	336	1	days	High		OV-like c1			miRNA cluster 2	cluster 2		TCGA-24-1928			days	336	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	77	Bilateral	TCGA-24-1928-F26403	TCGA-24-1928	TCGA-24-1928-01A	Stage IIIC	-28126		336	0	336		70				2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.5	NO		1.5			G3	Recurrence					TCGA-24-1928.dc4407fb-d15b-44d5-9c3b-129cca67d8f1.pdf	1928		WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.3			24	11-20 mm	Ovary		A	DECEASED	1998	TCGA-24-1928-01	TCGA-24-1928-01		681d19fb-e521-4105-8d76-275624c1d3b0		TCGA-24-1928-01		TCGA-24-1928-01A-01D-0652-05				433d642a-06fe-454f-a2bf-3e0afb3dd23b	TCGA-24-1928-01A-01D-0648-01	TCGA-24-1928-01			TCGA-24-1928-01A-01D-0648-01	433d642a-06fe-454f-a2bf-3e0afb3dd23b		433d642a-06fe-454f-a2bf-3e0afb3dd23b		TCGA-24-1928-01	TCGA-24-1928-01	433d642a-06fe-454f-a2bf-3e0afb3dd23b		TCGA-24-1928-01A-01R-0655-07	
TCGA-24-1930-01	1	TCGA-24-1930-01	2467	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-1930			days	2467	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	53	Bilateral	TCGA-24-1930-F26410	TCGA-24-1930	TCGA-24-1930-01A	Stage IIIC	-19387		2467	0	2467		544	0			2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO	100	1			G3	Recurrence					TCGA-24-1930.746ac85a-ea6d-4d60-859f-69bf580a707c.pdf	1930	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	1998	TCGA-24-1930-01	TCGA-24-1930-01		3412c513-36c6-459c-9f66-3dd15d0d8e72		TCGA-24-1930-01		TCGA-24-1930-01A-01D-0652-05		TCGA-24-1930-01A-21-1559-20		d85ca8ac-9458-4f3a-b2ef-db4df852f75e	TCGA-24-1930-01A-01D-0648-01	TCGA-24-1930-01	bf3c2d8b-6072-4f59-8f19-128cfff7314e		TCGA-24-1930-01A-01D-0648-01	d85ca8ac-9458-4f3a-b2ef-db4df852f75e		d85ca8ac-9458-4f3a-b2ef-db4df852f75e		TCGA-24-1930-01	TCGA-24-1930-01	d85ca8ac-9458-4f3a-b2ef-db4df852f75e		TCGA-24-1930-01A-01R-0655-07	
TCGA-24-2019-01	0	TCGA-24-2019-01	148	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-24-2019			days	148	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			46	Bilateral	TCGA-24-2019-F26429	TCGA-24-2019	TCGA-24-2019-01A	Stage IIIC	-17009			0	148			1			2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						TCGA-24-2019.15a77e5d-acfb-4013-81de-ef9d2f6398d1.pdf	2019	Other		YES			NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2009	TCGA-24-2019-01	TCGA-24-2019-01		437a6ae6-ad96-446e-ad48-d2d8f608e915		TCGA-24-2019-01		TCGA-24-2019-01A-02D-0667-05				52908652-f29a-4517-8ff6-6f4cd31c691b	TCGA-24-2019-01A-02D-0663-01	TCGA-24-2019-01			TCGA-24-2019-01A-02D-0663-01	52908652-f29a-4517-8ff6-6f4cd31c691b		52908652-f29a-4517-8ff6-6f4cd31c691b	TCGA-24-2019-01A-02W-0722-08	TCGA-24-2019-01	TCGA-24-2019-01	52908652-f29a-4517-8ff6-6f4cd31c691b	TCGA-24-2019-01A-02W-0722-08	TCGA-24-2019-01A-02R-0670-07	
TCGA-24-2020-01	1	TCGA-24-2020-01	4624	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-2020			days	4624	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-24-2020-F26431	TCGA-24-2020	TCGA-24-2020-01A	Stage IIIC	-24682		4624	0	4624		723				2010-3-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1			G3	Recurrence					TCGA-24-2020.4f529d42-acb0-4c02-bd0f-d4a650655df8.pdf	2020		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1994	TCGA-24-2020-01	TCGA-24-2020-01		dfccfa2b-c85a-4ef7-815f-75d1042b5c6d		TCGA-24-2020-01		TCGA-24-2020-01A-01D-0652-05		TCGA-24-2020-01A-21-1560-20		19765b4f-458e-4f02-bf96-01498d80ac83	TCGA-24-2020-01A-01D-0648-01	TCGA-24-2020-01	809ac07d-5244-462e-a41e-531eeb193296		TCGA-24-2020-01A-01D-0648-01	19765b4f-458e-4f02-bf96-01498d80ac83		19765b4f-458e-4f02-bf96-01498d80ac83		TCGA-24-2020-01	TCGA-24-2020-01	19765b4f-458e-4f02-bf96-01498d80ac83		TCGA-24-2020-01A-01R-0655-07	
TCGA-24-2023-01	1	TCGA-24-2023-01	1364	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-24-2023			days	1364	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-24-2023-F26442	TCGA-24-2023	TCGA-24-2023-01A	Stage IIIA	-19901		1364	0	1364		1069				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3	Recurrence					TCGA-24-2023.2a255fa6-65cd-4fb7-9d08-1b6aadd6682b.pdf	2023		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1994	TCGA-24-2023-01	TCGA-24-2023-01		feeee3cc-2213-4b46-b985-4575d7dcbf23		TCGA-24-2023-01		TCGA-24-2023-01A-01D-0652-05		TCGA-24-2023-01A-21-1560-20		11fd4bb1-0f8d-4830-a7f0-83897a5df11d	TCGA-24-2023-01A-01D-0648-01	TCGA-24-2023-01	53cd60af-85e4-468e-a6f8-f21be9631a23		TCGA-24-2023-01A-01D-0648-01	11fd4bb1-0f8d-4830-a7f0-83897a5df11d		11fd4bb1-0f8d-4830-a7f0-83897a5df11d		TCGA-24-2023-01	TCGA-24-2023-01	11fd4bb1-0f8d-4830-a7f0-83897a5df11d		TCGA-24-2023-01A-01R-0655-07	
TCGA-24-2024-01	1	TCGA-24-2024-01	1769	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2024			days	1769	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Bilateral	TCGA-24-2024-F26450	TCGA-24-2024	TCGA-24-2024-01A	Stage IIIC	-26476		1769	0	1769		421				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3	Recurrence					TCGA-24-2024.4189cfa0-00c3-42fb-91b9-d2f4b4887061.pdf	2024		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1994	TCGA-24-2024-01	TCGA-24-2024-01		3f66920b-c10b-4768-a706-c8a6cef1c149		TCGA-24-2024-01		TCGA-24-2024-01A-02D-0667-05		TCGA-24-2024-01A-03-1563-20		bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	TCGA-24-2024-01A-02D-0663-01	TCGA-24-2024-01	c3771a58-897b-4427-8dbb-70214f74dc03		TCGA-24-2024-01A-02D-0663-01	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce		bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	TCGA-24-2024-01A-02W-0722-08	TCGA-24-2024-01	TCGA-24-2024-01	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	TCGA-24-2024-01A-02W-0722-08	TCGA-24-2024-01A-02R-0670-07	
TCGA-24-2026-01	1	TCGA-24-2026-01	1059	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-2026			days	1059	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			79	Bilateral	TCGA-24-2026-F26456	TCGA-24-2026		Stage IIIC	-29050		1059	0	1059						2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3							2026			YES			NO		Primary Tumor	01				24	>20 mm	Ovary			DECEASED	1995	TCGA-24-2026-01	TCGA-24-2026-01		ccb2b163-3da6-4594-b55b-c63221fc8ad5		TCGA-24-2026-01		TCGA-24-2026-01A-01D-0652-05		TCGA-24-2026-01A-21-1560-20		ce0fd762-e18f-4cca-a4c4-c064dca62e60	TCGA-24-2026-01A-01D-0648-01	TCGA-24-2026-01	f68086f7-8d41-4631-9346-849088f1f577		TCGA-24-2026-01A-01D-0648-01	ce0fd762-e18f-4cca-a4c4-c064dca62e60		ce0fd762-e18f-4cca-a4c4-c064dca62e60		TCGA-24-2026-01	TCGA-24-2026-01	ce0fd762-e18f-4cca-a4c4-c064dca62e60		TCGA-24-2026-01A-01R-0655-07	
TCGA-24-2027-01	1	TCGA-24-2027-01	3337	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-2027			days	3337	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-24-2027-F26460	TCGA-24-2027	TCGA-24-2027-01A	Stage IV	-18835		3337	0	3337		617	0			2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6			G3	Recurrence					TCGA-24-2027.8a4d0373-9d57-4cf7-ac78-d8b558d43df6.pdf	2027	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			24	>20 mm	Ovary		A	DECEASED	1995	TCGA-24-2027-01	TCGA-24-2027-01		e9c0e81a-4be2-4ab2-a0fe-33ea200f4047		TCGA-24-2027-01		TCGA-24-2027-01A-01D-0652-05		TCGA-24-2027-01A-21-1560-20		fc1f34ba-12e1-46d8-85ef-15b9486b37c2	TCGA-24-2027-01A-01D-0648-01	TCGA-24-2027-01	55afc19d-b001-47f3-9d3d-9bc9a8681031		TCGA-24-2027-01A-01D-0648-01	fc1f34ba-12e1-46d8-85ef-15b9486b37c2		fc1f34ba-12e1-46d8-85ef-15b9486b37c2		TCGA-24-2027-01	TCGA-24-2027-01	fc1f34ba-12e1-46d8-85ef-15b9486b37c2		TCGA-24-2027-01A-01R-0655-07	
TCGA-24-2029-01	1	TCGA-24-2029-01	439	1	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 2		TCGA-24-2029			days	439	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	75	Bilateral	TCGA-24-2029-F26476	TCGA-24-2029		Stage IIIC	-27527		439	0	439		372				2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						2029		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				24	>20 mm	Ovary			DECEASED	1995		TCGA-24-2029-01		fc252b6a-222d-4529-a609-012e71c0b436		TCGA-24-2029-01		TCGA-24-2029-01A-01D-0652-05		TCGA-24-2029-01A-21-1560-20			TCGA-24-2029-01A-01D-0648-01	TCGA-24-2029-01	c10a5aef-aa73-4f20-acef-a5bd42e29fca		TCGA-24-2029-01A-01D-0648-01					TCGA-24-2029-01				TCGA-24-2029-01A-01R-0655-07	
TCGA-24-2030-01	1	TCGA-24-2030-01	1701	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-24-2030			days	1701	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	87	Left	TCGA-24-2030-F26480	TCGA-24-2030	TCGA-24-2030-01A	Stage IIIC	-31900		1701	0	1641		646				2010-2-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.5			G3	Recurrence					TCGA-24-2030.bb1b63ab-1e13-4401-ab6a-0325da96b17f.pdf	2030		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	1995		TCGA-24-2030-01		07894e29-8a70-415e-a10d-389d652f11a5		TCGA-24-2030-01		TCGA-24-2030-01A-01D-0667-05		TCGA-24-2030-01A-21-1560-20			TCGA-24-2030-01A-01D-0663-01	TCGA-24-2030-01	827506c7-c89c-4301-971d-b42ace20769e		TCGA-24-2030-01A-01D-0663-01				TCGA-24-2030-01A-01W-0722-08	TCGA-24-2030-01			TCGA-24-2030-01A-01W-0722-08	TCGA-24-2030-01A-01R-0670-07	
TCGA-24-2033-01	1	TCGA-24-2033-01	562	1	days	High	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-2033			days	562	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	87	Bilateral	TCGA-24-2033-F26490	TCGA-24-2033		Stage IIIC	-31977		562	0	562		351				2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						2033		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01				24	>20 mm	Ovary			DECEASED	1995	TCGA-24-2033-01	TCGA-24-2033-01		a735c975-e05c-4389-a39d-80c25462dfe6		TCGA-24-2033-01		TCGA-24-2033-01A-01D-0667-05		TCGA-24-2033-01A-21-1560-20		b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	TCGA-24-2033-01A-01D-0663-01	TCGA-24-2033-01	d671c1b8-d45e-4d50-bf32-458677874c49		TCGA-24-2033-01A-01D-0663-01	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76		b03b75e2-d1d0-4fd7-b66e-891f7b0acb76		TCGA-24-2033-01	TCGA-24-2033-01	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76		TCGA-24-2033-01A-01R-0670-07	
TCGA-24-2035-01	1	TCGA-24-2035-01	857	1	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-2035			days	857	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Left	TCGA-24-2035-F26496	TCGA-24-2035		Stage IIIC	-23855		857	0	857		287	0			2010-3-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						2035	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01				24	1-10 mm	Ovary			DECEASED	1996	TCGA-24-2035-01	TCGA-24-2035-01		ede49e4b-e555-4d20-99cb-e98ea98ddec2		TCGA-24-2035-01		TCGA-24-2035-01A-01D-0667-05				e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	TCGA-24-2035-01A-01D-0663-01	TCGA-24-2035-01			TCGA-24-2035-01A-01D-0663-01	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0		e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	TCGA-24-2035-01A-01W-0722-08	TCGA-24-2035-01	TCGA-24-2035-01	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	TCGA-24-2035-01A-01W-0722-08	TCGA-24-2035-01A-01R-0670-07	
TCGA-24-2036-01	1	TCGA-24-2036-01	1947	1	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-2036			days	1947	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	50		TCGA-24-2036-F26505	TCGA-24-2036	TCGA-24-2036-01A	Stage IIIA	-18582		1947	0	1947		914	0			2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1			G3	Recurrence					TCGA-24-2036.3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e.pdf	2036	Other	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1996	TCGA-24-2036-01			b7b09d06-e228-4549-b19a-99561867345b				TCGA-24-2036-01A-01D-0667-05		TCGA-24-2036-01A-21-1560-20		788ade22-382b-49ca-b2b1-447a2072d0ea	TCGA-24-2036-01A-01D-0663-01	TCGA-24-2036-01	bcde7ed3-4bc7-41c7-99af-f132bda4a6ef		TCGA-24-2036-01A-01D-0663-01	788ade22-382b-49ca-b2b1-447a2072d0ea		788ade22-382b-49ca-b2b1-447a2072d0ea		TCGA-24-2036-01	TCGA-24-2036-01	788ade22-382b-49ca-b2b1-447a2072d0ea		TCGA-24-2036-01A-01R-0670-07	
TCGA-24-2038-01	1	TCGA-24-2038-01	1354	1	days	Iq	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 12	TCGA-24-2038			days	1354	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Right	TCGA-24-2038-F26518	TCGA-24-2038	TCGA-24-2038-01A	Stage IIIA	-24957		1354	0	1354		1169				2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1			GB	Recurrence					TCGA-24-2038.82958234-9de0-429f-8e63-3e8891f1df81.pdf	2038		WITH TUMOR	NO	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-2038-01	TCGA-24-2038-01		05783372-9fc0-426a-a1ea-203af160b5b6		TCGA-24-2038-01		TCGA-24-2038-01A-01D-0667-05		TCGA-24-2038-01A-21-1560-20		372a8471-dff3-44c0-9393-94ad511a7374	TCGA-24-2038-01A-01D-0663-01	TCGA-24-2038-01	b9526a72-d01f-46bc-896d-4798319abebf		TCGA-24-2038-01A-01D-0663-01	372a8471-dff3-44c0-9393-94ad511a7374		372a8471-dff3-44c0-9393-94ad511a7374	TCGA-24-2038-01A-01W-0722-08	TCGA-24-2038-01	TCGA-24-2038-01	372a8471-dff3-44c0-9393-94ad511a7374	TCGA-24-2038-01A-01W-0722-08	TCGA-24-2038-01A-01R-0670-07	
TCGA-24-2254-01	1	TCGA-24-2254-01	1736	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 2	TCGA-24-2254			days	1736	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Bilateral	TCGA-24-2254-F26523	TCGA-24-2254	TCGA-24-2254-01A	Stage IIIC	-24407		1736	0	1736		606	0			2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1		YES	G3	Recurrence					TCGA-24-2254.3788629f-17da-4075-af61-cf124bdfb48e.pdf	2254	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	2003	TCGA-24-2254-01	TCGA-24-2254-01		b8cac420-a963-4be2-9ecf-dd92700477e1		TCGA-24-2254-01		TCGA-24-2254-01A-01D-0667-05		TCGA-24-2254-01A-21-1560-20		e496319b-df71-44a0-bfa6-90f50ae54654	TCGA-24-2254-01A-01D-0663-01	TCGA-24-2254-01	9525da91-59ae-487e-b9cb-925f263dfcb6		TCGA-24-2254-01A-01D-0663-01	e496319b-df71-44a0-bfa6-90f50ae54654		e496319b-df71-44a0-bfa6-90f50ae54654	TCGA-24-2254-01A-01W-0722-08	TCGA-24-2254-01	TCGA-24-2254-01	e496319b-df71-44a0-bfa6-90f50ae54654	TCGA-24-2254-01A-01W-0722-08	TCGA-24-2254-01A-01R-0670-07	
TCGA-24-2260-01	1	TCGA-24-2260-01	1100	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2260			days	1100	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-2260-F26532	TCGA-24-2260	TCGA-24-2260-01A	Stage IIIB	-27112		1100	0	1100		667				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		1	NO		1.7			G3	Recurrence					TCGA-24-2260.920817f6-bd04-4e9a-8f41-ba28be22cbc8.pdf	2260		WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1992		TCGA-24-2260-01		0bfc4955-78bd-4883-b7b0-a262b6c1594f		TCGA-24-2260-01		TCGA-24-2260-01A-01D-0667-05		TCGA-24-2260-01A-21-1560-20			TCGA-24-2260-01A-01D-0663-01	TCGA-24-2260-01	34ce0e32-d482-45e5-8663-edf50b16309a		TCGA-24-2260-01A-01D-0663-01				TCGA-24-2260-01A-01W-0722-08	TCGA-24-2260-01			TCGA-24-2260-01A-01W-0722-08	TCGA-24-2260-01A-01R-0670-07	
TCGA-24-2261-01	1	TCGA-24-2261-01	24	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-2261			days	24	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			76	Left	TCGA-24-2261-F26540	TCGA-24-2261	TCGA-24-2261-01A	Stage IIIC	-27897		24	0	24						2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.4	NO		1.7		YES	G3						TCGA-24-2261.6145afd6-e7d7-47bc-a659-ac84c3434e86.pdf	2261		WITH TUMOR	NO			NO		Primary Tumor	01	0.4			24	11-20 mm	Ovary		A	DECEASED	1992	TCGA-24-2261-01	TCGA-24-2261-01		8c41ba6a-3315-4903-9cd5-ac3f82576008		TCGA-24-2261-01		TCGA-24-2261-01A-01D-0667-05		TCGA-24-2261-01A-21-1560-20		75e9506a-d007-4fb2-8bdd-7e7780653a63	TCGA-24-2261-01A-01D-0663-01	TCGA-24-2261-01	cbbb0190-5bfe-4a4f-aabe-63d68021b388		TCGA-24-2261-01A-01D-0663-01	75e9506a-d007-4fb2-8bdd-7e7780653a63		75e9506a-d007-4fb2-8bdd-7e7780653a63	TCGA-24-2261-01A-01W-0722-08	TCGA-24-2261-01	TCGA-24-2261-01	75e9506a-d007-4fb2-8bdd-7e7780653a63	TCGA-24-2261-01A-01W-0722-08	TCGA-24-2261-01A-01R-0670-07	
TCGA-24-2262-01	1	TCGA-24-2262-01	11	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2262			days	11	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Right	TCGA-24-2262-F26542	TCGA-24-2262	TCGA-24-2262-01A	Stage IIIC	-20861		11	0	11						2010-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G3						TCGA-24-2262.d58b58ac-365c-43d0-a893-0becfb6e9fff.pdf	2262		WITH TUMOR	NO			NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1992	TCGA-24-2262-01	TCGA-24-2262-01		8462f214-6bf7-4018-b40b-f9a3f3847542		TCGA-24-2262-01		TCGA-24-2262-01A-01D-0708-05		TCGA-24-2262-01A-21-1560-20		efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	TCGA-24-2262-01A-01D-0704-01	TCGA-24-2262-01	5d31db74-24ef-4322-9880-5189dee10ccb		TCGA-24-2262-01A-01D-0704-01	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe		efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	TCGA-24-2262-01A-01W-0799-08	TCGA-24-2262-01	TCGA-24-2262-01	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	TCGA-24-2262-01A-01W-0799-08	TCGA-24-2262-01A-01R-0711-07	
TCGA-24-2267-01	1	TCGA-24-2267-01	1446	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2267			days	1446	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-24-2267-F26544	TCGA-24-2267	TCGA-24-2267-01A	Stage IIB	-21293		1446	0	1446		512				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5		YES	G3	Recurrence					TCGA-24-2267.24844312-f32c-4366-945e-96d9a923f82a.pdf	2267		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			24	No Macroscopic disease	Ovary		A	DECEASED	1993	TCGA-24-2267-01	TCGA-24-2267-01		7d6e82dd-4715-42df-8325-444be465aa24		TCGA-24-2267-01		TCGA-24-2267-01A-01D-0708-05		TCGA-24-2267-01A-21-1560-20		9ebb3535-6536-49fc-a88b-473235972378	TCGA-24-2267-01A-01D-0704-01	TCGA-24-2267-01	25f1b635-6318-41d5-a0c8-37e8d263dddd		TCGA-24-2267-01A-01D-0704-01	9ebb3535-6536-49fc-a88b-473235972378		9ebb3535-6536-49fc-a88b-473235972378	TCGA-24-2267-01A-01W-0799-08	TCGA-24-2267-01	TCGA-24-2267-01	9ebb3535-6536-49fc-a88b-473235972378	TCGA-24-2267-01A-01W-0799-08	TCGA-24-2267-01A-01R-0711-07	
TCGA-24-2271-01	1	TCGA-24-2271-01	962	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2271			days	962	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-2271-F26557	TCGA-24-2271	TCGA-24-2271-01A	Stage IIIC	-20399		962	0	962		827				2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6		YES	G3	Recurrence					TCGA-24-2271.87d64a93-9b08-48a5-a26e-1cc4b5ac8bde.pdf	2271		WITH TUMOR	YES		Physical Examination	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary	YES	A	DECEASED	1999	TCGA-24-2271-01	TCGA-24-2271-01		3f1bd8a1-5a33-4c68-9d62-a65289c677dd		TCGA-24-2271-01		TCGA-24-2271-01A-01D-0708-05		TCGA-24-2271-01A-21-1560-20		f3581696-e1db-4d0f-9ce7-5fb0f5c08906	TCGA-24-2271-01A-01D-0704-01	TCGA-24-2271-01	9651ae11-92cc-4085-b9f5-b141eff0fb99		TCGA-24-2271-01A-01D-0704-01	f3581696-e1db-4d0f-9ce7-5fb0f5c08906		f3581696-e1db-4d0f-9ce7-5fb0f5c08906	TCGA-24-2271-01A-01W-0799-08	TCGA-24-2271-01	TCGA-24-2271-01	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	TCGA-24-2271-01A-01W-0799-08	TCGA-24-2271-01A-01R-0711-07	
TCGA-24-2280-01	0	TCGA-24-2280-01	2143	0	days	Squamous		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-2280			days	2143	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Bilateral	TCGA-24-2280-F26561	TCGA-24-2280	TCGA-24-2280-01A	Stage IIIC	-27356			0	2143		535	0			2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5			G3	Recurrence					TCGA-24-2280.deb1a0d1-92a0-4c10-b491-a6a1ca5e3192.pdf	2280	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2004		TCGA-24-2280-01		964fcf21-982e-474f-ab2d-cfcb0bbd0e15		TCGA-24-2280-01		TCGA-24-2280-01A-01D-0708-05					TCGA-24-2280-01A-01D-0704-01	TCGA-24-2280-01			TCGA-24-2280-01A-01D-0704-01				TCGA-24-2280-01A-01W-0799-08	TCGA-24-2280-01			TCGA-24-2280-01A-01W-0799-08	TCGA-24-2280-01A-01R-0711-07	
TCGA-24-2281-01	0	TCGA-24-2281-01	1357	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2281			days	1357	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			68	Bilateral	TCGA-24-2281-F26570	TCGA-24-2281	TCGA-24-2281-01A	Stage IIA	-25019			0	1357			0			2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5		YES	G3						TCGA-24-2281.363dc00f-480d-4a3f-8950-80a6bc0b7dd8.pdf	2281	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.2			24	1-10 mm	Ovary		A	LIVING	2006	TCGA-24-2281-01	TCGA-24-2281-01		0ca4dc50-aee3-49e2-b327-b86ddfce658f		TCGA-24-2281-01		TCGA-24-2281-01A-01D-0708-05		TCGA-24-2281-01A-21-1560-20		44948279-405d-42f6-ad29-465150ee6d85	TCGA-24-2281-01A-01D-0704-01	TCGA-24-2281-01	e83257be-084b-405a-8098-b10055d1ad85		TCGA-24-2281-01A-01D-0704-01	44948279-405d-42f6-ad29-465150ee6d85		44948279-405d-42f6-ad29-465150ee6d85	TCGA-24-2281-01A-01W-0799-08	TCGA-24-2281-01	TCGA-24-2281-01	44948279-405d-42f6-ad29-465150ee6d85	TCGA-24-2281-01A-01W-0799-08	TCGA-24-2281-01A-01R-0711-07	
TCGA-24-2288-01	1	TCGA-24-2288-01	25	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 8	TCGA-24-2288			days	25	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			70	Bilateral	TCGA-24-2288-F26574	TCGA-24-2288	TCGA-24-2288-01A	Stage IIIC	-25831		25	0	25						2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2		YES	G3						TCGA-24-2288.a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45.pdf	2288		WITH TUMOR	YES			NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	1999	TCGA-24-2288-01	TCGA-24-2288-01		bea203c5-e349-4941-aa28-d3b9372ad7a2		TCGA-24-2288-01		TCGA-24-2288-01A-01D-0708-05		TCGA-24-2288-01A-21-1560-20		dbc2cfac-df65-4750-af39-37760bad1057	TCGA-24-2288-01A-01D-0704-01	TCGA-24-2288-01	7c143023-df5b-42cb-958b-962d6f607e92		TCGA-24-2288-01A-01D-0704-01	dbc2cfac-df65-4750-af39-37760bad1057		dbc2cfac-df65-4750-af39-37760bad1057	TCGA-24-2288-01A-01W-0799-08	TCGA-24-2288-01	TCGA-24-2288-01	dbc2cfac-df65-4750-af39-37760bad1057	TCGA-24-2288-01A-01W-0799-08	TCGA-24-2288-01A-01R-0711-07	
TCGA-24-2289-01	1	TCGA-24-2289-01	2049	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 8	TCGA-24-2289			days	2049	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-24-2289-F26578	TCGA-24-2289	TCGA-24-2289-01A	Stage IV	-25191		2049	0	2049		568				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.5			G3	Recurrence					TCGA-24-2289.3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d.pdf	2289		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01	0.4			24	>20 mm	Ovary		A	DECEASED	1997	TCGA-24-2289-01	TCGA-24-2289-01		9ef0fcf7-e7c3-4c19-ab2b-185392963182		TCGA-24-2289-01		TCGA-24-2289-01A-01D-0708-05		TCGA-24-2289-01A-21-1560-20		bdc4400c-c552-450b-a806-2ae10f61cca8	TCGA-24-2289-01A-01D-0704-01	TCGA-24-2289-01	992227e4-86a6-4703-ac81-cae8ea4a5dac		TCGA-24-2289-01A-01D-0704-01	bdc4400c-c552-450b-a806-2ae10f61cca8		bdc4400c-c552-450b-a806-2ae10f61cca8	TCGA-24-2289-01A-01W-0799-08	TCGA-24-2289-01	TCGA-24-2289-01	bdc4400c-c552-450b-a806-2ae10f61cca8	TCGA-24-2289-01A-01W-0799-08	TCGA-24-2289-01A-01R-0711-07	
TCGA-24-2290-01	1	TCGA-24-2290-01	1102	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2290			days	1102	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56		TCGA-24-2290-F26583	TCGA-24-2290	TCGA-24-2290-01A	Stage IIIC	-20530		1102	0	1102		324	0			2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Tumor resection		1	NO		1.5			G3	Recurrence					TCGA-24-2290.71036f77-0d99-427a-883c-75624453890d.pdf	2290	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			24	1-10 mm	Omentum		A	DECEASED	1997	TCGA-24-2290-01	TCGA-24-2290-01		ad9e04b7-2000-411e-81bd-d1d22381d5c8		TCGA-24-2290-01		TCGA-24-2290-01A-01D-0708-05		TCGA-24-2290-01A-21-1560-20		a3173b33-aa16-48a2-b733-0345aad49755	TCGA-24-2290-01A-01D-0704-01	TCGA-24-2290-01	7ede9f43-4fe6-4cd4-a1fe-b6a0677b40d9		TCGA-24-2290-01A-01D-0704-01	a3173b33-aa16-48a2-b733-0345aad49755		a3173b33-aa16-48a2-b733-0345aad49755	TCGA-24-2290-01A-01W-0799-08	TCGA-24-2290-01	TCGA-24-2290-01	a3173b33-aa16-48a2-b733-0345aad49755	TCGA-24-2290-01A-01W-0799-08	TCGA-24-2290-01A-01R-0711-07	
TCGA-24-2293-01	1	TCGA-24-2293-01	506	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation c1uster 9	TCGA-24-2293			days	506	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			47	Right	TCGA-24-2293-F26598	TCGA-24-2293	TCGA-24-2293-01A		-17235		506	0	506						2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Tumor resection		1.1	NO		1.3			G3						TCGA-24-2293.caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7.pdf	2293			YES	Partial Remission/Response		NO		Primary Tumor	01	0.3			24	>20 mm	Omentum		A	DECEASED	1995	TCGA-24-2293-01	TCGA-24-2293-01		87480009-8495-4826-9d10-dbe6dc6281f1		TCGA-24-2293-01		TCGA-24-2293-01A-01D-0708-05		TCGA-24-2293-01A-21-1560-20		d554a1f1-3e8a-4b8c-a458-36e6550905dd	TCGA-24-2293-01A-01D-0704-01	TCGA-24-2293-01	a40fdeac-ebb6-4f9f-9f90-837deef5095e		TCGA-24-2293-01A-01D-0704-01	d554a1f1-3e8a-4b8c-a458-36e6550905dd		d554a1f1-3e8a-4b8c-a458-36e6550905dd	TCGA-24-2293-01A-01W-0799-08	TCGA-24-2293-01	TCGA-24-2293-01	d554a1f1-3e8a-4b8c-a458-36e6550905dd	TCGA-24-2293-01A-01W-0799-08	TCGA-24-2293-01A-01R-0711-07	
TCGA-24-2295-01	1	TCGA-24-2295-01	1007	1	days	High		OV-like c1	OV-like c4					TCGA-24-2295			days	1007	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	69	Right	TCGA-24-2295-F26605	TCGA-24-2295	TCGA-24-2295-01A	Stage IIIC	-25416		1007	0	1007		281				2010-4-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.1		YES	G3	Recurrence					TCGA-24-2295.44d946e9-12ae-437b-9211-1be42b4d6439.pdf	2295		WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.4			24	>20 mm	Ovary		A	DECEASED	1995				8a525a38-29e3-457d-a665-e05297e6b07a				TCGA-24-2295-01A-01D-0708-05		TCGA-24-2295-01A-21-1560-20			TCGA-24-2295-01A-01D-0704-01	TCGA-24-2295-01	eb245ed7-60fc-47eb-9d75-4704c337b943		TCGA-24-2295-01A-01D-0704-01					TCGA-24-2295-01				TCGA-24-2295-01A-01R-0711-07	
TCGA-24-2297-01	1	TCGA-24-2297-01	1699	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-2297			days	1699	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			56	Bilateral	TCGA-24-2297-F26612	TCGA-24-2297	TCGA-24-2297-01A	Stage IIIC	-20487		1699	0	1699						2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3						TCGA-24-2297.12b02227-4050-4d02-bdb8-939d348a4c19.pdf	2297			YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			24	>20 mm	Ovary		A	DECEASED	1993	TCGA-24-2297-01	TCGA-24-2297-01		971a0b51-b807-436b-ac4c-ef9cc2e2038d		TCGA-24-2297-01		TCGA-24-2297-01A-01D-0708-05		TCGA-24-2297-01A-21-1560-20		2b0089bc-b493-4179-bf5c-e58550e1ee5b	TCGA-24-2297-01A-01D-0704-01	TCGA-24-2297-01	f700e3e2-462f-4889-82fa-ac614983d642		TCGA-24-2297-01A-01D-0704-01	2b0089bc-b493-4179-bf5c-e58550e1ee5b		2b0089bc-b493-4179-bf5c-e58550e1ee5b		TCGA-24-2297-01	TCGA-24-2297-01	2b0089bc-b493-4179-bf5c-e58550e1ee5b		TCGA-24-2297-01A-01R-0711-07	
TCGA-24-2298-01	1	TCGA-24-2298-01	1620	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-2298			days	1620	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-24-2298-F26616	TCGA-24-2298	TCGA-24-2298-01A	Stage IIIC	-20453		1620	0	1620		469				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1			G3	Recurrence					TCGA-24-2298.fe9d7bf4-a278-4842-b911-018d0127ef20.pdf	2298		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			24	>20 mm	Ovary		A	DECEASED	1993	TCGA-24-2298-01	TCGA-24-2298-01		9c71ce7f-4e80-46bc-b66c-c893614dd207		TCGA-24-2298-01		TCGA-24-2298-01A-01D-0708-05		TCGA-24-2298-01A-21-1560-20		7b39cb0a-7152-4037-9989-57545a1df980	TCGA-24-2298-01A-01D-0704-01	TCGA-24-2298-01	a99356d2-7d94-4274-9720-3defe513159a		TCGA-24-2298-01A-01D-0704-01	7b39cb0a-7152-4037-9989-57545a1df980		7b39cb0a-7152-4037-9989-57545a1df980	TCGA-24-2298-01A-01W-0799-08	TCGA-24-2298-01	TCGA-24-2298-01	7b39cb0a-7152-4037-9989-57545a1df980	TCGA-24-2298-01A-01W-0799-08	TCGA-24-2298-01A-01R-0711-07	
TCGA-25-1312-01	1	TCGA-25-1312-01	31	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-25-1312			days	31	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			69	Left	TCGA-25-1312-F26626	TCGA-25-1312	TCGA-25-1312-01A	Stage IV	-25537		31	0	31						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3						TCGA-25-1312.9AD5ADDB-713E-4FF7-97F1-123FA771AC5B.pdf	1312						NO		Primary Tumor	01	1			25	1-10 mm	Ovary		A	DECEASED	2001	TCGA-25-1312-01	TCGA-25-1312-01		c31a0d45-5e8c-4fcb-b773-1bd3744b5eea		TCGA-25-1312-01		TCGA-25-1312-01A-01D-0460-05		TCGA-25-1312-01A-11-1562-20		0d7561dc-7069-41df-ba49-8fcd4df52efb	TCGA-25-1312-01A-01D-0452-01	TCGA-25-1312-01	43e59c4e-4bf0-45d0-9c02-1d1c43eeef9b		TCGA-25-1312-01A-01D-0452-01	0d7561dc-7069-41df-ba49-8fcd4df52efb		0d7561dc-7069-41df-ba49-8fcd4df52efb		TCGA-25-1312-01	TCGA-25-1312-01	0d7561dc-7069-41df-ba49-8fcd4df52efb		TCGA-25-1312-01A-01R-0456-07	
TCGA-25-1313-01	1	TCGA-25-1313-01	820	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-25-1313			days	820	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Bilateral	TCGA-25-1313-F26628	TCGA-25-1313	TCGA-25-1313-01A	Stage IV	-22982		820	0	820		394				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		2			G3	Recurrence					TCGA-25-1313.3F5AAE21-3694-4AC2-8A18-4970090A08F4.pdf	1313		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers			Primary Tumor	01	1.5			25	1-10 mm	Ovary		A	DECEASED	2000	TCGA-25-1313-01	TCGA-25-1313-01		5e71901f-ac21-4d6d-8705-ab20c65ec0f0		TCGA-25-1313-01		TCGA-25-1313-01A-01D-0460-05		TCGA-25-1313-01A-21-1562-20		ab99683f-6116-463d-8bf6-5782809d4729	TCGA-25-1313-01A-01D-0452-01	TCGA-25-1313-01	291a8a6a-23e2-42c9-a260-8696b9795cf2		TCGA-25-1313-01A-01D-0452-01	ab99683f-6116-463d-8bf6-5782809d4729		ab99683f-6116-463d-8bf6-5782809d4729	TCGA-25-1313-01A-01W-0492-08	TCGA-25-1313-01	TCGA-25-1313-01	ab99683f-6116-463d-8bf6-5782809d4729	TCGA-25-1313-01A-01W-0492-08	TCGA-25-1313-01A-01R-0456-07	
TCGA-25-1314-01	1	TCGA-25-1314-01	1004	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-25-1314			days	1004	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	42	Bilateral	TCGA-25-1314-F26633	TCGA-25-1314		Stage IV	-15462		1004	0	974		274				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Progression of Disease						1314		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01				25	1-10 mm	Ovary			DECEASED	2000	TCGA-25-1314-01	TCGA-25-1314-01		da862d11-c970-44ee-af78-1179902f9310		TCGA-25-1314-01		TCGA-25-1314-01A-01D-0460-05		TCGA-25-1314-01A-21-1562-20		b571f7cf-e9b8-493f-822b-a489f114420b	TCGA-25-1314-01A-01D-0452-01	TCGA-25-1314-01	b17945ba-39d6-400d-8e3e-e81123595c51		TCGA-25-1314-01A-01D-0452-01	b571f7cf-e9b8-493f-822b-a489f114420b		b571f7cf-e9b8-493f-822b-a489f114420b		TCGA-25-1314-01	TCGA-25-1314-01	b571f7cf-e9b8-493f-822b-a489f114420b		TCGA-25-1314-01A-01R-0456-07	
TCGA-25-1315-01	1	TCGA-25-1315-01	1583	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1315			days	1583	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-25-1315-F26639	TCGA-25-1315	TCGA-25-1315-01A	Stage IIIC	-18263		1583	0	1553		153				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		3.5			G3	Progression of Disease					TCGA-25-1315.486E22A0-A224-4471-BA52-9F52E021B131.pdf	1315		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.9			25	1-10 mm	Ovary		A	DECEASED	2000	TCGA-25-1315-01	TCGA-25-1315-01		6f8cdfc3-aada-43e2-a9ce-9d8d437b9442		TCGA-25-1315-01		TCGA-25-1315-01A-01D-0460-05	TCGA-25-1315-01A-01W-0494-09	TCGA-25-1315-01A-21-1562-20	TCGA-25-1315-01A-01W-0494-09	b6908d33-80c8-4fc0-bd1d-829ec3161527	TCGA-25-1315-01A-01D-0452-01	TCGA-25-1315-01	1ecf4db0-2d32-4ad5-a14a-ce5065f7fb01		TCGA-25-1315-01A-01D-0452-01	b6908d33-80c8-4fc0-bd1d-829ec3161527		b6908d33-80c8-4fc0-bd1d-829ec3161527		TCGA-25-1315-01	TCGA-25-1315-01	b6908d33-80c8-4fc0-bd1d-829ec3161527	TCGA-25-1315-01A-01W-0494-09	TCGA-25-1315-01A-01R-0456-07	
TCGA-25-1316-01	1	TCGA-25-1316-01	1279	1	days	BRCA-LUAD+	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 12	TCGA-25-1316			days	1279	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Right	TCGA-25-1316-F26646	TCGA-25-1316	TCGA-25-1316-01A	Stage IIIC	-20331		1279	0	1126		276				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3	Progression of Disease					TCGA-25-1316.B766CB7E-C4EC-489C-AEF0-BE28132D5BA5.pdf	1316		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	1.5			25	1-10 mm	Ovary		A	DECEASED	2000	TCGA-25-1316-01	TCGA-25-1316-01		5c167e3e-7757-4a02-b218-81c2ba107bfa		TCGA-25-1316-01		TCGA-25-1316-01A-01D-0460-05	TCGA-25-1316-01A-01W-0494-09	TCGA-25-1316-01A-21-20	TCGA-25-1316-01A-01W-0494-09	6cb5e275-1284-482b-a4e9-933acf9aad44	TCGA-25-1316-01A-01D-0452-01	TCGA-25-1316-01	4d3e28c0-7510-4c0e-a4c2-d2af7bcb82b4		TCGA-25-1316-01A-01D-0452-01	6cb5e275-1284-482b-a4e9-933acf9aad44		6cb5e275-1284-482b-a4e9-933acf9aad44		TCGA-25-1316-01	TCGA-25-1316-01	6cb5e275-1284-482b-a4e9-933acf9aad44	TCGA-25-1316-01A-01W-0494-09	TCGA-25-1316-01A-01R-0456-07	
TCGA-25-1317-01	1	TCGA-25-1317-01	61	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-1317			days	61	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			66	Bilateral	TCGA-25-1317-F26651	TCGA-25-1317	TCGA-25-1317-01A	Stage IIIC	-24199		61	0							2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.4	NO		1.5			G3						TCGA-25-1317.5DC53520-0991-42B6-B10D-0D62C3F92BAD.pdf	1317			YES			NO		Primary Tumor	01	0.5			25		Ovary		A	DECEASED	2000	TCGA-25-1317-01	TCGA-25-1317-01	TCGA-25-1317-01A-01W-0490-10	5b49f5cc-28fd-4b1e-ae8e-6391f99ccb46		TCGA-25-1317-01	TCGA-25-1317-01A-01W-0490-10	TCGA-25-1317-01A-01D-0460-05				423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	TCGA-25-1317-01A-01D-0452-01	TCGA-25-1317-01			TCGA-25-1317-01A-01D-0452-01	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf		423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf		TCGA-25-1317-01	TCGA-25-1317-01	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	TCGA-25-1317-01A-01W-0490-10	TCGA-25-1317-01A-01R-0456-07	
TCGA-25-1318-01	1	TCGA-25-1318-01	1064	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1318			days	1064	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-25-1318-F26655	TCGA-25-1318	TCGA-25-1318-01A	Stage IIIC	-19755		1064	0	1064		185				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		4.5			G3	Recurrence					TCGA-25-1318.D9B9F69A-265C-42F4-BCD2-4B136A7FE935.pdf	1318		WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.8			25	1-10 mm	Ovary		A	DECEASED	2000	TCGA-25-1318-01	TCGA-25-1318-01	TCGA-25-1318-01A-01W-0490-10	f912d9b2-2f49-4c3f-aed0-3edc0065d54b		TCGA-25-1318-01	TCGA-25-1318-01A-01W-0490-10	TCGA-25-1318-01A-01D-0460-05		TCGA-25-1318-01A-21-1562-20		4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	TCGA-25-1318-01A-01D-0452-01	TCGA-25-1318-01	2f954b2b-ab8d-4f81-8717-e85d500987ee		TCGA-25-1318-01A-01D-0452-01	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5		4d3e0164-1346-4e8e-b478-29bd8b1f1ce5		TCGA-25-1318-01	TCGA-25-1318-01	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	TCGA-25-1318-01A-01W-0490-10	TCGA-25-1318-01A-01R-0456-07	
TCGA-25-1319-01	1	TCGA-25-1319-01	1977	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1319			days	1977	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-25-1319-F26660	TCGA-25-1319	TCGA-25-1319-01A	Stage IIIC	-26786		1977	0	1977		730				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3	Recurrence					TCGA-25-1319.62BFD64E-1C60-49A8-BAD0-B173DD22C951.pdf	1319			YES			NO		Primary Tumor	01	1			25	11-20 mm	Ovary		A	DECEASED	2000	TCGA-25-1319-01	TCGA-25-1319-01		7f028062-e863-4f7d-8ec6-8e91da60fc74		TCGA-25-1319-01		TCGA-25-1319-01A-01D-0460-05		TCGA-25-1319-01A-21-1562-20		8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	TCGA-25-1319-01A-01D-0452-01	TCGA-25-1319-01	09ef1041-497f-409f-9892-b5a1631a647f		TCGA-25-1319-01A-01D-0452-01	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e		8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	TCGA-25-1319-01A-01W-0492-08	TCGA-25-1319-01	TCGA-25-1319-01	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	TCGA-25-1319-01A-01W-0492-08	TCGA-25-1319-01A-01R-0456-07	
TCGA-25-1320-01	1	TCGA-25-1320-01	1155	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-1320			days	1155	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-25-1320-F26664	TCGA-25-1320	TCGA-25-1320-01A	Stage IIIC	-24018		1155	0	1124		424				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		3	NO		3.4			G3	Recurrence					TCGA-25-1320.AF68EF8D-A31D-453B-8083-CF6B9EE4E838.pdf	1320		WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	1			25	1-10 mm	Ovary		A	DECEASED	2001	TCGA-25-1320-01	TCGA-25-1320-01		7a1cfa3d-a19e-42b1-91b5-485891ff2d34		TCGA-25-1320-01		TCGA-25-1320-01A-01D-0460-05		TCGA-25-1320-01A-21-1562-20		52697815-ede2-4ce3-a6d0-2680f6b9bb73	TCGA-25-1320-01A-01D-0452-01	TCGA-25-1320-01	d1b3fd86-d1f2-4621-980a-19f3d9ee76f4		TCGA-25-1320-01A-01D-0452-01	52697815-ede2-4ce3-a6d0-2680f6b9bb73		52697815-ede2-4ce3-a6d0-2680f6b9bb73	TCGA-25-1320-01A-01W-0492-08	TCGA-25-1320-01	TCGA-25-1320-01	52697815-ede2-4ce3-a6d0-2680f6b9bb73	TCGA-25-1320-01A-01W-0492-08	TCGA-25-1320-01A-01R-0456-07	
TCGA-25-1321-01	1	TCGA-25-1321-01	1033	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1321			days	1033	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-25-1321-F26670	TCGA-25-1321	TCGA-25-1321-01A	Stage IIIC	-23987		1033	0	1033		454	0			2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.6	NO		3			G3	Recurrence					TCGA-25-1321.5D309784-AED1-4946-817D-37AC8969315C.pdf	1321	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.8			25	No Macroscopic disease	Ovary		A	DECEASED	2001	TCGA-25-1321-01	TCGA-25-1321-01		8f9bea4f-6738-429b-8ebb-8ae8cf65d294		TCGA-25-1321-01		TCGA-25-1321-01A-01D-0460-05		TCGA-25-1321-01A-21-1562-20		74ad9d3e-97a9-419d-8842-3fb37d3f099a	TCGA-25-1321-01A-01D-0452-01	TCGA-25-1321-01	9790631d-f673-415e-8644-5419b2b956b2		TCGA-25-1321-01A-01D-0452-01	74ad9d3e-97a9-419d-8842-3fb37d3f099a		74ad9d3e-97a9-419d-8842-3fb37d3f099a	TCGA-25-1321-01A-01W-0492-08	TCGA-25-1321-01	TCGA-25-1321-01	74ad9d3e-97a9-419d-8842-3fb37d3f099a	TCGA-25-1321-01A-01W-0492-08	TCGA-25-1321-01A-01R-0456-07	
TCGA-25-1322-01	1	TCGA-25-1322-01	91	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1322			days	91	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Bilateral	TCGA-25-1322-F26676	TCGA-25-1322	TCGA-25-1322-01A	Stage IV	-22646		91	0	91						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.8	NO		2.6			G3						TCGA-25-1322.6EAF4358-51F9-4999-A219-39178418CC9C.pdf	1322		WITH TUMOR	YES			NO		Primary Tumor	01	0.8			25	>20 mm	Ovary		A	DECEASED	2001	TCGA-25-1322-01	TCGA-25-1322-01		34a7dcf3-fc87-4334-8ee0-77166a5398fa		TCGA-25-1322-01		TCGA-25-1322-01A-01D-0460-05	TCGA-25-1322-01A-01W-0494-09	TCGA-25-1322-01A-21-20	TCGA-25-1322-01A-01W-0494-09	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	TCGA-25-1322-01A-01D-0452-01	TCGA-25-1322-01	90cba3ae-e75e-4a1e-bc31-293ac260cf96		TCGA-25-1322-01A-01D-0452-01	bce04e1e-a90c-4e81-bd16-415cccc9d7e2		bce04e1e-a90c-4e81-bd16-415cccc9d7e2		TCGA-25-1322-01	TCGA-25-1322-01	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	TCGA-25-1322-01A-01W-0494-09	TCGA-25-1322-01A-01R-0456-07	
TCGA-25-1323-01	1	TCGA-25-1323-01	395	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1		TCGA-25-1323			days	395	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Bilateral	TCGA-25-1323-F26680	TCGA-25-1323	TCGA-25-1323-01A	Stage IIIC	-26602		395	0	365		365				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		2.5			G3	Progression of Disease					TCGA-25-1323.AFE55BB2-F0FC-4B39-A61A-2287B62354AD.pdf	1323		WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO		Primary Tumor	01	0.6			25	1-10 mm	Ovary		A	DECEASED	2001	TCGA-25-1323-01	TCGA-25-1323-01		61b1bbe5-434f-4d88-aadb-a42344b0e0fb		TCGA-25-1323-01		TCGA-25-1323-01A-01D-0460-05		TCGA-25-1323-01A-21-1562-20		cd401b89-ae05-4775-94b0-6800f88652b0	TCGA-25-1323-01A-01D-0452-01	TCGA-25-1323-01	e89ce7f4-4c3f-4c48-a222-506d3806ad33		TCGA-25-1323-01A-01D-0452-01	cd401b89-ae05-4775-94b0-6800f88652b0		cd401b89-ae05-4775-94b0-6800f88652b0		TCGA-25-1323-01	TCGA-25-1323-01	cd401b89-ae05-4775-94b0-6800f88652b0		TCGA-25-1323-01A-01R-0456-07	
TCGA-25-1324-01	1	TCGA-25-1324-01	1035	1	days			OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 11	TCGA-25-1324			days	1035	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			74	Bilateral	TCGA-25-1324-F26685	TCGA-25-1324	TCGA-25-1324-01A	Stage IIIC	-27090		1035	0	1035						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						TCGA-25-1324.53AE406F-E6E6-4137-A7B3-01DAFAEDE783.pdf	1324			YES			NO		Primary Tumor	01	0.8			25	1-10 mm	Ovary		A	DECEASED	2001	TCGA-25-1324-01	TCGA-25-1324-01	TCGA-25-1324-01A-01W-0490-10	dadc9a44-fbec-4109-b5e5-4a21ad28eb63		TCGA-25-1324-01	TCGA-25-1324-01A-01W-0490-10	TCGA-25-1324-01A-01D-0460-05				790c6d79-9f7d-4e9a-89db-43b26fe16816		TCGA-25-1324-01				790c6d79-9f7d-4e9a-89db-43b26fe16816		790c6d79-9f7d-4e9a-89db-43b26fe16816				790c6d79-9f7d-4e9a-89db-43b26fe16816	TCGA-25-1324-01A-01W-0490-10	TCGA-25-1324-01A-01R-0456-07	
TCGA-25-1325-01	1	TCGA-25-1325-01	976	1	days			OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-25-1325			days	976	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			77	Left	TCGA-25-1325-F26689	TCGA-25-1325	TCGA-25-1325-01A	Stage IV	-28183		976	0	976						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.4	NO		5			G3						TCGA-25-1325.E9315413-584C-4F29-B05D-657DB9A0B4F5.pdf	1325						NO		Primary Tumor	01	1.3			25	>20 mm	Ovary		A	DECEASED	2002		TCGA-25-1325-01	TCGA-25-1325-01A-01W-0490-10	7d8ca51a-3995-47a6-89ad-63ffd81e32a0		TCGA-25-1325-01	TCGA-25-1325-01A-01W-0490-10	TCGA-25-1325-01A-01D-0460-05		TCGA-25-1325-01A-21-1562-20				TCGA-25-1325-01	8896ef4e-3809-4ed8-befa-a014b7b81da1											TCGA-25-1325-01A-01R-0456-07	
TCGA-25-1326-01	1	TCGA-25-1326-01	1249	1	days		C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1326			days	1249	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-25-1326-F26691	TCGA-25-1326	TCGA-25-1326-01A	Stage IIIC	-22339		1249	0	945		396				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3	Recurrence					TCGA-25-1326.B17E5B27-48DB-4E64-A1C3-CAE4921C14DF.pdf	1326		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	1.2			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1326-01	TCGA-25-1326-01		f01d69dc-1d50-4afb-83de-8124b93685a9		TCGA-25-1326-01		TCGA-25-1326-01A-01D-0460-05		TCGA-25-1326-01A-21-1562-20		b29bd766-95b1-46fa-a070-d2206cd5722a		TCGA-25-1326-01	6e7bb043-ec9a-4648-9acd-14526dca800e			b29bd766-95b1-46fa-a070-d2206cd5722a		b29bd766-95b1-46fa-a070-d2206cd5722a	TCGA-25-1326-01A-01W-0492-08			b29bd766-95b1-46fa-a070-d2206cd5722a	TCGA-25-1326-01A-01W-0492-08	TCGA-25-1326-01A-01R-0456-07	
TCGA-25-1328-01	1	TCGA-25-1328-01	2009	1	days		C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-25-1328			days	2009	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	38	Bilateral	TCGA-25-1328-F26698	TCGA-25-1328	TCGA-25-1328-01A	Stage IIIC	-13911		2009	0	1979		244				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.8	NO		2.8			G3	Recurrence					TCGA-25-1328.A2DA7EB3-8E42-4E86-9352-99673F51AEFF.pdf	1328		WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	1			25	1-10 mm	Ovary		A	DECEASED	2001	TCGA-25-1328-01	TCGA-25-1328-01		73b10e0b-cb82-49ec-8bdd-07d79bc2b8d6		TCGA-25-1328-01		TCGA-25-1328-01A-01D-0460-05		TCGA-25-1328-01A-21-1562-20		9ba8d6bf-1541-4127-bc60-73091d2d81c7		TCGA-25-1328-01	d064cdc4-ad95-4e85-b9b0-6871d9c2698d			9ba8d6bf-1541-4127-bc60-73091d2d81c7		9ba8d6bf-1541-4127-bc60-73091d2d81c7	TCGA-25-1328-01A-01W-0492-08			9ba8d6bf-1541-4127-bc60-73091d2d81c7	TCGA-25-1328-01A-01W-0492-08	TCGA-25-1328-01A-01R-0456-07	
TCGA-25-1329-01	1	TCGA-25-1329-01	457	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1329			days	457	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			76	Bilateral	TCGA-25-1329-F26705	TCGA-25-1329	TCGA-25-1329-01A	Stage IIIC	-28093		457	0	90						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2.6	NO		3			G3						TCGA-25-1329.857409C6-75EC-4935-85BC-6D5F66AF4DB3.pdf	1329			YES					Primary Tumor	01	0.6			25	11-20 mm	Ovary		A	DECEASED	2002	TCGA-25-1329-01	TCGA-25-1329-01		3bd2e158-9743-44cd-a5c3-0ba7179b8660		TCGA-25-1329-01		TCGA-25-1329-01A-01D-0460-05		TCGA-25-1329-01A-21-1562-20		5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	TCGA-25-1329-01A-01D-0452-01	TCGA-25-1329-01	299168d0-39ac-4d64-9345-88fe0f6746ee		TCGA-25-1329-01A-01D-0452-01	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8		5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	TCGA-25-1329-01A-01W-0492-08	TCGA-25-1329-01	TCGA-25-1329-01	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	TCGA-25-1329-01A-01W-0492-08	TCGA-25-1329-01A-01R-0456-07	
TCGA-25-1623-01	1	TCGA-25-1623-01	565	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1623			days	565	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-1623-F26707	TCGA-25-1623	TCGA-25-1623-01A	Stage IV	-26060		565	0	565		342				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.8			G3	Recurrence					TCGA-25-1623.A57CB221-076A-4EE5-8C77-D1E33070597C.pdf	1623		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			25	No Macroscopic disease	Ovary		A	DECEASED	2006	TCGA-25-1623-01	TCGA-25-1623-01	TCGA-25-1623-01A-01W-0615-10	47640c72-6c10-4956-8a89-0c5f0b12cc49		TCGA-25-1623-01	TCGA-25-1623-01A-01W-0615-10	TCGA-25-1623-01A-01D-0536-05		TCGA-25-1623-01A-21-1558-20		3e4f0ca7-8428-47df-80a3-3bc9153aedfa	TCGA-25-1623-01A-01D-0533-01	TCGA-25-1623-01	ef62a625-cf2c-45d1-aa59-9d44e16a37fa		TCGA-25-1623-01A-01D-0533-01	3e4f0ca7-8428-47df-80a3-3bc9153aedfa		3e4f0ca7-8428-47df-80a3-3bc9153aedfa		TCGA-25-1623-01	TCGA-25-1623-01	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	TCGA-25-1623-01A-01W-0615-10	TCGA-25-1623-01A-01R-0540-07	
TCGA-25-1625-01	1	TCGA-25-1625-01	840	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1625			days	840	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Bilateral	TCGA-25-1625-F26712	TCGA-25-1625	TCGA-25-1625-01A	Stage IIIC	-24298		840	0	548		526				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5			G3	Recurrence					TCGA-25-1625.BDE314E3-1E2C-440E-8561-A260C1D0933A.pdf	1625		WITH TUMOR	YES	Stable Disease	Imaging Study	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2006	TCGA-25-1625-01	TCGA-25-1625-01	TCGA-25-1625-01A-01W-0615-10	b176a30a-0977-46e6-b577-a421ca9bb340		TCGA-25-1625-01	TCGA-25-1625-01A-01W-0615-10	TCGA-25-1625-01A-01D-0536-05		TCGA-25-1625-01A-21-1558-20		921fab94-5522-4c08-8e02-13fb6ea2d388	TCGA-25-1625-01A-01D-0533-01	TCGA-25-1625-01	ffb78d5c-46f5-4f3a-8572-55df5db80a1d		TCGA-25-1625-01A-01D-0533-01	921fab94-5522-4c08-8e02-13fb6ea2d388		921fab94-5522-4c08-8e02-13fb6ea2d388		TCGA-25-1625-01	TCGA-25-1625-01	921fab94-5522-4c08-8e02-13fb6ea2d388	TCGA-25-1625-01A-01W-0615-10	TCGA-25-1625-01A-01R-0540-07	
TCGA-25-1626-01	1	TCGA-25-1626-01	518	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1626			days	518	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Right	TCGA-25-1626-F26716	TCGA-25-1626	TCGA-25-1626-01A	Stage IIIC	-23932		518	0	481		318				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.4			G3	Recurrence					TCGA-25-1626.4B54A1C9-6F08-435B-B85F-736D4278EA82.pdf	1626		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			25	>20 mm	Ovary		A	DECEASED	2006	TCGA-25-1626-01	TCGA-25-1626-01	TCGA-25-1626-01A-01W-0615-10	a1ed5a8a-8ac2-4d94-96e0-92bb4dcc8af6		TCGA-25-1626-01	TCGA-25-1626-01A-01W-0615-10	TCGA-25-1626-01A-01D-0536-05		TCGA-25-1626-01A-21-1558-20		daaba89d-acd3-4670-a618-89e5973b03f4	TCGA-25-1626-01A-01D-0533-01	TCGA-25-1626-01	7a9090de-0e14-4fc3-a2d7-c42629b3afd7		TCGA-25-1626-01A-01D-0533-01	daaba89d-acd3-4670-a618-89e5973b03f4		daaba89d-acd3-4670-a618-89e5973b03f4		TCGA-25-1626-01	TCGA-25-1626-01	daaba89d-acd3-4670-a618-89e5973b03f4	TCGA-25-1626-01A-01W-0615-10	TCGA-25-1626-01A-01R-0540-07	
TCGA-25-1627-01	1	TCGA-25-1627-01	394	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1627			days	394	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Bilateral	TCGA-25-1627-F26722	TCGA-25-1627	TCGA-25-1627-01A	Stage IIIC	-26784		394	0	11						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						TCGA-25-1627.FB36B0F9-6519-4CF5-9A74-F7015FD405FF.pdf	1627			YES			NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2003	TCGA-25-1627-01	TCGA-25-1627-01	TCGA-25-1627-01A-01W-0615-10	d1eafd5b-5036-44dd-b902-92951e9d31c5		TCGA-25-1627-01	TCGA-25-1627-01A-01W-0615-10	TCGA-25-1627-01A-01D-0536-05		TCGA-25-1627-01A-21-1558-20		0fc68715-c7fc-4481-a5bf-68a281f5ec64	TCGA-25-1627-01A-01D-0533-01	TCGA-25-1627-01	a2210172-a1e0-4bbf-a38a-363571251f90		TCGA-25-1627-01A-01D-0533-01	0fc68715-c7fc-4481-a5bf-68a281f5ec64		0fc68715-c7fc-4481-a5bf-68a281f5ec64		TCGA-25-1627-01	TCGA-25-1627-01	0fc68715-c7fc-4481-a5bf-68a281f5ec64	TCGA-25-1627-01A-01W-0615-10	TCGA-25-1627-01A-01R-0540-07	
TCGA-25-1628-01	1	TCGA-25-1628-01	627	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1628			days	627	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67		TCGA-25-1628-F26724	TCGA-25-1628	TCGA-25-1628-01A	Stage IIIC	-24488		627	0	627		287				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		2			G3	Recurrence					TCGA-25-1628.790D6E48-15D0-45F9-B6DD-182787298EBA.pdf	1628		WITH TUMOR	YES	Stable Disease	Imaging Study	NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1628-01	TCGA-25-1628-01	TCGA-25-1628-01A-01W-0615-10	7db7c522-1983-4b98-b630-2ddbd5d4aefa		TCGA-25-1628-01	TCGA-25-1628-01A-01W-0615-10	TCGA-25-1628-01A-01D-0536-05		TCGA-25-1628-01A-21-1558-20		a3083fd8-f5d0-486b-bf3d-31ae094b1cbf	TCGA-25-1628-01A-01D-0533-01	TCGA-25-1628-01	f7ac6f1b-7ee1-4536-84ae-48d20a61df99		TCGA-25-1628-01A-01D-0533-01	a3083fd8-f5d0-486b-bf3d-31ae094b1cbf		a3083fd8-f5d0-486b-bf3d-31ae094b1cbf		TCGA-25-1628-01	TCGA-25-1628-01	a3083fd8-f5d0-486b-bf3d-31ae094b1cbf	TCGA-25-1628-01A-01W-0615-10	TCGA-25-1628-01A-01R-0540-07	
TCGA-25-1630-01	1	TCGA-25-1630-01	1162	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1630			days	1162	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Bilateral	TCGA-25-1630-F26729	TCGA-25-1630		Stage IIIC	-27006		1162	0	239						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3							1630			YES	Complete Remission/Response		NO		Primary Tumor	01				25	1-10 mm	Ovary			DECEASED	2002	TCGA-25-1630-01	TCGA-25-1630-01	TCGA-25-1630-01A-01W-0615-10	f497f9fd-9a0e-446e-98fa-265e325e194e		TCGA-25-1630-01	TCGA-25-1630-01A-01W-0615-10	TCGA-25-1630-01A-01D-0536-05		TCGA-25-1630-01A-21-1558-20		c5a82b6e-048d-4377-9b6c-4417ba1876fe	TCGA-25-1630-01A-01D-0533-01	TCGA-25-1630-01	c0b3ff41-c34a-4f86-b029-5a761ff85b2e		TCGA-25-1630-01A-01D-0533-01	c5a82b6e-048d-4377-9b6c-4417ba1876fe		c5a82b6e-048d-4377-9b6c-4417ba1876fe		TCGA-25-1630-01	TCGA-25-1630-01	c5a82b6e-048d-4377-9b6c-4417ba1876fe	TCGA-25-1630-01A-01W-0615-10	TCGA-25-1630-01A-01R-0540-07	
TCGA-25-1631-01	1	TCGA-25-1631-01	9	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1631			days	9	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Bilateral	TCGA-25-1631-F26733	TCGA-25-1631	TCGA-25-1631-01A	Stage IIIC	-26687		9	0	9						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		2			G3						TCGA-25-1631.1C74F61E-1131-4782-8117-20C59B86D845.pdf	1631		TUMOR FREE	NO			NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1631-01	TCGA-25-1631-01	TCGA-25-1631-01A-01W-0615-10	2fab3946-dfac-449c-971a-9312801bbe51		TCGA-25-1631-01	TCGA-25-1631-01A-01W-0615-10	TCGA-25-1631-01A-01D-0536-05		TCGA-25-1631-01A-21-1558-20		29c4cab9-c19e-4416-ad88-484cc02a980f	TCGA-25-1631-01A-01D-0533-01	TCGA-25-1631-01	51225525-5680-46ab-8e00-f35ed4df6470		TCGA-25-1631-01A-01D-0533-01	29c4cab9-c19e-4416-ad88-484cc02a980f		29c4cab9-c19e-4416-ad88-484cc02a980f		TCGA-25-1631-01	TCGA-25-1631-01	29c4cab9-c19e-4416-ad88-484cc02a980f	TCGA-25-1631-01A-01W-0615-10	TCGA-25-1631-01A-01R-0540-07	
TCGA-25-1632-01	1	TCGA-25-1632-01	1799	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 8	TCGA-25-1632			days	1799	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	68	Bilateral	TCGA-25-1632-F26735	TCGA-25-1632	TCGA-25-1632-01A	Stage IV	-24993		1799	0	1732		537				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.4			G3	Recurrence					TCGA-25-1632.F083C2B4-20DE-440F-B6A8-2F332346CECA.pdf	1632		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1632-01	TCGA-25-1632-01	TCGA-25-1632-01A-01W-0615-10	8736b37d-cdc1-4e9e-8215-edb675c8a072		TCGA-25-1632-01	TCGA-25-1632-01A-01W-0615-10	TCGA-25-1632-01A-01D-0536-05		TCGA-25-1632-01A-21-1558-20		12c78d62-6045-4f77-bd84-9ab5a38f4635	TCGA-25-1632-01A-01D-0533-01	TCGA-25-1632-01	105464b7-4efd-4ed6-a906-2dab64b49ad0		TCGA-25-1632-01A-01D-0533-01	12c78d62-6045-4f77-bd84-9ab5a38f4635		12c78d62-6045-4f77-bd84-9ab5a38f4635		TCGA-25-1632-01	TCGA-25-1632-01	12c78d62-6045-4f77-bd84-9ab5a38f4635	TCGA-25-1632-01A-01W-0615-10	TCGA-25-1632-01A-01R-0540-07	
TCGA-25-1633-01	1	TCGA-25-1633-01	1891	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1633			days	1891	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Bilateral	TCGA-25-1633-F26742	TCGA-25-1633	TCGA-25-1633-01A	Stage IIIC	-23407		1891	0	1843		616				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.3			G3	Recurrence					TCGA-25-1633.B3B45EA2-B154-45DC-B49D-422500EA1D9C.pdf	1633		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.2			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1633-01	TCGA-25-1633-01	TCGA-25-1633-01A-01W-0615-10	9f229f84-97c9-4684-8eb7-f2af666e3399		TCGA-25-1633-01	TCGA-25-1633-01A-01W-0615-10	TCGA-25-1633-01A-01D-0536-05		TCGA-25-1633-01A-21-1558-20		7517c446-401d-4501-bf27-916e0835deac	TCGA-25-1633-01A-01D-0533-01	TCGA-25-1633-01	a9062738-4ec8-464c-b5c9-abd82bf322bc		TCGA-25-1633-01A-01D-0533-01	7517c446-401d-4501-bf27-916e0835deac		7517c446-401d-4501-bf27-916e0835deac		TCGA-25-1633-01	TCGA-25-1633-01	7517c446-401d-4501-bf27-916e0835deac	TCGA-25-1633-01A-01W-0615-10	TCGA-25-1633-01A-01R-0540-07	
TCGA-25-1634-01	1	TCGA-25-1634-01	1091	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-25-1634			days	1091	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	75	Bilateral	TCGA-25-1634-F26749	TCGA-25-1634		Stage IIIC	-27749		1091	0	1081		380				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1634		WITH TUMOR	YES	Complete Remission/Response	Other Method	NO		Primary Tumor	01				25	No Macroscopic disease	Ovary			DECEASED	2002	TCGA-25-1634-01	TCGA-25-1634-01	TCGA-25-1634-01A-01W-0615-10	e3aae8d6-511b-40ce-8ade-6208c6fcdb9f		TCGA-25-1634-01	TCGA-25-1634-01A-01W-0615-10	TCGA-25-1634-01A-01D-0536-05				d10f0cee-d755-43cc-8d3d-8974cea0defb	TCGA-25-1634-01A-01D-0533-01	TCGA-25-1634-01			TCGA-25-1634-01A-01D-0533-01	d10f0cee-d755-43cc-8d3d-8974cea0defb		d10f0cee-d755-43cc-8d3d-8974cea0defb		TCGA-25-1634-01	TCGA-25-1634-01	d10f0cee-d755-43cc-8d3d-8974cea0defb	TCGA-25-1634-01A-01W-0615-10	TCGA-25-1634-01A-01R-0540-07	
TCGA-25-1635-01	1	TCGA-25-1635-01	1583	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1635			days	1583	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-1635-F26756	TCGA-25-1635	TCGA-25-1635-01A	Stage IIIC	-26200		1583	0	1558		614				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.7			G3	Recurrence					TCGA-25-1635.28168C52-FD75-4B43-918B-C48CC8DA9C66.pdf	1635		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1635-01	TCGA-25-1635-01	TCGA-25-1635-01A-01W-0615-10	2fc96f18-9f32-4d5f-b768-587981329254		TCGA-25-1635-01	TCGA-25-1635-01A-01W-0615-10	TCGA-25-1635-01A-01D-0536-05		TCGA-25-1635-01A-21-1558-20		877d96a2-6e5c-472c-b190-59fcfd1febb4	TCGA-25-1635-01A-01D-0533-01	TCGA-25-1635-01	e22c9a04-50e5-40e2-9df0-66c86b6f3b38		TCGA-25-1635-01A-01D-0533-01	877d96a2-6e5c-472c-b190-59fcfd1febb4		877d96a2-6e5c-472c-b190-59fcfd1febb4		TCGA-25-1635-01	TCGA-25-1635-01	877d96a2-6e5c-472c-b190-59fcfd1febb4	TCGA-25-1635-01A-01W-0615-10	TCGA-25-1635-01A-01R-0540-07	
TCGA-25-1870-01	1	TCGA-25-1870-01	455	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-25-1870			days	455	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-25-1870-F26763	TCGA-25-1870		Stage IIIC	-21550		455	0	455		243				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1870		WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01				25	11-20 mm	Ovary			DECEASED	1994	TCGA-25-1870-01	TCGA-25-1870-01		fc0c9f6b-6603-4200-9190-25422af07078		TCGA-25-1870-01		TCGA-25-1870-01A-01D-0652-05				c446d667-ea88-40fe-ad97-fd3fcceb7dd1	TCGA-25-1870-01A-01D-0648-01	TCGA-25-1870-01			TCGA-25-1870-01A-01D-0648-01	c446d667-ea88-40fe-ad97-fd3fcceb7dd1		c446d667-ea88-40fe-ad97-fd3fcceb7dd1		TCGA-25-1870-01	TCGA-25-1870-01	c446d667-ea88-40fe-ad97-fd3fcceb7dd1		TCGA-25-1870-01A-01R-0655-07	
TCGA-25-1871-01	1	TCGA-25-1871-01	760	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-25-1871			days	760	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	70	Bilateral	TCGA-25-1871-F26769	TCGA-25-1871	TCGA-25-1871-01A	Stage IIIC	-25627		760	0	760		230				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.7			G3	Recurrence					TCGA-25-1871.737827A6-C99E-49BE-90AD-004FE8DF11F1.pdf	1871		WITH TUMOR	YES	Progressive Disease	Physical Examination	NO		Primary Tumor	01	0.1			25	11-20 mm	Ovary		A	DECEASED	1993	TCGA-25-1871-01	TCGA-25-1871-01		2ee780b4-d0ac-4d56-9120-fdf5e98b4249		TCGA-25-1871-01		TCGA-25-1871-01A-01D-0652-05				efcc36b2-e351-4875-b743-df58480bc9fb	TCGA-25-1871-01A-01D-0648-01	TCGA-25-1871-01			TCGA-25-1871-01A-01D-0648-01	efcc36b2-e351-4875-b743-df58480bc9fb		efcc36b2-e351-4875-b743-df58480bc9fb		TCGA-25-1871-01	TCGA-25-1871-01	efcc36b2-e351-4875-b743-df58480bc9fb		TCGA-25-1871-01A-01R-0655-07	
TCGA-25-1877-01	1	TCGA-25-1877-01	730	1	days	High		OV-like c1			miRNA cluster 1	cluster 3		TCGA-25-1877			days	730	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	81	Left	TCGA-25-1877-F26774	TCGA-25-1877	TCGA-25-1877-01A	Stage IIIC	-29615		730	0	549		549				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.7			G3	Recurrence					TCGA-25-1877.D98B5A1F-DF34-43E7-826F-BCB45DEC582D.pdf	1877		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	1993		TCGA-25-1877-01		8918bbfe-a867-41ea-a137-46e704232e6d		TCGA-25-1877-01		TCGA-25-1877-01A-01D-0652-05					TCGA-25-1877-01A-01D-0648-01	TCGA-25-1877-01			TCGA-25-1877-01A-01D-0648-01					TCGA-25-1877-01				TCGA-25-1877-01A-01R-0655-07	
TCGA-25-1878-01	1	TCGA-25-1878-01	2587	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-25-1878			days	2587	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-25-1878-F26779	TCGA-25-1878		Stage IIIC	-22035		2587	0	2587		971				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1878		WITH TUMOR	YES	Complete Remission/Response	Molecular Markers	NO		Primary Tumor	01				25	1-10 mm	Ovary			DECEASED	1994		TCGA-25-1878-01		f38efeef-0f8b-48f8-8ad9-caaaad82eecc		TCGA-25-1878-01		TCGA-25-1878-01A-01D-0652-05		TCGA-25-1878-01A-21-1559-20			TCGA-25-1878-01A-01D-0648-01	TCGA-25-1878-01	c747a216-2d46-4b01-a34d-651fa616109a		TCGA-25-1878-01A-01D-0648-01					TCGA-25-1878-01				TCGA-25-1878-01A-01R-0655-07	
TCGA-25-2042-01	1	TCGA-25-2042-01	396	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation c1uster 9	TCGA-25-2042			days	396	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Bilateral	TCGA-25-2042-F26785	TCGA-25-2042	TCGA-25-2042-01A	Stage IIIC	-22127		396	0	396	123					2009-11-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.4			G3	Metastatic	YES				TCGA-25-2042.4D14A408-E3F6-47EB-A67C-0606450DB0C5.pdf	2042		WITH TUMOR	YES	Progressive Disease	First Seen At Further Surgery	NO		Primary Tumor	01	0.3			25	>20 mm	Ovary		A	DECEASED	2006	TCGA-25-2042-01	TCGA-25-2042-01		4873bfbf-079c-407d-9d8f-5bab18d1c3a0		TCGA-25-2042-01		TCGA-25-2042-01A-01D-0708-05		TCGA-25-2042-01A-21-1560-20		ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c	TCGA-25-2042-01A-01D-0704-01	TCGA-25-2042-01	59676524-6b40-4bcc-b488-120781e23d22		TCGA-25-2042-01A-01D-0704-01	ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c		ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c	TCGA-25-2042-01A-01W-0799-08	TCGA-25-2042-01	TCGA-25-2042-01	ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c	TCGA-25-2042-01A-01W-0799-08	TCGA-25-2042-01A-01R-0711-07	
TCGA-25-2390-01		TCGA-25-2390-01			days			OV-like c1	OV-like c4					TCGA-25-2390			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			80			TCGA-25-2390	TCGA-25-2390-01A		-29257			0							2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES			0.6	NO		1.6									TCGA-25-2390.B57A7111-209E-4FD3-8E2E-868B70BFF806.pdf	2390								Primary Tumor	01	0.3			25		Ovary		A		2003								TCGA-25-2390-01A-01D-0708-05		TCGA-25-2390-01A-21-1560-20					29f6e462-4410-445e-8777-3402fc8488be											TCGA-25-2390-01A-01R-0711-07	
TCGA-25-2391-01	1	TCGA-25-2391-01	1492	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2391			days	1492	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Bilateral	TCGA-25-2391-F26796	TCGA-25-2391	TCGA-25-2391-01A	Stage IIIC	-20939		1492	0	1492						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						TCGA-25-2391.32AC761D-67A0-46C5-AB01-AE9BBE7307CA.pdf	2391		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			25	>20 mm	Ovary		A	DECEASED	2003	TCGA-25-2391-01	TCGA-25-2391-01		bf367755-354c-4d12-a8a8-7a1373b8d397		TCGA-25-2391-01		TCGA-25-2391-01A-01D-0708-05		TCGA-25-2391-01A-21-1560-20		0ee0c708-77c4-4ac3-be13-0d08e6444003	TCGA-25-2391-01A-01D-0704-01	TCGA-25-2391-01	53220d7f-967c-4101-82ce-24495a3e2b9a		TCGA-25-2391-01A-01D-0704-01	0ee0c708-77c4-4ac3-be13-0d08e6444003		0ee0c708-77c4-4ac3-be13-0d08e6444003	TCGA-25-2391-01A-01W-0799-08	TCGA-25-2391-01	TCGA-25-2391-01	0ee0c708-77c4-4ac3-be13-0d08e6444003	TCGA-25-2391-01A-01W-0799-08	TCGA-25-2391-01A-01R-0711-07	
TCGA-25-2392-01	1	TCGA-25-2392-01	31	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 2	TCGA-25-2392			days	31	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			75	Bilateral	TCGA-25-2392-F26801	TCGA-25-2392	TCGA-25-2392-01A	Stage IV	-27667		31	0	31						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						TCGA-25-2392.C520D0D6-F104-492C-A4C2-844390F55570.pdf	2392			NO			NO		Primary Tumor	01	0.3			25	11-20 mm	Ovary		A	DECEASED	2003	TCGA-25-2392-01	TCGA-25-2392-01		62414e51-fd9a-4ed8-bc34-c4d194fdc884		TCGA-25-2392-01		TCGA-25-2392-01A-01D-0708-05				95b7a71d-8cf5-4660-ac1d-52a888cd2f20	TCGA-25-2392-01A-01D-0704-01	TCGA-25-2392-01			TCGA-25-2392-01A-01D-0704-01	95b7a71d-8cf5-4660-ac1d-52a888cd2f20		95b7a71d-8cf5-4660-ac1d-52a888cd2f20	TCGA-25-2392-01A-01W-0799-08	TCGA-25-2392-01	TCGA-25-2392-01	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	TCGA-25-2392-01A-01W-0799-08	TCGA-25-2392-01A-01R-0711-07	
TCGA-25-2393-01	1	TCGA-25-2393-01	1157	1	days	High	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2393			days	1157	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	81	Left	TCGA-25-2393-F26803	TCGA-25-2393	TCGA-25-2393-01A	Stage IIIC	-29585		1157	0	1157		305				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.3			G3	Recurrence					TCGA-25-2393.0B780E04-2DE3-4C56-9B93-1919F4BBE5D4.pdf	2393		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			25	11-20 mm	Ovary		A	DECEASED	2003	TCGA-25-2393-01	TCGA-25-2393-01		93d53663-d5fc-4a27-8844-d58f09f47c64		TCGA-25-2393-01		TCGA-25-2393-01A-01D-0708-05		TCGA-25-2393-01A-21-1560-20		93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	TCGA-25-2393-01A-01D-0704-01	TCGA-25-2393-01	7ab7162d-0b8e-42de-80ee-70a7aa8ef6a5		TCGA-25-2393-01A-01D-0704-01	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e		93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	TCGA-25-2393-01A-01W-0799-08	TCGA-25-2393-01	TCGA-25-2393-01	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	TCGA-25-2393-01A-01W-0799-08	TCGA-25-2393-01A-01R-0711-07	
TCGA-25-2396-01	1	TCGA-25-2396-01	92	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2396			days	92	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Bilateral	TCGA-25-2396-F26808	TCGA-25-2396	TCGA-25-2396-01A	Stage IIIC	-26145		92	0	92						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1			G3						TCGA-25-2396.5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF.pdf	2396						NO		Primary Tumor	01	1			25	No Macroscopic disease	Ovary		A	DECEASED	2004	TCGA-25-2396-01	TCGA-25-2396-01		5cbceba0-c820-45dc-926d-ee4893659503		TCGA-25-2396-01		TCGA-25-2396-01A-01D-0708-05		TCGA-25-2396-01A-21-1560-20		43352a4d-f866-4ed7-81f5-5dc478c10992	TCGA-25-2396-01A-01D-0704-01	TCGA-25-2396-01	abf3ad2e-f8d1-4a58-a48b-eaf3b553e793		TCGA-25-2396-01A-01D-0704-01	43352a4d-f866-4ed7-81f5-5dc478c10992		43352a4d-f866-4ed7-81f5-5dc478c10992	TCGA-25-2396-01A-01W-0799-08	TCGA-25-2396-01	TCGA-25-2396-01	43352a4d-f866-4ed7-81f5-5dc478c10992	TCGA-25-2396-01A-01W-0799-08	TCGA-25-2396-01A-01R-0711-07	
TCGA-25-2397-01	1	TCGA-25-2397-01	365	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-25-2397			days	365	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Bilateral	TCGA-25-2397-F26810	TCGA-25-2397	TCGA-25-2397-01A	Stage IV	-21581		365	0	365						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		2.2			G3						TCGA-25-2397.D67C4E1F-6A68-4EE6-B143-22038C05C926.pdf	2397						NO		Primary Tumor	01	0.7			25	No Macroscopic disease	Ovary		A	DECEASED	2004	TCGA-25-2397-01	TCGA-25-2397-01		3faab68c-41ef-4eef-8ed1-1d5c7c5b9a8b		TCGA-25-2397-01		TCGA-25-2397-01A-01D-0708-05		TCGA-25-2397-01A-21-1560-20		7ad7080c-730b-4a5d-a8c1-f6387fbee72e	TCGA-25-2397-01A-01D-0704-01	TCGA-25-2397-01	eac7612a-49d6-4b40-84b7-c68db54e56c1		TCGA-25-2397-01A-01D-0704-01	7ad7080c-730b-4a5d-a8c1-f6387fbee72e		7ad7080c-730b-4a5d-a8c1-f6387fbee72e		TCGA-25-2397-01	TCGA-25-2397-01	7ad7080c-730b-4a5d-a8c1-f6387fbee72e		TCGA-25-2397-01A-01R-0711-07	
TCGA-25-2398-01	1	TCGA-25-2398-01	1369	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2398			days	1369	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-2398-F26812	TCGA-25-2398	TCGA-25-2398-01A	Stage IIIC	-26267		1369	0	1369		577				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5			G3	Recurrence					TCGA-25-2398.CFF4E9E3-AC10-4A50-BE90-5A12822FEF42.pdf	2398		WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.5			25	1-10 mm	Ovary		A	DECEASED	2004	TCGA-25-2398-01	TCGA-25-2398-01		bcdd8efe-1f50-4bb6-904a-b8bdfd32dfbd		TCGA-25-2398-01		TCGA-25-2398-01A-01D-0708-05		TCGA-25-2398-01A-21-1563-20		3a080008-8266-4e2d-a143-adac14991b22	TCGA-25-2398-01A-01D-0704-01	TCGA-25-2398-01	b081cedd-6727-478d-9ebf-22ad78c34b27		TCGA-25-2398-01A-01D-0704-01	3a080008-8266-4e2d-a143-adac14991b22		3a080008-8266-4e2d-a143-adac14991b22	TCGA-25-2398-01A-01W-0799-08	TCGA-25-2398-01	TCGA-25-2398-01	3a080008-8266-4e2d-a143-adac14991b22	TCGA-25-2398-01A-01W-0799-08	TCGA-25-2398-01A-01R-0711-07	
TCGA-25-2399-01	1	TCGA-25-2399-01	608	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2399			days	608	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	80	Bilateral	TCGA-25-2399-F26818	TCGA-25-2399	TCGA-25-2399-01A	Stage IIIC	-29373		608	0	608		243				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6			G3	Recurrence					TCGA-25-2399.38AEA3BF-A853-4719-B308-63884A6F8F13.pdf	2399		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			25	>20 mm	Ovary		A	DECEASED	2004	TCGA-25-2399-01	TCGA-25-2399-01		a05df1ef-35d1-4fe3-a944-ab5c6b52d468		TCGA-25-2399-01		TCGA-25-2399-01A-01D-0708-05		TCGA-25-2399-01A-21-1560-20		28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	TCGA-25-2399-01A-01D-0704-01	TCGA-25-2399-01	27dde0e4-5be8-4045-910b-24c0535a4623		TCGA-25-2399-01A-01D-0704-01	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1		28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	TCGA-25-2399-01A-01W-0799-08	TCGA-25-2399-01	TCGA-25-2399-01	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	TCGA-25-2399-01A-01W-0799-08	TCGA-25-2399-01A-01R-0711-07	
TCGA-25-2400-01	1	TCGA-25-2400-01	1278	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2400			days	1278	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-25-2400-F26823	TCGA-25-2400	TCGA-25-2400-01A	Stage IIIC	-27789		1278	0	1278		577				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1			G3	Recurrence					TCGA-25-2400.0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C.pdf	2400		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			25	No Macroscopic disease	Ovary		A	DECEASED	2004	TCGA-25-2400-01	TCGA-25-2400-01		1dab017a-bf35-4cec-9bef-f03b5c5b363c		TCGA-25-2400-01		TCGA-25-2400-01A-01D-0708-05		TCGA-25-2400-01A-21-1560-20		5c98c2c5-806f-4562-ad57-e152ea8388ab	TCGA-25-2400-01A-01D-0704-01	TCGA-25-2400-01	ab4e5114-ba2a-4706-8be1-a359c4e5b547		TCGA-25-2400-01A-01D-0704-01	5c98c2c5-806f-4562-ad57-e152ea8388ab		5c98c2c5-806f-4562-ad57-e152ea8388ab	TCGA-25-2400-01A-01W-0799-08	TCGA-25-2400-01	TCGA-25-2400-01	5c98c2c5-806f-4562-ad57-e152ea8388ab	TCGA-25-2400-01A-01W-0799-08	TCGA-25-2400-01A-01R-0711-07	
TCGA-25-2401-01	1	TCGA-25-2401-01	90	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-25-2401			days	90	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64	Bilateral	TCGA-25-2401-F26829	TCGA-25-2401	TCGA-25-2401-01A	Stage IIIC	-23711		90	0	90						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.8			G3						TCGA-25-2401.5B192072-1F11-4316-AC39-81085F7E425D.pdf	2401						NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2004	TCGA-25-2401-01	TCGA-25-2401-01		d34e80bb-5261-478c-9aa8-6732cc107f9f		TCGA-25-2401-01		TCGA-25-2401-01A-01D-0708-05		TCGA-25-2401-01A-21-1560-20		c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c	TCGA-25-2401-01A-01D-0704-01	TCGA-25-2401-01	8b55fa70-3074-4209-ab77-4634075aa0d1		TCGA-25-2401-01A-01D-0704-01	c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c		c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c	TCGA-25-2401-01A-01W-0799-08	TCGA-25-2401-01	TCGA-25-2401-01	c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c	TCGA-25-2401-01A-01W-0799-08	TCGA-25-2401-01A-01R-0711-07	
TCGA-25-2404-01	1	TCGA-25-2404-01	883	1	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2404			days	883	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	38	Bilateral	TCGA-25-2404-F26831	TCGA-25-2404	TCGA-25-2404-01A	Stage IIIC	-14184		883	0	883		426				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		2			G3	Recurrence					TCGA-25-2404.7B13E549-204D-47F8-93EB-D8C5C8D259FA.pdf	2404		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			25	No Macroscopic disease	Ovary		A	DECEASED	2005	TCGA-25-2404-01	TCGA-25-2404-01		df215206-d33b-40b7-94dc-86d5a3cfbc87		TCGA-25-2404-01		TCGA-25-2404-01A-01D-0708-05		TCGA-25-2404-01A-21-1560-20		05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	TCGA-25-2404-01A-01D-0704-01	TCGA-25-2404-01	2300785c-d77b-4d40-94e5-7947b18f9c24		TCGA-25-2404-01A-01D-0704-01	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e		05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	TCGA-25-2404-01A-01W-0799-08	TCGA-25-2404-01	TCGA-25-2404-01	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	TCGA-25-2404-01A-01W-0799-08	TCGA-25-2404-01A-01R-0711-07	
TCGA-25-2408-01	1	TCGA-25-2408-01	943	1	days	Iq	C9-OV	Low purity c2	OV-like c4		miRNA cluster 1	cluster 6	mutation c1uster 9	TCGA-25-2408			days	943	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary		NO	37	Bilateral	TCGA-25-2408-F26837	TCGA-25-2408	TCGA-25-2408-01A	Stage IV	-13606		943	0	943		334				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G2	Recurrence					TCGA-25-2408.2A91BE69-31C8-456E-8EBB-8AD08AAAB3A9.pdf	2408		WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2005		TCGA-25-2408-01		a693a4be-bb91-4608-bacb-4ffa101e413a		TCGA-25-2408-01		TCGA-25-2408-01A-01D-0708-05		TCGA-25-2408-01A-21-1562-20			TCGA-25-2408-01A-01D-0704-01	TCGA-25-2408-01	19590adb-d236-4acf-a78f-275de0e8f0e1		TCGA-25-2408-01A-01D-0704-01				TCGA-25-2408-01A-01W-0799-08	TCGA-25-2408-01			TCGA-25-2408-01A-01W-0799-08	TCGA-25-2408-01A-01R-0711-07	
TCGA-25-2409-01	1	TCGA-25-2409-01	821	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-2409			days	821	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-25-2409-F26841	TCGA-25-2409	TCGA-25-2409-01A	Stage IV	-26267		821	0	821		304				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		1.5			G3	Recurrence					TCGA-25-2409.89A631C6-5000-4A96-B752-879EAA7231CB.pdf	2409		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	2005	TCGA-25-2409-01	TCGA-25-2409-01		71b8d6ab-57cb-411e-89f3-9ea82e67abff		TCGA-25-2409-01		TCGA-25-2409-01A-01D-0708-05		TCGA-25-2409-01A-21-1560-20		4e5f3a15-68fd-4be0-b368-e0bd04eaf872	TCGA-25-2409-01A-01D-0704-01	TCGA-25-2409-01	bfaa6831-b085-4b98-90a5-fef72266d642		TCGA-25-2409-01A-01D-0704-01	4e5f3a15-68fd-4be0-b368-e0bd04eaf872		4e5f3a15-68fd-4be0-b368-e0bd04eaf872	TCGA-25-2409-01A-01W-0799-08	TCGA-25-2409-01	TCGA-25-2409-01	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	TCGA-25-2409-01A-01W-0799-08	TCGA-25-2409-01A-01R-0711-07	
TCGA-29-1688-01	1	TCGA-29-1688-01	2400	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6		TCGA-29-1688			days	2400	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	39	Bilateral	TCGA-29-1688-F27124	TCGA-29-1688	TCGA-29-1688-01A	Stage IIIC	-14574		2400	0	2400		184				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		2.5			G2	Recurrence					TCGA-29-1688.cb2bd608-b9d4-497e-9058-2269dc86b5b3.pdf	1688		WITH TUMOR	YES	Stable Disease	First Seen At Further Surgery	NO		Primary Tumor	01	0.5			29		Ovary	YES	A	DECEASED	1992	TCGA-29-1688-01	TCGA-29-1688-01		065ec84d-9986-4b99-8c58-3d0a578cd8fb		TCGA-29-1688-01		TCGA-29-1688-01A-01D-0563-05		TCGA-29-1688-01A-21-1558-20	TCGA-29-1688-01A-01W-0633-09	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	TCGA-29-1688-01A-01D-0559-01	TCGA-29-1688-01	46d8cea8-b5a2-4136-bfeb-4969e3ccbd85		TCGA-29-1688-01A-01D-0559-01	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf		5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf		TCGA-29-1688-01	TCGA-29-1688-01	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf		TCGA-29-1688-01A-01R-0566-07	
TCGA-29-1690-01	1	TCGA-29-1690-01	1448	1	days	Iq	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1690			days	1448	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			66	Bilateral	TCGA-29-1690-F27142	TCGA-29-1690	TCGA-29-1690-01A	Stage IIIC	-24319		1448	0	1360						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.3	NO		1.4			G2						TCGA-29-1690.a44f0507-fc95-410a-a6b2-b66caacee30e.pdf	1690		WITH TUMOR	YES			NO		Primary Tumor	01	0.7			29	11-20 mm	Ovary		A	DECEASED	1993	TCGA-29-1690-01	TCGA-29-1690-01		21ed8b03-3122-4467-8542-a90a261e9934		TCGA-29-1690-01		TCGA-29-1690-01A-01D-0563-05		TCGA-29-1690-01A-21-1558-20	TCGA-29-1690-01A-01W-0633-09	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	TCGA-29-1690-01A-01D-0559-01	TCGA-29-1690-01	865fd9bb-d8c0-43d0-874c-ce6e69ce93be		TCGA-29-1690-01A-01D-0559-01	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6		d78906d7-c8f2-4bf0-86cc-2b60b067aaa6		TCGA-29-1690-01	TCGA-29-1690-01	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6		TCGA-29-1690-01A-01R-0566-07	
TCGA-29-1691-01	1	TCGA-29-1691-01	1470	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-29-1691			days	1470	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-29-1691-F27148	TCGA-29-1691		Stage IIIC	-18664		1470	0	1435		613				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G2	Recurrence						1691		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				29	1-10 mm	Ovary			DECEASED	1995	TCGA-29-1691-01	TCGA-29-1691-01		cbacc51e-d8b4-4dab-8ba8-7e769d19c26a		TCGA-29-1691-01		TCGA-29-1691-01A-01D-0563-05		TCGA-29-1691-01A-21-1558-20	TCGA-29-1691-01A-01W-0633-09	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	TCGA-29-1691-01A-01D-0559-01	TCGA-29-1691-01	e634e64b-7b5c-4d33-88f9-c5c83442fdc1		TCGA-29-1691-01A-01D-0559-01	f83833b8-8cb2-44d8-8ac7-c4d2d2463053		f83833b8-8cb2-44d8-8ac7-c4d2d2463053		TCGA-29-1691-01	TCGA-29-1691-01	f83833b8-8cb2-44d8-8ac7-c4d2d2463053		TCGA-29-1691-01A-01R-0566-07	
TCGA-29-1692-01	1	TCGA-29-1692-01	2872	1	days	High		OV-like c1						TCGA-29-1692			days	2872	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Right	TCGA-29-1692-F27159	TCGA-29-1692	TCGA-29-1692-01B	Stage IIIC	-21193		2872	0	2872		544	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.7			G2	Recurrence					TCGA-29-1692.522E504C-7F53-4E91-A684-FD7B3C54CF06.pdf	1692	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		NO	R1	Primary Tumor	01	0.2			29	11-20 mm	Ovary		B	DECEASED	1997				2ecbe10e-1afc-4a38-91ee-cb0cc670f254				TCGA-29-1692-01B-01D-0807-05					TCGA-29-1692-01B-01D-2069-01	TCGA-29-1692-01			TCGA-29-1692-01B-01D-2069-01					TCGA-29-1692-01				TCGA-29-1692-01B-01R-0810-07	
TCGA-29-1692-02	1	TCGA-29-1692-02	2872	1	days			OV-like c1						TCGA-29-1692			days	2872	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Right	TCGA-29-1692-F27159	TCGA-29-1692	TCGA-29-1692-02A	Stage IIIC	-21193		2872	0	2872		544	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G2	Recurrence					TCGA-29-1692.FF9EECFF-66C4-440F-91AB-42ACCEED0A3B.pdf	1692	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		NO	R1	Recurrent Tumor	02	0.6			29	11-20 mm	Ovary		A	DECEASED	1997				4001650f-30d3-46dd-8ba2-7f148afe4ba7				TCGA-29-1692-02A-01D-0807-05							fb710151-c817-4915-90d2-2997726ceccd											TCGA-29-1692-02A-01R-0810-07	
TCGA-29-1693-01	0	TCGA-29-1693-01	3096	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1693			days	3096	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	72	Left	TCGA-29-1693-F27174	TCGA-29-1693	TCGA-29-1693-01A	Stage IIIC	-26300			0	3096		694	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.7		YES	G3	Recurrence					TCGA-29-1693.90087244-634d-45eb-a877-ff7cc6bd2282.pdf	1693	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary	YES	A	LIVING	2001	TCGA-29-1693-01	TCGA-29-1693-01		111c7bf6-d79d-48e4-adf8-94bc0c538ab5		TCGA-29-1693-01		TCGA-29-1693-01A-01D-0563-05		TCGA-29-1693-01A-21-1558-20	TCGA-29-1693-01A-01W-0633-09	7e5d2390-1e04-4e46-aa48-4b0131076007	TCGA-29-1693-01A-01D-0559-01	TCGA-29-1693-01	75dd78d6-cd26-476f-927f-ddb0d4a9c66f		TCGA-29-1693-01A-01D-0559-01	7e5d2390-1e04-4e46-aa48-4b0131076007		7e5d2390-1e04-4e46-aa48-4b0131076007		TCGA-29-1693-01	TCGA-29-1693-01	7e5d2390-1e04-4e46-aa48-4b0131076007		TCGA-29-1693-01A-01R-0566-07	
TCGA-29-1694-01	1	TCGA-29-1694-01	1187	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1694			days	1187	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	45	Bilateral	TCGA-29-1694-F27192	TCGA-29-1694	TCGA-29-1694-01A	Stage IIIC	-16523		1187	0	[Discrepancy]	206		1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2			GX	Locoregional Disease	YES				TCGA-29-1694.ccfb9f1d-1779-4fae-a34f-c46a19d4b095.pdf	1694	Other	WITH TUMOR	YES	Stable Disease	First Seen At Further Surgery	NO		Primary Tumor	01	0.3			29	11-20 mm	Ovary		A	DECEASED	2002	TCGA-29-1694-01	TCGA-29-1694-01		57cead11-58b6-4d8e-ab66-b742de63ae1d		TCGA-29-1694-01		TCGA-29-1694-01A-01D-0563-05		TCGA-29-1694-01A-21-1558-20	TCGA-29-1694-01A-01W-0633-09	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	TCGA-29-1694-01A-01D-0559-01	TCGA-29-1694-01	463fec61-5758-4225-b43e-b77f36ece717		TCGA-29-1694-01A-01D-0559-01	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6		e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6		TCGA-29-1694-01	TCGA-29-1694-01	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6		TCGA-29-1694-01A-01R-0566-07	
TCGA-29-1695-01	1	TCGA-29-1695-01	1229	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-29-1695			days	1229	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Left	TCGA-29-1695-F27204	TCGA-29-1695	TCGA-29-1695-01A	Stage IIIC	-22895		1229	0	24						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G2						TCGA-29-1695.136a4380-2a2a-489f-8675-886e876f17f7.pdf	1695						NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2003	TCGA-29-1695-01	TCGA-29-1695-01		43c657df-dd50-4c53-a5de-e73d3a5e1b0c		TCGA-29-1695-01		TCGA-29-1695-01A-01D-0563-05		TCGA-29-1695-01A-21-1558-20	TCGA-29-1695-01A-01W-0633-09	33f1dda6-7601-48c6-b46d-f0ba759e4048	TCGA-29-1695-01A-01D-0559-01	TCGA-29-1695-01	997dba94-b0d4-4872-b93b-d561f71f6ba3		TCGA-29-1695-01A-01D-0559-01	33f1dda6-7601-48c6-b46d-f0ba759e4048		33f1dda6-7601-48c6-b46d-f0ba759e4048		TCGA-29-1695-01	TCGA-29-1695-01	33f1dda6-7601-48c6-b46d-f0ba759e4048		TCGA-29-1695-01A-01R-0566-07	
TCGA-29-1696-01	1	TCGA-29-1696-01	1032	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1696			days	1032	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	43	Right	TCGA-29-1696-F27206	TCGA-29-1696	TCGA-29-1696-01A	Stage IIIC	-15818		1032	0	1025		342				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		NO	G2	Recurrence					TCGA-29-1696.5e817943-3108-4838-bf8c-85c4507eb873.pdf	1696		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			29	1-10 mm	Ovary		A	DECEASED	2003	TCGA-29-1696-01	TCGA-29-1696-01		fea497c6-293b-49aa-9d5f-021f2f89913e		TCGA-29-1696-01		TCGA-29-1696-01A-01D-0563-05		TCGA-29-1696-01A-21-1558-20	TCGA-29-1696-01A-01W-0633-09	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	TCGA-29-1696-01A-01D-0559-01	TCGA-29-1696-01	93ea52c3-dc03-4845-9493-f1ecdd9e9124		TCGA-29-1696-01A-01D-0559-01	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef		23c4ab1a-f8ce-47be-ab03-abfc66ea70ef		TCGA-29-1696-01	TCGA-29-1696-01	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef		TCGA-29-1696-01A-01R-0566-07	
TCGA-29-1697-01	1	TCGA-29-1697-01	949	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 12	cluster 5		TCGA-29-1697			days	949	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	62	Bilateral	TCGA-29-1697-F27216	TCGA-29-1697	TCGA-29-1697-01A	Stage IIIC	-22933		949	0	949		500	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.9			G3	Recurrence					TCGA-29-1697.294ba09f-347a-4129-847d-211cdf73ca99.pdf	1697	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2003	TCGA-29-1697-01	TCGA-29-1697-01		bd90331c-acc6-49f5-8943-065fbfb16519		TCGA-29-1697-01		TCGA-29-1697-01A-01D-0563-05		TCGA-29-1697-01A-21-1558-20	TCGA-29-1697-01A-01W-0633-09	75435634-4311-49d8-8e42-ae1069c1e2ef	TCGA-29-1697-01A-01D-0559-01	TCGA-29-1697-01	9efe9dcc-44d7-47ae-b404-d324e821910e		TCGA-29-1697-01A-01D-0559-01	75435634-4311-49d8-8e42-ae1069c1e2ef		75435634-4311-49d8-8e42-ae1069c1e2ef		TCGA-29-1697-01	TCGA-29-1697-01	75435634-4311-49d8-8e42-ae1069c1e2ef		TCGA-29-1697-01A-01R-0566-07	
TCGA-29-1698-01	0	TCGA-29-1698-01	2078	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1698			days	2078	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-29-1698-F27227	TCGA-29-1698	TCGA-29-1698-01A	Stage IIIC	-19611			0	2078		181				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.4			G3	Recurrence					TCGA-29-1698.133f2df5-6c22-4653-9d2e-f3d5971502b0.pdf	1698		WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.3			29	1-10 mm	Ovary		A	LIVING	2004	TCGA-29-1698-01	TCGA-29-1698-01		86e20816-f37a-4686-876b-3ef6f0be521a		TCGA-29-1698-01		TCGA-29-1698-01A-01D-0563-05		TCGA-29-1698-01A-21-1558-20	TCGA-29-1698-01A-01W-0633-09	74970c45-4cc5-4952-9846-ce2d959437ea	TCGA-29-1698-01A-01D-0559-01	TCGA-29-1698-01	a40be7ea-f682-4d3e-a749-74aec6961b88		TCGA-29-1698-01A-01D-0559-01	74970c45-4cc5-4952-9846-ce2d959437ea		74970c45-4cc5-4952-9846-ce2d959437ea		TCGA-29-1698-01	TCGA-29-1698-01	74970c45-4cc5-4952-9846-ce2d959437ea		TCGA-29-1698-01A-01R-0566-07	
TCGA-29-1699-01	1	TCGA-29-1699-01	1106	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-29-1699	1106	0	days	1106	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Bilateral	TCGA-29-1699-F41729	TCGA-29-1699	TCGA-29-1699-01A	Stage IIIC	-21130		1106	0	16			1		Progressive Disease	2013-8-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.5		YES	G3			NO			TCGA-29-1699.9e2cf2f9-c45c-4702-8b6f-565c59730036.pdf	1699	Preoperative							Primary Tumor	01	0.6			29	1-10 mm	Ovary		A	DECEASED	2004	TCGA-29-1699-01	TCGA-29-1699-01		036b4d31-1291-4092-9442-9950564a6699		TCGA-29-1699-01		TCGA-29-1699-01A-01D-0563-05		TCGA-29-1699-01A-21-1558-20	TCGA-29-1699-01A-01W-0633-09	6d1d8c8a-fea0-4a47-bd2a-124270561406	TCGA-29-1699-01A-01D-0559-01	TCGA-29-1699-01	21c96f53-087e-42c2-86ce-ea45cf876627		TCGA-29-1699-01A-01D-0559-01	6d1d8c8a-fea0-4a47-bd2a-124270561406		6d1d8c8a-fea0-4a47-bd2a-124270561406		TCGA-29-1699-01	TCGA-29-1699-01	6d1d8c8a-fea0-4a47-bd2a-124270561406		TCGA-29-1699-01A-01R-0566-07	
TCGA-29-1701-01	1	TCGA-29-1701-01	515	1	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-29-1701			days	515	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-29-1701-F27243	TCGA-29-1701	TCGA-29-1701-01A	Stage IIIC	-20737		515	0	514		298	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.3		YES	G3	Recurrence					TCGA-29-1701.f7568046-b77a-4654-9f94-8978bd3e22c4.pdf	1701	Post-Adjuvant Therapy	WITH TUMOR	NO	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.6			29		Ovary	YES	A	DECEASED	2004	TCGA-29-1701-01	TCGA-29-1701-01		9ffceda1-d2ab-4689-baee-eab0b133ded9		TCGA-29-1701-01		TCGA-29-1701-01A-01D-0563-05		TCGA-29-1701-01A-21-1558-20	TCGA-29-1701-01A-01W-0633-09	e5e6f25b-d641-4598-8bb1-0850750ef048	TCGA-29-1701-01A-01D-0559-01	TCGA-29-1701-01	d770980a-b6ef-4e85-8ed6-a22702326573		TCGA-29-1701-01A-01D-0559-01	e5e6f25b-d641-4598-8bb1-0850750ef048		e5e6f25b-d641-4598-8bb1-0850750ef048		TCGA-29-1701-01	TCGA-29-1701-01	e5e6f25b-d641-4598-8bb1-0850750ef048		TCGA-29-1701-01A-01R-0566-07	
TCGA-29-1702-01	1	TCGA-29-1702-01	728	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-29-1702			days	728	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	84	Right	TCGA-29-1702-F27249	TCGA-29-1702	TCGA-29-1702-01A	Stage IIIC	-30910		728	0	568		286	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence					TCGA-29-1702.f825bb6c-afc2-48ea-9286-09c09c7e9918.pdf	1702	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			29	1-10 mm	Ovary		A	DECEASED	2005	TCGA-29-1702-01	TCGA-29-1702-01		3a13cc49-5376-4695-9e64-45b457b9d36b		TCGA-29-1702-01		TCGA-29-1702-01A-01D-0563-05		TCGA-29-1702-01A-21-1558-20	TCGA-29-1702-01A-01W-0633-09	c317689f-a405-4486-9a22-ff6eadd2d5b8	TCGA-29-1702-01A-01D-0559-01	TCGA-29-1702-01	0160cfab-a19a-415e-a418-5679ae8d6779		TCGA-29-1702-01A-01D-0559-01	c317689f-a405-4486-9a22-ff6eadd2d5b8		c317689f-a405-4486-9a22-ff6eadd2d5b8		TCGA-29-1702-01	TCGA-29-1702-01	c317689f-a405-4486-9a22-ff6eadd2d5b8		TCGA-29-1702-01A-01R-0566-07	
TCGA-29-1703-01	1	TCGA-29-1703-01	1815	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-29-1703			days	1815	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-29-1703-F27255	TCGA-29-1703	TCGA-29-1703-01A	Stage IIIC	-20622		1815	0	1815		324	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.4			G2	Recurrence					TCGA-29-1703.c8397af0-67d2-4e69-993b-7349657e9953.pdf	1703	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	DECEASED	2005	TCGA-29-1703-01	TCGA-29-1703-01		059bf2b5-7752-44aa-935c-8b9c482e29e2		TCGA-29-1703-01		TCGA-29-1703-01A-01D-0563-05		TCGA-29-1703-01A-21-1558-20	TCGA-29-1703-01A-01W-0633-09	64e3f978-d213-45e2-bb52-e9b9a2032dc0	TCGA-29-1703-01A-01D-0559-01	TCGA-29-1703-01	13530c03-540d-4e0d-a760-c0f6946f0480		TCGA-29-1703-01A-01D-0559-01	64e3f978-d213-45e2-bb52-e9b9a2032dc0		64e3f978-d213-45e2-bb52-e9b9a2032dc0		TCGA-29-1703-01	TCGA-29-1703-01	64e3f978-d213-45e2-bb52-e9b9a2032dc0		TCGA-29-1703-01A-01R-0566-07	
TCGA-29-1704-01	0	TCGA-29-1704-01	1587	0	days	High		OV-like c1						TCGA-29-1704			days	1587	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Bilateral	TCGA-29-1704-F27269	TCGA-29-1704		Stage IIIC	-22511			0	1587		568	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1704	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Primary Tumor	01				29	11-20 mm	Ovary			LIVING	2005				bbc42149-d2c4-44f9-a59f-bd9397bc96e8				TCGA-29-1704-01B-01D-0807-05					TCGA-29-1704-01B-01D-0803-01	TCGA-29-1704-01			TCGA-29-1704-01B-01D-0803-01					TCGA-29-1704-01				TCGA-29-1704-01B-01R-0810-07	
TCGA-29-1704-02	0	TCGA-29-1704-02	1587	0	days			OV-like c1						TCGA-29-1704			days	1587	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Bilateral	TCGA-29-1704-F27269	TCGA-29-1704	TCGA-29-1704-02A	Stage IIIC	-22511			0	1587		568	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G3	Recurrence					TCGA-29-1704.4C689C80-12E5-4E40-8A12-910D07C8C084.pdf	1704	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Recurrent Tumor	02	0.2			29	11-20 mm	Ovary		A	LIVING	2005								TCGA-29-1704-02A-01D-0807-05																			
TCGA-29-1705-01	1	TCGA-29-1705-01	555	1	days	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1705			days	555	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-29-1705-F27279	TCGA-29-1705	TCGA-29-1705-01A	Stage IIIC	-17530		555	0	555		283	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.8			G2	Recurrence					TCGA-29-1705.e7a899e9-2c61-4bda-874c-0f1b456e5dfc.pdf	1705	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.7			29	>20 mm	Ovary		A	DECEASED	2005	TCGA-29-1705-01	TCGA-29-1705-01		3d4c3c05-1760-43b8-9a4d-e66ebfaf9533		TCGA-29-1705-01		TCGA-29-1705-01A-01D-0563-05		TCGA-29-1705-01A-21-1558-20	TCGA-29-1705-01A-01W-0633-09	d1603029-2b45-4c5c-b313-8846d0ebdbdb	TCGA-29-1705-01A-01D-0559-01	TCGA-29-1705-01	94faea93-a4a5-45c7-9b05-b342bec4e176,daae8ca1-a6fd-43cc-a82e-32ffe02803c7		TCGA-29-1705-01A-01D-0559-01	d1603029-2b45-4c5c-b313-8846d0ebdbdb		d1603029-2b45-4c5c-b313-8846d0ebdbdb		TCGA-29-1705-01	TCGA-29-1705-01	d1603029-2b45-4c5c-b313-8846d0ebdbdb		TCGA-29-1705-01A-01R-0566-07	
TCGA-29-1705-02	1	TCGA-29-1705-02	555	1	days		C9-OV	OV-like c1			miRNA cluster 3			TCGA-29-1705			days	555	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-29-1705-F27279	TCGA-29-1705	TCGA-29-1705-02A	Stage IIIC	-17530		555	0	555		283	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.3			G2	Recurrence					TCGA-29-1705.EADA1E69-0CAB-4521-ABE4-035F73ABB54A.pdf	1705	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Recurrent Tumor	02	0.4			29	>20 mm	Ovary		A	DECEASED	2005		TCGA-29-1705-02		83b8567f-7316-4c8b-877d-b5db5bf8c9da		TCGA-29-1705-02		TCGA-29-1705-02A-01D-0807-05							032aec92-5009-4a62-94cf-7dca39023322											TCGA-29-1705-02A-01R-0810-07	
TCGA-29-1707-01	0	TCGA-29-1707-01	1277	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1707			days	1277	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	41	Left	TCGA-29-1707-F27288	TCGA-29-1707	TCGA-29-1707-01A	Stage IIC	-15017			0	1277		1201	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G3	Recurrence					TCGA-29-1707.da725324-2b94-47d4-a35c-a5f2233a024f.pdf	1707	Post-Adjuvant Therapy		YES	Complete Remission/Response	Other Method	NO		Primary Tumor	01	0.5			29	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-29-1707-01		5a0fb2e7-59de-4180-9b11-456580ad1d78		TCGA-29-1707-01		TCGA-29-1707-01A-01D-0563-05		TCGA-29-1707-01A-21-1559-20	TCGA-29-1707-01A-01W-0633-09		TCGA-29-1707-01A-01D-0559-01	TCGA-29-1707-01	c7511c99-d363-45ed-9d27-cff988927e46,26e9028d-8002-4408-82e8-68bf43f27fec		TCGA-29-1707-01A-01D-0559-01					TCGA-29-1707-01				TCGA-29-1707-01A-01R-0566-07	
TCGA-29-1707-02	0	TCGA-29-1707-02	1277	0	days			OV-like c1			miRNA cluster 1			TCGA-29-1707			days	1277	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	41	Left	TCGA-29-1707-F27288	TCGA-29-1707	TCGA-29-1707-02A	Stage IIC	-15017			0	1277		1201	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence					TCGA-29-1707.264DFD3E-7413-4DEA-A115-14887718139D.pdf	1707	Post-Adjuvant Therapy		YES	Complete Remission/Response	Other Method	NO		Recurrent Tumor	02	0.5			29	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-29-1707-02		ef4e079b-c946-4598-a7dd-575e48a4a133		TCGA-29-1707-02		TCGA-29-1707-02A-01D-0807-05							08fc3ec8-3c83-4ffc-bd91-67e6b162790b											TCGA-29-1707-02A-01R-0810-07	
TCGA-29-1710-01	1	TCGA-29-1710-01	951	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 6		TCGA-29-1710			days	951	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1710-F27294	TCGA-29-1710	TCGA-29-1710-01A	Stage IIIC	-19969		951	0	889		315	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.8			G2	Recurrence					TCGA-29-1710.52a0d2ae-7467-40f0-b8f3-59812cfac52a.pdf	1710	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	DECEASED	2006	TCGA-29-1710-01	TCGA-29-1710-01		31aaa27c-8eaf-4030-9067-d505d9abf983		TCGA-29-1710-01		TCGA-29-1710-01A-02D-0563-05			TCGA-29-1710-01A-02W-0633-09	3bf24456-4b70-4313-a04d-19aba239108d	TCGA-29-1710-01A-02D-0559-01	TCGA-29-1710-01	34b987ae-5e5a-435b-b1f3-0cf9623f1337		TCGA-29-1710-01A-02D-0559-01	3bf24456-4b70-4313-a04d-19aba239108d		3bf24456-4b70-4313-a04d-19aba239108d		TCGA-29-1710-01	TCGA-29-1710-01	3bf24456-4b70-4313-a04d-19aba239108d		TCGA-29-1710-01A-02R-0566-07	
TCGA-29-1710-02	1	TCGA-29-1710-02	951	1	days			OV-like c1						TCGA-29-1710			days	951	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1710-F27294	TCGA-29-1710	TCGA-29-1710-02A	Stage IIIC	-19969		951	0	889		315	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1			G2	Recurrence					TCGA-29-1710.4FD493D6-DAA8-497E-8EB2-ED2A97034B23.pdf	1710	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Recurrent Tumor	02	0.3			29	1-10 mm	Ovary		A	DECEASED	2006				4a8f0084-d5a6-4f5b-bc46-8494a2bfe6b1				TCGA-29-1710-02A-01D-0807-05							8fdfe883-7ce3-46b5-a3c7-e34b59a5557c											TCGA-29-1710-02A-01R-0810-07	
TCGA-29-1711-01	0	TCGA-29-1711-01	1053	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-29-1711			days	1053	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			45	Bilateral	TCGA-29-1711-F27307	TCGA-29-1711	TCGA-29-1711-01A	Stage IIIC	-16485			0	1053			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.2			G2						TCGA-29-1711.e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d.pdf	1711	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2006	TCGA-29-1711-01	TCGA-29-1711-01		299a04e7-e90f-4a24-a211-7f0bd18b3ea0		TCGA-29-1711-01		TCGA-29-1711-01A-01D-0563-05		TCGA-29-1711-01A-21-1559-20	TCGA-29-1711-01A-01W-0633-09	c512a6e3-8bc8-4188-b264-89b2fe02baa8	TCGA-29-1711-01A-01D-0559-01	TCGA-29-1711-01	8aedfe25-9010-4502-a25c-88ed899eeb22		TCGA-29-1711-01A-01D-0559-01	c512a6e3-8bc8-4188-b264-89b2fe02baa8		c512a6e3-8bc8-4188-b264-89b2fe02baa8		TCGA-29-1711-01	TCGA-29-1711-01	c512a6e3-8bc8-4188-b264-89b2fe02baa8		TCGA-29-1711-01A-01R-0566-07	
TCGA-29-1761-01	1	TCGA-29-1761-01	528	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1761			days	528	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			80	Bilateral	TCGA-29-1761-F27312	TCGA-29-1761	TCGA-29-1761-01A	Stage IIIC	-29337		528	0	517						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.9			G3						TCGA-29-1761.63defa27-e729-4514-bdd2-d887c4100854.pdf	1761		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	1998	TCGA-29-1761-01	TCGA-29-1761-01		288d1cec-45f2-448c-8bf1-ce001420d126		TCGA-29-1761-01		TCGA-29-1761-01A-01D-0563-05		TCGA-29-1761-01A-21-1559-20	TCGA-29-1761-01A-01W-0633-09	c4446f6f-fae9-414c-8bae-7c78bb894982	TCGA-29-1761-01A-01D-0559-01	TCGA-29-1761-01	1dfcb901-e9df-4eee-af4c-5c9c22cbe0e8		TCGA-29-1761-01A-01D-0559-01	c4446f6f-fae9-414c-8bae-7c78bb894982		c4446f6f-fae9-414c-8bae-7c78bb894982		TCGA-29-1761-01	TCGA-29-1761-01	c4446f6f-fae9-414c-8bae-7c78bb894982		TCGA-29-1761-01A-01R-0566-07	
TCGA-29-1762-01	1	TCGA-29-1762-01	2634	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-29-1762			days	2634	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-29-1762-F27316	TCGA-29-1762	TCGA-29-1762-01A	Stage IV	-21879		2634	0	2606		1375	2			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		0.9			G2	Recurrence					TCGA-29-1762.f94712a1-78da-4341-9ac9-6ea41c11610e.pdf	1762	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	1998	TCGA-29-1762-01	TCGA-29-1762-01		49c0d36f-14fc-49f0-90a0-57cfbd8ec25b		TCGA-29-1762-01		TCGA-29-1762-01A-01D-0563-05		TCGA-29-1762-01A-21-1559-20	TCGA-29-1762-01A-01W-0633-09	c3559ae3-3355-4f38-9c07-e557e435fcbd	TCGA-29-1762-01A-01D-0559-01	TCGA-29-1762-01	a8bcbfb3-7a83-4170-8b2c-fa5447b5abce		TCGA-29-1762-01A-01D-0559-01	c3559ae3-3355-4f38-9c07-e557e435fcbd		c3559ae3-3355-4f38-9c07-e557e435fcbd		TCGA-29-1762-01	TCGA-29-1762-01	c3559ae3-3355-4f38-9c07-e557e435fcbd		TCGA-29-1762-01A-01R-0566-07	
TCGA-29-1763-01	0	TCGA-29-1763-01	2032	0	days	High		Low purity c2		OV-like c16	miRNA cluster 1	cluster 2		TCGA-29-1763			days	2032	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	43	Bilateral	TCGA-29-1763-F27325	TCGA-29-1763		Stage IIC	-16021			0	2032		428	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G2	Recurrence						1763	Other	WITH TUMOR	YES	Complete Remission/Response	Other Method	NO		Primary Tumor	01				29	1-10 mm	Ovary			LIVING	2004	TCGA-29-1763-01	TCGA-29-1763-01		afc40d40-daf1-4bb5-8813-017913722541		TCGA-29-1763-01		TCGA-29-1763-01A-02D-0563-05			TCGA-29-1763-01A-02W-0633-09	af63aa43-ab5f-44c5-85cf-01d84be261a3	TCGA-29-1763-01A-02D-0559-01	TCGA-29-1763-01			TCGA-29-1763-01A-02D-0559-01	af63aa43-ab5f-44c5-85cf-01d84be261a3		af63aa43-ab5f-44c5-85cf-01d84be261a3		TCGA-29-1763-01	TCGA-29-1763-01	af63aa43-ab5f-44c5-85cf-01d84be261a3		TCGA-29-1763-01A-02R-0566-07	
TCGA-29-1764-01	0	TCGA-29-1764-01	1914	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-29-1764			days	1914	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-29-1764-F27338	TCGA-29-1764	TCGA-29-1764-01A	Stage IIIC	-18012			0	1914		792	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		0.6			G2	Recurrence					TCGA-29-1764.3bae7a57-63d7-4770-a960-cd8f0749ca17.pdf	1764	Other	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	LIVING	2004		TCGA-29-1764-01		523d9b2a-4c0b-479c-917c-2086480c8558		TCGA-29-1764-01		TCGA-29-1764-01A-01D-0563-05		TCGA-29-1764-01A-21-1559-20	TCGA-29-1764-01A-01W-0633-09		TCGA-29-1764-01A-01D-0559-01	TCGA-29-1764-01	3c3a33be-9e62-4a32-946a-15f32661e2a1		TCGA-29-1764-01A-01D-0559-01					TCGA-29-1764-01				TCGA-29-1764-01A-01R-0566-07	
TCGA-29-1766-01	1	TCGA-29-1766-01	1199	1	days	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-29-1766			days	1199	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	74	Right	TCGA-29-1766-F27350	TCGA-29-1766		Stage IIIC	-27359		1199	0	1190		672	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C48.2	8441/3	C48.2	YES	Tumor resection								G2	Recurrence						1766	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01				29	11-20 mm	Peritoneum ovary			DECEASED	2006		TCGA-29-1766-01		a7005558-9983-48f6-8252-943b8a9dd384		TCGA-29-1766-01		TCGA-29-1766-01A-01D-0563-05		TCGA-29-1766-01A-21-1559-20	TCGA-29-1766-01A-01W-0633-09		TCGA-29-1766-01A-01D-0559-01	TCGA-29-1766-01	dd8951d2-5b83-4b78-9b04-52d474639e2f		TCGA-29-1766-01A-01D-0559-01					TCGA-29-1766-01				TCGA-29-1766-01A-01R-0566-07	
TCGA-29-1768-01	1	TCGA-29-1768-01	952	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-29-1768			days	952	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-29-1768-F27358	TCGA-29-1768	TCGA-29-1768-01A	Stage IV	-18396		952	0	950		547	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1			G3	Recurrence					TCGA-29-1768.12d9b343-a52d-4a36-ba7b-31bfeb66da50.pdf	1768	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2006		TCGA-29-1768-01		83edce75-1b96-4e56-8042-76fc6e87f25f		TCGA-29-1768-01		TCGA-29-1768-01A-01D-0563-05		TCGA-29-1768-01A-21-1559-20	TCGA-29-1768-01A-01W-0633-09		TCGA-29-1768-01A-01D-0559-01	TCGA-29-1768-01	f70a1542-3bd5-4ebe-880a-e8f7c75faaba		TCGA-29-1768-01A-01D-0559-01					TCGA-29-1768-01				TCGA-29-1768-01A-01R-0566-07	
TCGA-29-1769-01	0	TCGA-29-1769-01	699	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-29-1769			days	699	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			40	Bilateral	TCGA-29-1769-F27366	TCGA-29-1769	TCGA-29-1769-01A	Stage IIIC	-14754			0	699			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1		NO	G3						TCGA-29-1769.67f144b3-c10b-4f96-a70b-6794d817170f.pdf	1769	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	LIVING	2007		TCGA-29-1769-01		8e7a34f7-d49b-46c8-8b74-374232c60b71		TCGA-29-1769-01		TCGA-29-1769-01A-01D-0581-05		TCGA-29-1769-01A-21-1559-20	TCGA-29-1769-01A-01W-0639-09		TCGA-29-1769-01A-01D-0577-01	TCGA-29-1769-01	161fd24e-ed8c-41ef-8f00-000b3554d9e8		TCGA-29-1769-01A-01D-0577-01					TCGA-29-1769-01				TCGA-29-1769-01A-01R-0584-07	
TCGA-29-1770-01	0	TCGA-29-1770-01	741	0	days	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1770			days	741	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1770-F27373	TCGA-29-1770	TCGA-29-1770-01A	Stage IIIC	-20015			0	741		377	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2			G2	Recurrence					TCGA-29-1770.05816aac-55d2-4604-9300-e268f73338fe.pdf	1770	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.5			29	1-10 mm	Ovary		A	LIVING	2007	TCGA-29-1770-01	TCGA-29-1770-01		17024b36-bf59-4753-bcb3-7ddda14f1556		TCGA-29-1770-01		TCGA-29-1770-01A-01D-0563-05		TCGA-29-1770-01A-21-1559-20	TCGA-29-1770-01A-01W-0633-09	5ba75bb8-6229-4d6a-80e5-9a79a548e167	TCGA-29-1770-01A-01D-0559-01	TCGA-29-1770-01	1577dc3d-937d-4fbb-b280-25f969e43f81		TCGA-29-1770-01A-01D-0559-01	5ba75bb8-6229-4d6a-80e5-9a79a548e167		5ba75bb8-6229-4d6a-80e5-9a79a548e167		TCGA-29-1770-01	TCGA-29-1770-01	5ba75bb8-6229-4d6a-80e5-9a79a548e167		TCGA-29-1770-01A-01R-0566-07	
TCGA-29-1770-02	0	TCGA-29-1770-02	741	0	days		C9-OV	Low purity c2		OV-like c16	miRNA cluster 3			TCGA-29-1770			days	741	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-29-1770-F27373	TCGA-29-1770	TCGA-29-1770-02A	Stage IIIC	-20015			0	741		377	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.4			G2	Recurrence					TCGA-29-1770.49220236-FBFE-44AA-89BC-FC4E7CBC94FA.pdf	1770	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Recurrent Tumor	02	0.2			29	1-10 mm	Ovary		A	LIVING	2007		TCGA-29-1770-02		4ccece6b-c6cf-4921-81e5-af3780afffbc		TCGA-29-1770-02		TCGA-29-1770-02A-01D-0807-05				ea119111-5217-4b8a-88e0-36dc77782241						ea119111-5217-4b8a-88e0-36dc77782241		ea119111-5217-4b8a-88e0-36dc77782241				ea119111-5217-4b8a-88e0-36dc77782241		TCGA-29-1770-02A-01R-0810-07	
TCGA-29-1771-01	0	TCGA-29-1771-01	686	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1771			days	686	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-29-1771-F27383	TCGA-29-1771		Stage IIIC	-28093			0	686		595	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G2	Recurrence						1771	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				29	>20 mm	Ovary			LIVING	2007		TCGA-29-1771-01		d95ccef1-6cfa-4bda-ab09-c931f8c7a344		TCGA-29-1771-01		TCGA-29-1771-01A-01D-0563-05		TCGA-29-1771-01A-21-1559-20	TCGA-29-1771-01A-01W-0633-09		TCGA-29-1771-01A-01D-0559-01	TCGA-29-1771-01	b69387b5-4b22-4ef1-8711-d1e406c1afdc		TCGA-29-1771-01A-01D-0559-01					TCGA-29-1771-01				TCGA-29-1771-01A-01R-0566-07	
TCGA-29-1774-01	0	TCGA-29-1774-01	527	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1774			days	527	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	82	Bilateral	TCGA-29-1774-F27391	TCGA-29-1774		Stage IIIC	-29991			0	527		234	2			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1774		WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01				29	>20 mm	Ovary			LIVING	2008		TCGA-29-1774-01		d9a5abd2-9d18-48b7-a38a-c69c134e6086		TCGA-29-1774-01		TCGA-29-1774-01A-01D-0581-05		TCGA-29-1774-01A-21-1559-20	TCGA-29-1774-01A-01W-0639-09		TCGA-29-1774-01A-01D-0577-01	TCGA-29-1774-01	eed4cd8b-16bc-419f-8474-248270a93780		TCGA-29-1774-01A-01D-0577-01					TCGA-29-1774-01				TCGA-29-1774-01A-01R-0584-07	
TCGA-29-1775-01	0	TCGA-29-1775-01	376	0	days	High		OV-like c1	OV-like c4					TCGA-29-1775			days	376	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-29-1775-F27398	TCGA-29-1775	TCGA-29-1775-01A	Stage IIIC	-18943			0	376		341	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Incisional Biopsy		0.7	NO		1.1			G2	Recurrence					TCGA-29-1775.8f5dd3e0-b6c8-443e-88d9-c9d02a531f60.pdf	1775	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.5			29	1-10 mm	Ovary		A	LIVING	2008				8ead8627-a2d2-4952-9d59-cb15c2ae2021				TCGA-29-1775-01A-01D-0581-05		TCGA-29-1775-01A-21-1559-20	TCGA-29-1775-01A-01W-0639-09		TCGA-29-1775-01A-01D-0577-01	TCGA-29-1775-01	8a55a793-3d3c-455f-a342-3c5cbd01f849		TCGA-29-1775-01A-01D-0577-01					TCGA-29-1775-01				TCGA-29-1775-01A-01R-0584-07	
TCGA-29-1776-01	0	TCGA-29-1776-01	360	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1776			days	360	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Bilateral	TCGA-29-1776-F27409	TCGA-29-1776	TCGA-29-1776-01A	Stage IIIC	-23016			0	360			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.9			G3						TCGA-29-1776.eb6df66e-c6ee-4c63-889d-9f4b6ca170c7.pdf	1776	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	LIVING	2008	TCGA-29-1776-01	TCGA-29-1776-01		1549eee5-f999-4053-b926-baae183792f1		TCGA-29-1776-01		TCGA-29-1776-01A-01D-0581-05		TCGA-29-1776-01A-21-1559-20	TCGA-29-1776-01A-01W-0639-09	50867fed-2fda-4c45-aa08-042087e7daa9	TCGA-29-1776-01A-01D-0577-01	TCGA-29-1776-01	3da0c471-ede3-480f-b692-f94939ed8ac3		TCGA-29-1776-01A-01D-0577-01	50867fed-2fda-4c45-aa08-042087e7daa9		50867fed-2fda-4c45-aa08-042087e7daa9		TCGA-29-1776-01	TCGA-29-1776-01	50867fed-2fda-4c45-aa08-042087e7daa9		TCGA-29-1776-01A-01R-0584-07	
TCGA-29-1777-01	0	TCGA-29-1777-01	374	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-29-1777			days	374	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			47	Bilateral	TCGA-29-1777-F27415	TCGA-29-1777	TCGA-29-1777-01A	Stage IIIC	-17356			0	374			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.3			G2						TCGA-29-1777.bfd59906-509b-4ca3-9282-c881f9962e15.pdf	1777	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.5			29	>20 mm	Ovary		A	LIVING	2008		TCGA-29-1777-01		79992944-6a6c-4f97-baf4-132689a69fff		TCGA-29-1777-01		TCGA-29-1777-01A-01D-0581-05		TCGA-29-1777-01A-21-1559-20	TCGA-29-1777-01A-01W-0639-09		TCGA-29-1777-01A-01D-0577-01	TCGA-29-1777-01	9b5e802b-56e7-4f93-8869-2db3170006bc		TCGA-29-1777-01A-01D-0577-01					TCGA-29-1777-01				TCGA-29-1777-01A-01R-0584-07	
TCGA-29-1778-01	0	TCGA-29-1778-01	454	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1778			days	454	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			77	Right	TCGA-29-1778-F27420	TCGA-29-1778	TCGA-29-1778-01A	Stage IIIC	-28147			0	454						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3						TCGA-29-1778.439a81dd-dc54-49e5-942c-4aa8d0be8701.pdf	1778		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			29	No Macroscopic disease	Ovary		A	LIVING	2008	TCGA-29-1778-01	TCGA-29-1778-01		0654179f-2887-47e8-b4f4-051312a4907c		TCGA-29-1778-01		TCGA-29-1778-01A-01D-0581-05		TCGA-29-1778-01A-21-1559-20	TCGA-29-1778-01A-01W-0639-09	7ecd0f7a-d186-422b-a2e1-833dfc400e39	TCGA-29-1778-01A-01D-0577-01	TCGA-29-1778-01	9a724a0a-6807-4995-889b-4b80a32e280d		TCGA-29-1778-01A-01D-0577-01	7ecd0f7a-d186-422b-a2e1-833dfc400e39		7ecd0f7a-d186-422b-a2e1-833dfc400e39		TCGA-29-1778-01	TCGA-29-1778-01	7ecd0f7a-d186-422b-a2e1-833dfc400e39		TCGA-29-1778-01A-01R-0584-07	
TCGA-29-1781-01	0	TCGA-29-1781-01	255	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2		TCGA-29-1781			days	255	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			69	Bilateral	TCGA-29-1781-F27427	TCGA-29-1781	TCGA-29-1781-01A	Stage IIIC	-25404			0	255			1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3						TCGA-29-1781.959c11fe-f170-49bc-a1fe-73b799741b93.pdf	1781	Pre-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response		NO		Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2009	TCGA-29-1781-01	TCGA-29-1781-01		b87d2ec7-4fbf-4ecd-99fd-4983eb2fb7d8		TCGA-29-1781-01		TCGA-29-1781-01A-01D-0563-05		TCGA-29-1781-01A-21-1559-20	TCGA-29-1781-01A-01W-0633-09	5fd66773-ed5a-438c-a7c1-d029f05798e5	TCGA-29-1781-01A-01D-0559-01	TCGA-29-1781-01	7b26743c-756e-45d0-8eaa-cffb1c11fef1		TCGA-29-1781-01A-01D-0559-01	5fd66773-ed5a-438c-a7c1-d029f05798e5		5fd66773-ed5a-438c-a7c1-d029f05798e5		TCGA-29-1781-01	TCGA-29-1781-01	5fd66773-ed5a-438c-a7c1-d029f05798e5		TCGA-29-1781-01A-01R-0566-07	
TCGA-29-1783-01	0	TCGA-29-1783-01	220	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1783			days	220	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Right	TCGA-29-1783-F27431	TCGA-29-1783	TCGA-29-1783-01A	Stage IIIC	-21284			0	220			1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3						TCGA-29-1783.6ebf4763-bb2a-4ef5-ab22-23460980df1c.pdf	1783	Post-Adjuvant Therapy	TUMOR FREE	YES			NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	LIVING	2009	TCGA-29-1783-01	TCGA-29-1783-01		2981b53e-f39a-4c5e-9254-dd1a6bf6c4e6		TCGA-29-1783-01		TCGA-29-1783-01A-01D-0563-05		TCGA-29-1783-01A-21-1559-20	TCGA-29-1783-01A-01W-0633-09	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	TCGA-29-1783-01A-01D-0559-01	TCGA-29-1783-01	82dd8748-e0c5-4030-bf40-fe5d229adeae		TCGA-29-1783-01A-01D-0559-01	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235		dad3688e-fdd7-4c85-a1df-cf0e1cc0a235		TCGA-29-1783-01	TCGA-29-1783-01	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235		TCGA-29-1783-01A-01R-0566-07	
TCGA-29-1784-01	0	TCGA-29-1784-01	163	0	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1784			days	163	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Right	TCGA-29-1784-F27436	TCGA-29-1784	TCGA-29-1784-01A	Stage IIIC	-20210			0	163			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3						TCGA-29-1784.e4614e5d-eb1f-4ac7-a17f-105936745e80.pdf	1784	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2009	TCGA-29-1784-01	TCGA-29-1784-01		3720cc8a-5b9c-44cb-ba9d-5540f1ece950		TCGA-29-1784-01		TCGA-29-1784-01A-02D-0563-05			TCGA-29-1784-01A-02W-0633-09	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	TCGA-29-1784-01A-02D-0559-01	TCGA-29-1784-01			TCGA-29-1784-01A-02D-0559-01	c72e442b-36f5-4ea6-a893-505b5ccd8c4f		c72e442b-36f5-4ea6-a893-505b5ccd8c4f		TCGA-29-1784-01	TCGA-29-1784-01	c72e442b-36f5-4ea6-a893-505b5ccd8c4f		TCGA-29-1784-01A-02R-0566-07	
TCGA-29-1785-01	1	TCGA-29-1785-01	1104	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1785			days	1104	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Right	TCGA-29-1785-F27442	TCGA-29-1785	TCGA-29-1785-01A	Stage IIIC	-20417		1104	0	1053		473	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2		YES	G3	Recurrence					TCGA-29-1785.b520ed75-17dd-420f-b444-4436bb03f40f.pdf	1785	Post-Adjuvant Therapy		YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2006	TCGA-29-1785-01	TCGA-29-1785-01		89db2b71-04a7-42f7-8480-a8ba3f118bcc		TCGA-29-1785-01		TCGA-29-1785-01A-01D-0563-05		TCGA-29-1785-01A-21-1559-20	TCGA-29-1785-01A-01W-0633-09	dcff1416-56fd-4d8e-a472-a40a00ef3066	TCGA-29-1785-01A-01D-0559-01	TCGA-29-1785-01	c7002a87-0a3e-4ffb-b976-b1d7f768dd30		TCGA-29-1785-01A-01D-0559-01	dcff1416-56fd-4d8e-a472-a40a00ef3066		dcff1416-56fd-4d8e-a472-a40a00ef3066		TCGA-29-1785-01	TCGA-29-1785-01	dcff1416-56fd-4d8e-a472-a40a00ef3066		TCGA-29-1785-01A-01R-0566-07	
TCGA-29-2414-01	1	TCGA-29-2414-01	2621	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 6		TCGA-29-2414			days	2621	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	75	Left	TCGA-29-2414-F27451	TCGA-29-2414	TCGA-29-2414-01A	Stage IIIC	-27417		2621	0	2621		552				2010-2-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G2	Recurrence					TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf	2414		WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Primary Tumor	01	0.5			29	11-20 mm	Ovary	NO	A	DECEASED	1998	TCGA-29-2414-01	TCGA-29-2414-01		9d580db8-ad4f-4ecb-affd-e9ae032e8ebb		TCGA-29-2414-01		TCGA-29-2414-01A-02D-0708-05				ecbadb01-01ec-4d9f-877c-75709d6f5914	TCGA-29-2414-01A-02D-2069-01	TCGA-29-2414-01	2433c714-344b-4fa6-91a4-2cab830a4485		TCGA-29-2414-01A-02D-2069-01	ecbadb01-01ec-4d9f-877c-75709d6f5914		ecbadb01-01ec-4d9f-877c-75709d6f5914		TCGA-29-2414-01	TCGA-29-2414-01	ecbadb01-01ec-4d9f-877c-75709d6f5914		TCGA-29-2414-01A-02R-0711-07	
TCGA-29-2414-02	1	TCGA-29-2414-02	2621	1	days			OV-like c1		OV-like c16	miRNA cluster 1			TCGA-29-2414			days	2621	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	75	Left	TCGA-29-2414-F27451	TCGA-29-2414	TCGA-29-2414-02A	Stage IIIC	-27417		2621	0	2621		552				2010-2-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G2	Recurrence					TCGA-29-2414.1A4882EA-818E-4A23-8584-2881D0DE8406.pdf	2414		WITH TUMOR	YES	Complete Remission/Response	Other Method	NO	R1	Recurrent Tumor	02	0.3			29	11-20 mm	Ovary	NO	A	DECEASED	1998		TCGA-29-2414-02		4e488bb5-78b0-4a28-b276-109b203230d4		TCGA-29-2414-02		TCGA-29-2414-02A-01D-0807-05				1558c0c4-6bd2-482d-9c4e-2430a402dacc			754eb22a-d0a5-4ea9-9fee-685e6d2cad7f			1558c0c4-6bd2-482d-9c4e-2430a402dacc		1558c0c4-6bd2-482d-9c4e-2430a402dacc				1558c0c4-6bd2-482d-9c4e-2430a402dacc		TCGA-29-2414-02A-01R-0810-07	
TCGA-29-2425-01	0	TCGA-29-2425-01	1977	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-29-2425			days	1977	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60		TCGA-29-2425-F27462	TCGA-29-2425	TCGA-29-2425-01A	Stage IIIC	-22089			0	1977		1577	0			2010-2-9	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G2	Progression of Disease					TCGA-29-2425.ec04e6ae-ae66-4fc2-b77b-485f77ce39bc.pdf	2425	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.5			29	>20 mm	Ovary		A	LIVING	2004	TCGA-29-2425-01	TCGA-29-2425-01		572ffa30-3fd6-49b7-a250-f8505555bde9		TCGA-29-2425-01		TCGA-29-2425-01A-01D-0708-05		TCGA-29-2425-01A-21-1560-20		3ce6b8c4-7020-447a-8eb8-5370eef05344	TCGA-29-2425-01A-01D-0704-01	TCGA-29-2425-01	8d87815d-6b5a-4713-9f0b-0ca8609996f2		TCGA-29-2425-01A-01D-0704-01	3ce6b8c4-7020-447a-8eb8-5370eef05344		3ce6b8c4-7020-447a-8eb8-5370eef05344		TCGA-29-2425-01	TCGA-29-2425-01	3ce6b8c4-7020-447a-8eb8-5370eef05344		TCGA-29-2425-01A-01R-0711-07	
TCGA-29-2427-01	0	TCGA-29-2427-01	1900	0	days	BRCA-LUAD+	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-29-2427			days	1900	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Left	TCGA-29-2427-F27470	TCGA-29-2427	TCGA-29-2427-01A	Stage IIIC	-21940			0	1900		1582	0			2010-2-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence					TCGA-29-2427.b53536ca-770c-4482-b2f7-4284d804db2e.pdf	2427	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.5			29	>20 mm	Ovary		A	LIVING	2004	TCGA-29-2427-01	TCGA-29-2427-01		68e99d72-4df2-4d2d-9e24-b8fc81942a46		TCGA-29-2427-01		TCGA-29-2427-01A-01D-0708-05		TCGA-29-2427-01A-21-1560-20		f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	TCGA-29-2427-01A-01D-0704-01	TCGA-29-2427-01	596d6d8e-d15c-442b-bcd4-ed2dec59aef2		TCGA-29-2427-01A-01D-0704-01	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a		f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	TCGA-29-2427-01A-01W-0799-08	TCGA-29-2427-01	TCGA-29-2427-01	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	TCGA-29-2427-01A-01W-0799-08	TCGA-29-2427-01A-01R-0711-07	
TCGA-29-2428-01	0	TCGA-29-2428-01	1372	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-29-2428			days	1372	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Left	TCGA-29-2428-F27478	TCGA-29-2428	TCGA-29-2428-01A	Stage IIIC	-21392			0	1372			0			2010-2-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.7		YES	G3						TCGA-29-2428.45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb.pdf	2428	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO	R1	Primary Tumor	01	0.4			29	>20 mm	Ovary		A	LIVING	2005	TCGA-29-2428-01	TCGA-29-2428-01		b7c8f2a5-de96-4a38-bfa4-2a6c1b8ea1e2		TCGA-29-2428-01		TCGA-29-2428-01A-01D-0708-05		TCGA-29-2428-01A-21-1560-20		9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	TCGA-29-2428-01A-01D-0704-01	TCGA-29-2428-01	364ced0b-2737-4f70-a7bb-a5a9171e4ef8		TCGA-29-2428-01A-01D-0704-01	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b		9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b		TCGA-29-2428-01	TCGA-29-2428-01	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b		TCGA-29-2428-01A-01R-0711-07	
TCGA-29-2429-01	1	TCGA-29-2429-01	421	1	days	High		OV-like c1	OV-like c4					TCGA-29-2429	421	0	days	421	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			79	Right	TCGA-29-2429-F44633	TCGA-29-2429	TCGA-29-2429-01A	Stage IIIC	-29156		421	0							2013-8-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1	YES		G3			NO			TCGA-29-2429.09804c6e-b6f3-482f-a23e-a4efa84f2ab7.pdf	2429		WITH TUMOR					R1	Primary Tumor	01	0.3			29	>20 mm	Ovary		A	DECEASED	2005				1142b276-1e85-4021-8fa7-85e562b6c747				TCGA-29-2429-01A-01D-1047-05		TCGA-29-2429-01A-21-1560-20	TCGA-29-2429-01A-01D-1526-09		TCGA-29-2429-01A-01D-1043-01	TCGA-29-2429-01	3ba731e2-2840-44c0-aa48-541f8f9e4d29		TCGA-29-2429-01A-01D-1043-01					TCGA-29-2429-01				TCGA-29-2429-01A-01R-1050-07	
TCGA-29-2431-01	0	TCGA-29-2431-01	1285	0	days	High		OV-like c1	OV-like c4					TCGA-29-2431			days	1285	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-29-2431-F27485	TCGA-29-2431	TCGA-29-2431-01A	Stage IIIC	-21833			0	1285		960	0			2010-6-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5			G2	Recurrence					TCGA-29-2431.cbd3ddd8-b431-4852-b4db-b4be535115d6.pdf	2431	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R0	Primary Tumor	01	0.3			29	1-10 mm	Ovary		A	LIVING	2006				88be95fd-3aa9-4279-91ff-e705db3e187c				TCGA-29-2431-01A-01D-1047-05		TCGA-29-2431-01A-21-1560-20	TCGA-29-2431-01A-01D-1526-09		TCGA-29-2431-01A-01D-1043-01	TCGA-29-2431-01	f02341bc-10e3-4bbf-98c8-0604616796ea		TCGA-29-2431-01A-01D-1043-01					TCGA-29-2431-01				TCGA-29-2431-01A-01R-1050-07	
TCGA-29-2432-01	1	TCGA-29-2432-01	653	1	days	High		OV-like c1	OV-like c4					TCGA-29-2432			days	653	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-29-2432-F27492	TCGA-29-2432	TCGA-29-2432-01A	Stage IIIC	-22605		653	0	360		174				2010-6-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.3			G3	Recurrence					TCGA-29-2432.9de0ca7f-0603-46a9-9c69-7e2196cbfb6f.pdf	2432		WITH TUMOR	YES	Progressive Disease		NO	R1	Primary Tumor	01	0.5			29	11-20 mm	Ovary		A	DECEASED	2008				6fcda1cc-9224-452c-8fda-369e73f2f05e				TCGA-29-2432-01A-01D-1047-05		TCGA-29-2432-01A-21-1560-20	TCGA-29-2432-01A-01D-1526-09		TCGA-29-2432-01A-01D-1043-01	TCGA-29-2432-01	a835eb6a-c37b-49de-bea5-9f9251f817a5		TCGA-29-2432-01A-01D-1043-01					TCGA-29-2432-01				TCGA-29-2432-01A-01R-1050-07	
TCGA-29-2434-01	0	TCGA-29-2434-01	349	0	days	High		OV-like c1	OV-like c4					TCGA-29-2434			days	349	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Left	TCGA-29-2434-F27505	TCGA-29-2434	TCGA-29-2434-01A	Stage IIIC	-18997			0	349						2010-6-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G3						TCGA-29-2434.0891ac31-d9ed-4cb3-82ae-8499fb4c29ea.pdf	2434		TUMOR FREE	YES	Complete Remission/Response		NO	R0	Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2009				7b45cfcd-a37c-4f92-b35f-e75ac6b1d000				TCGA-29-2434-01A-01D-1047-05		TCGA-29-2434-01A-21-1560-20	TCGA-29-2434-01A-01D-1526-09		TCGA-29-2434-01A-01D-1043-01	TCGA-29-2434-01	9eb175cd-3311-4f57-a37a-7a2463bc58fb		TCGA-29-2434-01A-01D-1043-01					TCGA-29-2434-01				TCGA-29-2434-01A-01R-1050-07	
TCGA-29-2435-01	0	TCGA-29-2435-01	34	0	days				OV-like c4					TCGA-29-2435			days	34	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Left	TCGA-29-2435-F27510	TCGA-29-2435	TCGA-29-2435-01A	Stage IV	-28779			0	34						2010-6-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5			G3						TCGA-29-2435.6EF128AE-31B6-483A-B0DD-9626CEEC278E.pdf	2435			YES				R1	Primary Tumor	01	0.3			29	11-20 mm	Ovary		A	LIVING	2009										TCGA-29-2435-01A-21-1560-20					84e1540d-c756-414e-92c9-3e0d5f45cd48												
TCGA-29-2436-01	0	TCGA-29-2436-01	297	0	days	COAD-READ		Low purity c2	OV-like c4					TCGA-29-2436			days	297	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			36	Bilateral	TCGA-29-2436-F27514	TCGA-29-2436	TCGA-29-2436-01A	Stage IIIC	-13346			0	297						2010-6-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.3			G2						TCGA-29-2436.0caa891b-3d47-44c1-bc75-0468afc11495.pdf	2436		TUMOR FREE	YES	Complete Remission/Response		NO	R0	Primary Tumor	01	0.4			29	1-10 mm	Ovary	YES	A	LIVING	2009				e467e3e0-9311-48ff-8da8-f3b9118011e7				TCGA-29-2436-01A-01D-1047-05		TCGA-29-2436-01A-21-1560-20	TCGA-29-2436-01A-01D-1526-09		TCGA-29-2436-01A-01D-1043-01	TCGA-29-2436-01	851a2dc8-da35-4a80-bcd1-1ed74ee459c7		TCGA-29-2436-01A-01D-1043-01					TCGA-29-2436-01				TCGA-29-2436-01A-01R-1050-07	
TCGA-29-A5NZ-01	0	TCGA-29-A5NZ-01	984	0	days									TCGA-29-A5NZ	879	1	days	984	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66		TCGA-29-A5NZ-F59530	TCGA-29-A5NZ	TCGA-29-A5NZ-01A	Stage IIIC	-24161	515	1088	0	984		879		Additional New Tumor Event		2014-5-14	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8460/3	C48.1	YES		1040		NO			NO		G3	Progression of Disease		YES	true	No	TCGA-29-A5NZ.B7F69EE0-E844-434B-A76B-390590C85864.pdf	A5NZ		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01				29		Omentum		A	LIVING	2011	TCGA-29-A5NZ-01	TCGA-29-A5NZ-01			TCGA-29-A5NZ-01A-11D-A409-05	TCGA-29-A5NZ-01						ea715147-2b94-4bed-9531-ba91c13630fe	TCGA-29-A5NZ-01A-11D-A402-01		8E54518A-2DD5-448F-AFA2-C23D91E0290D	TCGA-29-A5NZ-01A-11R-A406-31	TCGA-29-A5NZ-01A-11D-A402-01	ea715147-2b94-4bed-9531-ba91c13630fe	TCGA-29-A5NZ-01A-11R-A406-31	ea715147-2b94-4bed-9531-ba91c13630fe			TCGA-29-A5NZ-01	ea715147-2b94-4bed-9531-ba91c13630fe			
TCGA-30-1714-01	1	TCGA-30-1714-01	1158	1	days	High		OV-like c1			miRNA cluster 1	cluster 3		TCGA-30-1714			days	1158	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	68	Bilateral	TCGA-30-1714-F27518	TCGA-30-1714	TCGA-30-1714-01A	Stage IV	-25032		1158	0	1158		241				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		YES	G3	Recurrence					TCGA-30-1714.7bec7160-e40c-4b47-b0d6-93652c5e27f2.pdf	1714		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			30	1-10 mm	Ovary	NO	A	DECEASED	2001		TCGA-30-1714-01		9b91d688-3f05-43a9-8900-57027113b885		TCGA-30-1714-01		TCGA-30-1714-01A-02D-0563-05			TCGA-30-1714-01A-02W-0633-09		TCGA-30-1714-01A-02D-0559-01	TCGA-30-1714-01			TCGA-30-1714-01A-02D-0559-01					TCGA-30-1714-01				TCGA-30-1714-01A-02R-0566-07	
TCGA-30-1718-01	1	TCGA-30-1718-01	1579	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-30-1718			days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	44	Bilateral	TCGA-30-1718-F27534	TCGA-30-1718	TCGA-30-1718-01A	Stage IIIC	-16400		1579	0	1579		896				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.3		NO	G3	Recurrence					TCGA-30-1718.078da76a-b9f5-40d0-9a57-04c306ade36a.pdf	1718		WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2002	TCGA-30-1718-01	TCGA-30-1718-01		f9ba9bc4-5591-4a79-b8ad-fee2f83ea724		TCGA-30-1718-01		TCGA-30-1718-01A-01D-0563-05		TCGA-30-1718-01A-21-1559-20	TCGA-30-1718-01A-01W-0633-09	5abce979-686d-40c4-acd7-ef9cc5acf26f	TCGA-30-1718-01A-01D-0559-01	TCGA-30-1718-01	bd7cf7cb-3d3f-44ff-a0ad-f559a3d26370		TCGA-30-1718-01A-01D-0559-01	5abce979-686d-40c4-acd7-ef9cc5acf26f		5abce979-686d-40c4-acd7-ef9cc5acf26f		TCGA-30-1718-01	TCGA-30-1718-01	5abce979-686d-40c4-acd7-ef9cc5acf26f		TCGA-30-1718-01A-01R-0566-07	
TCGA-30-1853-01	1	TCGA-30-1853-01	1103	1	days	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-30-1853			days	1103	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-30-1853-F27542	TCGA-30-1853	TCGA-30-1853-01A	Stage IIIC	-21404		1103	0	1103		634				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence					TCGA-30-1853.ded9ba4c-8d3d-450b-a345-772a3e3ae288.pdf	1853		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary		A	DECEASED	2000		TCGA-30-1853-01		549e923d-4430-4b66-8378-af96f66646b7		TCGA-30-1853-01		TCGA-30-1853-01A-02D-0652-05					TCGA-30-1853-01A-02D-0648-01	TCGA-30-1853-01			TCGA-30-1853-01A-02D-0648-01				TCGA-30-1853-01A-02W-0699-08	TCGA-30-1853-01			TCGA-30-1853-01A-02W-0699-08	TCGA-30-1853-01A-02R-0655-07	
TCGA-30-1855-01	1	TCGA-30-1855-01	75	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-30-1855			days	75	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			61		TCGA-30-1855-F27550	TCGA-30-1855	TCGA-30-1855-01A	Stage IIIC	-22394		75	0	75						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3						TCGA-30-1855.cba111de-b005-4460-b4d1-d8b24126d1d3.pdf	1855		WITH TUMOR	NO			NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2001	TCGA-30-1855-01	TCGA-30-1855-01		b47399a9-31a2-4721-8da0-63bf21c6fcae		TCGA-30-1855-01		TCGA-30-1855-01A-01D-0581-05		TCGA-30-1855-01A-21-1559-20	TCGA-30-1855-01A-01W-0639-09	732d0664-c343-4a63-9dc3-40985e540a59	TCGA-30-1855-01A-01D-0577-01	TCGA-30-1855-01	6b1438ab-2904-4d21-865d-f14c76777f62		TCGA-30-1855-01A-01D-0577-01	732d0664-c343-4a63-9dc3-40985e540a59		732d0664-c343-4a63-9dc3-40985e540a59		TCGA-30-1855-01	TCGA-30-1855-01	732d0664-c343-4a63-9dc3-40985e540a59		TCGA-30-1855-01A-01R-0584-07	
TCGA-30-1856-01	1	TCGA-30-1856-01	477	1	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-30-1856			days	477	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-30-1856-F27552	TCGA-30-1856	TCGA-30-1856-01A	Stage IIIC	-20626		477	0	477		220				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence					TCGA-30-1856.281005d7-4231-467c-9c6c-43f536fcebe1.pdf	1856		WITH TUMOR	YES	Partial Remission/Response	First Seen At Further Surgery	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2001		TCGA-30-1856-01		73874ff9-38f8-4a31-9ac1-923793b88b91		TCGA-30-1856-01		TCGA-30-1856-01A-01D-0581-05		TCGA-30-1856-01A-21-1559-20	TCGA-30-1856-01A-01W-0639-09		TCGA-30-1856-01A-01D-0577-01	TCGA-30-1856-01	60d477e5-467d-4be3-b495-ed511519e4fa		TCGA-30-1856-01A-01D-0577-01					TCGA-30-1856-01				TCGA-30-1856-01A-01R-0584-07	
TCGA-30-1857-01	1	TCGA-30-1857-01	8	1	days	Squamous		OV-like c1			miRNA cluster 3	cluster 6		TCGA-30-1857			days	8	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64	Right	TCGA-30-1857-F27564	TCGA-30-1857	TCGA-30-1857-01A	Stage IV	-23689		8	0	8						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8			G3						TCGA-30-1857.e3d84909-0149-4691-a398-1a6b272dde60.pdf	1857		WITH TUMOR	NO			NO		Primary Tumor	01	0.4			30		Ovary		A	DECEASED	2001	TCGA-30-1857-01	TCGA-30-1857-01		bffff720-6d86-4661-9ae9-85605520064f		TCGA-30-1857-01		TCGA-30-1857-01A-02D-0581-05			TCGA-30-1857-01A-02W-0639-09	7fc46368-c523-4936-84e3-bb3f77db7c48	TCGA-30-1857-01A-02D-0577-01	TCGA-30-1857-01		TCGA-30-1857-01A-02R-1569-13	TCGA-30-1857-01A-02D-0577-01	7fc46368-c523-4936-84e3-bb3f77db7c48	TCGA-30-1857-01A-02R-1569-13	7fc46368-c523-4936-84e3-bb3f77db7c48		TCGA-30-1857-01	TCGA-30-1857-01	7fc46368-c523-4936-84e3-bb3f77db7c48		TCGA-30-1857-01A-02R-0584-07	
TCGA-30-1859-01	1	TCGA-30-1859-01	1463	1	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-30-1859			days	1463	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-30-1859-F27566	TCGA-30-1859	TCGA-30-1859-01A		-20498		1463	0	1463	210		0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.3	NO		1			G3	Locoregional Disease	YES				TCGA-30-1859.6c4d66bc-361f-465f-b18a-7bb1a0fc7752.pdf	1859	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.3			30	1-10 mm	Ovary		A	DECEASED	2002		TCGA-30-1859-01		4618e0b6-9a8d-4843-a67f-a0b0de96b4ec		TCGA-30-1859-01		TCGA-30-1859-01A-01D-0652-05		TCGA-30-1859-01A-21-1559-20			TCGA-30-1859-01A-01D-0648-01	TCGA-30-1859-01	063c9971-7f3f-45f5-8f42-11b3eca461fa		TCGA-30-1859-01A-01D-0648-01					TCGA-30-1859-01				TCGA-30-1859-01A-01R-0655-07	
TCGA-30-1860-01	1	TCGA-30-1860-01	1366	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6		TCGA-30-1860			days	1366	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	58	Bilateral	TCGA-30-1860-F27580	TCGA-30-1860	TCGA-30-1860-01A	Stage IIIC	-21406		1366	0	1366		397				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.5		NO	G3	Recurrence					TCGA-30-1860.d5b8e59f-1ae5-4e22-b933-48e48a364788.pdf	1860		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			30	>20 mm	Ovary	NO	A	DECEASED	2002	TCGA-30-1860-01	TCGA-30-1860-01		713acb94-3fd4-444d-ae04-e79c1ee73b3a		TCGA-30-1860-01		TCGA-30-1860-01A-01D-0652-05		TCGA-30-1860-01A-21-1559-20		1b8eed7b-173e-4e38-80a4-a3a0aea469a1	TCGA-30-1860-01A-01D-0648-01	TCGA-30-1860-01	5c4486d9-1d91-4f42-83fd-85526c4f0836		TCGA-30-1860-01A-01D-0648-01	1b8eed7b-173e-4e38-80a4-a3a0aea469a1		1b8eed7b-173e-4e38-80a4-a3a0aea469a1		TCGA-30-1860-01	TCGA-30-1860-01	1b8eed7b-173e-4e38-80a4-a3a0aea469a1		TCGA-30-1860-01A-01R-0655-07	
TCGA-30-1861-01	1	TCGA-30-1861-01	1058	1	days	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-30-1861			days	1058	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			74	Bilateral		TCGA-30-1861	TCGA-30-1861-01A	Stage IIIC	-27103		1058	0	1058						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8			G3						TCGA-30-1861.446be880-d1d8-4b63-b4d5-5aa0468ccafe.pdf	1861								Primary Tumor	01	0.4			30	1-10 mm	Ovary		A	DECEASED	2002	TCGA-30-1861-01	TCGA-30-1861-01		617ac2af-9b70-4c2b-b659-02436e604267		TCGA-30-1861-01		TCGA-30-1861-01A-01D-0652-05		TCGA-30-1861-01A-21-1559-20		32a58029-c8aa-4647-a932-bbf57e82fc48	TCGA-30-1861-01A-01D-0648-01	TCGA-30-1861-01	7e253248-d889-4b00-a098-55cfcb18758b		TCGA-30-1861-01A-01D-0648-01	32a58029-c8aa-4647-a932-bbf57e82fc48		32a58029-c8aa-4647-a932-bbf57e82fc48		TCGA-30-1861-01	TCGA-30-1861-01	32a58029-c8aa-4647-a932-bbf57e82fc48		TCGA-30-1861-01A-01R-0655-07	
TCGA-30-1862-01	1	TCGA-30-1862-01	186	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-30-1862			days	186	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			65		TCGA-30-1862-F27593	TCGA-30-1862		Stage IV	-23895		186	0	186						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G2							1862		WITH TUMOR	NO			NO		Primary Tumor	01				30	>20 mm	Ovary			DECEASED	2003	TCGA-30-1862-01	TCGA-30-1862-01		b1c27950-57b3-4a9e-96f6-5c7232951f1c		TCGA-30-1862-01		TCGA-30-1862-01A-02D-0652-05				ab0701bc-0bc5-4008-a75b-5f665ef9c14a	TCGA-30-1862-01A-02D-0648-01	TCGA-30-1862-01			TCGA-30-1862-01A-02D-0648-01	ab0701bc-0bc5-4008-a75b-5f665ef9c14a		ab0701bc-0bc5-4008-a75b-5f665ef9c14a		TCGA-30-1862-01	TCGA-30-1862-01	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	TCGA-30-1862-01A-02W-0699-08	TCGA-30-1862-01A-02R-0655-07	
TCGA-30-1866-01	1	TCGA-30-1866-01	1114	1	days	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-30-1866			days	1114	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-30-1866-F27595	TCGA-30-1866		Stage IV	-22562		1114	0	1114		285				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G2	Recurrence						1866		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				30	1-10 mm	Ovary			DECEASED	2003		TCGA-30-1866-01		a334b0fd-05cc-4aa3-bbff-4439e2807085		TCGA-30-1866-01		TCGA-30-1866-01A-02D-0652-05					TCGA-30-1866-01A-02D-0648-01	TCGA-30-1866-01			TCGA-30-1866-01A-02D-0648-01					TCGA-30-1866-01				TCGA-30-1866-01A-02R-0655-07	
TCGA-30-1867-01	1	TCGA-30-1867-01	37	1	days	High		OV-like c1			miRNA cluster 1	cluster 6		TCGA-30-1867			days	37	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			46		TCGA-30-1867-F27605	TCGA-30-1867	TCGA-30-1867-01A	Stage IV	-17159		37	0	37						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.3	NO		0.3			GX						TCGA-30-1867.420a6b8c-33b8-4b1e-8bba-e299c20611c7.pdf	1867		WITH TUMOR	NO			NO		Primary Tumor	01	0.3			30		Ovary		A	DECEASED	2004		TCGA-30-1867-01		105890a2-5198-4ecf-af7f-6538542dc162		TCGA-30-1867-01		TCGA-30-1867-01A-01D-0652-05					TCGA-30-1867-01A-01D-0648-01	TCGA-30-1867-01			TCGA-30-1867-01A-01D-0648-01					TCGA-30-1867-01				TCGA-30-1867-01A-01R-0655-07	
TCGA-30-1869-01	1	TCGA-30-1869-01	1563	1	days			OV-like c1	OV-like c4					TCGA-30-1869			days	1563	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	50	Bilateral	TCGA-30-1869-F27607	TCGA-30-1869	TCGA-30-1869-01A	Stage IV	-18398		1563	0	1563		767				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection			NO				NO	G3	Recurrence					TCGA-30-1869.8d42d1a4-dff9-47a9-b95b-2eb27747308c.pdf	1869		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				30	1-10 mm	Ovary		A	DECEASED	2004								TCGA-30-1869-01A-01D-0652-05		TCGA-30-1869-01A-21-1559-20					014cbeef-19c7-4ac9-b9a0-5f95e07c5d45												
TCGA-30-1880-01	1	TCGA-30-1880-01	1751	1	days	Squamous		Low purity c2			miRNA cluster 1	cluster 3		TCGA-30-1880			days	1751	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Bilateral	TCGA-30-1880-F27620	TCGA-30-1880	TCGA-30-1880-01A	Stage IIIC	-20525		1751	0	1751		348				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence					TCGA-30-1880.D23622FE-9648-422D-AE92-B21F9B6E5A51.pdf	1880		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.2			30	No Macroscopic disease	Ovary		A	DECEASED	2001		TCGA-30-1880-01		2d39ca81-8c8c-43ab-b065-38627152d132		TCGA-30-1880-01		TCGA-30-1880-01A-01D-0652-05					TCGA-30-1880-01A-01D-0648-01	TCGA-30-1880-01			TCGA-30-1880-01A-01D-0648-01					TCGA-30-1880-01				TCGA-30-1880-01A-01R-0655-07	
TCGA-30-1887-01	1	TCGA-30-1887-01	738	1	days	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-30-1887			days	738	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			67	Bilateral	TCGA-30-1887-F27633	TCGA-30-1887	TCGA-30-1887-01A	Stage IIIC	-24495		738	0	738						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1		YES	G2						TCGA-30-1887.a074363f-dd94-4193-b583-70885400ff2f.pdf	1887		WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.5			30	1-10 mm	Ovary	YES	A	DECEASED	2005		TCGA-30-1887-01		1065d480-5815-40a4-93c6-faa8712a1e94		TCGA-30-1887-01		TCGA-30-1887-01A-01D-0652-05		TCGA-30-1887-01A-21-1559-20			TCGA-30-1887-01A-01D-0648-01	TCGA-30-1887-01	e26411ea-dc83-4441-a0f4-84fd52798fdd		TCGA-30-1887-01A-01D-0648-01					TCGA-30-1887-01				TCGA-30-1887-01A-01R-0655-07	
TCGA-30-1891-01	1	TCGA-30-1891-01	914	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-30-1891			days	914	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-30-1891-F27640	TCGA-30-1891	TCGA-30-1891-01A	Stage IIIC	-22344		914	0	914		181				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.2		NO	G2	Recurrence					TCGA-30-1891.F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B.pdf	1891		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2004	TCGA-30-1891-01	TCGA-30-1891-01		d97a0c15-2c1d-4af3-9e62-ff67cbf7b700		TCGA-30-1891-01		TCGA-30-1891-01A-01D-0652-05		TCGA-30-1891-01A-21-1559-20		690d1437-2a05-4263-8fa7-8f4481893b83	TCGA-30-1891-01A-01D-0648-01	TCGA-30-1891-01	7f8386ef-cf19-4207-86ae-13029c49d944		TCGA-30-1891-01A-01D-0648-01	690d1437-2a05-4263-8fa7-8f4481893b83		690d1437-2a05-4263-8fa7-8f4481893b83		TCGA-30-1891-01	TCGA-30-1891-01	690d1437-2a05-4263-8fa7-8f4481893b83	TCGA-30-1891-01A-01W-0699-08	TCGA-30-1891-01A-01R-0655-07	
TCGA-30-1892-01	1	TCGA-30-1892-01	1484	1	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 3	cluster 6		TCGA-30-1892			days	1484	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Left	TCGA-30-1892-F27654	TCGA-30-1892	TCGA-30-1892-01A	Stage IIIC	-19256		1484	0	1484		253				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence					TCGA-30-1892.fb7c966c-9b16-4781-9c01-2db480c88d63.pdf	1892		WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO		Primary Tumor	01	0.3			30	1-10 mm	Ovary		A	DECEASED	2004		TCGA-30-1892-01		e969eb72-cef5-4c16-b1fd-8a97324ce3e4		TCGA-30-1892-01		TCGA-30-1892-01A-01D-0652-05		TCGA-30-1892-01A-21-1559-20			TCGA-30-1892-01A-01D-0648-01	TCGA-30-1892-01	3c68d944-a329-44c2-8697-2f8c50a8b38c		TCGA-30-1892-01A-01D-0648-01					TCGA-30-1892-01				TCGA-30-1892-01A-01R-0655-07	
TCGA-31-1944-01	0	TCGA-31-1944-01	1386	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-31-1944			days	1386	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-31-1944-F27668	TCGA-31-1944	TCGA-31-1944-01A	Stage IIIC	-17207			0	1386		678				2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3	Recurrence					TCGA-31-1944.bd7361f7-07c1-4be8-92c6-4f0a3dea99b2.pdf	1944		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			31	No Macroscopic disease	Ovary	YES	A	LIVING	2005	TCGA-31-1944-01	TCGA-31-1944-01		b9b5c6a5-cbc8-4645-9ce1-131c26e36683		TCGA-31-1944-01		TCGA-31-1944-01A-01D-0652-05		TCGA-31-1944-01A-21-1559-20		c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	TCGA-31-1944-01A-01D-0648-01	TCGA-31-1944-01	332735d2-c077-400a-b011-1f0984b07339		TCGA-31-1944-01A-01D-0648-01	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2		c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2		TCGA-31-1944-01	TCGA-31-1944-01	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2		TCGA-31-1944-01A-01R-0655-07	
TCGA-31-1946-01	0	TCGA-31-1946-01	918	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-31-1946			days	918	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	30	Bilateral	TCGA-31-1946-F27679	TCGA-31-1946	TCGA-31-1946-01A	Stage IIIC	-11146			0	918		664				2009-10-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1		NO	G3	Recurrence					TCGA-31-1946.5ef31a8f-38e7-486b-8efc-99cd8c1ec06d.pdf	1946		WITH TUMOR	YES		Physical Examination	NO		Primary Tumor	01	0.3			31	No Macroscopic disease	Ovary	YES	A	LIVING	2006	TCGA-31-1946-01	TCGA-31-1946-01		fb4cc131-9ac0-4615-b8c1-802273c4c6cf		TCGA-31-1946-01		TCGA-31-1946-01A-01D-0652-05		TCGA-31-1946-01A-21-1559-20		05abb2f5-07c3-42da-92d9-0b4560fb6f09	TCGA-31-1946-01A-01D-0648-01	TCGA-31-1946-01	fb44d557-9e0a-40d5-83c3-3b9431e72d9d		TCGA-31-1946-01A-01D-0648-01	05abb2f5-07c3-42da-92d9-0b4560fb6f09		05abb2f5-07c3-42da-92d9-0b4560fb6f09		TCGA-31-1946-01	TCGA-31-1946-01	05abb2f5-07c3-42da-92d9-0b4560fb6f09		TCGA-31-1946-01A-01R-0655-07	
TCGA-31-1950-01	0	TCGA-31-1950-01	571	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-31-1950			days	571	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-31-1950-F27688	TCGA-31-1950	TCGA-31-1950-01A	Stage IIIC	-28100			0	571		349	1			2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.2		NO	G2	Recurrence					TCGA-31-1950.4ed80cbd-e56d-4d09-b8ac-2b6535346b73.pdf	1950	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.2			31	1-10 mm	Ovary	NO	A	LIVING	2007		TCGA-31-1950-01		72689370-cb7a-4e3b-8964-2dcde6633902		TCGA-31-1950-01		TCGA-31-1950-01A-01D-0652-05		TCGA-31-1950-01A-21-1559-20		a32eba80-dbe9-464e-8102-5f77a3c7e177	TCGA-31-1950-01A-01D-0648-01	TCGA-31-1950-01	6f927c4d-19b8-4bc9-92eb-da2402ed6e31		TCGA-31-1950-01A-01D-0648-01	a32eba80-dbe9-464e-8102-5f77a3c7e177		a32eba80-dbe9-464e-8102-5f77a3c7e177	TCGA-31-1950-01A-01W-0699-08	TCGA-31-1950-01		a32eba80-dbe9-464e-8102-5f77a3c7e177	TCGA-31-1950-01A-01W-0699-08	TCGA-31-1950-01A-01R-0655-07	
TCGA-31-1951-01	0	TCGA-31-1951-01	684	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-31-1951			days	684	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Left	TCGA-31-1951-F27692	TCGA-31-1951	TCGA-31-1951-01A	Stage IIIC	-21352			0	684		659				2010-1-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.7		YES	G3	Recurrence					TCGA-31-1951.b10efe75-1420-47d2-9c5b-202b09099357.pdf	1951		WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01	0.3			31	No Macroscopic disease	Ovary	YES	A	LIVING	2007	TCGA-31-1951-01	TCGA-31-1951-01		c9806ee2-6323-4078-bfc0-6fc773a7f66e		TCGA-31-1951-01		TCGA-31-1951-01A-01D-0652-05		TCGA-31-1951-01A-21-1559-20		197ea6b5-5716-4e5c-9c7f-92ed4521682a	TCGA-31-1951-01A-01D-0648-01	TCGA-31-1951-01	a6bb52ad-58cf-4ee0-ae89-9615811f4de6		TCGA-31-1951-01A-01D-0648-01	197ea6b5-5716-4e5c-9c7f-92ed4521682a		197ea6b5-5716-4e5c-9c7f-92ed4521682a		TCGA-31-1951-01	TCGA-31-1951-01	197ea6b5-5716-4e5c-9c7f-92ed4521682a		TCGA-31-1951-01A-01R-0655-07	
TCGA-31-1953-01	0	TCGA-31-1953-01	204	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-31-1953			days	204	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Bilateral	TCGA-31-1953-F27698	TCGA-31-1953	TCGA-31-1953-01A	Stage IIIC	-19064			0	204		70	1			2009-10-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1		NO	G3	Recurrence					TCGA-31-1953.c824400d-b062-4a04-b805-f717426d688e.pdf	1953	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.1			31		Ovary	NO	A	LIVING	2008	TCGA-31-1953-01	TCGA-31-1953-01		b3f75e69-3519-46eb-821c-773c2506d7fd		TCGA-31-1953-01		TCGA-31-1953-01A-01D-0652-05				7b31fc47-0299-4449-aa5b-622ba549371f	TCGA-31-1953-01A-01D-0648-01	TCGA-31-1953-01			TCGA-31-1953-01A-01D-0648-01	7b31fc47-0299-4449-aa5b-622ba549371f		7b31fc47-0299-4449-aa5b-622ba549371f		TCGA-31-1953-01	TCGA-31-1953-01	7b31fc47-0299-4449-aa5b-622ba549371f	TCGA-31-1953-01A-01W-0699-08	TCGA-31-1953-01A-01R-0655-07	
TCGA-31-1955-01	0	TCGA-31-1955-01	1293	0	days	Squamous		OV-like c1	OV-like c4					TCGA-31-1955			days	1293	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	43	Bilateral	TCGA-31-1955-F27704	TCGA-31-1955	TCGA-31-1955-01A	Stage IIIC	-15926			0	1293		918				2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.4		NO	G3	Recurrence					TCGA-31-1955.16f5a24e-2c57-42fe-bd79-ef174d44b8b1.pdf	1955		WITH TUMOR	YES		Physical Examination	YES		Primary Tumor	01	0.4			31	No Macroscopic disease	Ovary	YES	A	LIVING	2005								TCGA-31-1955-01A-01D-0652-05		TCGA-31-1955-01A-21-1559-20			TCGA-31-1955-01A-01D-0648-01	TCGA-31-1955-01	47461ed4-1491-4f27-bd9c-cbd1ee184f5a		TCGA-31-1955-01A-01D-0648-01					TCGA-31-1955-01				TCGA-31-1955-01A-01R-0655-07	
TCGA-31-1956-01	0	TCGA-31-1956-01	1342	0	days	Squamous		OV-like c1		OV-like c16	miRNA cluster 3	cluster 6		TCGA-31-1956			days	1342	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Left	TCGA-31-1956-F27711	TCGA-31-1956	TCGA-31-1956-01A	Stage IIIB	-22100			0	1342	119					2009-10-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		YES	G3	Locoregional Disease	YES				TCGA-31-1956.3646c24b-c4b7-400b-bc93-7ef485c6892c.pdf	1956		WITH TUMOR	YES			NO		Primary Tumor	01	0.2			31		Ovary	NO	A	LIVING	2005	TCGA-31-1956-01	TCGA-31-1956-01		c6dcadc5-be05-4d61-b82a-bc5111fb2634		TCGA-31-1956-01		TCGA-31-1956-01A-01D-0652-05				24cfcfd9-ce30-4e24-9470-60265efd6721	TCGA-31-1956-01A-01D-0648-01	TCGA-31-1956-01			TCGA-31-1956-01A-01D-0648-01	24cfcfd9-ce30-4e24-9470-60265efd6721		24cfcfd9-ce30-4e24-9470-60265efd6721		TCGA-31-1956-01	TCGA-31-1956-01	24cfcfd9-ce30-4e24-9470-60265efd6721		TCGA-31-1956-01A-01R-0655-07	
TCGA-31-1959-01	0	TCGA-31-1959-01	67	0	days	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-31-1959			days	67	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Bilateral	TCGA-31-1959-F27715	TCGA-31-1959	TCGA-31-1959-01A	Stage IV	-18247			0	67						2009-10-20	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy		0.7	NO		1.1		YES	G2						TCGA-31-1959.c78c6998-1f86-4dd2-bf41-78f12d43c33a.pdf	1959		WITH TUMOR	YES			NO		Primary Tumor	01	0.2			31		Ovary	YES	A	LIVING	2009	TCGA-31-1959-01	TCGA-31-1959-01		427e1629-b22d-4421-b6f5-ffbd672fd164		TCGA-31-1959-01		TCGA-31-1959-01A-01D-0652-05				25b1eb9f-7b97-4da2-96a9-a4a3aaaca192	TCGA-31-1959-01A-01D-0648-01	TCGA-31-1959-01			TCGA-31-1959-01A-01D-0648-01	25b1eb9f-7b97-4da2-96a9-a4a3aaaca192		25b1eb9f-7b97-4da2-96a9-a4a3aaaca192		TCGA-31-1959-01	TCGA-31-1959-01	25b1eb9f-7b97-4da2-96a9-a4a3aaaca192	TCGA-31-1959-01A-01W-0699-08	TCGA-31-1959-01A-01R-0655-07	
TCGA-36-1568-01	0	TCGA-36-1568-01	875	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-36-1568			days	875	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	52	Bilateral	TCGA-36-1568-F27850	TCGA-36-1568	TCGA-36-1568-01A	Stage IIIC	-19311			0	875		548				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.6		NO	G3	Recurrence					TCGA-36-1568.dad4bbdc-0156-48c2-a975-27ccfb9152a3.pdf	1568		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			36		Ovary		A	LIVING	2007	TCGA-36-1568-01	TCGA-36-1568-01	TCGA-36-1568-01A-01W-0615-10	cde7f1d6-c4c9-4fc3-a6cf-696addee91d6		TCGA-36-1568-01	TCGA-36-1568-01A-01W-0615-10	TCGA-36-1568-01A-01D-0536-05		TCGA-36-1568-01A-21-1558-20		4e539c62-454a-4b1c-bde1-6951ee12d109	TCGA-36-1568-01A-01D-0533-01	TCGA-36-1568-01	b9598717-cdb9-49e1-a8d5-49ec5189cb31		TCGA-36-1568-01A-01D-0533-01	4e539c62-454a-4b1c-bde1-6951ee12d109		4e539c62-454a-4b1c-bde1-6951ee12d109		TCGA-36-1568-01	TCGA-36-1568-01	4e539c62-454a-4b1c-bde1-6951ee12d109	TCGA-36-1568-01A-01W-0615-10	TCGA-36-1568-01A-01R-0540-07	
TCGA-36-1569-01	0	TCGA-36-1569-01	885	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-36-1569			days	885	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Bilateral	TCGA-36-1569-F27855	TCGA-36-1569	TCGA-36-1569-01A	Stage IIIC	-19151			0	885			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.6		YES	G3						TCGA-36-1569.52192360-2ACE-401C-9642-B3D6F677362D.pdf	1569	Preoperative		YES	Partial Remission/Response		NO		Primary Tumor	01	0.4			36	1-10 mm	Ovary		A	LIVING	2007	TCGA-36-1569-01	TCGA-36-1569-01	TCGA-36-1569-01A-01W-0615-10	3ae2deaa-bc6d-4b38-b9ea-56e91c83b53a		TCGA-36-1569-01	TCGA-36-1569-01A-01W-0615-10	TCGA-36-1569-01A-01D-0536-05		TCGA-36-1569-01A-21-1558-20		bb12d2f5-1865-435a-8edf-f9ee7689e0a4	TCGA-36-1569-01A-01D-0533-01	TCGA-36-1569-01	44783ce8-15cb-45b3-9a4f-e45925356334		TCGA-36-1569-01A-01D-0533-01	bb12d2f5-1865-435a-8edf-f9ee7689e0a4		bb12d2f5-1865-435a-8edf-f9ee7689e0a4		TCGA-36-1569-01	TCGA-36-1569-01	bb12d2f5-1865-435a-8edf-f9ee7689e0a4	TCGA-36-1569-01A-01W-0615-10	TCGA-36-1569-01A-01R-0540-07	
TCGA-36-1570-01	0	TCGA-36-1570-01	655	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-36-1570			days	655	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	49	Bilateral	TCGA-36-1570-F27857	TCGA-36-1570	TCGA-36-1570-01A	Stage IIIC	-17956			0	655		375	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.3		YES	G3	Recurrence					TCGA-36-1570.f83833f4-a820-4fb9-a040-c238084976c3.pdf	1570	Preoperative	WITH TUMOR	YES	Partial Remission/Response	Physical Examination	NO		Primary Tumor	01	0.7			36	>20 mm	Ovary	YES	A	LIVING	2007	TCGA-36-1570-01	TCGA-36-1570-01	TCGA-36-1570-01A-01W-0615-10	2893bba4-3d68-4a21-97d6-51342437a657		TCGA-36-1570-01	TCGA-36-1570-01A-01W-0615-10	TCGA-36-1570-01A-01D-0536-05		TCGA-36-1570-01A-21-1558-20		cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	TCGA-36-1570-01A-01D-0533-01	TCGA-36-1570-01	0bd6d1dc-2f53-479b-bbaa-ef70250341a2		TCGA-36-1570-01A-01D-0533-01	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7		cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7		TCGA-36-1570-01	TCGA-36-1570-01	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	TCGA-36-1570-01A-01W-0615-10	TCGA-36-1570-01A-01R-0540-07	
TCGA-36-1571-01	1	TCGA-36-1571-01	695	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-36-1571			days	695	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-36-1571-F27862	TCGA-36-1571	TCGA-36-1571-01A	Stage IIIB	-19608		695	0	695		375				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		NO	G3	Recurrence					TCGA-36-1571.cee6fb75-8fcc-4347-824e-b00b96e6e481.pdf	1571		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.9			36	No Macroscopic disease	Ovary	NO	A	DECEASED	2007	TCGA-36-1571-01	TCGA-36-1571-01	TCGA-36-1571-01A-01W-0615-10	62f86b95-1bfe-4123-8f09-311c9c826de0		TCGA-36-1571-01	TCGA-36-1571-01A-01W-0615-10	TCGA-36-1571-01A-01D-0536-05		TCGA-36-1571-01A-21-1558-20		55c68aef-938c-4f68-a74d-f408673fff9c	TCGA-36-1571-01A-01D-0533-01	TCGA-36-1571-01	8add1736-9ac5-4d0e-9969-7ea6ffaf635c		TCGA-36-1571-01A-01D-0533-01	55c68aef-938c-4f68-a74d-f408673fff9c		55c68aef-938c-4f68-a74d-f408673fff9c		TCGA-36-1571-01	TCGA-36-1571-01	55c68aef-938c-4f68-a74d-f408673fff9c	TCGA-36-1571-01A-01W-0615-10	TCGA-36-1571-01A-01R-0540-07	
TCGA-36-1574-01	0	TCGA-36-1574-01	686	0	days	Squamous	C9-OV	Low purity c2		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-36-1574			days	686	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	48	Bilateral	TCGA-36-1574-F27868	TCGA-36-1574		Stage IIIC	-17847			0	686		648	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence						1574	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				36	>20 mm	Ovary			LIVING	2007	TCGA-36-1574-01	TCGA-36-1574-01	TCGA-36-1574-01A-01W-0615-10	d83bcf90-4a10-4318-ac80-4ae41ea88894		TCGA-36-1574-01	TCGA-36-1574-01A-01W-0615-10	TCGA-36-1574-01A-01D-0536-05				ff781a4f-7281-4195-880f-3df099a401cc	TCGA-36-1574-01A-01D-0533-01	TCGA-36-1574-01			TCGA-36-1574-01A-01D-0533-01	ff781a4f-7281-4195-880f-3df099a401cc		ff781a4f-7281-4195-880f-3df099a401cc		TCGA-36-1574-01	TCGA-36-1574-01	ff781a4f-7281-4195-880f-3df099a401cc	TCGA-36-1574-01A-01W-0615-10	TCGA-36-1574-01A-01R-0540-07	
TCGA-36-1575-01	0	TCGA-36-1575-01	260	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-36-1575			days	260	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			83		TCGA-36-1575-F27872	TCGA-36-1575		Stage IIIB	-30592			0	260						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G3							1575		TUMOR FREE	YES			NO		Primary Tumor	01				36	No Macroscopic disease	Ovary	NO		LIVING	2006	TCGA-36-1575-01	TCGA-36-1575-01	TCGA-36-1575-01A-01W-0615-10	fb275fb0-6793-4401-99a0-5d3bdf2a7ac0		TCGA-36-1575-01	TCGA-36-1575-01A-01W-0615-10	TCGA-36-1575-01A-01D-0536-05		TCGA-36-1575-01A-21-1558-20		a28ef775-c78b-416f-afeb-89ba265440f0	TCGA-36-1575-01A-01D-0533-01	TCGA-36-1575-01	ba2a2d99-a0a6-4d8d-a207-d1a82501f18d		TCGA-36-1575-01A-01D-0533-01	a28ef775-c78b-416f-afeb-89ba265440f0		a28ef775-c78b-416f-afeb-89ba265440f0		TCGA-36-1575-01	TCGA-36-1575-01	a28ef775-c78b-416f-afeb-89ba265440f0	TCGA-36-1575-01A-01W-0615-10	TCGA-36-1575-01A-01R-0540-07	
TCGA-36-1576-01	0	TCGA-36-1576-01	915	0	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-36-1576			days	915	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76		TCGA-36-1576-F27874	TCGA-36-1576	TCGA-36-1576-01A	Stage IIIC	-27778			0	915		817	2			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		2.6		YES	G3	Recurrence					TCGA-36-1576.2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f.pdf	1576	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			36	>20 mm	Ovary	YES	A	LIVING	2006	TCGA-36-1576-01	TCGA-36-1576-01	TCGA-36-1576-01A-01W-0615-10	15528051-b343-4e7d-9433-b9fc052e7d77		TCGA-36-1576-01	TCGA-36-1576-01A-01W-0615-10	TCGA-36-1576-01A-01D-0536-05		TCGA-36-1576-01A-21-1558-20		55b6bd7c-e77d-4019-93e9-b5410e4807b2	TCGA-36-1576-01A-01D-0533-01	TCGA-36-1576-01	e1158086-b305-4b38-8ebe-43bd33c73952		TCGA-36-1576-01A-01D-0533-01	55b6bd7c-e77d-4019-93e9-b5410e4807b2		55b6bd7c-e77d-4019-93e9-b5410e4807b2		TCGA-36-1576-01	TCGA-36-1576-01	55b6bd7c-e77d-4019-93e9-b5410e4807b2	TCGA-36-1576-01A-01W-0615-10	TCGA-36-1576-01A-01R-0540-07	
TCGA-36-1577-01	0	TCGA-36-1577-01	783	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-36-1577			days	783	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			43	Bilateral	TCGA-36-1577-F27878	TCGA-36-1577	TCGA-36-1577-01A	Stage IIC	-15804			0	783						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		1.7			G2						TCGA-36-1577.0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc.pdf	1577		TUMOR FREE	YES	Complete Remission/Response		YES		Primary Tumor	01	0.6			36	No Macroscopic disease	Ovary		A	LIVING	2007	TCGA-36-1577-01	TCGA-36-1577-01	TCGA-36-1577-01A-01W-0615-10	ea44120c-4ba1-426a-a989-11ce1ca54e15		TCGA-36-1577-01	TCGA-36-1577-01A-01W-0615-10	TCGA-36-1577-01A-01D-0536-05		TCGA-36-1577-01A-21-1558-20		9ec93bbd-5c62-4974-984f-f86301f0d27e	TCGA-36-1577-01A-01D-0533-01	TCGA-36-1577-01	ec733c30-ab8b-454e-88f9-8ee34bcf0416		TCGA-36-1577-01A-01D-0533-01	9ec93bbd-5c62-4974-984f-f86301f0d27e		9ec93bbd-5c62-4974-984f-f86301f0d27e		TCGA-36-1577-01	TCGA-36-1577-01	9ec93bbd-5c62-4974-984f-f86301f0d27e	TCGA-36-1577-01A-01W-0615-10	TCGA-36-1577-01A-01R-0540-07	
TCGA-36-1578-01	0	TCGA-36-1578-01	847	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-36-1578			days	847	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63		TCGA-36-1578-F27884	TCGA-36-1578	TCGA-36-1578-01A	Stage IV	-23329			0	847		310	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		0.6			G3	Recurrence					TCGA-36-1578.6BD44F43-7D75-4DF3-891D-7E08291F020C.pdf	1578	Preoperative	WITH TUMOR	YES		Imaging Study	NO		Primary Tumor	01	0.5			36	>20 mm	Ovary	NO	A	LIVING	2007	TCGA-36-1578-01	TCGA-36-1578-01	TCGA-36-1578-01A-01W-0615-10	644de2b8-bb23-4161-b6dc-dbb926d573f0		TCGA-36-1578-01	TCGA-36-1578-01A-01W-0615-10	TCGA-36-1578-01A-01D-0536-05		TCGA-36-1578-01A-21-1558-20		7ecb58fe-e2fe-4dc8-996b-2b959da43566	TCGA-36-1578-01A-01D-0533-01	TCGA-36-1578-01	cb41005f-cf76-417e-9ce8-8b5d3047609c		TCGA-36-1578-01A-01D-0533-01	7ecb58fe-e2fe-4dc8-996b-2b959da43566		7ecb58fe-e2fe-4dc8-996b-2b959da43566		TCGA-36-1578-01	TCGA-36-1578-01	7ecb58fe-e2fe-4dc8-996b-2b959da43566	TCGA-36-1578-01A-01W-0615-10	TCGA-36-1578-01A-01R-0540-07	
TCGA-36-1580-01	1	TCGA-36-1580-01	737	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-36-1580			days	737	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	82		TCGA-36-1580-F27889	TCGA-36-1580	TCGA-36-1580-01A	Stage IIIC	-29992		737	0	737		440	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		2			G3	Recurrence					TCGA-36-1580.a647e4da-8579-4848-b545-bc857db85d98.pdf	1580	Preoperative	WITH TUMOR	YES		Physical Examination	NO		Primary Tumor	01	0.4			36	>20 mm	Ovary		A	DECEASED	2007	TCGA-36-1580-01	TCGA-36-1580-01	TCGA-36-1580-01A-01W-0615-10	2b7461a0-84ad-4a91-b136-395c33f059fc		TCGA-36-1580-01	TCGA-36-1580-01A-01W-0615-10	TCGA-36-1580-01A-01D-0536-05		TCGA-36-1580-01A-21-1558-20		6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	TCGA-36-1580-01A-01D-0533-01	TCGA-36-1580-01	1d325272-4508-4a42-97ba-9e59edf59993		TCGA-36-1580-01A-01D-0533-01	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3		6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3		TCGA-36-1580-01	TCGA-36-1580-01	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	TCGA-36-1580-01A-01W-0615-10	TCGA-36-1580-01A-01R-0540-07	
TCGA-36-1581-01	0	TCGA-36-1581-01	751	0	days	High	C1-LUAD-enriched	Cluster 5	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 6		TCGA-36-1581			days	751	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Left	TCGA-36-1581-F27893	TCGA-36-1581		Stage IIC	-23272			0	751		702	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3	Recurrence						1581	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01				36	No Macroscopic disease	Ovary			LIVING	2007	TCGA-36-1581-01	TCGA-36-1581-01		ba4c8ab9-f8ee-48ab-a513-ab43f71b8723		TCGA-36-1581-01		TCGA-36-1581-01A-01D-0536-05		TCGA-36-1581-01A-03-1563-20		d84c76a9-dbee-4720-8639-91382101b27a	TCGA-36-1581-01A-01D-0533-01	TCGA-36-1581-01	c3ce568b-8558-45db-97b4-23882e482cbf		TCGA-36-1581-01A-01D-0533-01	d84c76a9-dbee-4720-8639-91382101b27a		d84c76a9-dbee-4720-8639-91382101b27a		TCGA-36-1581-01	TCGA-36-1581-01	d84c76a9-dbee-4720-8639-91382101b27a		TCGA-36-1581-01A-01R-0540-07	
TCGA-36-2529-01	0	TCGA-36-2529-01	1066	0	days	High		OV-like c1	OV-like c4					TCGA-36-2529			days	1066	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-36-2529-F27897	TCGA-36-2529		Stage IIIC	-26092			0	1066		567	0			2010-8-17	FEMALE	Serous Cystadenocarcinoma	No	C48.2	8441/3	C48.2	YES	Tumor resection								G3	Recurrence						2529	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Physical Examination	NO	R1	Primary Tumor	01				36	>20 mm	Peritoneum ovary			LIVING	2007				d63b58d4-56b8-4879-b103-74cb3f92c242				TCGA-36-2529-01A-01D-1047-05		TCGA-36-2529-01A-21-1560-20			TCGA-36-2529-01A-01D-1043-01	TCGA-36-2529-01	a954f069-3088-49e6-839f-d823017cfa40		TCGA-36-2529-01A-01D-1043-01					TCGA-36-2529-01				TCGA-36-2529-01A-01R-1050-07	
TCGA-36-2530-01	0	TCGA-36-2530-01	1004	0	days	Squamous			OV-like c4					TCGA-36-2530			days	1004	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	38	Bilateral	TCGA-36-2530-F27906	TCGA-36-2530		Stage IIIC	-13885			0	1004		630				2010-8-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)							NO	G3	Recurrence						2530		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01				36	11-20 mm	Ovary			LIVING	2007				f4fa786b-3eaf-45ab-9d3e-4cf7ec61de3c						TCGA-36-2530-01A-21-1560-20	TCGA-36-2530-01A-01D-1526-09		TCGA-36-2530-01A-01D-1043-01	TCGA-36-2530-01	ae583504-181e-4199-a79c-8fd11d3c99af		TCGA-36-2530-01A-01D-1043-01					TCGA-36-2530-01				TCGA-36-2530-01A-01R-1050-07	
TCGA-36-2532-01	0	TCGA-36-2532-01	897	0	days	Squamous		OV-like c1	OV-like c4					TCGA-36-2532			days	897	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			61	Bilateral	TCGA-36-2532-F27913	TCGA-36-2532	TCGA-36-2532-01A	Stage IIIC	-22333			0	897						2010-8-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy		0.9	NO		2.7		YES	G3						TCGA-36-2532.d99b756c-2a3c-48cd-844e-ce61f811c3a0.pdf	2532		WITH TUMOR	YES			NO	R0	Primary Tumor	01	0.7			36	No Macroscopic disease	Ovary	YES	A	LIVING	2007				0830b9f6-0220-4c58-9c8b-58478ac2f49e				TCGA-36-2532-01A-01D-1047-05		TCGA-36-2532-01A-21-1560-20	TCGA-36-2532-01A-01D-1526-09		TCGA-36-2532-01A-01D-1043-01	TCGA-36-2532-01	0ee5a901-a30a-493d-895a-6e674967a5eb		TCGA-36-2532-01A-01D-1043-01					TCGA-36-2532-01				TCGA-36-2532-01A-01R-1050-07	
TCGA-36-2533-01		TCGA-36-2533-01			days	Squamous		OV-like c1	OV-like c4					TCGA-36-2533			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Right		TCGA-36-2533	TCGA-36-2533-01A	Stage IIIC	-20187			0	0						2010-9-14	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1		YES	G3						TCGA-36-2533.ebe9dfc0-28ac-4d22-a18b-b910aa2814e0.pdf	2533								Primary Tumor	01	0.4			36		Ovary		A		2007				06bf48f2-1c9a-42eb-bf68-505501a4c354				TCGA-36-2533-01A-01D-1047-05		TCGA-36-2533-01A-21-1560-20	TCGA-36-2533-01A-01D-1526-09		TCGA-36-2533-01A-01D-1043-01	TCGA-36-2533-01	6b83e35e-5d42-43db-a0cc-a5979af12af3		TCGA-36-2533-01A-01D-1043-01					TCGA-36-2533-01				TCGA-36-2533-01A-01R-1050-07	
TCGA-36-2534-01	0	TCGA-36-2534-01	907	0	days	Squamous		OV-like c1	OV-like c4					TCGA-36-2534			days	907	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	72	Right	TCGA-36-2534-F27918	TCGA-36-2534	TCGA-36-2534-01A	Stage IIIC	-26621			0	907		383	1			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5			G3	Progression of Disease					TCGA-36-2534.b62a4922-ad09-4422-8cb2-bea80a0fe533.pdf	2534	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.5			36	>20 mm	Ovary		A	LIVING	2007				39d1a308-db4f-4161-ad51-7cb9ccb4d059				TCGA-36-2534-01A-01D-1047-05		TCGA-36-2534-01A-21-1560-20	TCGA-36-2534-01A-01D-1526-09		TCGA-36-2534-01A-01D-1043-01	TCGA-36-2534-01	d32b063f-7dc4-4081-8ba5-301ea0f98089		TCGA-36-2534-01A-01D-1043-01					TCGA-36-2534-01				TCGA-36-2534-01A-01R-1050-07	
TCGA-36-2537-01	0	TCGA-36-2537-01	788	0	days	Squamous		OV-like c1	OV-like c4					TCGA-36-2537			days	788	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	39	Bilateral	TCGA-36-2537-F27923	TCGA-36-2537	TCGA-36-2537-01A	Stage IIIC	-14595			0	788		431	2			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.2			G3	Progression of Disease					TCGA-36-2537.9b122691-9140-439e-9ef6-16701081b905.pdf	2537	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.8			36	>20 mm	Ovary		A	LIVING	2008				74f16c9d-4f75-4307-a243-35a387eb20db				TCGA-36-2537-01A-01D-1047-05		TCGA-36-2537-01A-21-1560-20	TCGA-36-2537-01A-01D-1526-09		TCGA-36-2537-01A-01D-1043-01	TCGA-36-2537-01	dab8df2a-7a8a-4735-9548-ebac64341b3a		TCGA-36-2537-01A-01D-1043-01					TCGA-36-2537-01				TCGA-36-2537-01A-01R-1050-07	
TCGA-36-2538-01	0	TCGA-36-2538-01	763	0	days	Squamous		OV-like c1	OV-like c4					TCGA-36-2538			days	763	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	37	Right	TCGA-36-2538-F27930	TCGA-36-2538	TCGA-36-2538-01A	Stage IIIB	-13681			0	763		523				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		1		NO	G3	Recurrence					TCGA-36-2538.e78dd67e-58f2-4b75-b3a5-1ca9ee6e01e5.pdf	2538		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.3			36	11-20 mm	Ovary	NO	A	LIVING	2008				8e5e1961-d950-4ae8-9f07-1c5a10c82ad4				TCGA-36-2538-01A-01D-1047-05		TCGA-36-2538-01A-21-20	TCGA-36-2538-01A-01D-1526-09		TCGA-36-2538-01A-01D-1043-01	TCGA-36-2538-01	da67724e-5273-48f5-8545-56c9a944c0a8		TCGA-36-2538-01A-01D-1043-01					TCGA-36-2538-01				TCGA-36-2538-01A-01R-1050-07	
TCGA-36-2539-01		TCGA-36-2539-01			days	Squamous		OV-like c1	OV-like c4					TCGA-36-2539			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-36-2539-01A																						0.6	NO		1.3									TCGA-36-2539.c388f1d4-53dd-4e8b-bc68-ded38c816530.pdf									Primary Tumor	01	0.4							A						f335ca72-d387-445f-a46c-542b608b2646				TCGA-36-2539-01A-01D-1047-05		TCGA-36-2539-01A-21-20	TCGA-36-2539-01A-01D-1526-09		TCGA-36-2539-01A-01D-1043-01		22ebbb58-a3c5-4473-82e6-4c4e0a5995e5		TCGA-36-2539-01A-01D-1043-01									TCGA-36-2539-01A-01R-1050-07	
TCGA-36-2540-01	0	TCGA-36-2540-01	724	0	days	Kirc+		Low purity c2	OV-like c4					TCGA-36-2540			days	724	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	26	Bilateral	TCGA-36-2540-F27936	TCGA-36-2540	TCGA-36-2540-01A	Stage IIIC	-9760			0	724		665	0			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		YES	G1	Recurrence					TCGA-36-2540.d66d4750-20f9-4e75-bdb7-b48de6dbc449.pdf	2540	Preoperative	WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.2			36	>20 mm	Ovary	YES	A	LIVING	2008				75cee431-5541-49ea-a935-5e3b287f367b				TCGA-36-2540-01A-01D-1047-05		TCGA-36-2540-01A-21-20	TCGA-36-2540-01A-01D-1526-09		TCGA-36-2540-01A-01D-1043-01	TCGA-36-2540-01	72b43e39-cb64-4610-b39e-02cc4b39c541		TCGA-36-2540-01A-01D-1043-01					TCGA-36-2540-01				TCGA-36-2540-01A-01R-1050-07	
TCGA-36-2542-01	0	TCGA-36-2542-01	657	0	days	Squamous		OV-like c1	OV-like c4					TCGA-36-2542			days	657	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Bilateral	TCGA-36-2542-F27942	TCGA-36-2542		Stage IIIB	-21902			0	657						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3							2542		TUMOR FREE	YES	Complete Remission/Response		NO	R1	Primary Tumor	01				36	1-10 mm	Ovary			LIVING	2008				e4d9b54f-bf90-484f-9f85-06cd87712fd7				TCGA-36-2542-01A-01D-1047-05		TCGA-36-2542-01A-21-20	TCGA-36-2542-01A-01D-1526-09		TCGA-36-2542-01A-01D-1043-01	TCGA-36-2542-01	e58dd1a4-afb0-40c4-a0b2-aad520bcd0c9		TCGA-36-2542-01A-01D-1043-01					TCGA-36-2542-01				TCGA-36-2542-01A-01R-1050-07	
TCGA-36-2543-01	1	TCGA-36-2543-01	68	1	days	High		OV-like c1	OV-like c4					TCGA-36-2543			days	68	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	85	Bilateral	TCGA-36-2543-F27946	TCGA-36-2543	TCGA-36-2543-01A	Stage IIIC	-31211		68	0	68		27	3			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.5	NO		1.6			G3	Progression of Disease					TCGA-36-2543.ec25ac8e-1a07-459b-a986-c78edfff88c0.pdf	2543	Other	WITH TUMOR	NO	Progressive Disease		NO	R1	Primary Tumor	01	0.4			36	>20 mm	Ovary		A	DECEASED	2008				c25023f6-f376-41b0-8346-3f898a11fd1f				TCGA-36-2543-01A-01D-1047-05		TCGA-36-2543-01A-21-20	TCGA-36-2543-01A-01D-1526-09		TCGA-36-2543-01A-01D-1043-01	TCGA-36-2543-01	2146a3b5-3eb9-47be-9143-3a5de8c4a0d5		TCGA-36-2543-01A-01D-1043-01					TCGA-36-2543-01				TCGA-36-2543-01A-01R-1050-07	
TCGA-36-2544-01	0	TCGA-36-2544-01	638	0	days	Squamous		OV-like c1	OV-like c4					TCGA-36-2544			days	638	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-36-2544-F27948	TCGA-36-2544	TCGA-36-2544-01A	Stage IIIC	-21384			0	638		325				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		2.3			G3	Progression of Disease					TCGA-36-2544.87f69148-d6fb-4b70-8404-c24b106b6195.pdf	2544		WITH TUMOR	YES	Partial Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.7			36	>20 mm	Ovary		A	LIVING	2008				7f53f5f6-c900-4ebb-87d8-9e1edcbe1de5				TCGA-36-2544-01A-01D-1047-05		TCGA-36-2544-01A-21-20	TCGA-36-2544-01A-01D-1526-09		TCGA-36-2544-01A-01D-1043-01	TCGA-36-2544-01	5ef7b46e-b379-4137-a5ab-91c9d6de74a3		TCGA-36-2544-01A-01D-1043-01					TCGA-36-2544-01				TCGA-36-2544-01A-01R-1050-07	
TCGA-36-2545-01	0	TCGA-36-2545-01	557	0	days	Squamous		OV-like c1	OV-like c4					TCGA-36-2545			days	557	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			42	Bilateral	TCGA-36-2545-F27954	TCGA-36-2545	TCGA-36-2545-01A	Stage IIIA	-15444			0	557						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		2			G3						TCGA-36-2545.e8e6f050-7372-41f3-b198-72ddb241fb08.pdf	2545		TUMOR FREE	YES			NO	R0	Primary Tumor	01	0.8			36	No Macroscopic disease	Ovary		A	LIVING	2008				625f1165-c70d-4a7f-be3b-ff55aca5ca12				TCGA-36-2545-01A-01D-1047-05		TCGA-36-2545-01A-21-20	TCGA-36-2545-01A-01D-1526-09		TCGA-36-2545-01A-01D-1043-01	TCGA-36-2545-01	ecfb4f91-8c7a-465b-86f0-054855f71fe5		TCGA-36-2545-01A-01D-1043-01					TCGA-36-2545-01				TCGA-36-2545-01A-01R-1050-07	
TCGA-36-2547-01	0	TCGA-36-2547-01	624	0	days	High		OV-like c1	OV-like c4					TCGA-36-2547			days	624	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64	Left	TCGA-36-2547-F27958	TCGA-36-2547	TCGA-36-2547-01A	Stage IIIC	-23706			0	624						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.7			G3						TCGA-36-2547.f615f400-96c3-42f3-bee9-c273b1a16b63.pdf	2547			YES			NO	R0	Primary Tumor	01	0.7			36	No Macroscopic disease	Ovary		A	LIVING	2008				40ca7354-e907-4a61-853e-c1d66651f9a3				TCGA-36-2547-01A-01D-1047-05		TCGA-36-2547-01A-21-20	TCGA-36-2547-01A-01D-1526-09		TCGA-36-2547-01A-01D-1043-01	TCGA-36-2547-01	48b9af43-88a1-46c9-b6c7-ec1d1ac9e5f9		TCGA-36-2547-01A-01D-1043-01					TCGA-36-2547-01				TCGA-36-2547-01A-01R-1050-07	
TCGA-36-2548-01	0	TCGA-36-2548-01	431	0	days	High		OV-like c1	OV-like c4					TCGA-36-2548			days	431	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Right	TCGA-36-2548-F27962	TCGA-36-2548	TCGA-36-2548-01A	Stage IIIC	-20897			0	431		395				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Other method, specify:		0.7	NO		1.3			G3	Recurrence					TCGA-36-2548.68bf291c-3320-46f9-8e5f-7de81f0c6964.pdf	2548		WITH TUMOR	YES		Imaging Study	NO	R1	Primary Tumor	01	0.7			36	>20 mm	Ovary		A	LIVING	2008				abe78829-2661-4c6e-ba83-03e06963d9aa				TCGA-36-2548-01A-01D-1047-05		TCGA-36-2548-01A-21-20	TCGA-36-2548-01A-01D-1526-09		TCGA-36-2548-01A-01D-1043-01	TCGA-36-2548-01	4794aace-89fb-4e9e-b117-3234ef1fc792		TCGA-36-2548-01A-01D-1043-01					TCGA-36-2548-01				TCGA-36-2548-01A-01R-1050-07	
TCGA-36-2549-01	0	TCGA-36-2549-01	184	0	days	BRCA-LUAD+		OV-like c1	OV-like c4					TCGA-36-2549			days	184	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			54	Bilateral	TCGA-36-2549-F27966	TCGA-36-2549	TCGA-36-2549-01A	Stage IIC	-20076			0	184						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.4			G3						TCGA-36-2549.42b18428-81f6-48d0-8a5f-fd08926128b1.pdf	2549		TUMOR FREE	YES			NO	R0	Primary Tumor	01	0.6			36	No Macroscopic disease	Ovary		A	LIVING	2008				3dac49f4-f485-4050-93d1-cbc22eef91d9				TCGA-36-2549-01A-01D-1047-05		TCGA-36-2549-01A-21-20			TCGA-36-2549-01A-01D-1043-01	TCGA-36-2549-01	0b81fd60-103b-484a-a954-839f7941bf98		TCGA-36-2549-01A-01D-1043-01					TCGA-36-2549-01				TCGA-36-2549-01A-01R-1050-07	
TCGA-36-2551-01	0	TCGA-36-2551-01	492	0	days	High		OV-like c1	OV-like c4					TCGA-36-2551			days	492	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-36-2551-F27970	TCGA-36-2551	TCGA-36-2551-01A	Stage IIIC	-21045			0	492		338				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		1		NO	G3	Recurrence					TCGA-36-2551.c3e022a3-b58d-437b-a990-691730e9daf1.pdf	2551		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO	R1	Primary Tumor	01	0.3			36	>20 mm	Ovary		A	LIVING	2009				543cc9e3-5fb6-4229-aedb-a55273230b98				TCGA-36-2551-01A-01D-1047-05		TCGA-36-2551-01A-21-20	TCGA-36-2551-01A-01D-1526-09		TCGA-36-2551-01A-01D-1043-01	TCGA-36-2551-01	ceb02af7-9228-4bfa-812b-f1d88482c383		TCGA-36-2551-01A-01D-1043-01					TCGA-36-2551-01				TCGA-36-2551-01A-01R-1050-07	
TCGA-36-2552-01	0	TCGA-36-2552-01	349	0	days	High		OV-like c1	OV-like c4					TCGA-36-2552			days	349	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			64	Bilateral	TCGA-36-2552-F27976	TCGA-36-2552	TCGA-36-2552-01A	Stage IIC	-23379			0	349						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.3			G3						TCGA-36-2552.9504a356-0742-44f1-a218-62b769e64a33.pdf	2552		TUMOR FREE	YES			NO	R0	Primary Tumor	01	0.8			36	No Macroscopic disease	Ovary		A	LIVING	2009				4f0b1c4b-e033-4679-a32a-9bf80ff6d42d				TCGA-36-2552-01A-01D-1047-05		TCGA-36-2552-01A-21-20	TCGA-36-2552-01A-01D-1526-09		TCGA-36-2552-01A-01D-1043-01	TCGA-36-2552-01	984b6351-1d3e-4ef1-99c4-d99895a3a49b		TCGA-36-2552-01A-01D-1043-01					TCGA-36-2552-01				TCGA-36-2552-01A-01R-1050-07	
TCGA-3P-A9WA-01	0	TCGA-3P-A9WA-01	420	0	days									TCGA-3P-A9WA	420	0	days	420	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Left	TCGA-3P-A9WA-F67273	TCGA-3P-A9WA	TCGA-3P-A9WA-01A	Stage IIB	-20211	126		0	420				Scheduled Follow-up Submission	Complete Remission/Response	2014-11-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8440/3	C56.9	YES	Other method, specify:	660		NO	100		NO		G3			NO	false	Yes, History of Synchronous/Bilateral Malignancy	TCGA-3P-A9WA.4B2E4D3D-128A-49DD-AE0B-ACFC78615B16.pdf	A9WA	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO	RX	Primary Tumor	01		YES	NO	3P		Ovary		A	LIVING	2013	TCGA-3P-A9WA-01	TCGA-3P-A9WA-01			TCGA-3P-A9WA-01A-11D-A409-05	TCGA-3P-A9WA-01						94e91d8c-244a-48cf-af09-9412659e6759	TCGA-3P-A9WA-01A-11D-A402-01		7C867DDB-C776-4764-8E77-F2CE4D474116	TCGA-3P-A9WA-01A-11R-A406-31	TCGA-3P-A9WA-01A-11D-A402-01	94e91d8c-244a-48cf-af09-9412659e6759	TCGA-3P-A9WA-01A-11R-A406-31	94e91d8c-244a-48cf-af09-9412659e6759			TCGA-3P-A9WA-01	94e91d8c-244a-48cf-af09-9412659e6759			
TCGA-42-2582-01	1	TCGA-42-2582-01	1447	1	days	High		OV-like c1	OV-like c4					TCGA-42-2582	1179	1	days	1447	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	49	Bilateral	TCGA-42-2582-F34657	TCGA-42-2582	TCGA-42-2582-01A	Stage IIIC	-17961		1447	0	435		1179	1	Additional New Tumor Event	Progressive Disease	2013-3-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.3	NO	YES	G3	Progression of Disease		YES			TCGA-42-2582.04201F3C-F4FF-4F85-8C14-F1D754DAFDD6.pdf	2582		WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R0	Primary Tumor	01	0.2			42	No Macroscopic disease	Ovary		A	DECEASED	2009				7f63006e-7016-483d-9a09-7d535a342d3a				TCGA-42-2582-01A-01D-1047-05		TCGA-42-2582-01A-21-20	TCGA-42-2582-01A-01D-1526-09		TCGA-42-2582-01A-01D-1043-01	TCGA-42-2582-01	61f8ad02-1fe9-48ca-b317-c573aba61c08		TCGA-42-2582-01A-01D-1043-01					TCGA-42-2582-01				TCGA-42-2582-01A-01R-1231-07	
TCGA-42-2587-01	0	TCGA-42-2587-01	722	0	days	Squamous		OV-like c1	OV-like c4					TCGA-42-2587			days	722	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			75	Bilateral	TCGA-42-2587-F28795	TCGA-42-2587	TCGA-42-2587-01A	Stage IIIC	-27510			0	722						2011-8-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.4		YES	G3						TCGA-42-2587.dc4896ef-1797-4796-8869-e9f5d19456d2.pdf	2587		TUMOR FREE	YES	Complete Remission/Response		NO	R1	Primary Tumor	01	0.6			42	>20 mm	Ovary	YES	A	LIVING	2009				e8013ca8-18e0-42ee-aa94-b7171902da03				TCGA-42-2587-01A-01D-1047-05		TCGA-42-2587-01A-21-1563-20	TCGA-42-2587-01A-01D-1526-09		TCGA-42-2587-01A-01D-1043-01	TCGA-42-2587-01	934207be-d750-48bc-a51a-c6740d415d56		TCGA-42-2587-01A-01D-1043-01					TCGA-42-2587-01				TCGA-42-2587-01A-01R-1050-07	
TCGA-42-2588-01	1	TCGA-42-2588-01	880	1	days	High		OV-like c1	OV-like c4					TCGA-42-2588			days	880	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Bilateral	TCGA-42-2588-F28821	TCGA-42-2588		Stage IV	-22377		880	0	287		267	2			2012-1-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)							YES	G3	Progression of Disease						2588	Preoperative	WITH TUMOR	YES	Progressive Disease		NO	R2	Primary Tumor	01				42	>20 mm	Ovary			DECEASED	2009				fd52301b-6882-4868-95e8-501ec794f7a8				TCGA-42-2588-01A-01D-1047-05		TCGA-42-2588-01A-21-20	TCGA-42-2588-01A-01D-1526-09		TCGA-42-2588-01A-01D-1043-01	TCGA-42-2588-01	ba162045-6055-466e-bf4d-ff04006919db		TCGA-42-2588-01A-01D-1043-01					TCGA-42-2588-01				TCGA-42-2588-01A-01R-1050-07	
TCGA-42-2589-01	0	TCGA-42-2589-01	1278	0	days	High		OV-like c1	OV-like c4					TCGA-42-2589	1274	1	days	1278	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	54	Bilateral	TCGA-42-2589-F41366	TCGA-42-2589	TCGA-42-2589-01A	Stage IIIC	-19852			0	1278		1274		Additional New Tumor Event	Progressive Disease	2013-3-15	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Fine needle aspiration biopsy		1	NO		1	NO	YES	G3			YES			TCGA-42-2589.07cceb21-4aca-4343-965e-81960a40cff2.pdf	2589		WITH TUMOR	YES	Complete Remission/Response		NO	R0	Primary Tumor	01	0.5			42	1-10 mm	Ovary		A	LIVING	2009				9add86b7-a9d7-41ea-8536-41a204c97ae1				TCGA-42-2589-01A-01D-1047-05		TCGA-42-2589-01A-21-20	TCGA-42-2589-01A-01D-1526-09		TCGA-42-2589-01A-01D-1043-01	TCGA-42-2589-01	77d0cab8-5a58-4fed-ac41-68dff4f946cd		TCGA-42-2589-01A-01D-1043-01					TCGA-42-2589-01				TCGA-42-2589-01A-01R-1050-07	
TCGA-42-2590-01	1	TCGA-42-2590-01	317	1	days	High		OV-like c1	OV-like c4					TCGA-42-2590			days	317	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	57	Bilateral	TCGA-42-2590-F28809	TCGA-42-2590	TCGA-42-2590-01A	Stage IV	-20965		317	0	227		226	1			2011-5-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		2.2			G2	Progression of Disease					TCGA-42-2590.9c7c0209-b1d6-4174-b57e-e8bcd3e5d766.pdf	2590	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	Imaging Study	NO	R1	Primary Tumor	01	0.4			42	>20 mm	Ovary		A	DECEASED	2009				919946b9-3135-45fd-9fdd-b2d40c8bc3ba				TCGA-42-2590-01A-01D-1047-05		TCGA-42-2590-01A-21-20	TCGA-42-2590-01A-01D-1526-09		TCGA-42-2590-01A-01D-1043-01	TCGA-42-2590-01	043ea617-6eec-43ae-a45c-b5cffacc7695		TCGA-42-2590-01A-01D-1043-01					TCGA-42-2590-01				TCGA-42-2590-01A-01R-1050-07	
TCGA-42-2591-01	0	TCGA-42-2591-01	1240	0	days	Squamous		OV-like c1	OV-like c4					TCGA-42-2591	1240	0	days	1240	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-42-2591-F41420	TCGA-42-2591	TCGA-42-2591-01A	Stage IIIC	-18654			0	1240				Scheduled Follow-up Submission	Complete Remission/Response	2013-3-18	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5	NO	YES	GX			NO			TCGA-42-2591.f4c9e6c0-c6bf-4793-a5de-c85c347b4097.pdf	2591		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.6			42	No Macroscopic disease	Ovary		A	LIVING	2009				5c6e2798-32a6-4fb9-b246-c6267f7dfc51				TCGA-42-2591-01A-01D-1047-05		TCGA-42-2591-01A-21-20	TCGA-42-2591-01A-01D-1526-09		TCGA-42-2591-01A-01D-1043-01	TCGA-42-2591-01	0a1bb74b-fa00-4320-b966-ea146e76c9fa		TCGA-42-2591-01A-01D-1043-01					TCGA-42-2591-01				TCGA-42-2591-01A-01R-1050-07	
TCGA-42-2593-01	1	TCGA-42-2593-01	45	1	days	High		OV-like c1	OV-like c4					TCGA-42-2593	45	0	days	45	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			67	Bilateral	TCGA-42-2593-F39341	TCGA-42-2593	TCGA-42-2593-01A	Stage IIIC	-24823		45	0				4	Scheduled Follow-up Submission		2013-1-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.9	NO	YES	G3			NO			TCGA-42-2593.302c2898-9b19-494b-86a5-f0ff3cab7163.pdf	2593	Other	WITH TUMOR	NO			NO	R2	Primary Tumor	01	0.4	YES	NO	42	>20 mm	Ovary	YES	A	DECEASED	2009				f5e8a865-c4eb-4043-9a8f-7979d3fe6532				TCGA-42-2593-01A-01D-1047-05		TCGA-42-2593-01A-21-20			TCGA-42-2593-01A-01D-1043-01		8ae9695c-082b-4011-b078-f55aa285fa11		TCGA-42-2593-01A-01D-1043-01									TCGA-42-2593-01A-01R-1050-07	
TCGA-57-1582-01	1	TCGA-57-1582-01	731	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-57-1582			days	731	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Left	TCGA-57-1582-F28059	TCGA-57-1582	TCGA-57-1582-01A	Stage IIIC			731	0	731						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		2		YES	G3						TCGA-57-1582.0ed35510-c6ad-416b-8b57-e97005471dc1.pdf	1582		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.6			57	1-10 mm	Ovary	YES	A	DECEASED	2006	TCGA-57-1582-01	TCGA-57-1582-01	TCGA-57-1582-01A-01W-0615-10	18e8fac4-913e-4c0f-bb6e-3d19b58518cc		TCGA-57-1582-01	TCGA-57-1582-01A-01W-0615-10	TCGA-57-1582-01A-01D-0536-05				cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	TCGA-57-1582-01A-01D-0533-01	TCGA-57-1582-01			TCGA-57-1582-01A-01D-0533-01	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90		cb7a4405-b9a5-4e1a-825f-c3ee205c8a90		TCGA-57-1582-01	TCGA-57-1582-01	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	TCGA-57-1582-01A-01W-0615-10	TCGA-57-1582-01A-01R-0540-07	
TCGA-57-1583-01	1	TCGA-57-1583-01	346	1	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-57-1583			days	346	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Left	TCGA-57-1583-F28068	TCGA-57-1583	TCGA-57-1583-01A	Stage IIIC	-21167		346	0	346						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.4		NO	G3						TCGA-57-1583.b899b485-621f-46df-8bda-97b0fbe10b6d.pdf	1583		WITH TUMOR	YES			NO		Primary Tumor	01	0.4			57	No Macroscopic disease	Ovary	NO	A	DECEASED	2006	TCGA-57-1583-01	TCGA-57-1583-01	TCGA-57-1583-01A-01W-0615-10	bb6bfbc9-0379-4f74-8720-186fa0a165b9		TCGA-57-1583-01	TCGA-57-1583-01A-01W-0615-10	TCGA-57-1583-01A-01D-0536-05				3a37e320-0301-4f2b-bf09-f102c12502b1	TCGA-57-1583-01A-01D-0533-01	TCGA-57-1583-01			TCGA-57-1583-01A-01D-0533-01	3a37e320-0301-4f2b-bf09-f102c12502b1		3a37e320-0301-4f2b-bf09-f102c12502b1		TCGA-57-1583-01	TCGA-57-1583-01	3a37e320-0301-4f2b-bf09-f102c12502b1	TCGA-57-1583-01A-01W-0615-10	TCGA-57-1583-01A-01R-0540-07	
TCGA-57-1584-01	0	TCGA-57-1584-01	643	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 3	TCGA-57-1584			days	643	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-57-1584-F28072	TCGA-57-1584		Stage IIIC	-17263			0	643		530	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence						1584	Pre-Adjuvant Therapy	WITH TUMOR	NO		Imaging Study	NO		Primary Tumor	01				57	1-10 mm	Ovary	YES		LIVING	2007	TCGA-57-1584-01	TCGA-57-1584-01	TCGA-57-1584-01A-01W-0615-10	e10d4b1f-cba8-4e34-af2e-331949b18dba		TCGA-57-1584-01	TCGA-57-1584-01A-01W-0615-10	TCGA-57-1584-01A-01D-0536-05				e92b95df-bacb-4083-b2de-78e540ec0e68	TCGA-57-1584-01A-01D-0533-01	TCGA-57-1584-01			TCGA-57-1584-01A-01D-0533-01	e92b95df-bacb-4083-b2de-78e540ec0e68		e92b95df-bacb-4083-b2de-78e540ec0e68		TCGA-57-1584-01	TCGA-57-1584-01	e92b95df-bacb-4083-b2de-78e540ec0e68	TCGA-57-1584-01A-01W-0615-10	TCGA-57-1584-01A-01R-0540-07	
TCGA-57-1585-01	1	TCGA-57-1585-01	53	1	days	Squamous		OV-like c1			miRNA cluster 3	cluster 6		TCGA-57-1585			days	53	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Bilateral	TCGA-57-1585-F28076	TCGA-57-1585	TCGA-57-1585-01A	Stage IIIC	-20862		53	0	53						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		0.8		YES	G3						TCGA-57-1585.2c748aca-e5b2-4418-9820-1343293d379f.pdf	1585		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.3			57	11-20 mm	Ovary	YES	A	DECEASED	2007	TCGA-57-1585-01	TCGA-57-1585-01		9485c5c9-3fa8-48a3-bb75-a152f1547ae3		TCGA-57-1585-01		TCGA-57-1585-01A-01D-0536-05				06df1324-bc1b-4bc3-bb01-4ef55a5aeef5	TCGA-57-1585-01A-01D-0533-01	TCGA-57-1585-01			TCGA-57-1585-01A-01D-0533-01	06df1324-bc1b-4bc3-bb01-4ef55a5aeef5		06df1324-bc1b-4bc3-bb01-4ef55a5aeef5		TCGA-57-1585-01	TCGA-57-1585-01	06df1324-bc1b-4bc3-bb01-4ef55a5aeef5		TCGA-57-1585-01A-01R-0540-07	
TCGA-57-1586-01	0	TCGA-57-1586-01	679	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-57-1586			days	679	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	66	Bilateral	TCGA-57-1586-F28080	TCGA-57-1586		Stage IIIC	-24304			0	679		259				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence						1586		WITH TUMOR	YES		Molecular Markers	NO		Primary Tumor	01				57	11-20 mm	Ovary	YES		LIVING	2007		TCGA-57-1586-01		ec771953-9297-4d7d-aa29-531499b3e2eb		TCGA-57-1586-01		TCGA-57-1586-01A-02D-0563-05		TCGA-57-1586-01A-03-1563-20	TCGA-57-1586-01A-02W-0633-09		TCGA-57-1586-01A-02D-0559-01	TCGA-57-1586-01	a93a15b9-aef1-403b-85c4-1d5203e6d9dc		TCGA-57-1586-01A-02D-0559-01					TCGA-57-1586-01				TCGA-57-1586-01A-02R-0566-07	
TCGA-57-1992-01	0	TCGA-57-1992-01	882	0	days	High		OV-like c1						TCGA-57-1992			days	882	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Left	TCGA-57-1992-F28090	TCGA-57-1992	TCGA-57-1992-01A	Stage IC				0	882						2009-12-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.3		YES	G3						TCGA-57-1992.77c742d8-bb0b-4ea9-9f61-9606c78c438e.pdf	1992		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			57	No Macroscopic disease	Ovary	YES	A	LIVING	2006				6fcb27b1-5f0d-4c30-b9a4-205f60bc880b				TCGA-57-1992-01A-01D-0652-05					TCGA-57-1992-01A-01D-0648-01	TCGA-57-1992-01			TCGA-57-1992-01A-01D-0648-01					TCGA-57-1992-01				TCGA-57-1992-01A-01R-0655-07	
TCGA-57-1993-01	0	TCGA-57-1993-01	763	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-57-1993			days	763	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			56	Bilateral	TCGA-57-1993-F28092	TCGA-57-1993	TCGA-57-1993-01A	Stage IIIC	-20498			0	763						2010-1-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.5		YES	G3						TCGA-57-1993.55495e3a-6052-4fb1-b8a9-10b54dcdfbea.pdf	1993		TUMOR FREE	YES			NO	R0	Primary Tumor	01	0.5			57	No Macroscopic disease	Ovary	YES	A	LIVING	2007	TCGA-57-1993-01	TCGA-57-1993-01		f8c91078-d156-4ee9-96c9-7ec6937c40b3		TCGA-57-1993-01		TCGA-57-1993-01A-01D-0652-05				55f9061c-54e7-465c-af61-21d8bc8ecbe0	TCGA-57-1993-01A-01D-0648-01	TCGA-57-1993-01			TCGA-57-1993-01A-01D-0648-01	55f9061c-54e7-465c-af61-21d8bc8ecbe0		55f9061c-54e7-465c-af61-21d8bc8ecbe0	TCGA-57-1993-01A-01W-0699-08	TCGA-57-1993-01	TCGA-57-1993-01	55f9061c-54e7-465c-af61-21d8bc8ecbe0	TCGA-57-1993-01A-01W-0699-08	TCGA-57-1993-01A-01R-0655-07	
TCGA-57-1994-01	0	TCGA-57-1994-01	761	0	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-57-1994			days	761	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63		TCGA-57-1994-F28096	TCGA-57-1994	TCGA-57-1994-01A		-23062			0	761						2011-6-10	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5									TCGA-57-1994.54c3dd01-b473-424f-987a-c5d6e972e9bb.pdf	1994			NO			NO		Primary Tumor	01	0.4			57		Ovary		A	LIVING	2004	TCGA-57-1994-01	TCGA-57-1994-01		24fbfb49-2a8c-40af-b607-577cc3001b2d		TCGA-57-1994-01		TCGA-57-1994-01A-01D-0652-05				2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	TCGA-57-1994-01A-01D-0648-01	TCGA-57-1994-01			TCGA-57-1994-01A-01D-0648-01	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8		2cf309ea-0c2e-4f28-a94b-342dc9a1aae8		TCGA-57-1994-01	TCGA-57-1994-01	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8		TCGA-57-1994-01A-01R-0655-07	
TCGA-59-2348-01	0	TCGA-59-2348-01	5481	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2348			days	5481	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			59	Bilateral	TCGA-59-2348-F28098	TCGA-59-2348	TCGA-59-2348-01A	Stage IIIC				0	5481						2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		2			G3						TCGA-59-2348.ffb300e9-cb06-4162-a751-f079fec57153.pdf	2348		TUMOR FREE		Complete Remission/Response				Primary Tumor	01	0.4			59		Ovary		A	LIVING	1994	TCGA-59-2348-01	TCGA-59-2348-01		139d2d19-f3e9-46fc-bd88-b57709af9ec5		TCGA-59-2348-01		TCGA-59-2348-01A-01D-0708-05		TCGA-59-2348-01A-21-1560-20		7162d809-ff1a-4346-bb00-c8086386ec46	TCGA-59-2348-01A-01D-0704-01	TCGA-59-2348-01	c37d3098-f79e-4ce7-9ed5-884d82725dff		TCGA-59-2348-01A-01D-0704-01	7162d809-ff1a-4346-bb00-c8086386ec46		7162d809-ff1a-4346-bb00-c8086386ec46	TCGA-59-2348-01A-01W-0799-08	TCGA-59-2348-01	TCGA-59-2348-01	7162d809-ff1a-4346-bb00-c8086386ec46	TCGA-59-2348-01A-01W-0799-08	TCGA-59-2348-01A-01R-0711-07	
TCGA-59-2349-01	1	TCGA-59-2349-01	2437	1	days	Kirc+		Cluster 5	BRCA basal-like c6					TCGA-59-2349			days	2437	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Left	TCGA-59-2349-F28100	TCGA-59-2349	TCGA-59-2349-01A	Stage IA			2437	0							2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.3			G3						TCGA-59-2349.a56064eb-651a-4a7d-b32c-5c890821e338.pdf	2349				Complete Remission/Response				Primary Tumor	01	0.3	NO	YES	59	No Macroscopic disease	Ovary		A	DECEASED	1994				7557f686-ae87-4ab8-b7df-b1f1b0850e51				TCGA-59-2349-01A-01D-0708-05		TCGA-59-2349-01A-21-1560-20			TCGA-59-2349-01A-01D-0704-01	TCGA-59-2349-01	96c57593-695a-4b64-997b-b465ed28917c		TCGA-59-2349-01A-01D-0704-01					TCGA-59-2349-01				TCGA-59-2349-01A-01R-0711-07	
TCGA-59-2350-01	1	TCGA-59-2350-01	679	1	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-59-2350			days	679	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			44	Bilateral	TCGA-59-2350-F28102	TCGA-59-2350		Stage IV			679	0			211				2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Progression of Disease						2350		WITH TUMOR		Partial Remission/Response				Primary Tumor	01		NO	YES	59	1-10 mm	Ovary			DECEASED	1995	TCGA-59-2350-01	TCGA-59-2350-01		e5b094fc-335d-4a9e-9ead-d0bda9695e33		TCGA-59-2350-01		TCGA-59-2350-01A-01D-0708-05				e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	TCGA-59-2350-01A-01D-0704-01	TCGA-59-2350-01			TCGA-59-2350-01A-01D-0704-01	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0		e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	TCGA-59-2350-01A-01W-0799-08	TCGA-59-2350-01	TCGA-59-2350-01	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	TCGA-59-2350-01A-01W-0799-08	TCGA-59-2350-01A-01R-0711-07	
TCGA-59-2351-01	0	TCGA-59-2351-01	3532	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-59-2351			days	3532	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	51	Bilateral	TCGA-59-2351-F28104	TCGA-59-2351	TCGA-59-2351-01A	Stage IIIC				0	3532		2139				2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		2			G3	Progression of Disease					TCGA-59-2351.6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad.pdf	2351		TUMOR FREE		Complete Remission/Response	Imaging Study			Primary Tumor	01	0.4	NO	YES	59	1-10 mm	Ovary		A	LIVING	1999	TCGA-59-2351-01	TCGA-59-2351-01		2c72e167-d9b6-47e2-ae10-3183a6d13e7a		TCGA-59-2351-01		TCGA-59-2351-01A-01D-0708-05		TCGA-59-2351-01A-21-1560-20		7e58cfd1-07eb-44e2-a563-fa7a00b338a3	TCGA-59-2351-01A-01D-0704-01	TCGA-59-2351-01	2cdeaf4d-f2c6-44fd-872e-965ef80e505b		TCGA-59-2351-01A-01D-0704-01	7e58cfd1-07eb-44e2-a563-fa7a00b338a3		7e58cfd1-07eb-44e2-a563-fa7a00b338a3	TCGA-59-2351-01A-01W-0799-08	TCGA-59-2351-01	TCGA-59-2351-01	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	TCGA-59-2351-01A-01W-0799-08	TCGA-59-2351-01A-01R-0711-07	
TCGA-59-2352-01	1	TCGA-59-2352-01	286	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-59-2352			days	286	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Right		TCGA-59-2352	TCGA-59-2352-01A	Stage IIIC			286	0							2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.2	NO		2			G3						TCGA-59-2352.15f65643-b84c-4239-bc14-0ddacdfe0425.pdf	2352		WITH TUMOR						Primary Tumor	01	0.4	NO	YES	59		Ovary		A	DECEASED	2002	TCGA-59-2352-01	TCGA-59-2352-01		87ec1cd8-27d3-4cde-a59b-58c82ab8cbbe		TCGA-59-2352-01		TCGA-59-2352-01A-01D-0708-05		TCGA-59-2352-01A-21-1560-20		a209a8f4-9462-4ade-be57-caaec54999cb	TCGA-59-2352-01A-01D-0704-01	TCGA-59-2352-01	d9066d98-0039-4956-9e7e-9931b8c28379		TCGA-59-2352-01A-01D-0704-01	a209a8f4-9462-4ade-be57-caaec54999cb		a209a8f4-9462-4ade-be57-caaec54999cb	TCGA-59-2352-01A-01W-0799-08	TCGA-59-2352-01	TCGA-59-2352-01	a209a8f4-9462-4ade-be57-caaec54999cb	TCGA-59-2352-01A-01W-0799-08	TCGA-59-2352-01A-01R-0711-07	
TCGA-59-2354-01	1	TCGA-59-2354-01	1046	1	days	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2354			days	1046	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Left	TCGA-59-2354-F28107	TCGA-59-2354	TCGA-59-2354-01A	Stage IIIC			1046	0			462				2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		2.4		YES	G3	Progression of Disease					TCGA-59-2354.cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc.pdf	2354		WITH TUMOR	YES	Stable Disease	Imaging Study			Primary Tumor	01	0.3			59	1-10 mm	Ovary		A	DECEASED	2005	TCGA-59-2354-01	TCGA-59-2354-01		e0e3aedf-ace3-4525-83c2-887b517837c0		TCGA-59-2354-01		TCGA-59-2354-01A-01D-0708-05		TCGA-59-2354-01A-21-1560-20		33367eb6-4ca9-4daf-9e47-30a47a78e144	TCGA-59-2354-01A-01D-0704-01	TCGA-59-2354-01	d80db939-9815-4d8b-8d3d-927a54355003		TCGA-59-2354-01A-01D-0704-01	33367eb6-4ca9-4daf-9e47-30a47a78e144		33367eb6-4ca9-4daf-9e47-30a47a78e144	TCGA-59-2354-01A-01W-0799-08	TCGA-59-2354-01	TCGA-59-2354-01	33367eb6-4ca9-4daf-9e47-30a47a78e144	TCGA-59-2354-01A-01W-0799-08	TCGA-59-2354-01A-01R-0711-07	
TCGA-59-2355-01	1	TCGA-59-2355-01	65	1	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-59-2355			days	65	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			58	Right	TCGA-59-2355-F28111	TCGA-59-2355	TCGA-59-2355-01A	Stage IV			65	0							2010-1-29	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		YES	G3						TCGA-59-2355.322bedf6-e6b5-4275-a186-0075a2ec271e.pdf	2355		WITH TUMOR	YES					Primary Tumor	01	0.2			59	>20 mm	Ovary		A	DECEASED	2006	TCGA-59-2355-01	TCGA-59-2355-01		9c18086a-f203-48f5-af4c-d756fe1b266b		TCGA-59-2355-01		TCGA-59-2355-01A-01D-0708-05				866c7355-e2ec-4816-953f-7bf791033283	TCGA-59-2355-01A-01D-0704-01	TCGA-59-2355-01			TCGA-59-2355-01A-01D-0704-01	866c7355-e2ec-4816-953f-7bf791033283		866c7355-e2ec-4816-953f-7bf791033283	TCGA-59-2355-01A-01W-0799-08	TCGA-59-2355-01	TCGA-59-2355-01	866c7355-e2ec-4816-953f-7bf791033283	TCGA-59-2355-01A-01W-0799-08	TCGA-59-2355-01A-01R-0711-07	
TCGA-59-2363-01	0	TCGA-59-2363-01	165	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2363			days	165	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			40	Bilateral	TCGA-59-2363-F28115	TCGA-59-2363	TCGA-59-2363-01A	Stage IIIA				0	165						2010-2-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5		NO	G3						TCGA-59-2363.9b047485-eb2b-4fc1-a22a-d96046b63bf2.pdf	2363		TUMOR FREE	YES	Complete Remission/Response		NO	R0	Primary Tumor	01	0.4			59	No Macroscopic disease	Ovary	NO	A	LIVING	2007	TCGA-59-2363-01	TCGA-59-2363-01		0ef0c1bf-9885-4be9-85b1-ed400a1a940f		TCGA-59-2363-01		TCGA-59-2363-01A-01D-0708-05		TCGA-59-2363-01A-21-1560-20		1d3f29ac-5f19-452d-99b6-72c0abf1ce32	TCGA-59-2363-01A-01D-0704-01	TCGA-59-2363-01	abdc5a45-9e20-4c0e-b854-9a2ec535245a		TCGA-59-2363-01A-01D-0704-01	1d3f29ac-5f19-452d-99b6-72c0abf1ce32		1d3f29ac-5f19-452d-99b6-72c0abf1ce32	TCGA-59-2363-01A-01W-0799-08	TCGA-59-2363-01	TCGA-59-2363-01	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	TCGA-59-2363-01A-01W-0799-08	TCGA-59-2363-01A-01R-0711-07	
TCGA-59-2372-01	1	TCGA-59-2372-01	1363	1	days	High		OV-like c1	OV-like c4					TCGA-59-2372			days	1363	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			73	Bilateral	TCGA-59-2372-F28119	TCGA-59-2372	TCGA-59-2372-01A	Stage IIIC			1363	0							2010-2-12	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1		NO	G2						TCGA-59-2372.4411c3e9-2751-45eb-bc8f-e64ca2940a09.pdf	2372			YES			NO	R0	Primary Tumor	01	0.5			59	No Macroscopic disease	Ovary	NO	A	DECEASED	2005				b368a37f-fa86-47ae-9a1c-d1038f19a663				TCGA-59-2372-01A-01D-1047-05		TCGA-59-2372-01A-21-1560-20	TCGA-59-2372-01A-01D-1526-09		TCGA-59-2372-01A-01D-1043-01	TCGA-59-2372-01	7d66df01-e224-4584-8c36-f54735a2fc53		TCGA-59-2372-01A-01D-1043-01					TCGA-59-2372-01				TCGA-59-2372-01A-01R-1050-07	
TCGA-59-A5PD-01	1	TCGA-59-A5PD-01	624	1	days									TCGA-59-A5PD			days	624	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Right		TCGA-59-A5PD	TCGA-59-A5PD-01A	Stage IC	-20263	730	624	0				0			2013-6-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	130		NO	100			YES	G3			YES	false	Yes, History of Synchronous/Bilateral Malignancy	TCGA-59-A5PD.9A3CB382-654F-4DFD-BF41-7615710D2825.pdf	A5PD	Preoperative	WITH TUMOR	NO	Complete Remission/Response		NO		Primary Tumor	01		NO	YES	59		Ovary	YES	A	DECEASED	2011	TCGA-59-A5PD-01	TCGA-59-A5PD-01			TCGA-59-A5PD-01A-11D-A409-05	TCGA-59-A5PD-01						356a00a0-d19a-498c-8ed7-20ce89cd21eb	TCGA-59-A5PD-01A-11D-A402-01		8E787AAF-9659-4F93-97F9-CD58BD1FEC1D	TCGA-59-A5PD-01A-11R-A406-31	TCGA-59-A5PD-01A-11D-A402-01	356a00a0-d19a-498c-8ed7-20ce89cd21eb	TCGA-59-A5PD-01A-11R-A406-31	356a00a0-d19a-498c-8ed7-20ce89cd21eb			TCGA-59-A5PD-01	356a00a0-d19a-498c-8ed7-20ce89cd21eb			
TCGA-5X-AA5U-01	0	TCGA-5X-AA5U-01	361	0	days									TCGA-5X-AA5U	361	0	days	361	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			61	Right	TCGA-5X-AA5U-F69358	TCGA-5X-AA5U	TCGA-5X-AA5U-01A	Stage IIC	-22438	11		0	361			0	Scheduled Follow-up Submission	Complete Remission/Response	2015-1-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Tumor resection	230		NO	100		NO	NO	GX			NO	true	Yes, History of Synchronous/Bilateral Malignancy	TCGA-5X-AA5U.28F20F49-20C6-4B93-957D-8DAEF04657AE.pdf	AA5U	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		NO	R0	Primary Tumor	01		YES	NO	5X		Ovary	NO	A	LIVING	2013	TCGA-5X-AA5U-01	TCGA-5X-AA5U-01			TCGA-5X-AA5U-01A-11D-A409-05	TCGA-5X-AA5U-01						4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9	TCGA-5X-AA5U-01A-11D-A402-01		3372257B-B9F7-42AF-8EC4-AC69618A0A35	TCGA-5X-AA5U-01A-11R-A406-31	TCGA-5X-AA5U-01A-11D-A402-01	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9	TCGA-5X-AA5U-01A-11R-A406-31	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9			TCGA-5X-AA5U-01	4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9			
TCGA-61-1721-01	0	TCGA-61-1721-01	338	0	days	Quiet	C5-KIRC	Low purity c2	OV-like c4	GBM-like c6	miRNA cluster 3	cluster 6		TCGA-61-1721			days	338	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			38	Bilateral	TCGA-61-1721-F28123	TCGA-61-1721	TCGA-61-1721-01A	Stage IV	-13894			0	338						2009-6-2	FEMALE	Serous Cystadenocarcinoma	Yes	C56.9	8441/3	C56.9	YES	Excisional Biopsy		0.9	NO		1		YES	G1						TCGA-61-1721.f44d906c-f069-45e6-9cc4-49eb0da74226.pdf	1721		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			61		Ovary	YES	A	LIVING	2008	TCGA-61-1721-01	TCGA-61-1721-01		13cc06b1-0e57-4cfe-bfe1-b6ec96321199		TCGA-61-1721-01		TCGA-61-1721-01A-01D-0652-05		TCGA-61-1721-01A-21-1559-20		226f9774-e22b-4b8b-8259-934edb649fc3	TCGA-61-1721-01A-01D-0648-01	TCGA-61-1721-01	0479fc63-879d-4b50-b014-20d276a2d13d		TCGA-61-1721-01A-01D-0648-01	226f9774-e22b-4b8b-8259-934edb649fc3		226f9774-e22b-4b8b-8259-934edb649fc3		TCGA-61-1721-01	TCGA-61-1721-01	226f9774-e22b-4b8b-8259-934edb649fc3		TCGA-61-1721-01A-01R-0655-07	
TCGA-61-1722-01	0	TCGA-61-1722-01	246	0	days	High		OV-like c1	OV-like c4					TCGA-61-1722			days	246	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			89	Bilateral	TCGA-61-1722-F28129	TCGA-61-1722	TCGA-61-1722-01A	Stage IB	-32853			0	246						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						TCGA-61-1722.059421f4-442e-4e81-a726-7a8486c74cdc.pdf	1722		WITH TUMOR	NO	Stable Disease		NO		Primary Tumor	01	0.2			61	No Macroscopic disease	Ovary	NO	A	LIVING	2008				79b7ffda-716b-4253-a580-4b1372a8f152				TCGA-61-1722-01A-01D-0581-05		TCGA-61-1722-01A-21-1559-20	TCGA-61-1722-01A-01D-1556-09		TCGA-61-1722-01A-01D-0577-01	TCGA-61-1722-01	b17eace3-8ff6-4e2c-abd1-81f67343d8d1		TCGA-61-1722-01A-01D-0577-01					TCGA-61-1722-01				TCGA-61-1722-01A-01R-0584-07	
TCGA-61-1724-01	1	TCGA-61-1724-01	637	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 5		TCGA-61-1724			days	637	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	47	Bilateral	TCGA-61-1724-F28135	TCGA-61-1724		Stage IIIC	-17168		637	0	637	187					2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G3	Locoregional Disease	YES					1724		WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01				61	No Macroscopic disease	Ovary	YES		DECEASED	2007	TCGA-61-1724-01	TCGA-61-1724-01		af7c2e4b-c7c1-46d1-854e-c75365f3c967		TCGA-61-1724-01		TCGA-61-1724-01A-01D-0652-05		TCGA-61-1724-01A-21-1559-20		faab5b85-3c69-4c64-bba0-a8d5404939a2	TCGA-61-1724-01A-01D-0648-01	TCGA-61-1724-01	eb6edbbc-bc05-4627-b5af-6f91d7b6c5dd		TCGA-61-1724-01A-01D-0648-01	faab5b85-3c69-4c64-bba0-a8d5404939a2		faab5b85-3c69-4c64-bba0-a8d5404939a2		TCGA-61-1724-01	TCGA-61-1724-01	faab5b85-3c69-4c64-bba0-a8d5404939a2		TCGA-61-1724-01A-01R-0655-07	
TCGA-61-1725-01	0	TCGA-61-1725-01	956	0	days	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 2		TCGA-61-1725			days	956	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-1725-F28143	TCGA-61-1725	TCGA-61-1725-01A	Stage IIIC	-14782			0	956		844				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1		YES	G3	Recurrence					TCGA-61-1725.8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04.pdf	1725		WITH TUMOR	YES	Stable Disease	Imaging Study	NO		Primary Tumor	01	0.4			61	11-20 mm	Ovary	YES	A	LIVING	2007	TCGA-61-1725-01	TCGA-61-1725-01		be16e66f-a839-44c7-b700-4a95d366435f		TCGA-61-1725-01		TCGA-61-1725-01A-01D-0581-05			TCGA-61-1725-01A-01W-0639-09	748ff969-cb49-4f22-994f-6debe734c38f	TCGA-61-1725-01A-01D-0577-01	TCGA-61-1725-01			TCGA-61-1725-01A-01D-0577-01	748ff969-cb49-4f22-994f-6debe734c38f		748ff969-cb49-4f22-994f-6debe734c38f		TCGA-61-1725-01	TCGA-61-1725-01	748ff969-cb49-4f22-994f-6debe734c38f		TCGA-61-1725-01A-01R-0584-07	
TCGA-61-1727-01	0	TCGA-61-1727-01	564	0	days	Squamous		OV-like c1	OV-like c4					TCGA-61-1727			days	564	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			74	Right	TCGA-61-1727-F28152	TCGA-61-1727	TCGA-61-1727-01A	Stage IC	-27203			0	564						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1			G3						TCGA-61-1727.f8e2cbf2-911a-48a7-ad80-c23124af44fe.pdf	1727		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2007				ea305cbb-1171-49bd-be79-debefe08023f				TCGA-61-1727-01A-01D-0581-05		TCGA-61-1727-01A-21-1559-20	TCGA-61-1727-01A-01W-0639-09		TCGA-61-1727-01A-01D-0577-01	TCGA-61-1727-01	3d14831f-1ab6-43e9-bd15-0c6e930304e8		TCGA-61-1727-01A-01D-0577-01					TCGA-61-1727-01				TCGA-61-1727-01A-01R-0584-07	
TCGA-61-1728-01	0	TCGA-61-1728-01	848	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-1728			days	848	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	59	Bilateral	TCGA-61-1728-F28156	TCGA-61-1728	TCGA-61-1728-01A	Stage IV	-21582			0	848		533				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.1		NO	G3	Recurrence					TCGA-61-1728.7611c4d4-f58b-404e-93f1-949c865c9e12.pdf	1728		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	NO	A	LIVING	2007	TCGA-61-1728-01	TCGA-61-1728-01		54635249-84d5-466b-b956-e125a7113132		TCGA-61-1728-01		TCGA-61-1728-01A-01D-0652-05				bf909020-d6a1-49f1-8007-4192d39abd04	TCGA-61-1728-01A-01D-0648-01	TCGA-61-1728-01			TCGA-61-1728-01A-01D-0648-01	bf909020-d6a1-49f1-8007-4192d39abd04		bf909020-d6a1-49f1-8007-4192d39abd04	TCGA-61-1728-01A-01W-0699-08	TCGA-61-1728-01	TCGA-61-1728-01	bf909020-d6a1-49f1-8007-4192d39abd04	TCGA-61-1728-01A-01W-0699-08	TCGA-61-1728-01A-01R-0655-07	
TCGA-61-1730-01	1	TCGA-61-1730-01	132	1	days	High		OV-like c1	OV-like c4					TCGA-61-1730			days	132	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Left	TCGA-61-1730-F28161	TCGA-61-1730	TCGA-61-1730-01A	Stage IC	-28508		132	0	132						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.2		NO	G3						TCGA-61-1730.4624968a-27c1-4f4f-b9f1-3e6997c15a21.pdf	1730		WITH TUMOR	NO			NO		Primary Tumor	01	0.4			61	1-10 mm	Ovary	NO	A	DECEASED	2007				59246787-027e-4aea-8a7e-04521b0f96a6				TCGA-61-1730-01A-01D-0581-05		TCGA-61-1730-01A-21-1559-20	TCGA-61-1730-01A-01W-0639-09		TCGA-61-1730-01A-01D-0577-01	TCGA-61-1730-01	1a49f3dd-f92d-4206-bce7-05a2ff6df71e		TCGA-61-1730-01A-01D-0577-01					TCGA-61-1730-01				TCGA-61-1730-01A-01R-0584-07	
TCGA-61-1733-01	0	TCGA-61-1733-01	967	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-61-1733			days	967	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-61-1733-F28163	TCGA-61-1733	TCGA-61-1733-01A	Stage IIIC	-26180			0	967		175				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		YES	G3	Recurrence					TCGA-61-1733.bc4e6e92-d716-4ab3-8459-4f339caecffd.pdf	1733		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.2			61	No Macroscopic disease	Ovary	YES	A	LIVING	2006	TCGA-61-1733-01	TCGA-61-1733-01		dd206c0f-dd03-40ee-ad76-e6b3bf84ffc8		TCGA-61-1733-01		TCGA-61-1733-01A-01D-0581-05		TCGA-61-1733-01A-21-1559-20	TCGA-61-1733-01A-01W-0639-09	e6f856bf-0694-4c21-aecc-0d8dd54761f1	TCGA-61-1733-01A-01D-0577-01	TCGA-61-1733-01	1b2390f5-f59e-4c94-8586-35b620e0dc4d		TCGA-61-1733-01A-01D-0577-01	e6f856bf-0694-4c21-aecc-0d8dd54761f1		e6f856bf-0694-4c21-aecc-0d8dd54761f1		TCGA-61-1733-01	TCGA-61-1733-01	e6f856bf-0694-4c21-aecc-0d8dd54761f1		TCGA-61-1733-01A-01R-0584-07	
TCGA-61-1734-01	0	TCGA-61-1734-01	866	0	days	Squamous		OV-like c1	OV-like c4					TCGA-61-1734			days	866	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Bilateral	TCGA-61-1734-F28171	TCGA-61-1734	TCGA-61-1734-01B	Stage IC	-19026			0	866						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2		YES	G3						TCGA-61-1734.32d02aa2-1c81-417b-87a8-a5ed4035f5c0.pdf	1734		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			61		Ovary	YES	B	LIVING	2006				b3b6480c-a96b-44c5-9590-e0659b2fc9ad				TCGA-61-1734-01B-01D-0667-05		TCGA-61-1734-01B-21-1559-20			TCGA-61-1734-01B-01D-0663-01	TCGA-61-1734-01	8d84c559-ee21-4b79-a879-99d3bc6a624e		TCGA-61-1734-01B-01D-0663-01					TCGA-61-1734-01				TCGA-61-1734-01B-01R-0670-07	
TCGA-61-1736-01	1	TCGA-61-1736-01	1484	1	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-1736			days	1484	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Bilateral	TCGA-61-1736-F28175	TCGA-61-1736	TCGA-61-1736-01B	Stage IIIC	-16613		1484	0	1484		764				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Excisional Biopsy		0.8	NO		1		YES	G3	Recurrence					TCGA-61-1736.c034e484-683b-463c-999d-eb1fd9741292.pdf	1736		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61		Ovary	YES	B	DECEASED	2005	TCGA-61-1736-01	TCGA-61-1736-01		4f3d65e1-2001-48dc-bded-b8dd0a949c2c		TCGA-61-1736-01		TCGA-61-1736-01B-01D-0667-05		TCGA-61-1736-01B-21-1559-20		89f1ae39-c387-4dff-be38-e3b7265222bb	TCGA-61-1736-01B-01D-0663-01	TCGA-61-1736-01	de7da1bd-3d13-495a-a931-5ae952aa5ea3		TCGA-61-1736-01B-01D-0663-01	89f1ae39-c387-4dff-be38-e3b7265222bb		89f1ae39-c387-4dff-be38-e3b7265222bb	TCGA-61-1736-01B-01W-0722-08	TCGA-61-1736-01	TCGA-61-1736-01	89f1ae39-c387-4dff-be38-e3b7265222bb	TCGA-61-1736-01B-01W-0722-08	TCGA-61-1736-01B-01R-0670-07	
TCGA-61-1737-01	0	TCGA-61-1737-01	1364	0	days	High		OV-like c1			miRNA cluster 1	cluster 5		TCGA-61-1737			days	1364	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			42	Bilateral	TCGA-61-1737-F28182	TCGA-61-1737	TCGA-61-1737-01A	Stage IV	-15515			0	1364						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.3	NO		0.7		YES	G3						TCGA-61-1737.2fa09bf8-8be5-411c-a9cf-16c12ed1390f.pdf	1737		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	LIVING	2005	TCGA-61-1737-01	TCGA-61-1737-01		478e4825-4983-4315-aeda-12145a87f92b		TCGA-61-1737-01		TCGA-61-1737-01A-01D-0581-05			TCGA-61-1737-01A-01W-0639-09	b442230a-d330-45da-adf7-76873d18645c	TCGA-61-1737-01A-01D-0577-01	TCGA-61-1737-01			TCGA-61-1737-01A-01D-0577-01	b442230a-d330-45da-adf7-76873d18645c		b442230a-d330-45da-adf7-76873d18645c		TCGA-61-1737-01	TCGA-61-1737-01	b442230a-d330-45da-adf7-76873d18645c		TCGA-61-1737-01A-01R-0584-07	
TCGA-61-1738-01	1	TCGA-61-1738-01	1089	1	days	High	C9-OV	UCEC Serous c4	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 5		TCGA-61-1738			days	1089	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	60	Right	TCGA-61-1738-F28190	TCGA-61-1738	TCGA-61-1738-01A	Stage IIIC	-21965		1089	0	1089		276				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.2		YES	G3	Recurrence					TCGA-61-1738.05898c76-9832-4724-ada5-ff47eb3838b5.pdf	1738		WITH TUMOR	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	DECEASED	2005	TCGA-61-1738-01	TCGA-61-1738-01		4c4af8bd-a614-4875-bdb5-4e8c64c4d134		TCGA-61-1738-01		TCGA-61-1738-01A-01D-0581-05		TCGA-61-1738-01A-21-1559-20	TCGA-61-1738-01A-01W-0639-09	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	TCGA-61-1738-01A-01D-0577-01	TCGA-61-1738-01	3fed489e-8243-43c5-8ca2-37979d540d22		TCGA-61-1738-01A-01D-0577-01	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7		1ca9af90-a8db-4f7e-b17a-0bf32fed98c7		TCGA-61-1738-01	TCGA-61-1738-01	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7		TCGA-61-1738-01A-01R-0584-07	
TCGA-61-1740-01	1	TCGA-61-1740-01	74	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2		TCGA-61-1740			days	74	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Right	TCGA-61-1740-F28198	TCGA-61-1740	TCGA-61-1740-01A	Stage IIIC	-26169		74	0	74			3			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		YES	G3						TCGA-61-1740.b87690ba-0cd2-458e-938f-553cd5ab6d84.pdf	1740	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.3			61	>20 mm	Ovary	YES	A	DECEASED	2005	TCGA-61-1740-01	TCGA-61-1740-01		7e650317-6bd3-4ad9-b4ad-47178983707c		TCGA-61-1740-01		TCGA-61-1740-01A-01D-0581-05		TCGA-61-1740-01A-21-1559-20	TCGA-61-1740-01A-01W-0639-09	e7825482-380d-4323-a4fb-d11b365c7073	TCGA-61-1740-01A-01D-0577-01	TCGA-61-1740-01	3349b819-24fe-404f-a480-0e94ed56a1cd		TCGA-61-1740-01A-01D-0577-01	e7825482-380d-4323-a4fb-d11b365c7073		e7825482-380d-4323-a4fb-d11b365c7073		TCGA-61-1740-01	TCGA-61-1740-01	e7825482-380d-4323-a4fb-d11b365c7073		TCGA-61-1740-01A-01R-0584-07	
TCGA-61-1741-01	1	TCGA-61-1741-01	1024	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-61-1741			days	1024	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	76	Bilateral	TCGA-61-1741-F28201	TCGA-61-1741	TCGA-61-1741-01A	Stage IIIB	-27762		1024	0	1024		488				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3	Recurrence					TCGA-61-1741.e2d0ec41-559c-48d4-8c4d-59e0f9d48823.pdf	1741		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61	>20 mm	Ovary	NO	A	DECEASED	2004	TCGA-61-1741-01	TCGA-61-1741-01		fba783f9-28fc-41c2-b82a-1fcc55d19941		TCGA-61-1741-01		TCGA-61-1741-01A-02D-0581-05		TCGA-61-1741-01A-11-1563-20	TCGA-61-1741-01A-02W-0639-09	92d5764e-c576-47cd-a6bd-68ed0365c213	TCGA-61-1741-01A-02D-0577-01	TCGA-61-1741-01	4da87c92-0d8f-4475-b5c8-332329e3d7b2		TCGA-61-1741-01A-02D-0577-01	92d5764e-c576-47cd-a6bd-68ed0365c213		92d5764e-c576-47cd-a6bd-68ed0365c213		TCGA-61-1741-01	TCGA-61-1741-01	92d5764e-c576-47cd-a6bd-68ed0365c213		TCGA-61-1741-01A-02R-0584-07	
TCGA-61-1743-01	1	TCGA-61-1743-01	1329	1	days	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 1		TCGA-61-1743			days	1329	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary		NO	53	Bilateral	TCGA-61-1743-F28209	TCGA-61-1743	TCGA-61-1743-01A	Stage IIC	-19365		1329	0	1329		809				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G2	Recurrence					TCGA-61-1743.190b258b-d756-4872-b5f4-53c2d10e86b1.pdf	1743		WITH TUMOR	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			61	No Macroscopic disease	Ovary		A	DECEASED	2004	TCGA-61-1743-01	TCGA-61-1743-01		5e99b999-2c02-4a1b-97b6-176afa3edfb3		TCGA-61-1743-01		TCGA-61-1743-01A-01D-0652-05		TCGA-61-1743-01A-21-1559-20		f3277084-b0a8-43df-946e-dc792bbb8cdb	TCGA-61-1743-01A-01D-0648-01	TCGA-61-1743-01	a6fffcf6-69f4-4c40-b183-a0345dacff1a		TCGA-61-1743-01A-01D-0648-01	f3277084-b0a8-43df-946e-dc792bbb8cdb		f3277084-b0a8-43df-946e-dc792bbb8cdb		TCGA-61-1743-01	TCGA-61-1743-01	f3277084-b0a8-43df-946e-dc792bbb8cdb		TCGA-61-1743-01A-01R-0655-07	
TCGA-61-1895-01	0	TCGA-61-1895-01	44	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1895			days	44	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			52	Bilateral	TCGA-61-1895-F28213	TCGA-61-1895	TCGA-61-1895-01A	Stage IIIB	-19060			0	44						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.1		YES	G3						TCGA-61-1895.b33d3a26-d864-4669-b06e-1335be4e9e3a.pdf	1895		TUMOR FREE	YES	Stable Disease		NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	LIVING	2009		TCGA-61-1895-01		7ca1db65-98e8-471a-81d5-063d6c3c3a0c		TCGA-61-1895-01		TCGA-61-1895-01A-01D-0581-05		TCGA-61-1895-01A-21-1559-20	TCGA-61-1895-01A-01W-0639-09		TCGA-61-1895-01A-01D-0577-01	TCGA-61-1895-01	9525c377-b25f-422f-8da7-60319fc43d79		TCGA-61-1895-01A-01D-0577-01					TCGA-61-1895-01				TCGA-61-1895-01A-01R-0584-07	
TCGA-61-1899-01	0	TCGA-61-1899-01	256	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1899			days	256	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			81	Left	TCGA-61-1899-F28217	TCGA-61-1899	TCGA-61-1899-01A	Stage IIIC	-29692			0	256						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						TCGA-61-1899.0b416e24-55c4-4235-b56b-9dc1507ee5ef.pdf	1899		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2008		TCGA-61-1899-01		06aa647b-fe58-4a63-976b-9bd171297b87		TCGA-61-1899-01		TCGA-61-1899-01A-01D-0581-05		TCGA-61-1899-01A-21-1559-20	TCGA-61-1899-01A-01W-0639-09		TCGA-61-1899-01A-01D-0577-01	TCGA-61-1899-01	fdb5929a-eedd-48b3-9938-5d08ac8ba4fc		TCGA-61-1899-01A-01D-0577-01					TCGA-61-1899-01				TCGA-61-1899-01A-01R-0584-07	
TCGA-61-1900-01	0	TCGA-61-1900-01	176	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-61-1900			days	176	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-61-1900-F28221	TCGA-61-1900	TCGA-61-1900-01A	Stage IIIB	-18963			0	176						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.5		NO	G3						TCGA-61-1900.b0dd202d-16dc-42ec-ad83-6f02b37b919f.pdf	1900		TUMOR FREE	YES	Stable Disease		NO		Primary Tumor	01	0.6			61	No Macroscopic disease	Ovary	NO	A	LIVING	2008	TCGA-61-1900-01	TCGA-61-1900-01		c5d1eb0e-d7a4-49e1-9a07-1abe99e33881		TCGA-61-1900-01		TCGA-61-1900-01A-01D-0581-05		TCGA-61-1900-01A-21-1559-20	TCGA-61-1900-01A-01W-0639-09	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	TCGA-61-1900-01A-01D-0577-01	TCGA-61-1900-01	c3a92cba-410a-4853-8bae-4bec74b693d7		TCGA-61-1900-01A-01D-0577-01	92adf6a1-4880-4ee4-8ebe-09a943dbfe04		92adf6a1-4880-4ee4-8ebe-09a943dbfe04		TCGA-61-1900-01	TCGA-61-1900-01	92adf6a1-4880-4ee4-8ebe-09a943dbfe04		TCGA-61-1900-01A-01R-0584-07	
TCGA-61-1901-01	1	TCGA-61-1901-01	347	1	days	Squamous		OV-like c1			miRNA cluster 1	cluster 6		TCGA-61-1901			days	347	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	65	Bilateral	TCGA-61-1901-F28226	TCGA-61-1901		Stage IV	-24042		347	0	347		329				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)							YES	G3	Progression of Disease						1901		WITH TUMOR	YES	Stable Disease	Imaging Study	NO		Primary Tumor	01				61		Ovary	YES		DECEASED	2008		TCGA-61-1901-01		e34c17f8-b6a2-4c24-bba7-d9548a0cca89		TCGA-61-1901-01		TCGA-61-1901-01A-01D-0581-05			TCGA-61-1901-01A-01W-0639-09		TCGA-61-1901-01A-01D-0577-01	TCGA-61-1901-01			TCGA-61-1901-01A-01D-0577-01					TCGA-61-1901-01				TCGA-61-1901-01A-01R-0584-07	
TCGA-61-1903-01	0	TCGA-61-1903-01	396	0	days	High		OV-like c1	OV-like c4					TCGA-61-1903			days	396	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Bilateral	TCGA-61-1903-F28231	TCGA-61-1903	TCGA-61-1903-01A	Stage IB	-20381			0	396						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2		NO	G3						TCGA-61-1903.879ac4e3-cb0d-4fcb-a51d-8cbc6ad0c4a0.pdf	1903		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			61		Ovary	NO	A	LIVING	2007				9bcc6171-29ca-40b3-880a-2e3e95a95f94				TCGA-61-1903-01A-01D-0581-05		TCGA-61-1903-01A-21-1559-20	TCGA-61-1903-01A-01W-0639-09		TCGA-61-1903-01A-01D-0577-01	TCGA-61-1903-01	57c3b3e8-b200-43e1-9f63-f7e0f872ca8c		TCGA-61-1903-01A-01D-0577-01					TCGA-61-1903-01				TCGA-61-1903-01A-01R-0584-07	
TCGA-61-1904-01	0	TCGA-61-1904-01	276	0	days	High		OV-like c1						TCGA-61-1904			days	276	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Bilateral	TCGA-61-1904-F28236	TCGA-61-1904		Stage IIIC	-22009			0	276						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G3							1904		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				61	1-10 mm	Ovary	NO		LIVING	2007				ac3f73b4-4953-4836-8834-43729c647ac3				TCGA-61-1904-01A-01D-0581-05			TCGA-61-1904-01A-01W-0639-09		TCGA-61-1904-01A-01D-0577-01	TCGA-61-1904-01			TCGA-61-1904-01A-01D-0577-01					TCGA-61-1904-01				TCGA-61-1904-01A-01R-0584-07	
TCGA-61-1906-01	1	TCGA-61-1906-01	1038	1	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-61-1906			days	1038	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Bilateral	TCGA-61-1906-F28240	TCGA-61-1906	TCGA-61-1906-01A	Stage IIIC	-20378		1038	0	1038		236				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3	Recurrence					TCGA-61-1906.a540b6e3-4a34-4546-a91a-a6bcd09921bd.pdf	1906		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			61	11-20 mm	Ovary	YES	A	DECEASED	2006		TCGA-61-1906-01		9e164e07-0887-4e9d-8e54-92e2b9621257		TCGA-61-1906-01		TCGA-61-1906-01A-01D-0581-05		TCGA-61-1906-01A-21-1559-20	TCGA-61-1906-01A-01W-0639-09		TCGA-61-1906-01A-01D-0577-01	TCGA-61-1906-01	f3b04ec3-bd80-437b-be87-aa7b75249821		TCGA-61-1906-01A-01D-0577-01					TCGA-61-1906-01				TCGA-61-1906-01A-01R-0584-07	
TCGA-61-1907-01	0	TCGA-61-1907-01	952	0	days	Squamous	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 4		TCGA-61-1907			days	952	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-61-1907-F28250	TCGA-61-1907	TCGA-61-1907-01A	Stage IIIC	-23204			0	952		743				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.9	NO		1.6			G3	Recurrence					TCGA-61-1907.ae7e4795-496e-47d0-ad60-cec04e5876b0.pdf	1907		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.4			61	11-20 mm	Ovary	YES	A	LIVING	2006	TCGA-61-1907-01	TCGA-61-1907-01		429e7e1a-3ded-46a3-9eee-aa048cbfade2		TCGA-61-1907-01		TCGA-61-1907-01A-01D-0581-05		TCGA-61-1907-01A-21-1559-20	TCGA-61-1907-01A-01W-0639-09	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	TCGA-61-1907-01A-01D-0577-01	TCGA-61-1907-01	2356261e-fe60-47da-9f8e-c06bfe510a03		TCGA-61-1907-01A-01D-0577-01	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed		6d9a1fe4-7131-487c-a7ff-0cf8a53919ed		TCGA-61-1907-01	TCGA-61-1907-01	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed		TCGA-61-1907-01A-01R-0584-07	
TCGA-61-1910-01	0	TCGA-61-1910-01	1127	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-61-1910			days	1127	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			56	Bilateral	TCGA-61-1910-F28256	TCGA-61-1910	TCGA-61-1910-01A	Stage IIC	-20779			0	1127						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3						TCGA-61-1910.32905714-6e41-4df8-91dd-6d3068475b40.pdf	1910		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			61	1-10 mm	Ovary	YES	A	LIVING	2006	TCGA-61-1910-01	TCGA-61-1910-01		e61d1b4c-7a8a-431c-bef5-1be42deda0c1		TCGA-61-1910-01		TCGA-61-1910-01A-01D-0581-05		TCGA-61-1910-01A-21-1559-20	TCGA-61-1910-01A-01W-0639-09	65e4e40b-f27f-4b84-9979-af659564363d	TCGA-61-1910-01A-01D-0577-01	TCGA-61-1910-01	18b958a6-f51e-4fb3-a240-cfe22c05d967		TCGA-61-1910-01A-01D-0577-01	65e4e40b-f27f-4b84-9979-af659564363d		65e4e40b-f27f-4b84-9979-af659564363d		TCGA-61-1910-01	TCGA-61-1910-01	65e4e40b-f27f-4b84-9979-af659564363d		TCGA-61-1910-01A-01R-0584-07	
TCGA-61-1911-01	0	TCGA-61-1911-01	1293	0	days	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 2		TCGA-61-1911			days	1293	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	55	Left	TCGA-61-1911-F28260	TCGA-61-1911	TCGA-61-1911-01A	Stage IIA	-20144			0	1293		844				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		2		YES	G3	Recurrence					TCGA-61-1911.ba6325b4-af61-42cc-b84c-aacee9d7ecc8.pdf	1911		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61		Ovary	YES	A	LIVING	2005		TCGA-61-1911-01		70685d12-f206-43bd-bc6d-1954ffa1b600		TCGA-61-1911-01		TCGA-61-1911-01A-01D-0581-05		TCGA-61-1911-01A-21-1559-20	TCGA-61-1911-01A-01W-0639-09		TCGA-61-1911-01A-01D-0577-01	TCGA-61-1911-01	18959b13-60ff-43b5-8f53-acee023d775a		TCGA-61-1911-01A-01D-0577-01					TCGA-61-1911-01				TCGA-61-1911-01A-01R-0584-07	
TCGA-61-1913-01	0	TCGA-61-1913-01	1488	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1913			days	1488	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Right	TCGA-61-1913-F28269	TCGA-61-1913	TCGA-61-1913-01A	Stage IIIB	-17575			0	1488						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1			G3						TCGA-61-1913.b789ee6d-d1e2-4836-8bdc-3c59b0729ee1.pdf	1913		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			61	1-10 mm	Ovary	YES	A	LIVING	2005		TCGA-61-1913-01		7b569b43-ae4c-4611-8852-1e8213c1d7ae		TCGA-61-1913-01		TCGA-61-1913-01A-01D-0581-05		TCGA-61-1913-01A-21-1559-20	TCGA-61-1913-01A-01W-0639-09		TCGA-61-1913-01A-01D-0577-01	TCGA-61-1913-01	a97ee569-979a-4d19-bf30-61dd734ed78d		TCGA-61-1913-01A-01D-0577-01					TCGA-61-1913-01				TCGA-61-1913-01A-01R-0584-07	
TCGA-61-1914-01	0	TCGA-61-1914-01	1722	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-61-1914			days	1722	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-61-1914-F28273	TCGA-61-1914	TCGA-61-1914-01A	Stage IIIC	-23850			0	1722		1674				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2		YES	G3	Recurrence					TCGA-61-1914.b634b2cf-9e8d-4dd4-8442-337c22522a43.pdf	1914		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61	>20 mm	Ovary	YES	A	LIVING	2003	TCGA-61-1914-01	TCGA-61-1914-01		32a0bd09-8cc4-46e6-a36d-67478fab51fc		TCGA-61-1914-01		TCGA-61-1914-01A-01D-0581-05		TCGA-61-1914-01A-21-1559-20	TCGA-61-1914-01A-01W-0639-09	0d75483f-eab3-41c8-b2cc-453af29b6f44	TCGA-61-1914-01A-01D-0577-01	TCGA-61-1914-01	7497a274-7ee4-423f-a0bd-59afb02a305e		TCGA-61-1914-01A-01D-0577-01	0d75483f-eab3-41c8-b2cc-453af29b6f44		0d75483f-eab3-41c8-b2cc-453af29b6f44		TCGA-61-1914-01	TCGA-61-1914-01	0d75483f-eab3-41c8-b2cc-453af29b6f44		TCGA-61-1914-01A-01R-0584-07	
TCGA-61-1915-01	0	TCGA-61-1915-01	2061	0	days	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1915			days	2061	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			50	Bilateral	TCGA-61-1915-F28280	TCGA-61-1915	TCGA-61-1915-01A	Stage IIC	-18424			0	2061						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G3						TCGA-61-1915.1c305700-d86f-449a-a556-02f32484dda1.pdf	1915		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			61		Ovary	YES	A	LIVING	2003		TCGA-61-1915-01		4c9b5377-7e2c-4a97-9663-3ff18822053c		TCGA-61-1915-01		TCGA-61-1915-01A-01D-0581-05		TCGA-61-1915-01A-21-1559-20	TCGA-61-1915-01A-01W-0639-09		TCGA-61-1915-01A-01D-0577-01	TCGA-61-1915-01	407fd5a4-3e13-42c6-9f10-424562adfee5		TCGA-61-1915-01A-01D-0577-01					TCGA-61-1915-01				TCGA-61-1915-01A-01R-0584-07	
TCGA-61-1916-01	1	TCGA-61-1916-01	475	1	days	Quiet		OV-like c1	OV-like c4					TCGA-61-1916			days	475	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			53	Bilateral	TCGA-61-1916-F28284	TCGA-61-1916		Stage IIIC	-19463		475	0	475		326				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G2	Recurrence						1916			YES			NO	R1	Primary Tumor	01				61	1-10 mm	Ovary	YES		DECEASED	2002				aab4f5cd-7169-41e6-ae24-2bddbd752f62				TCGA-61-1916-01A-01D-0807-05		TCGA-61-1916-01A-21-1559-20				TCGA-61-1916-01	e7b8ce5d-a28b-44c9-8b3a-d52882fce319											TCGA-61-1916-01A-01R-0810-07	
TCGA-61-1916-02	1	TCGA-61-1916-02	475	1	days			OV-like c1						TCGA-61-1916			days	475	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			53	Bilateral	TCGA-61-1916-F28284	TCGA-61-1916	TCGA-61-1916-02A	Stage IIIC	-19463		475	0	475		326				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.8			G2	Recurrence					TCGA-61-1916.C85D2BF7-498B-4E17-9F13-899AC8D6EC88.pdf	1916			YES			NO	R1	Recurrent Tumor	02	0.3			61	1-10 mm	Ovary	YES	A	DECEASED	2002				6490d8bc-620c-45d2-9314-97ec1b52e4d0				TCGA-61-1916-02A-01D-0807-05																		TCGA-61-1916-02A-01R-0810-07	
TCGA-61-1917-01	1	TCGA-61-1917-01	1321	1	days	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-61-1917			days	1321	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			60	Bilateral	TCGA-61-1917-F28290	TCGA-61-1917	TCGA-61-1917-01A	Stage IIIB	-21972		1321	0	1321						2009-11-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		2			G3						TCGA-61-1917.ebb81051-f181-4878-85ac-7e00ad6aca85.pdf	1917			YES	Complete Remission/Response		NO		Primary Tumor	01	0.1			61		Ovary	NO	A	DECEASED	2002	TCGA-61-1917-01	TCGA-61-1917-01		5005b439-42ac-4dc7-aa13-3817d6091536		TCGA-61-1917-01		TCGA-61-1917-01A-01D-0652-05				519aea8b-5e08-47b2-bb98-b311f2dba540	TCGA-61-1917-01A-01D-0648-01	TCGA-61-1917-01			TCGA-61-1917-01A-01D-0648-01	519aea8b-5e08-47b2-bb98-b311f2dba540		519aea8b-5e08-47b2-bb98-b311f2dba540		TCGA-61-1917-01	TCGA-61-1917-01	519aea8b-5e08-47b2-bb98-b311f2dba540		TCGA-61-1917-01A-01R-0655-07	
TCGA-61-1918-01	1	TCGA-61-1918-01	479	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-61-1918			days	479	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	45	Bilateral	TCGA-61-1918-F28295	TCGA-61-1918	TCGA-61-1918-01A	Stage IV	-16689		479	0	479		413				2009-11-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1			G3	Recurrence					TCGA-61-1918.6c95bd12-e871-4e4e-961f-09a64c1fe2de.pdf	1918		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2002	TCGA-61-1918-01	TCGA-61-1918-01		5f2955fc-dc80-4ce8-93d6-6db708af6ea4		TCGA-61-1918-01		TCGA-61-1918-01A-01D-0652-05		TCGA-61-1918-01A-21-1559-20		62f75d97-ea9e-4694-8c83-1a0e6d137a02	TCGA-61-1918-01A-01D-0648-01	TCGA-61-1918-01	8c7cf533-1039-4e1a-9a0a-83c8d8c2e597		TCGA-61-1918-01A-01D-0648-01	62f75d97-ea9e-4694-8c83-1a0e6d137a02		62f75d97-ea9e-4694-8c83-1a0e6d137a02		TCGA-61-1918-01	TCGA-61-1918-01	62f75d97-ea9e-4694-8c83-1a0e6d137a02		TCGA-61-1918-01A-01R-0655-07	
TCGA-61-1919-01	1	TCGA-61-1919-01	1161	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-1919			days	1161	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	58	Bilateral	TCGA-61-1919-F28300	TCGA-61-1919	TCGA-61-1919-01A	Stage IIIC	-21199		1161	0	1161		439				2009-11-30	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.5			G2	Recurrence					TCGA-61-1919.240a49a3-b611-4949-b3b9-3799d8c0dc46.pdf	1919			YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			61		Ovary		A	DECEASED	2001	TCGA-61-1919-01	TCGA-61-1919-01		e2935fb6-7c83-4691-b144-029cd17eadac		TCGA-61-1919-01		TCGA-61-1919-01A-01D-0652-05		TCGA-61-1919-01A-21-1559-20		056cca38-92df-42ff-b064-b0c243f8a82f	TCGA-61-1919-01A-01D-0648-01	TCGA-61-1919-01	278e1675-c8e6-4578-b83d-4cd82de93d4b		TCGA-61-1919-01A-01D-0648-01	056cca38-92df-42ff-b064-b0c243f8a82f		056cca38-92df-42ff-b064-b0c243f8a82f		TCGA-61-1919-01	TCGA-61-1919-01	056cca38-92df-42ff-b064-b0c243f8a82f	TCGA-61-1919-01A-01W-0699-08	TCGA-61-1919-01A-01R-0655-07	
TCGA-61-1995-01	0	TCGA-61-1995-01	61	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-61-1995			days	61	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			43	Bilateral	TCGA-61-1995-F28302	TCGA-61-1995	TCGA-61-1995-01A	Stage IIIC	-16016			0	61						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1		YES	G3						TCGA-61-1995.5ea6d43b-376d-43cb-873f-c33ec814a95d.pdf	1995		WITH TUMOR	YES	Stable Disease		NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	LIVING	2009	TCGA-61-1995-01	TCGA-61-1995-01		180584fa-7aa6-4182-b57b-4e02365663e1		TCGA-61-1995-01		TCGA-61-1995-01A-01D-0667-05		TCGA-61-1995-01A-21-1559-20		13b2c972-c6ef-4d1f-8ada-f831d2606023	TCGA-61-1995-01A-01D-0663-01	TCGA-61-1995-01	1bdc5555-06ec-496c-ac44-b8847ca95fb5		TCGA-61-1995-01A-01D-0663-01	13b2c972-c6ef-4d1f-8ada-f831d2606023		13b2c972-c6ef-4d1f-8ada-f831d2606023	TCGA-61-1995-01A-01W-0722-08	TCGA-61-1995-01	TCGA-61-1995-01	13b2c972-c6ef-4d1f-8ada-f831d2606023	TCGA-61-1995-01A-01W-0722-08	TCGA-61-1995-01A-01R-0670-07	
TCGA-61-1998-01	0	TCGA-61-1998-01	168	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-1998			days	168	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Bilateral	TCGA-61-1998-F28306	TCGA-61-1998	TCGA-61-1998-01A	Stage IIIC	-17855			0	168						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3						TCGA-61-1998.788d25c6-75c4-4c85-be93-98dec021219a.pdf	1998		WITH TUMOR	YES			NO		Primary Tumor	01	0.1			61	1-10 mm	Ovary	YES	A	LIVING	2009	TCGA-61-1998-01	TCGA-61-1998-01		03f33fd8-fd9b-46b0-8291-ba92d1d32102		TCGA-61-1998-01		TCGA-61-1998-01A-01D-0667-05				0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	TCGA-61-1998-01A-01D-0663-01	TCGA-61-1998-01			TCGA-61-1998-01A-01D-0663-01	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d		0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	TCGA-61-1998-01A-01W-0722-08	TCGA-61-1998-01	TCGA-61-1998-01	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	TCGA-61-1998-01A-01W-0722-08	TCGA-61-1998-01A-01R-0670-07	
TCGA-61-2000-01	0	TCGA-61-2000-01	441	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-2000			days	441	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	67	Bilateral	TCGA-61-2000-F28311	TCGA-61-2000	TCGA-61-2000-01A	Stage IIIC	-24723			0	441		339				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1		YES	G3	Recurrence					TCGA-61-2000.4e13b897-c34a-4422-9c66-7ca8b2734ef2.pdf	2000		WITH TUMOR	YES	Stable Disease	Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	LIVING	2008	TCGA-61-2000-01	TCGA-61-2000-01		4150fb96-e722-40db-a6d0-d55e60cc30f6		TCGA-61-2000-01		TCGA-61-2000-01A-01D-0667-05		TCGA-61-2000-01A-21-1559-20		f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	TCGA-61-2000-01A-01D-0663-01	TCGA-61-2000-01	c7083eed-998f-456d-b294-5fbcf50eff88		TCGA-61-2000-01A-01D-0663-01	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109		f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	TCGA-61-2000-01A-01W-0722-08	TCGA-61-2000-01	TCGA-61-2000-01	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	TCGA-61-2000-01A-01W-0722-08	TCGA-61-2000-01A-01R-0670-07	
TCGA-61-2002-01	0	TCGA-61-2002-01	547	0	days	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2002			days	547	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			46	Bilateral	TCGA-61-2002-F28321	TCGA-61-2002	TCGA-61-2002-01A	Stage IIIC	-17115			0	547						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1.2		YES	G3						TCGA-61-2002.8030b8aa-9686-45b3-bf39-1889a6b8b36f.pdf	2002		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.2			61	11-20 mm	Ovary	YES	A	LIVING	2008	TCGA-61-2002-01	TCGA-61-2002-01		a31ab004-2dce-4cd6-a015-88c43ca44086		TCGA-61-2002-01		TCGA-61-2002-01A-01D-0667-05				14cd154a-6ea5-4ad9-92e4-72f53ee5d60b	TCGA-61-2002-01A-01D-0663-01	TCGA-61-2002-01			TCGA-61-2002-01A-01D-0663-01	14cd154a-6ea5-4ad9-92e4-72f53ee5d60b		14cd154a-6ea5-4ad9-92e4-72f53ee5d60b	TCGA-61-2002-01A-01W-0722-08	TCGA-61-2002-01	TCGA-61-2002-01	14cd154a-6ea5-4ad9-92e4-72f53ee5d60b	TCGA-61-2002-01A-01W-0722-08	TCGA-61-2002-01A-01R-0670-07	
TCGA-61-2003-01	0	TCGA-61-2003-01	122	0	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-2003			days	122	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			53	Bilateral	TCGA-61-2003-F28327	TCGA-61-2003	TCGA-61-2003-01A	Stage IIIC	-19605			0	122						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.4	NO		1.5		YES	G2						TCGA-61-2003.79c66510-6e38-470f-9e91-d774665d39a6.pdf	2003		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	LIVING	2008	TCGA-61-2003-01	TCGA-61-2003-01		a878c841-59fa-4ef2-af20-dc8937f92b9b		TCGA-61-2003-01		TCGA-61-2003-01A-01D-0667-05		TCGA-61-2003-01A-21-1559-20		bc200f3a-6d31-4480-8785-987f14cfa319	TCGA-61-2003-01A-01D-0663-01	TCGA-61-2003-01	379f3f36-fb28-4eb4-8c56-24c0382bf38f		TCGA-61-2003-01A-01D-0663-01	bc200f3a-6d31-4480-8785-987f14cfa319		bc200f3a-6d31-4480-8785-987f14cfa319	TCGA-61-2003-01A-01W-0722-08	TCGA-61-2003-01	TCGA-61-2003-01	bc200f3a-6d31-4480-8785-987f14cfa319	TCGA-61-2003-01A-01W-0722-08	TCGA-61-2003-01A-01R-0670-07	
TCGA-61-2008-01	0	TCGA-61-2008-01	932	0	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-2008			days	932	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2008-F28334	TCGA-61-2008	TCGA-61-2008-01A	Stage IIC	-14791			0	932		818				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2		YES	G2	Recurrence					TCGA-61-2008.25448427-9a2c-4c36-bc9d-40a82d6e3710.pdf	2008		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	LIVING	2007	TCGA-61-2008-01	TCGA-61-2008-01		5df0fa21-8263-4992-a797-44e2a1981b93		TCGA-61-2008-01		TCGA-61-2008-01A-02D-0667-05				10271f7f-cce6-44fd-8754-7a4beabfb394	TCGA-61-2008-01A-02D-0663-01	TCGA-61-2008-01	53527bf6-168b-469b-bbb3-d5e7640ee38a		TCGA-61-2008-01A-02D-0663-01	10271f7f-cce6-44fd-8754-7a4beabfb394		10271f7f-cce6-44fd-8754-7a4beabfb394	TCGA-61-2008-01A-02W-0722-08	TCGA-61-2008-01	TCGA-61-2008-01	10271f7f-cce6-44fd-8754-7a4beabfb394	TCGA-61-2008-01A-02W-0722-08	TCGA-61-2008-01A-02R-0670-07	
TCGA-61-2008-02	0	TCGA-61-2008-02	932	0	days		C9-OV	OV-like c1		OV-like c16	miRNA cluster 1		mutation cluster 5	TCGA-61-2008			days	932	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2008-F28334	TCGA-61-2008	TCGA-61-2008-02A	Stage IIC	-14791			0	932		818				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.5	NO		2		YES	G2	Recurrence					TCGA-61-2008.614D7B6A-B3B4-4F1B-9762-0749D559247F.pdf	2008		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Recurrent Tumor	02	0.3			61	No Macroscopic disease	Ovary	YES	A	LIVING	2007		TCGA-61-2008-02		0d478984-a92d-491d-88e6-4a7621463012		TCGA-61-2008-02		TCGA-61-2008-02A-01D-0807-05				b90a4b33-cb6f-4c75-bc26-ff316ea81cce			540b245e-be19-4b26-a9fa-a4b3dd9a2975			b90a4b33-cb6f-4c75-bc26-ff316ea81cce		b90a4b33-cb6f-4c75-bc26-ff316ea81cce				b90a4b33-cb6f-4c75-bc26-ff316ea81cce		TCGA-61-2008-02A-01R-0810-07	
TCGA-61-2009-01	0	TCGA-61-2009-01	1212	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 2	TCGA-61-2009			days	1212	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	65	Bilateral	TCGA-61-2009-F28341	TCGA-61-2009	TCGA-61-2009-01A	Stage IIIC	-23772			0	1212		101				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		2		YES	G3	Recurrence					TCGA-61-2009.39de8c59-e593-47d3-932d-575a4537b4dc.pdf	2009		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.2			61	11-20 mm	Ovary	YES	A	LIVING	2006	TCGA-61-2009-01	TCGA-61-2009-01		c8e01e3b-9789-4216-b771-18ac3b062a4c		TCGA-61-2009-01		TCGA-61-2009-01A-01D-0667-05		TCGA-61-2009-01A-21-1559-20		b6ed2184-0885-49ba-8b00-a3e57e4e5500	TCGA-61-2009-01A-01D-0663-01	TCGA-61-2009-01	8e12e5af-19de-4c90-a0b6-da67eeb438f4		TCGA-61-2009-01A-01D-0663-01	b6ed2184-0885-49ba-8b00-a3e57e4e5500		b6ed2184-0885-49ba-8b00-a3e57e4e5500	TCGA-61-2009-01A-01W-0722-08	TCGA-61-2009-01	TCGA-61-2009-01	b6ed2184-0885-49ba-8b00-a3e57e4e5500	TCGA-61-2009-01A-01W-0722-08	TCGA-61-2009-01A-01R-0670-07	
TCGA-61-2012-01	0	TCGA-61-2012-01	932	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 8	TCGA-61-2012			days	932	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			81	Left	TCGA-61-2012-F28352	TCGA-61-2012	TCGA-61-2012-01A	Stage IIC	-29830			0	932						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.6		YES	G2						TCGA-61-2012.534e3236-b9e7-4b0b-a2a3-2fc3a96fac81.pdf	2012			YES			YES		Primary Tumor	01	0.4			61		Ovary	YES	A	LIVING	2006	TCGA-61-2012-01	TCGA-61-2012-01		12b5e477-31d5-4ec1-ac90-989ce781c36a		TCGA-61-2012-01		TCGA-61-2012-01A-01D-0667-05		TCGA-61-2012-01A-21-1559-20		929c2bc4-4cee-4f82-b336-918fe041a588	TCGA-61-2012-01A-01D-0663-01	TCGA-61-2012-01	6eb6997b-a982-44b0-ab5a-5faaa1b0c2be		TCGA-61-2012-01A-01D-0663-01	929c2bc4-4cee-4f82-b336-918fe041a588		929c2bc4-4cee-4f82-b336-918fe041a588	TCGA-61-2012-01A-01W-0722-08	TCGA-61-2012-01	TCGA-61-2012-01	929c2bc4-4cee-4f82-b336-918fe041a588	TCGA-61-2012-01A-01W-0722-08	TCGA-61-2012-01A-01R-0670-07	
TCGA-61-2016-01	1	TCGA-61-2016-01	36	1	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2016			days	36	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-61-2016-F28357	TCGA-61-2016	TCGA-61-2016-01A	Stage IIIC	-18788		36	0							2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		YES	G3						TCGA-61-2016.1bb87fde-9ff0-4c33-a388-b655f9647407.pdf	2016		WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01	0.1			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2006	TCGA-61-2016-01	TCGA-61-2016-01		4e470958-8a7a-4a48-a609-2d7f49b49bbf		TCGA-61-2016-01		TCGA-61-2016-01A-01D-0667-05				a391b870-b6fb-4ca8-b425-2331fceae442	TCGA-61-2016-01A-01D-0663-01	TCGA-61-2016-01			TCGA-61-2016-01A-01D-0663-01	a391b870-b6fb-4ca8-b425-2331fceae442		a391b870-b6fb-4ca8-b425-2331fceae442	TCGA-61-2016-01A-01W-0722-08	TCGA-61-2016-01	TCGA-61-2016-01	a391b870-b6fb-4ca8-b425-2331fceae442	TCGA-61-2016-01A-01W-0722-08	TCGA-61-2016-01A-01R-0670-07	
TCGA-61-2017-01	0	TCGA-61-2017-01	1398	0	days	Squamous		OV-like c1	OV-like c4					TCGA-61-2017			days	1398	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	64	Bilateral	TCGA-61-2017-F28359	TCGA-61-2017	TCGA-61-2017-01A	Stage IIIC	-23509			0	1398		1006				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		NO	G1	Recurrence					TCGA-61-2017.b24757fc-4585-496e-b89e-f3dafac36b8b.pdf	2017		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.3			61	1-10 mm	Ovary	NO	A	LIVING	2005				7cfe4d7d-392d-4612-a29a-80ddafdfcbd0				TCGA-61-2017-01A-01D-0667-05		TCGA-61-2017-01A-21-1559-20			TCGA-61-2017-01A-01D-0663-01	TCGA-61-2017-01	62d181c0-c0fb-44b3-9837-040f5780c2ff		TCGA-61-2017-01A-01D-0663-01					TCGA-61-2017-01				TCGA-61-2017-01A-01R-0670-07	
TCGA-61-2018-01	0	TCGA-61-2018-01	1381	0	days	High		OV-like c1	OV-like c4					TCGA-61-2018			days	1381	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Bilateral	TCGA-61-2018-F28366	TCGA-61-2018	TCGA-61-2018-01A	Stage IC	-22929			0	1381						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.9		NO	G3						TCGA-61-2018.2aec8abd-7bdc-4ca3-a404-7dce57aea7c7.pdf	2018		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			61	No Macroscopic disease	Ovary	NO	A	LIVING	2005				a13bb1ee-868f-4891-921f-d0005ebe1ab8				TCGA-61-2018-01A-01D-0667-05		TCGA-61-2018-01A-21-1559-20			TCGA-61-2018-01A-01D-0663-01	TCGA-61-2018-01	99bf9379-737b-4b8c-9196-2c1fa0148eae		TCGA-61-2018-01A-01D-0663-01					TCGA-61-2018-01				TCGA-61-2018-01A-01R-0670-07	
TCGA-61-2087-01	0	TCGA-61-2087-01	146	0	days	High		OV-like c1	OV-like c4					TCGA-61-2087			days	146	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			49	Left	TCGA-61-2087-F28372	TCGA-61-2087		Stage IC	-18182			0	146						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							NO	G3							2087		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				61	No Macroscopic disease	Ovary	NO		LIVING	2009				a60b189b-6316-4098-adc7-fefca69b803b				TCGA-61-2087-01A-01D-0667-05		TCGA-61-2087-01A-21-1560-20			TCGA-61-2087-01A-01D-0663-01	TCGA-61-2087-01	b59fdd2e-4ec7-4e64-95fd-f5777ecdc89b		TCGA-61-2087-01A-01D-0663-01					TCGA-61-2087-01				TCGA-61-2087-01A-01R-0670-07	
TCGA-61-2088-01	0	TCGA-61-2088-01	145	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-61-2088			days	145	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			51	Bilateral	TCGA-61-2088-F28377	TCGA-61-2088	TCGA-61-2088-01A	Stage IIIC	-18770			0	145						2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.4		NO	G3						TCGA-61-2088.62624308-45b6-46f3-85a0-5a4639b44bf3.pdf	2088		TUMOR FREE	YES			NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2009	TCGA-61-2088-01	TCGA-61-2088-01		9959458a-de14-4d2d-b13f-9ab2f0c88bf1		TCGA-61-2088-01		TCGA-61-2088-01A-01D-0667-05		TCGA-61-2088-01A-21-1560-20		62fdea50-f152-4f43-9130-a93079b5e61f	TCGA-61-2088-01A-01D-0663-01	TCGA-61-2088-01	2b716c21-1692-4b95-9363-0c6a23de28d6		TCGA-61-2088-01A-01D-0663-01	62fdea50-f152-4f43-9130-a93079b5e61f		62fdea50-f152-4f43-9130-a93079b5e61f		TCGA-61-2088-01	TCGA-61-2088-01	62fdea50-f152-4f43-9130-a93079b5e61f	TCGA-61-2088-01A-01W-0722-08	TCGA-61-2088-01A-01R-0670-07	
TCGA-61-2092-01	0	TCGA-61-2092-01	1573	0	days	BRCA-LUAD+	C9-OV	UCEC non-CIMP c3	OV-like c4	COADREAD-like c15	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2092			days	1573	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			57	Bilateral	TCGA-61-2092-F28381	TCGA-61-2092	TCGA-61-2092-01A	Stage IIIC	-21072			0	1573						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.2	NO		1.3		NO	G3						TCGA-61-2092.35b4bfa3-e6a5-4b55-a7f1-bc39953422c0.pdf	2092		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2004	TCGA-61-2092-01	TCGA-61-2092-01		cf1288eb-e5c8-4c90-9f83-f3bdcbd94a96		TCGA-61-2092-01		TCGA-61-2092-01A-01D-0667-05		TCGA-61-2092-01A-21-1560-20		0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	TCGA-61-2092-01A-01D-0663-01	TCGA-61-2092-01	94487130-5cc1-4f68-beab-57c211204449		TCGA-61-2092-01A-01D-0663-01	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a		0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	TCGA-61-2092-01A-01W-0722-08	TCGA-61-2092-01	TCGA-61-2092-01	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	TCGA-61-2092-01A-01W-0722-08	TCGA-61-2092-01A-01R-0670-07	
TCGA-61-2094-01	0	TCGA-61-2094-01	2182	0	days	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-2094			days	2182	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			63	Bilateral	TCGA-61-2094-F28385	TCGA-61-2094	TCGA-61-2094-01A	Stage IIIC	-23273			0	2182						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		2			G3						TCGA-61-2094.205b0520-854c-480e-881d-89bc8cbcff75.pdf	2094		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.3			61		Ovary		A	LIVING	2003	TCGA-61-2094-01	TCGA-61-2094-01		1429ef11-964e-4e8b-afbb-8f38b75ad39f		TCGA-61-2094-01		TCGA-61-2094-01A-01D-0667-05		TCGA-61-2094-01A-21-1560-20		c6e1c591-3225-482a-8350-112b664a37e6	TCGA-61-2094-01A-01D-0663-01	TCGA-61-2094-01	1ac0ed16-0e91-4c45-9b9d-b68ceb9940da		TCGA-61-2094-01A-01D-0663-01	c6e1c591-3225-482a-8350-112b664a37e6		c6e1c591-3225-482a-8350-112b664a37e6	TCGA-61-2094-01A-01W-0722-08	TCGA-61-2094-01	TCGA-61-2094-01	c6e1c591-3225-482a-8350-112b664a37e6	TCGA-61-2094-01A-01W-0722-08	TCGA-61-2094-01A-01R-0670-07	
TCGA-61-2095-01	1	TCGA-61-2095-01	1875	1	days	Kirc+	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-61-2095			days	1875	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-61-2095-F28389	TCGA-61-2095	TCGA-61-2095-01A	Stage IIIC	-19797		1875	0			445				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G2	Recurrence					TCGA-61-2095.3e08408b-b76a-4a32-b3f1-4590459f4af8.pdf	2095		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2003	TCGA-61-2095-01	TCGA-61-2095-01		5229ff68-9cae-49dc-aba8-757026e6e452		TCGA-61-2095-01		TCGA-61-2095-01A-01D-0667-05		TCGA-61-2095-01A-21-1560-20		15a11ef0-5e18-44d0-ba50-73cf356b8408	TCGA-61-2095-01A-01D-0663-01	TCGA-61-2095-01	74a1f15a-05c4-4d85-a731-9a4e5281f644		TCGA-61-2095-01A-01D-0663-01	15a11ef0-5e18-44d0-ba50-73cf356b8408		15a11ef0-5e18-44d0-ba50-73cf356b8408	TCGA-61-2095-01A-01W-0722-08	TCGA-61-2095-01	TCGA-61-2095-01	15a11ef0-5e18-44d0-ba50-73cf356b8408	TCGA-61-2095-01A-01W-0722-08	TCGA-61-2095-01A-01R-0670-07	
TCGA-61-2095-02	1	TCGA-61-2095-02	1875	1	days		C9-OV	OV-like c1					mutation c1uster 9	TCGA-61-2095			days	1875	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	54	Bilateral	TCGA-61-2095-F28389	TCGA-61-2095	TCGA-61-2095-02A	Stage IIIC	-19797		1875	0			445				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G2	Recurrence					TCGA-61-2095.309AA9DC-F958-45C3-B596-362ADA553B8C.pdf	2095		WITH TUMOR	YES	Complete Remission/Response	Imaging Study	NO		Recurrent Tumor	02	0.3			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2003				9105d49a-b3ca-4453-95c7-3bb78b3e9e80				TCGA-61-2095-02A-01D-0807-05																		TCGA-61-2095-02A-01R-0810-07	
TCGA-61-2096-01	0	TCGA-61-2096-01	1776	0	days	Squamous		OV-like c1	OV-like c4					TCGA-61-2096			days	1776	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	56	Right	TCGA-61-2096-F28398	TCGA-61-2096	TCGA-61-2096-01A	Stage IC	-20663			0	1776		421				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G2	Recurrence					TCGA-61-2096.9f95fe7d-4865-4ca5-bb57-9d47c388a7ed.pdf	2096		TUMOR FREE	YES	Progressive Disease	Imaging Study	NO		Primary Tumor	01	0.5			61	No Macroscopic disease	Ovary		A	LIVING	2003				9497f7ac-b177-401b-a063-6297f90f009c				TCGA-61-2096-01A-01D-0667-05		TCGA-61-2096-01A-21-1560-20			TCGA-61-2096-01A-01D-0663-01	TCGA-61-2096-01	91b0b079-17b3-4c29-9ebd-1781ae28c86a		TCGA-61-2096-01A-01D-0663-01					TCGA-61-2096-01				TCGA-61-2096-01A-01R-0670-07	
TCGA-61-2097-01	0	TCGA-61-2097-01	1844	0	days	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2097			days	1844	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			71	Bilateral	TCGA-61-2097-F28413	TCGA-61-2097		Stage IIC	-25961			0	1844						2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection							YES	G2							2097		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01				61	1-10 mm	Ovary	YES		LIVING	2003	TCGA-61-2097-01	TCGA-61-2097-01		c1da73c7-9f61-41b6-90a1-fdc7bbf4ecd3		TCGA-61-2097-01		TCGA-61-2097-01A-02D-0667-05				d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	TCGA-61-2097-01A-02D-0663-01	TCGA-61-2097-01			TCGA-61-2097-01A-02D-0663-01	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1		d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	TCGA-61-2097-01A-02W-0722-08	TCGA-61-2097-01	TCGA-61-2097-01	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	TCGA-61-2097-01A-02W-0722-08	TCGA-61-2097-01A-02R-0670-07	
TCGA-61-2098-01	0	TCGA-61-2098-01	1993	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-61-2098			days	1993	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			62	Bilateral	TCGA-61-2098-F28418	TCGA-61-2098	TCGA-61-2098-01A	Stage IIIC	-22876			0	1993						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.7	NO		2			G2						TCGA-61-2098.d1c8ab49-5ba0-46c3-8205-53b4e39808b3.pdf	2098		TUMOR FREE	YES	Complete Remission/Response		NO		Primary Tumor	01	0.5			61	11-20 mm	Ovary	NO	A	LIVING	2003	TCGA-61-2098-01	TCGA-61-2098-01		0a007e29-e769-44ca-b0a8-465df5d46f4e		TCGA-61-2098-01		TCGA-61-2098-01A-01D-0667-05		TCGA-61-2098-01A-21-1560-20		d855f86a-f302-47fb-aa9f-5977632c695a	TCGA-61-2098-01A-01D-0663-01	TCGA-61-2098-01	f69ce3d8-2a32-4048-a786-50d7e153c051		TCGA-61-2098-01A-01D-0663-01	d855f86a-f302-47fb-aa9f-5977632c695a		d855f86a-f302-47fb-aa9f-5977632c695a		TCGA-61-2098-01	TCGA-61-2098-01	d855f86a-f302-47fb-aa9f-5977632c695a		TCGA-61-2098-01A-01R-0670-07	
TCGA-61-2101-01	1	TCGA-61-2101-01	1688	1	days	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2101			days	1688	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Bilateral	TCGA-61-2101-F28422	TCGA-61-2101	TCGA-61-2101-01A	Stage IIIC	-20287		1688	0				0			2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO	100	1.5			G2						TCGA-61-2101.b9d85995-85dd-4b00-b93f-3387cd018475.pdf	2101	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		NO		Primary Tumor	01	0.4			61	11-20 mm	Ovary		A	DECEASED	1999	TCGA-61-2101-01	TCGA-61-2101-01		504e1539-a518-4ef6-90b0-4ec6cd2ffbe8		TCGA-61-2101-01		TCGA-61-2101-01A-01D-0667-05		TCGA-61-2101-01A-21-1560-20		95970bdb-e1f2-49dc-903b-c30088cef71d	TCGA-61-2101-01A-01D-0663-01	TCGA-61-2101-01	c33bc4d6-607a-425b-bffd-e818b69949f8		TCGA-61-2101-01A-01D-0663-01	95970bdb-e1f2-49dc-903b-c30088cef71d		95970bdb-e1f2-49dc-903b-c30088cef71d	TCGA-61-2101-01A-01W-0722-08	TCGA-61-2101-01	TCGA-61-2101-01	95970bdb-e1f2-49dc-903b-c30088cef71d	TCGA-61-2101-01A-01W-0722-08	TCGA-61-2101-01A-01R-0670-07	
TCGA-61-2102-01	1	TCGA-61-2102-01	197	1	days	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-61-2102			days	197	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			74	Right	TCGA-61-2102-F28438	TCGA-61-2102	TCGA-61-2102-01A	Stage IIIC	-27256		197	0	197						2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.5			G3						TCGA-61-2102.f0521e47-1cc3-4f72-9efd-3d128f57e614.pdf	2102		WITH TUMOR	YES			NO		Primary Tumor	01	0.3			61		Ovary		A	DECEASED	1999	TCGA-61-2102-01	TCGA-61-2102-01		5b4f1e0c-f04d-4aa1-a794-5936189506d7		TCGA-61-2102-01		TCGA-61-2102-01A-01D-0667-05		TCGA-61-2102-01A-21-1560-20		7ac6af79-c14a-4026-84aa-a288afcb96da	TCGA-61-2102-01A-01D-0663-01	TCGA-61-2102-01	0f492d79-0174-4e9f-8693-2827ba83fd7c		TCGA-61-2102-01A-01D-0663-01	7ac6af79-c14a-4026-84aa-a288afcb96da		7ac6af79-c14a-4026-84aa-a288afcb96da	TCGA-61-2102-01A-01W-0722-08	TCGA-61-2102-01	TCGA-61-2102-01	7ac6af79-c14a-4026-84aa-a288afcb96da	TCGA-61-2102-01A-01W-0722-08	TCGA-61-2102-01A-01R-0670-07	
TCGA-61-2104-01	0	TCGA-61-2104-01	2338	0	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2104			days	2338	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Bilateral	TCGA-61-2104-F28442	TCGA-61-2104	TCGA-61-2104-01A	Stage IIC	-19432			0	2338		1680				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G2	Recurrence					TCGA-61-2104.38d2e115-ec9a-40e5-bfa0-30fb1db60691.pdf	2104			YES	Complete Remission/Response	Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2003	TCGA-61-2104-01	TCGA-61-2104-01		28510e09-fb60-4595-802a-48b0aafc09b9		TCGA-61-2104-01		TCGA-61-2104-01A-01D-0667-05		TCGA-61-2104-01A-21-1560-20		721a8fc8-bb54-4ec3-a19c-340c35f05280	TCGA-61-2104-01A-01D-0663-01	TCGA-61-2104-01	14d97fdf-fcf4-4471-8595-4b6b5401caf6		TCGA-61-2104-01A-01D-0663-01	721a8fc8-bb54-4ec3-a19c-340c35f05280		721a8fc8-bb54-4ec3-a19c-340c35f05280	TCGA-61-2104-01A-01W-0722-08	TCGA-61-2104-01	TCGA-61-2104-01	721a8fc8-bb54-4ec3-a19c-340c35f05280	TCGA-61-2104-01A-01W-0722-08	TCGA-61-2104-01A-01R-0670-07	
TCGA-61-2109-01	1	TCGA-61-2109-01	629	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2109			days	629	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2109-F28450	TCGA-61-2109	TCGA-61-2109-01A	Stage IIIC	-14900		629	0	629		465				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.7		NO	G3	Recurrence					TCGA-61-2109.c16bfe93-016f-49d4-8895-05b9055344c9.pdf	2109		WITH TUMOR	YES		Molecular Markers	NO		Primary Tumor	01	0.2			61	>20 mm	Ovary	NO	A	DECEASED	1999	TCGA-61-2109-01	TCGA-61-2109-01		37fc46df-f46d-462f-8761-d82c66b8a3a1		TCGA-61-2109-01		TCGA-61-2109-01A-01D-0667-05		TCGA-61-2109-01A-21-1560-20		c87ddfc3-d7a4-4704-b3cc-a19edfb63452	TCGA-61-2109-01A-01D-0663-01	TCGA-61-2109-01	d3e2505d-0838-4a9c-a626-ad04f9254dd1		TCGA-61-2109-01A-01D-0663-01	c87ddfc3-d7a4-4704-b3cc-a19edfb63452		c87ddfc3-d7a4-4704-b3cc-a19edfb63452	TCGA-61-2109-01A-01W-0722-08	TCGA-61-2109-01	TCGA-61-2109-01	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	TCGA-61-2109-01A-01W-0722-08	TCGA-61-2109-01A-01R-0670-07	
TCGA-61-2110-01	1	TCGA-61-2110-01	1354	1	days	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-61-2110			days	1354	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	56	Bilateral	TCGA-61-2110-F28456	TCGA-61-2110	TCGA-61-2110-01A	Stage IIIC	-20718		1354	0	1354		213				2009-12-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		0.4				Recurrence					TCGA-61-2110.d7a597dc-d607-4e20-90a9-a181d6c11d17.pdf	2110		WITH TUMOR	YES	Progressive Disease	First Seen At Further Surgery	NO		Primary Tumor	01	0.1			61	No Macroscopic disease	Ovary		A	DECEASED	1998	TCGA-61-2110-01	TCGA-61-2110-01		8f17192c-1ecb-4f31-8df0-a6dde0b8ce96		TCGA-61-2110-01		TCGA-61-2110-01A-01D-0667-05				6561cdb8-8499-41a6-8a79-ef0119e34c66	TCGA-61-2110-01A-01D-0663-01	TCGA-61-2110-01			TCGA-61-2110-01A-01D-0663-01	6561cdb8-8499-41a6-8a79-ef0119e34c66		6561cdb8-8499-41a6-8a79-ef0119e34c66	TCGA-61-2110-01A-01W-0722-08	TCGA-61-2110-01	TCGA-61-2110-01	6561cdb8-8499-41a6-8a79-ef0119e34c66	TCGA-61-2110-01A-01W-0722-08	TCGA-61-2110-01A-01R-0670-07	
TCGA-61-2111-01	0	TCGA-61-2111-01	3825	0	days	Squamous	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA c1uster 10	cluster 5	mutation cluster 5	TCGA-61-2111			days	3825	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	61	Left	TCGA-61-2111-F28467	TCGA-61-2111	TCGA-61-2111-01A	Stage IV	-22517			0	3825		2205				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.4	NO		1.5			G3	Recurrence					TCGA-61-2111.351930bc-ac4d-468e-9fe2-ba6f16c01444.pdf	2111		WITH TUMOR	YES	Complete Remission/Response	Other Method	NO		Primary Tumor	01	0.3			61		Ovary		A	LIVING	1998	TCGA-61-2111-01	TCGA-61-2111-01		3ee05aa8-a556-4d87-8aab-a76491d30640		TCGA-61-2111-01		TCGA-61-2111-01A-01D-0667-05		TCGA-61-2111-01A-21-1560-20		25c0888a-25b9-4cc0-a02f-6d363a341e8f	TCGA-61-2111-01A-01D-0663-01	TCGA-61-2111-01	975fb889-32f1-46e2-a558-b32d8a1b353f		TCGA-61-2111-01A-01D-0663-01	25c0888a-25b9-4cc0-a02f-6d363a341e8f		25c0888a-25b9-4cc0-a02f-6d363a341e8f	TCGA-61-2111-01A-01W-0722-08	TCGA-61-2111-01	TCGA-61-2111-01	25c0888a-25b9-4cc0-a02f-6d363a341e8f	TCGA-61-2111-01A-01W-0722-08	TCGA-61-2111-01A-01R-0670-07	
TCGA-61-2113-01	1	TCGA-61-2113-01	676	1	days	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-61-2113			days	676	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	53	Right	TCGA-61-2113-F28479	TCGA-61-2113	TCGA-61-2113-01A	Stage IIC	-19722		676	0	676		291				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6		YES	G3	Recurrence					TCGA-61-2113.d10e1b61-73c4-4ab7-bc4b-8c7827856602.pdf	2113			YES			NO		Primary Tumor	01	0.4			61		Ovary	YES	A	DECEASED	1999	TCGA-61-2113-01	TCGA-61-2113-01		9467c678-f573-4a50-83d9-ae3a0880354b		TCGA-61-2113-01		TCGA-61-2113-01A-01D-0667-05		TCGA-61-2113-01A-21-1562-20		d5752594-1a2c-47c8-a40b-bffd5b6b7e71	TCGA-61-2113-01A-01D-0663-01	TCGA-61-2113-01	a8827db2-9eab-4285-bf50-ab2b9e19be57		TCGA-61-2113-01A-01D-0663-01	d5752594-1a2c-47c8-a40b-bffd5b6b7e71		d5752594-1a2c-47c8-a40b-bffd5b6b7e71	TCGA-61-2113-01A-01W-0722-08	TCGA-61-2113-01	TCGA-61-2113-01	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	TCGA-61-2113-01A-01W-0722-08	TCGA-61-2113-01A-01R-0670-07	
TCGA-61-2610-01	1	TCGA-61-2610-01	1579	1	days				OV-like c4					TCGA-61-2610			days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Left	TCGA-61-2610-F28484	TCGA-61-2610	TCGA-61-2610-01A	Stage IIIC	-22481		1579	0	1579		524				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence					TCGA-61-2610.a5914371-94ab-4079-a6ea-11c79e9db4a1.pdf	2610		WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R1	Primary Tumor	01	0.4			61	11-20 mm	Ovary		A	DECEASED	1998										TCGA-61-2610-01A-21-20					a3cbaeb1-63e7-4818-aa6b-ce817827231b												
TCGA-61-2610-02	1	TCGA-61-2610-02	1579	1	days			OV-like c1						TCGA-61-2610			days	1579	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	YES	61	Left	TCGA-61-2610-F28484	TCGA-61-2610	TCGA-61-2610-02A	Stage IIIC	-22481		1579	0	1579		524				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G3	Recurrence					TCGA-61-2610.361A67F5-2116-457D-988A-5B1E5D1A689B.pdf	2610		WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R1	Recurrent Tumor	02	0.3			61	11-20 mm	Ovary		A	DECEASED	1998				30ed8178-1e57-4d4e-af54-ea8097a33bbe				TCGA-61-2610-02A-01D-1138-05			TCGA-61-2610-02A-01W-1092-09															TCGA-61-2610-02A-01R-1141-07	
TCGA-61-2611-02	1	TCGA-61-2611-02	483	1	days			Low purity c2						TCGA-61-2611			days	483	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	40	Bilateral	TCGA-61-2611-F28491	TCGA-61-2611	TCGA-61-2611-02A	Stage IIIC	-14782		483	0	483		383				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		0.7			G3	Recurrence					TCGA-61-2611.29965B48-14CA-467F-B825-8BC99A99544B.pdf	2611		WITH TUMOR	YES	Complete Remission/Response	First Seen At Further Surgery	NO	R1	Recurrent Tumor	02	0.3			61	1-10 mm	Ovary	YES	A	DECEASED	2008				2983d372-ea74-4ceb-a26e-7b4e6a8acf8f				TCGA-61-2611-02A-01D-1138-05			TCGA-61-2611-02A-01W-1092-09															TCGA-61-2611-02A-01R-1141-07	
TCGA-61-2612-01	1	TCGA-61-2612-01	193	1	days	High		OV-like c1	OV-like c4					TCGA-61-2612			days	193	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	63	Bilateral	TCGA-61-2612-F28496	TCGA-61-2612	TCGA-61-2612-01A	Stage IIIC	-23074		193	0	193		179				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		2	NO		2.5		YES	G3	Recurrence					TCGA-61-2612.48d32d40-9eef-43d2-beb6-75fcc071c52b.pdf	2612		WITH TUMOR	YES	Stable Disease	First Seen At Further Surgery	NO	R1	Primary Tumor	01	0.4			61	1-10 mm	Ovary	YES	A	DECEASED	2002				9b739900-7aff-4e27-aa8b-5feaaaa77247				TCGA-61-2612-01A-01D-1138-05		TCGA-61-2612-01A-21-20	TCGA-61-2612-01A-01W-1092-09		TCGA-61-2612-01A-01D-1134-01	TCGA-61-2612-01	7055e7b7-38bb-4fe4-841b-1419a6273bad		TCGA-61-2612-01A-01D-1134-01					TCGA-61-2612-01				TCGA-61-2612-01A-01R-1141-07	
TCGA-61-2613-01	1	TCGA-61-2613-01	945	1	days	Squamous		OV-like c1	OV-like c4					TCGA-61-2613			days	945	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	73	Bilateral	TCGA-61-2613-F28500	TCGA-61-2613	TCGA-61-2613-01A	Stage IIIC	-26779		945	0	945		358				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1			G3	Recurrence					TCGA-61-2613.6d7a40b1-02f0-4d7e-b3e2-e467e404a241.pdf	2613		WITH TUMOR	YES	Stable Disease	Imaging Study	NO	R1	Primary Tumor	01	0.3			61	11-20 mm	Ovary		A	DECEASED	1998				4f3e6b8b-2c5b-4c59-aca0-d3a6b7ee46b5				TCGA-61-2613-01A-01D-1138-05		TCGA-61-2613-01A-21-20	TCGA-61-2613-01A-01W-1092-09		TCGA-61-2613-01A-01D-1134-01	TCGA-61-2613-01	fce6b5fb-7b97-4af7-a919-0215363156f0		TCGA-61-2613-01A-01D-1134-01					TCGA-61-2613-01				TCGA-61-2613-01A-01R-1141-07	
TCGA-61-2614-01	1	TCGA-61-2614-01	262	1	days	High		OV-like c1	OV-like c4					TCGA-61-2614			days	262	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary	YES	NO	71	Bilateral	TCGA-61-2614-F28505	TCGA-61-2614	TCGA-61-2614-01A	Stage IIIC	-26142		262	0	262		38				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		0.4	NO		1.6		YES	G3	Recurrence					TCGA-61-2614.d0ffe1e5-5b41-4dfb-b82d-da937b5b345b.pdf	2614		WITH TUMOR	NO	Stable Disease	Imaging Study	NO	R1	Primary Tumor	01	0.3			61	1-10 mm	Ovary	YES	A	DECEASED	2007				59193352-8a67-49d4-9ca0-430c36fe0d12				TCGA-61-2614-01A-01D-1138-05		TCGA-61-2614-01A-21-20	TCGA-61-2614-01A-01W-1092-09		TCGA-61-2614-01A-01D-1134-01	TCGA-61-2614-01	81ab2618-ccb2-4a64-bab2-83e69633defe		TCGA-61-2614-01A-01D-1134-01					TCGA-61-2614-01				TCGA-61-2614-01A-01R-1141-07	
TCGA-72-4231-01		TCGA-72-4231-01			days			OV-like c1						TCGA-72-4231			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4231-01A																						0.3	NO		0.5																		Primary Tumor	01	0.1							A										TCGA-72-4231-01A-01D-1011-05					TCGA-72-4231-01A-01D-1017-01				TCGA-72-4231-01A-01D-1017-01										
TCGA-72-4232-01		TCGA-72-4232-01			days			OV-like c1						TCGA-72-4232			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4232-01A																						0.5	NO		0.6																		Primary Tumor	01	0.1							A										TCGA-72-4232-01A-01D-1011-05					TCGA-72-4232-01A-01D-1017-01				TCGA-72-4232-01A-01D-1017-01										
TCGA-72-4233-01		TCGA-72-4233-01			days			OV-like c1						TCGA-72-4233			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4233-01A																						0.3	NO		0.5																		Primary Tumor	01	0.1							A										TCGA-72-4233-01A-01D-1011-05					TCGA-72-4233-01A-01D-1017-01				TCGA-72-4233-01A-01D-1017-01										
TCGA-72-4234-01		TCGA-72-4234-01			days			OV-like c1						TCGA-72-4234			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4234-01A																						0.2	NO		1.2																		Primary Tumor	01	0.1							A										TCGA-72-4234-01A-01D-1011-05					TCGA-72-4234-01A-01D-1017-01				TCGA-72-4234-01A-01D-1017-01										
TCGA-72-4235-01		TCGA-72-4235-01			days			OV-like c1						TCGA-72-4235			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4235-01A																						0.6	NO		1																		Primary Tumor	01	0.1							A										TCGA-72-4235-01A-01D-1011-05					TCGA-72-4235-01A-01D-1017-01				TCGA-72-4235-01A-01D-1017-01										
TCGA-72-4236-01		TCGA-72-4236-01			days			OV-like c1						TCGA-72-4236			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4236-01A																						0.2	NO		0.4																		Primary Tumor	01	0.1							A										TCGA-72-4236-01A-01D-1011-05					TCGA-72-4236-01A-01D-1017-01				TCGA-72-4236-01A-01D-1017-01										
TCGA-72-4237-01		TCGA-72-4237-01			days			OV-like c1						TCGA-72-4237			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4237-01A																						0.3	NO		1.5																		Primary Tumor	01	0.1							A										TCGA-72-4237-01A-01D-1011-05					TCGA-72-4237-01A-01D-1017-01				TCGA-72-4237-01A-01D-1017-01										
TCGA-72-4238-01		TCGA-72-4238-01			days			OV-like c1						TCGA-72-4238			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4238-01A																						0.4	NO		1.5																		Primary Tumor	01	0.1							A										TCGA-72-4238-01A-01D-1011-05					TCGA-72-4238-01A-01D-1017-01				TCGA-72-4238-01A-01D-1017-01										
TCGA-72-4240-01		TCGA-72-4240-01			days			OV-like c1						TCGA-72-4240			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4240-01A																						1	NO		1																		Primary Tumor	01	0.1							A										TCGA-72-4240-01A-01D-1011-05					TCGA-72-4240-01A-01D-1017-01				TCGA-72-4240-01A-01D-1017-01										
TCGA-72-4241-01		TCGA-72-4241-01			days			OV-like c1						TCGA-72-4241			days		days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary							TCGA-72-4241-01A																						0.3	NO		2																		Primary Tumor	01	0.1							A										TCGA-72-4241-01A-01D-1011-05					TCGA-72-4241-01A-01D-1017-01				TCGA-72-4241-01A-01D-1017-01										
TCGA-OY-A56P-01	0	TCGA-OY-A56P-01	1207	0	days									TCGA-OY-A56P			days	1207	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			48	Right	TCGA-OY-A56P-F56664	TCGA-OY-A56P	TCGA-OY-A56P-01A	Stage IIIB	-17580	796		0	1207				Scheduled Follow-up Submission	Stable Disease	2014-2-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Tumor resection	390		NO			NO	NO	G3			YES	false	No	TCGA-OY-A56P.D916ED58-54D5-43FC-A5B0-6E4844A7F677.pdf	A56P		WITH TUMOR	YES	Complete Remission/Response		NO	R2	Primary Tumor	01		YES	NO	OY	1-10 mm	Ovary	NO	A	LIVING	2010	TCGA-OY-A56P-01	TCGA-OY-A56P-01			TCGA-OY-A56P-01A-12D-A409-05	TCGA-OY-A56P-01						05689fed-96dd-4c52-b51d-5dc799422b9a	TCGA-OY-A56P-01A-12D-A402-01		31FB79CF-D6E4-48CF-8EFD-45A81701E359	TCGA-OY-A56P-01A-12R-A406-31	TCGA-OY-A56P-01A-12D-A402-01	05689fed-96dd-4c52-b51d-5dc799422b9a	TCGA-OY-A56P-01A-12R-A406-31	05689fed-96dd-4c52-b51d-5dc799422b9a			TCGA-OY-A56P-01	05689fed-96dd-4c52-b51d-5dc799422b9a			
TCGA-OY-A56Q-01	0	TCGA-OY-A56Q-01	576	0	days									TCGA-OY-A56Q	576	0	days	576	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			78	Left	TCGA-OY-A56Q-F57585	TCGA-OY-A56Q	TCGA-OY-A56Q-01A	Stage IIA	-28623	120		0	576				Scheduled Follow-up Submission	Complete Remission/Response	2014-3-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	370		NO			NO	NO	G3			NO	false	No	TCGA-OY-A56Q.3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D.pdf	A56Q		TUMOR FREE	YES	Complete Remission/Response		NO	RX	Primary Tumor	01		YES	NO	OY	No Macroscopic disease	Ovary	NO	A	LIVING	2012	TCGA-OY-A56Q-01	TCGA-OY-A56Q-01			TCGA-OY-A56Q-01A-11D-A409-05	TCGA-OY-A56Q-01						3a1867ff-7c1e-47c1-854f-90c0af4b2d03	TCGA-OY-A56Q-01A-11D-A402-01		7029EE0E-6B69-4B6F-8648-FA831B7B70A5	TCGA-OY-A56Q-01A-11R-A406-31	TCGA-OY-A56Q-01A-11D-A402-01	3a1867ff-7c1e-47c1-854f-90c0af4b2d03	TCGA-OY-A56Q-01A-11R-A406-31	3a1867ff-7c1e-47c1-854f-90c0af4b2d03			TCGA-OY-A56Q-01	3a1867ff-7c1e-47c1-854f-90c0af4b2d03			
TCGA-VG-A8LO-01	1	TCGA-VG-A8LO-01	24	1	days									TCGA-VG-A8LO	24	0	days	24	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			55	Right		TCGA-VG-A8LO	TCGA-VG-A8LO-01A	Stage IV	-20274	122	24	0				4			2014-3-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Excisional Biopsy	260		NO	50				GB			NO	false	No	TCGA-VG-A8LO.6FF4C359-F127-44E6-A1A2-641D60A3665F.pdf	A8LO	Other	WITH TUMOR	YES			NO	R2	Primary Tumor	01		YES	NO	VG	>20 mm	Ovary		A	DECEASED	2013	TCGA-VG-A8LO-01	TCGA-VG-A8LO-01			TCGA-VG-A8LO-01A-11D-A409-05	TCGA-VG-A8LO-01						fbad0ba1-131d-48af-9957-e9ca56f54e84	TCGA-VG-A8LO-01A-11D-A402-01		0AA665F9-6A46-4A4C-B2E1-11D8EE17B447	TCGA-VG-A8LO-01A-11R-A406-31	TCGA-VG-A8LO-01A-11D-A402-01	fbad0ba1-131d-48af-9957-e9ca56f54e84	TCGA-VG-A8LO-01A-11R-A406-31	fbad0ba1-131d-48af-9957-e9ca56f54e84			TCGA-VG-A8LO-01	fbad0ba1-131d-48af-9957-e9ca56f54e84			
TCGA-WR-A838-01	1	TCGA-WR-A838-01	304	1	days									TCGA-WR-A838	304	0	days	304	days	TCGA Ovarian Cancer (OV)	ovarian serous cystadenocarcinoma	Ovary			72	Right	TCGA-WR-A838-F66184	TCGA-WR-A838	TCGA-WR-A838-01A	Stage IIIC	-26418	110	304	0	245		245	1	Scheduled Follow-up Submission	Progressive Disease	2014-10-3	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection	200		NO			NO	YES	G3	Progression of Disease		NO	false	No	TCGA-WR-A838.8F364931-727D-4099-A1D2-E96C61461479.pdf	A838	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		NO		Primary Tumor	01		NO	YES	WR		Ovary	YES	A	DECEASED	2013	TCGA-WR-A838-01	TCGA-WR-A838-01			TCGA-WR-A838-01A-12D-A409-05	TCGA-WR-A838-01						010e9bf0-b7a0-4c68-b028-90299840fbaf	TCGA-WR-A838-01A-12D-A402-01		95C1EF06-FB7C-4817-86A5-1E608DDA7102	TCGA-WR-A838-01A-12R-A406-31	TCGA-WR-A838-01A-12D-A402-01	010e9bf0-b7a0-4c68-b028-90299840fbaf	TCGA-WR-A838-01A-12R-A406-31	010e9bf0-b7a0-4c68-b028-90299840fbaf			TCGA-WR-A838-01	010e9bf0-b7a0-4c68-b028-90299840fbaf			
